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The self sufficient class HI monooxygenase, flavocytochrome P450 BM3, from 
Bacillus megaterium, is a heme containing redox enzyme that catalyses the hydroxylation of 
long-chain fatty acids. Flavocytochrome P450 BM3 contains several active-site residues 
that are highly conserved throughout the P450 superfamily. Of these, a phenylalanine 
(Phe393) has been shown to modulate the heme reduction potential (E m) across a 200 
mV range via interactions with the implicitly conserved heme-ligand cysteine. In 
addition, a distal threonine (Thr268) has been implicated in a variety of roles 
including proton donation, oxygen activation and substrate recognition. Substrate 
binding in P450 BM3 causes a shift in the spin state from low- to high-spin. This 
change in spin-state is accompanied by a positive shift in the reduction potential (AE m 
[WT + arachidonate (120 AM)] = +138 mV). Substitution of Thr268 by alanine or 
asparagine causes a significant decrease in the ability of the enzyme to generate the 
high-spin complex via substrate binding and consequently leads to a decrease in the 
substrate-induced potential shift (AE.. [T268A + arachidonate (120 AM)] = +73 mV, 
LEm [T268N + arachidonate (120 AM)] = +9 mV). Rate constants for the first electron 
transfer and for oxy-ferrous decay were measured by pre-steady-state stopped-flow 
kinetics and found to be almost entirely dependant on the heme reduction potential. 
More positive reduction potentials lead to enhanced rate constants for heme reduction 
and more stable oxy-ferrous species. In addition, substitutions of the threonine lead to 
an increase in the production of hydrogen peroxide in preference to hydroxylated 
product. These results suggest an important role for this active-site threonine in 
substrate recognition and in maintaining an efficiently functioning enzyme. However, 
the dependence of the rate constants for oxy-ferrous decay on reduction potential 
raises questions as to the importance of Thr268 in iron-oxygen-complex stabilisation. 
v 
The substrate binding, oxygen binding and first-electron transfer steps in the 
P450 catalytic cycle have been extensively studied in many different P450 enzymes. 
However, the second electron-transfer step leads to the formation of highly reactive 
intermediate species and as such is difficult to characterise. Multi-mixing pre-steady-
state kinetics were used to first generate the oxy-ferrous complex and then inject the 
second electron by means of reduced methyl viologen (E m = -430 mV). Second 
electron-transfer rate constants were measured for wild type and an array of active site 
mutant enzymes incorporation multiple substitutions of F393 and T268 residues. The 
rate constants for second electron transfer (kred2) for WT, F39311, F393A, F393W and 
F393Y displayed an exponential dependence on heme reduction potential with more 
negative potentials favouring higher kred2 values. This is in direct contrast to kred 
values where more positive potentials favour higher kred values. P450 mutant enzymes 
incorporating substitutions of T268 exhibited kred2 values which were low and 
independent of reduction potential. It is likely in this instance that the k,&2  values are 
artificially low due to inhibition of the proton donating pathway. 
The crystal structure of the F393A mutant enzyme of P450 BM3 shows that a 
glutamine residue (Q403) 'flips' into the cavity previously filled by the phenylalanine 
sidechain, forming an intramolecular H-bond with the cysteine thiolate. Multiple 
substitutions of F393 and Q403 were unsuccessful in introducing a positive charge 
close to the heme ligating cysteine (C400). However, the Q403K enzyme displayed 
unusual kinetic traces, indicative of an inhibited FAD to FMN electron transfer. This 
perturbation was relieved by increasing ionic strength suggesting that the changes 














A Ala Methionine M Met 
C Cys Asparagine N Asn 
D Asp Proline P Pro 
E Glu Glutamine Q Gin 
F Phe Arginine R Arg 
G Gly Serine S Ser 
H His Threonine T Thr 
I Ile Valine V Vat 
K Lys Tryptophan W Trp 
L Leu Tyrosine Y Tyr 
Standard Units 
m 	Metre °C 	Celsius 
A 	Angstrom 1 	Litre 
g 	Gram V 	Volt 
S 	 Second M 	Molar 
Kinetic Parameters 
kcat 	Maximal turnover rate constant 
KM 	 Michaelis constant 
Kd 	Dissociation constant 
ksat 	Observed rate constant at saturating concentrations of substrate 
kri 	Rate constant for first-electron transfer 
vii 
kred2 	Rate constant for second-electron transfer 
kautox 	 Rate constant for oxy-ferrous decay 
kobs 	Observed rate constant 





CYP Cytochrome P450 
CPR Cytochrome P450 Reductase 
Da Dalton 
dH20 Deionised water 
DMSO Dimethyl Sulfoxide 
Extinction coefficient at wavelength x nm 
E. co/i Escherichia co/i 
EDTA Ethylenediaminetetraacetic acid 
Em Midpoint potential 
EPR Electron Paramagnetic Resonance 
FAD Flavin Adenine Dinucleotide 
FMN Flavin Mononucleotide 
AG Free energy change 
AG* 	 Activation energy 
hd 	 Heme Domain 
viii 
I Ionic Strength 
MLCT Metal to Ligand Charge Transfer 
MOPS 3-(morpholino)-propanesulfonic acid 
NADH 13-Nicotinamide adenine dinucleotide 
NADPH 13-Nicotinamide adenine dinucleotide phosphate 
NOS Nitric Oxide Synthase 
OTTLE Optically Transparent Thin Layer Electrode 
ox Oxidised 
P450 BM3 Cytochrome P450 monooxygenase from Bacillus megaterium 
P450cam Cytochrme P450 monooxygenase from Pseudomonas putida 
PDB Protein data bank 
PIPES Piperazine-N,N'-bis[2-ethanesulfonic cis] 
red Reduced 
SDS-PAGE Sodium dodecylsuiphate-polyacrylamide gel electrophoresis 
SHE Standard hydrogen electrode 
RMSD Root mean square deviation 
Tris Tris(hydroxyl)aminomethane 
UV Ultra Violet 
vis visible 
WT Wild type 
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Chapter 1: Introduction 
1. Introduction 
1.1 The Beginnings of P450 Research 
The first published work relating to P450 biochemistry was a study of xenobiotic 
metabolism in liver microsomes. In 1955, Axelrod [1] and Brodie et al. [2] identified an 
enzyme in the endoplasmic reticulum of liver which was capable of oxidising xenobiotic 
compounds such as ephedrine and monomethyl-4-aminoantipyrine. Subsequently, in 
1958 both Garfinkel [3] and Klingenberg [4] reported the existence of a novel 
microsomal pigment in rat-liver. This 'pigment' was found to bind carbon monoxide 
when reduced, forming a distinct absorbance peak at 450 nm. However, it was 
particularly difficult to solubilise and hence the nature of the pigment was not 
determined. The term 'cytochrome P450' (igment-40nm) was first coined by Omura 
and Sato in the 1960's [5-8]. They discovered that CO only had an affinity for the 
reduced form and that on treatment with ethylisocyanide, the P450 generated a difference 
spectrum similar to that of haemoglobin [7]. They used optical absorption spectra to 
identify the microsomal CO-binding pigment as a b-type heme and named it after the 
characteristic CO-bound spectral feature. Electron-spin resonance spectroscopy identified 
the P450 as a low-spin ferric hemoprotein with a thiol ligand which, to an extent, 
explained the unusual Soret peak and its perturbation on ligand binding [9-11]. 
It was not until 1963, that the function of the P450 enzymes was determined. 
Estabrook et al. [12] made the connection between the metabolism of 
17-hydroxy-progesterone, which was inhibited by the presence of CO [13], and the 
discovery of microsomal P450 enzymes which bound CO. They subsequently proved the 
involvement of P45 Os in 1 7-hydroxy-progesterone hydroxylation as well as the oxidation 
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of a variety of other xeniobiotics [14]. This discovery led to a rapid increase in interest in 
the P450s, with the number of cited publications increasing almost exponentially. Now, 
some 50 years after their initial discovery, the catalytic cycle is largely understood 
[15-16] and the structures of many P450s have been solved [17-20], including many in 
complex with ligands, substrates and inhibitors [21-25]. 
1.2 General Background 
The cytochromes P450 are a large and extensively studied family of b-type heme-
containing redox enzymes that catalyse mono-oxygenation reactions on a huge variety of 
substrates [26-28]. In general, the reaction scheme is represented as the insertion of a 
molecule of oxygen (derived from molecular oxygen) into an organic substrate with the 
other oxygen atom forming water with the addition of 2 electrons (derived from NADH 
or NADPH) and 2 protons (Figure 1.1). 
RH + 	+ 2W + 2e- 
P450 ROH + H20 
Figure 1.1: General reaction scheme for P450 catalysed mono-oxygenation 
reactions. 
The number of P450 enzymes identified by sequence comparison has increased 
almost exponentially since 1982 as seen in figure 1.2. At the time of this thesis, the 
current number of partial and full sequences was around 4500 although an up to date 
figure can be found on the website of Dr. David Nelson: 
http://uimem.edu/CvtochromeP450.html  [29]. The sequences come from all forms of life, 
with about 40 % originating from animals, 30 % from plants, 12% from 
3 
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Figure 1.2: The total number of P450 sequences identified by sequence homology 
from 1982 to 2005. 
fungi, 13 % from bacteria and 5 % from protists [29]. It should be noted however that this 
distribution is representative of the genomic sequences available and not necessarily the 
true spread of P450s throughout the natural world. Plants in particular contain a large 
number of P450s with the genomic sequence of Arabidopsis (Arabidopsis thaliana) 
indicating the presence of 273 individual P450 enzymes (about 1% of the total genome) 
[30] and the more recent genome of rice (Oryza saliva) showing the presence of over 450 
P450s [30]. Mammals also contain significant amounts of P450s with the human genome 
itself containing 58 [31-32]. It has been reported that mammalian P450 diversity has been 
largely defined [29, 31-32] and most new sequences are similar (in sequence at least) to 
those already discovered. However, plant, insect, bacterial and fungal genomes continue 
to show new families indicating that their full diversity has not yet been discovered [29- 
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30]. Whatever the case, the total number of P450s is certain to increase as more genomic 
sequences become available. 
1.3 Nomenclature 
The large number of enzymes in the P450 superfamily has necessitated a 
structured naming system. The convention for P450 nomenclature is shown in figure 1.3. 
Each P450 is first classified by gene family, then sub-family and finally the specific gene 
[33]. The dendrogram in figure 1.3 shows a small section of the P450 gene tree for the 
CYP6 and CYP9 families adapted from the web sit of Dr. D Nelson [29]. The first branch 







e.g. for CYP9A1 WO 
6*13 6*14 
CYP = cytochrome P450 
6*16 
9 = genetic family 684 0:2 6B6 

















Figure 1.3: Nomenclature of cytochrome P450 superfamily and section of a genetic 
tree for the P450 families 6 and 9. The first branch point represents the difference 
between the genetic families. The next branching points divide the enzymes 
according to sub-family and the final branch points denote the specific gene. 
5 
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denote sub-families (A-W) and the final branch points are specific genes (1, 2, 3...). The 
shorter the links between branch points, the greater the similarity between the P450 
sequences. Although this classification system is now applied to all P450 enzymes, it is 
entirely based on genetic comparisons and has no functional implications. Some of the 
more intensively studied P450s predate this naming system and are commonly referred to 
by other names which reflect their function or origins such as P450cam (CYP 102) [34], 
which uses camphor as a substrate or P450 BM3 (CYP 1OIA1) [35], the third P450 from 
the soil bacterium _Bacillus Megaterium. 
1.4 Structure and Classification 
Structural characterisation of the P450s can be subdivided into two sections; the 
structure of the P450 and the structure of the supporting redox cofactors. 
P450 structure: The P450 proteins are comprised of 400-500 amino acids and maintain a 
common overall fold and tertiary structure despite often having less than 15 % sequence 
Ivy 
	 tp i;$L 
P450 BM3 	 P450 cam 	 P450 2B4 
Figure 1.4: Structural representation of P450 BM3 (1BU7), P450cam (1DZ4) and 
P450 2B4 (1P05) showing the conserved (trigonal prism) tertiary structure. Herne 
groups are shown in orange, cc-helixes in red and p3-sheets in yellow. 
on 








Figure 1.5: Schematic representation of P450 (IBU7) highlighting the different 
helices A—.K. Panel A shows the heme face on. Panel B shows a 900  rotation of the 
structure with the heme side on highlighting the positions of the I and L helices which 
sandwich the heme. 
VA 
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identity [36]. All P450s form a trigonal prismatic structure which is predominantly 
helical in nature although usually contains some 3-sheet (Figure 1.4). The core of the 
structure is typically made up of four main helical bundles, three of which run parallel to 
the heme plane; designated I, L, and D, and one which runs anti-parallel; E [37] (Figure 
1.5). The heme is buried in the centre of the protein fold between I and L helices with the 
L-helix containing the implicitly conserved heme ligand cysteine. The long I-helix runs 
directly across the distal face of the heme and contains a characteristic 'kink' in the 
helical structure as seen in figure 1.7 associated with a signature amino acid sequence 
(AIGGxE/DT). This anomaly in the structure provides a gap at the distal side of the heme 
which, in the resting state, is filled by a ligand water. It is likely that during the catalytic 
cycle, this kink is also necessary to allow oxygen binding and consequently it is often 
referred to as the oxygen binding pocket [38]. Other important helical bundles include 





Figure 1.6: Panels A and B show a cross section P450 BM3 in the absence (IBU7) 
and presence (1 FAG) of substrate respectively. In panel A the substrate access 
channel is clearly visible. On substrate binding, the channel is closed, preventing the 
dissociation of substrate during catalysis. 
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those involved in controlling substrate access and binding. However, due to the differing 
nature of substrates involved in the P450s, substrate contact points can be located on a 
number of structural features including the B, K, F, G and I helices. The F and G helices, 
at least in P450 BM3, have been show to move on substrate binding and have been 
implicated in controlling substrate access to the distal side of the heme [21] (Figure 1.6). 
Although there are significant differences in P450 sequences, there are some 
implicitly conserved primary structural features (Figure 1.7). All P450s contain a B-type 
protoheme LX cofactor with an FxxGxxxCxG binding motif [39]. The only implicitly 
conserved residue found in all P450 enzymes is the cysteine heme ligand which provides 
a direct link between the protein and porphyrin [40-42]. The removal of this residue via 
site directed mutagenesis (Cys-*His) has been shown to prevent the incorporation of 
heme and leads to the inactivation of the enzyme [43]. The arrangement of the heme and 
heme ligands is also highly conserved and is the key to the characteristic reactivity of 
P450s. It has been proposed that the strong electron donating character of the cysteine 
thiolate provides an 'electron push' onto the heme allowing it to achieve the reduction 
potentials necessary to stabilise the activated oxygen species [40-43]. When the cysteine 
is removed, even when the enzyme is reloaded with heme, the rate constants for NADH 
oxidation are still comparatively low [43]. There are several other highly conserved 
residues including a proximal phenylalanine [44-45] and distal threonine [46] which are 
also likely to be catalytically important (Figure 1.7). 
Redox partner structure: All P450s (with the exception of P450 nor) require the presence 
of a supporting cofactor or cofactors to supply reducing equivalents (derived from 
NAD(P)H) to the heme. One of the ways in which cytochrome P450 enzymes can be 
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Figure 1.7: Panel A: Active site of P450 BM3 (IBU7) showing 'kink' in the I-helix 
necessary for water and oxygen binding. Panel B: Characteristic arrangement of P450 
heme iron ligands (1 BU7). The equatorial ligands are provided by the porphyrin 
macrocvcle while the axial hands are orovided by a cvsteine residue and labile 
differentiated from each other is through the nature of these supporting redox cofactors. 
In general, the arrangement of redox cofactors allows the P450s to be separated into two 
main groups (Class I and II) although there are numerous examples of P450s which fall 
into neither category (Figure 1.8). 
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Class I P450s are three component systems comprising of the P450 protein with 
additional FAD containing ferrodoxin reductase and iron containing (ferrodoxin) 
proteins. The FAD subunit binds NADH and picks up two electrons in the form of a 
hydride. The electrons are then transferred sequentially to the P450 via a 2Fe2S 
ferredoxin. This arrangement of cofactors is commonly found in bacterial (e.g. P450cam 
[34]) and mitochondrial (e.g. P450scc [47]) systems. In bacterial systems the individual 
components are soluble whereas in mitochondria they are membrane bound and hence 
insoluble. 
Class II P450s are two component systems which consist of a P450 subunit and a diflavin 
reductase subunit which contains both FAD and FMN in a single protein fold. Typically, 
this arrangement of cofactors is seen in microsomal proteins [48-49] and is usually bound 
to the cytoplasmic side of the endoplasmic reticulum. The cytochrome P450 reductase 
(CPR) binds NADPH close to the FAD to facilitate hydride transfer. The electrons are 
then transferred sequentially to the heme via the FMN. 
As mentioned above there are several exceptions to this classification system, the 
most well known of which is P450 BM3 (CYP102A1 [35]) from Bacillus megaterium. 
P450 BM3 is a one component system which contains an FAD/FMN domain fused to a 
P450 domain via a short polypeptide linker. The structural similarity of the BM3 
reductase domain to the microsomal CPR subunit means that we can consider P450 BM3 
to be essentially a fused class II system [18]. Although P450 BM3 was the first P450 to 
display this configuration, there are now several BM3 homologues. There are a number 
of other examples of 'unique' redox cofactors including P450 RhI [50-51] (fused FMN-
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Figure 1.8: Diagrammatic representation of several different classes of cytochrome 
P450. Panel A: class I system comprised of FAD, iron sulfur and P450 subunits. 
Panel B: class II system comprised of FAD/FMIN reductase and P450 subunits. Panel 
C: class III system comprised of fused FADIFMIN reductase and P450 domains. 
Panels D and E: other unique combinations of redox cofactors seen in P450 Rhf and 
P450 cm. 
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[53] which is capable of taking electrons directly from NADH without the presence of 
any cofactors to facilitate electron transfer. 
1.5 Functions and Substrates 
The most common function of the P450 enzymes is the catalysis of regio- and 
stereo-specific hydroxylation reactions on non-activated hydrocarbons under 
physiological conditions [54-55]. This is an impressive feat considering that attempting 
uncatalysed reactions such as this under laboratory conditions would not only require 
high temperatures but would also be non-specific. The cytochromes P450 play a variety 
of roles in the biochemistry of both prokaryotes and eukaryotes. In mammals, P450s are 
generally, although not exclusively, found in the liver where they aid the detoxification 
process by metabolizing numerous xenobiotics [56-58]. The oxygenation of P450 
substrates increases their polarity and hydrophilicity, allowing them to be more easily 
excreted from the body. A good example of this is human CYP3A4 [59] which is part of 
the degradation pathway for over 50% of known drugs including diazepam and cocaine, a 
factor which makes it, and other mammalian P450s, an important target for the 
biomedical industry. Detoxification is not the only function of P450s in mammals, they 
also play important roles in steroid hormone synthesis [60] (and breakdown), cholesterol 
synthesis [61] and vitamin D metabolism [62]. The bacterial enzymes P450cam and 
P450cin are involved in metabolic pathways in which camphor and cineole are used, 
respectively, as unusual energy sources [22, 52]. P450s are also involved in antibiotic 
synthesis in fungi [63-64] and herbicide resistance in plants [65]. 
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Figure 1.9: A small selection of the wide variety of molecules which can act as the 
substrates for P450 enzymes. 
Coupled to this obvious diversity in function is a huge variety of substrate types 
from small molecules such as NO (P450nor) [66] to large molecules such as epithilone 
(P450epok) [67]. A small collection of some of these substrates is seen in figure 1.9. 
Clearly the structure of individual P450s must vary accordingly to accommodate and bind 
such a different range of substrates explaining, at least in part, their frequently low 
sequence identity. Interestingly, even when the substrates are similar such as for 
P450cam and P450cm (camphor and cineole respectively), sequence similarity is not 
necessarily high with these two enzymes exhibiting only 26% identity [22, 52]. Equally, 
it is interesting that a single P450 can act on structurally dissimilar substrates. An 
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example of this is P450 3A4 [59] which can hydroxylate both long-chain fatty acids such 
as arachidonate and large polycyclic compounds such as sterigmatocystin. 
1.6 Catalytic Cycle 
The universally accepted catalytic cycle for all cytochromes P450 was initially 
proposed in the late 1960s and few alterations have been made since then (for a review 
see [34]). In the absence of a catalyst, un-activated oxygen has a triplet ground state 
whereas most organic molecules have a singlet ground state and the reaction between a 
single and triplet is spin forbidden. As a result, the primary goal of P450s is to activate 
molecular oxygen in order for it to react with an organic substrate. Metal ions such as 
iron provide a suitable method for achieving this goal as they readily bind oxygen, 
allowing the formation of highly reactive species such as the peroxy-ferric (Fe(III)-00 2 ), 
hydroperoxy-ferric (Fe(III)-00H) and ferryl (Fe(IV)0) complexes [68]. The ability of 
a metal centre to form these species is, in part, governed by the iron ligands and 
surrounding protein and differences in these can lead to different functions [69]. An 
example of this can be seen in the comparison of hemoglobin with the P450s. Both 
contain heme and both bind oxygen, however, one is an oxygen carrier whereas the other 
promotes the formation of activated oxygen complexes. One important difference 
between them is in the nature of the iron ligands. The P450s all contain a cysteine ligand 
and it has been suggested that this cysteine plays an important role in their characteristic 
reactivity [40-43]. Conversely, hemoglobin has a histidine ligand and although it has 
been shown to catalyse some reactions, is not capable of generating the high oxidation 
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Figure 1.10: P450 catalytic cycle depicting 1: substrate binding, 2: first electron 
transfer, 3: Oxygen binding, 4: second-electron transfer, 5: formation of fenyl 
species, 6/7: rebound mechanism for oxygen insertion and 8: product dissociation. 
The 1, 2 and 4 electron uncoupling pathways to superoxide, peroxide and water are 
shown as dotted lines. 
state iron-oxygen complexes. 
The P450 mechanism requires two sequential one electron reductions and an 
oxygen binding step leading to the formation of multiple intermediates. These multiple 
iron-oxygen intermediates are reported to be responsible for the large variety of reactions 
which can be catalysed by the cytochromes P450 [69]. Many of the reaction steps such as 
the binding of substrate, first electron transfer and binding of oxygen have been 
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crystallographically characterized [17,70-72]. However the evidence for the activated 
oxygen species are all derived from spectroscopic studies [73-77]. As a result, the exact 
nature of these intermediates still remains one of the major questions in P450 
biochemistry. A schematic showing the P450 catalytic cycle is shown in figure 1.10. In 
the oxidised, resting state, the heme iron is equatorially ligated by 4 riitrogens from the 
porphyrin macrocycle and is axially ligated by a conserved cysteine and labile water 
(Figure 1.7). 
STEP 1. Substrate binding: In almost all cases, substrate binding displaces the distal iron-
ligated water [21,24,70,78-79]. This leads to a change in coordination geometry from 
octahedral 6-coordinate to square based pyramidal 5-coordinate (Figure 1.11). This 
change is accompanied by changes in the d-orbital energies and accordingly, a switch in 
the spin state from low- (s = '/2) to high-spin (s = /2) [21,24,70,78-79]. Furthermore, the 
presence of the heme ligand water stabilises the low-spin ferric heme. Consequently, the 
loss of this ligating water thermodynamically destabilizes the ferric state and the heme 
reduction potential undergoes a positive shift (typically by —lOOmV [44-45]). These two 
factors, kinetic and thermodynamic, act to pre-organise the P450 prior to electron transfer 
and increase the driving force respectively. As a result, they have been implicated as a 
'switch', accelerating electron transfer in the presence of substrate and preventing the 
unproductive consumption of reducing equivalents in the absence of substrate [44-45]. 
There are additional effects associated with substrate binding. In several P450s, substrate 
binding has been shown to induce significant structural changes including large 
movements of the I-, F- and G-helices [21]. It has been suggested that these changes may 
perform a variety of roles including controlling substrate access and recognition. 
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Figure 1.11: Diagrammatic representation of changes in geometry and d-electron 
configuration on substrate binding and reduction. Panel A: Resting state, ferric d5 
octahedral. Panel B: Substrate bound, ferric d5 square based pyramidal. Panel C: 
Reduced substrate bound, ferrous d6 square based pyramidal. 
STEP 2. First electron transfer. The first electron transfer leads to the reduction of the 
heme iron from the ferric to ferrous form (Figure 1.11). Reducing equivalents are derived 
from NAD(P)H and transferred to the heme via the associated redox partners. This one-
electron reduction of ferric heme facilitates the binding of oxygen which has a high 
affinity for the ferrous form but not the ferric. In some P450 enzymes, it has been 
suggested that this reduction process might also trigger a structural movement and that 
this might act to bring substrate closer to the heme-oxygen complex prior to catalysis 
[80]. In addition, studies have suggested that the affinity of a P450 enzyme for substrate 
is dramatically increased on reduction [81-82]. According to the Gibbs free energy 
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relation, the shift in reduction potential upon substrate binding (AE m) is related to the 
substrate dissociation constants (lCd)  of the two redox states of the enzyme i.e. - 
RT1n(Kj(ox)/K(j(red)) = -nFAEm. This implies that the positive shift in the heme reduction 
potential often associated with substrate binding is directly linked, through concomitant 
changes in the Gibbs free energy, with tighter substrate binding to the ferrous-forms of 
these enzymes. This predicts K cj values for P450 BM3 in the reduced form of 16 nM 
compared with 4 ttM in the oxidised form. Clearly this dramatic increase in substrate 
affinity might have a physiological role, possibly in maintaining a fully coupled catalytic 
cycle. 
STEP 3. Oxygen Binding: Molecular oxygen binds rapidly to ferrous heme forming an 
oxy-P450 species [83-84]. It has been shown that the iron-oxygen species has mixed 
character, existing as the resonance hybrid of the oxy-ferrous (Fe(II)-0 2) and superoxy-
ferric (Fe(III)-0 2 ) forms [76,85]. The recent crystal structure of oxygen bound P450cam 
[72] shows that the oxygen is bound end-on to the heme iron with the non-bound oxygen 
atom 'bent' towards a highly conserved active site threonine (Figure 1.12). This 
intermediate is the last species that can be easily observed by conventional spectroscopic 
methods. 
STEP 4. Second electron transfer: In some of the cytochromes P450, the second-electron 
transfer is reported to be the rate determining step [86-87]. The transfer of a second 
electron onto the iron-oxygen complex leads to the formation of a negatively charged 
peroxy-ferric species (Fe(III)-00). It is reported that the peroxy species in a number of 
P450s may be responsible for some uncharacteristic P450 activity. For example, the 
biosynthesis of some steroid hormones requires the oxidative removal of a methyl group 
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Figure 1.12: Active site crystal structure of oxygen bound P450cam (1DZ8). Oxygen 
binds end-on to the P450 heme-iron with the non bound oxygen orientated towards a 
highly conserved threonine. 
from androstenedione, a reaction catalysed by P450 aromatase. This reaction requires 
three individual reaction steps, the first two hydroxylate the methyl group to an aldehyde 
(formyl) followed by a final deforrnylation step. The first two steps are typical P450 
reactions utilizing an electrophilic active species such as the ferryl (Fe(IV)=O) complex, 
to insert an atom of oxygen into an organic substrate. The final step cannot be explained 
using the ferryl model and as such a different mechanism must be in action. It is now 
widely accepted that the most likely mechanism by which this reaction happens involves 
nucleophilic attack by the iron-peroxy complex [68,88-89]. Further discussion of the 
second electron transfer step can be found in chapter 4. 
Step 5. Protonation: Step 5 in the catalytic cycle involves two protonation steps and 
might be more accurately described as two separate events. The first protonation leads to 
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the formation of a hydroperoxy- ferric intermediate species (Fe(III)-00H). The 
characteristic P450 reactions are usually attributed to the ferryl species, however it is 
suggested that in some P450s, where the protonation steps are slow, that the 
hydroperoxy-ferric species is also capable of catalysis [68]. There is evidence that this 
species is capable of catalysing a number of electophilic reactions including epoxidations, 
sulfonations, aromatic substitutions and hydroxylations [68]. The second protonation step 
leads to the dissociation of water and the formation of the ferryl species, analogous to 
compound I in heme peroxidases [90]. This constitutes the 'primary' active species, 
responsible for the majority of the characteristic P450 hydroxylation reactions. The ferryl 
complex might be more accurately described as a high-valent t-radical cation species 
since there is a radical cation on the porphyrin. 
STEP 617. Oxygen insertion: It is impossible to generalize the mode of oxygen insertion 
due to the variety of reactions catalysed by the P450s. However, as hydroxylations are by 
far the most common P450 catalysed reaction, the mechanism by which this occurs will 
be given special consideration. Other, more unusual, reaction types are outlined in section 
1.7. The P450 catalysed hydroxylation reactions utilise the strong electrophilic nature of 
the ferryl species and the reaction proceeds via a hydrogen abstraction/oxygen insertion 
mechanism (referred to as the rebound mechanism) [91] as shown in figure 1.13. First, 
the ferryl species binds substrate and abstracts a proton generating a substrate radical 
species. The substrate radical then rebinds to the hydroxy-ferric porphyrin radical species 
via the oxygen atom and allows the formation of the hydroxylated product. 
8. Product release: The hydroxylated product (ROH) dissociates from the ferric heme 
and diffuses out of the enzyme and, with the addition of a water molecule, the enzyme 
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Figure 1.13: Diagrammatic representation of the rebound' mechanism of oxygen 
insertion. Substrate binds to the ferryl species which abstracts a proton and generates 
a substrate radical. This radical then rebinds to the hydroxyl-ferric species before the 
hydroxylated species dissociates. 
returns to the ferrous low-spin resting state. 
1.7 Reaction Types 
In addition to differences in function and substrate specificity, P450s are also 
capable of catalysing a variety of oxidative reactions (Figure 1.14). It has been suggested 
that this flexibility in catalysis is a result of the multiple oxidants generated during the 
catalytic cycle. Although the catalytic cycle is the same for all P450s, there is some 
variation in the mechanism of substrate oxidations. Some examples of these diverse P450 
reactions include; 
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Figure 1.14: Some different P450 reaction types including A: epoxidation, B: 
aromatic oxidation, C: heteroatom oxidation and D: dehydrogenation 
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C-H Bond hydroxylation: This is by far the most common reaction observe for the P450 
enzymes [92-94] where an atom of molecular oxygen is inserted across a CH bond 
(Figure 1.1) as described previously [91]. It is generally accepted that ferryl species is the 
catalytically active group responsible for this reaction. 
Epoxidation: Some P450s such as CYP2J2 are capable of the stereo-specific epoxidation 
of alkenes [95-96]. The industrial importance of these compounds makes P450s a target 
as 'green' catalysts. It has been suggested that the hydroperoxy-ferric intermediate acts as 
additional electrophile to the ferryl species and may be responsible for the catalysis of 
some reactions. 
Aromatic oxidation: Aromatic compounds are particularly stable towards oxidation 
reactions and C-H bond dissociation energies are often large. However, some P450s are 
capable of aromatic oxidations under mild conditions via the NIH shift mechanism [97-
98] as opposed to the 'rebound' H-atom abstraction mechanism proposed for most P450s. 
Heteroatom oxidation: The P450 oxygenation reactions are not limited to carbon atoms, 
but are also capable of adding an oxygen atom to nitrogen, sulphur, phosphorous and 
iodine atoms [99]. 
N- and 0-Dealkylation: The removal of alkyl groups from the heteroatoms N and 0 has 
been shown to be catalysed by some P45 Os [100]. 
Dehydrogenation: P450 enzymes can also carry out dehydrogenation reactions on 
organic molecules [101]. In this instance, both atoms of the bound oxygen molecule are 
converted into water while the substrate is converted to an alkene. 
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1.8 Flavocytochrome P450 BM3 
Flavocytochrome P450 BM3 is a bacterial class III P450 fatty acid hydroxylase 
from Bacillus megaterium first discovered by Narhi and Fulco in the mid 1980's [35]. It 
catalyses the sub-terminal hydroxylation of both saturated and unsaturated long-chain 
fatty acids (C 12-C20) such as laurate and arachidonate (Figure 1.9). It's specificity for long 
chain substrates can be explained by examining its binding pocket which is long, thin and 
hydrophobic [18,21]. P450 BM3 has an uncharacteristically high molecular weight of 
118 kDa when compared to other P450's (usually 40-60 kDa) due to all of its 
components being contained in a single polypeptide. Structurally, BM3 contains a 54kDa 
N-terminal diflavin reductase domain fused to a 64kDa C-terminal heme domain via a 
single, short, hydrophilic polypeptide. This results in an enzyme which is self sufficient 
and soluble and requires only NADPH, oxygen and substrate for catalytic activity. Apart 
from the unusual configuration of its redox cofactors, P450 BM3 is unremarkable in 
comparison to other P450s. It catalyses a typical hydroxylation reaction and contains all 
the highly conserved residues which are found throughout the P450 superfamily. These 
factors combined with its high activity (kcat —100 s_I ) and ease of expression in E. coli 
mean that BM3 provides a useful model for P450 systems without complications 
associated with the recognition and binding of multi component systems or the problems 
associated with solubilising membrane bound forms (class II) [102]. 
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1.9 Electron Transfer in Biological Systems 
Electron transfer reactions are prevalent throughout biology. They are involved in 
such physiologically important processes as aerobic respiration and photosynthesis. In the 
mitochondrial respiratory chain, ATP is produced by the oxidative phosphorylation of 
ADP. The formation of ATP by complex V [103] is driven by the formation of a 
transmenbrane proton electrochemical gradient generated by complexes I, III and N 
[104-106]. The generation of the electrochemical gradient is achieved by the transfer of 
electrons from NADH through the respiratory chain to molecular oxygen, coupled to the 
transfer of protons across the membrane. The photosynthetic process can be split into two 
sections commonly referred to as light and dark reactions. The first (light) reaction uses 
energy derived from light to carry out the photochemical oxidation of H 20 resulting in 
the reduction of NADP+ to NADPH and the formation of 02.  In addition, some of the 
energy derived from sunlight is used to produce ATP from ADP. In the second (dark) 
reaction, both NADPH and ATP are used in the reductive synthesis of carbohydrates 
from CO2 and water. Integral to both these processes are electron transfer reactions. 
As well as being responsible for helping to generating energy, electron transfer 
reactions are involved in many other biologically significant processes including nitrogen 
fixation, cell signalling, DNA repair, detoxification and numerous others. In all cases, 
biological electron transfer processes occur between or within proteins, mediated by the 
presence redox active cofactors. Frequently, these cofactors make use of the multiple 
oxidation states of metals such as iron, copper and molybdenum to support electron 
transfer; however some organic molecules such as fiavins and quinones are also used. 
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Essentially there are three different classes of electron-transfer reaction observed in 
proteins: 
Non-Adiabatic: The transfer of a single electron between two weakly-coupled redox 
centres such as an electron transfer between two cytochromes. 
Electron-Pair: The transfer of a pair of electrons between redox cofactors. One of the 
most common examples of this is the two electron reduction of FAD via a hydride 
transfer from NAD(P)H. 
Transduction: The accumulation of a number of electrons by a single redox cofactor 
which is then capable of multiple single-electron transfer events. Reactions of this type 
are seen in FAD which can undergo a two electron reduction and is then capable of 
performing two single electron transfers. 
As the transfer of electrons is involved (amongst other things) in the production 
of ATP, it is important not to waste reducing equivalents. It is critical therefore that the 
flow of electrons is specific and controlled. The redox centres themselves are 
indiscriminate and cannot control their redox transitions, consequently the structure of the 
protein is necessary to regulate the electron-transfer processes. There are several major 
factors which will govern the absolute rate of electron transfer. 
The thermodynamic driving force 
The distance between redox cofactors 
The intervening medium 
The reorganisation energy 
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1.9.1 Marcus Theory 
Marcus theory [107] provides a convenient model to describe non-adiabatic 
electron transfers processes. An example of a simple redox system would be where an 
electron is transferred between two species one of which donates and one of which 
accepts an electron: 
R - e-  -*O' 
O+e-+R 
Which combine to give: 
R+O — R+O 
By treating both reactants and products (R and 0) as undergoing simple harmonic 
oscillations, both can be represented as single separate parabolic energy wells. There are 
several other restrictions which are placed on this model. Firstly, energy is neither lost 
nor gained during the transfer process. The total energy of the system must remain 
constant until the electron transfer process is complete and the reaction can essentially be 
considered as a redistribution of electrons. Secondly, according to the Frank-Condon 
principal, electron transitions occur so rapidly that there is no change in the nuclear 
configuration of either species. While this is an approximation, it is adequate for 
describing biological systems. Figure 1.15 shows the basic elements of the Marcus theory 
for a self-exchange reaction whereby oxidised and reduced states of the same redox 
centre exchange an electron. It is important to realize that the two parabolas represent two 
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Figure 1.15: Diagrammatic representation of the relationship between activation 
energy (1G*),  driving force (AG) and reorganisation energy (A) for and electron 
transfer reaction. 
different states of the same system. However, if we were considering electron transfer 
between two dissimilar redox centers, the diagrammatic representation would remain the 
same. In this case the potential wells for oxidised and reduced would be a combination of 
both reactants. For either case, in order for the reaction to proceed, both the nuclear 
configuration and the energies of both states must be equal i.e. the point of intersection 
between the two potential wells. 
There are several terms which must be defined before continuing discussion of 
Marcus theory: 
1. AG*  is the activation energy or the energy require to stimulate the electron from 
its lowest energetic state (bottom of parabola) to the point where it can be 
transferred (intersection). 
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AG is the driving force of the reaction or the difference in the minimum energies 
before and after electron transfer. The value of AG is proportional to the relative 
reduction potentials of the two reactants according to the following equation. 
AG=-nFAE (1) 
A the reorganization energy is the energy required to change the nuclear 
configuration of the product(s) to that of the reactant(s) without an electron 
transfer. 
The driving force, activation energy and reorganisation energy are related according to 
the following equation: 
AG* = (AG +A)2 /4A 	(2) 
From this, it is evident that the reorganisation energy depends on the relative positions of 
the parabolas in both reaction coordinate and energy dimensions. 
The electron transfer rate is dependant on the activation barrier according to the 
Gaussian function: 
ket = 	exp (_AG*  I KT) (3) 
and hence 
ket=knexp-(AG+X)2 /4AKT 	(4) 
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Figure 1.16: The relationship between the log of the electron transfer rate constant 
(ket) and the driving force (AG) according to equation 4. 
where ket is the observed rate of electron transfer, k.. is the maximal rate of electron 
transfer (i.e. when AG* = 0) Y, is the Boltzman constant and T is the temperature in 
Kelvin. 
From equation 4, the change in ket with AG can be calculated (Figure 1.16). As A is 
always positive, it is evident that the major determining term in defining the absolute 
electron transfer rate will be (AG + A). Accordingly, in a system for which A is constant 
and there is a variation in the driving force, three situations arise (Figure 1.17). 
1. Normal (Figure 1.17 A): When (AG + A) is greater than 0. Increasing the driving 
force leads to an increase in the rate of electron transfer. 
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Activationless (Figure 1.17 B): When (AG + A) is equal to 0. There is no energy 
barrier to for the electron transfer to overcome. This corresponds to the maximal 
electron transfer rate i.e. ket = kmax. 
Inverted (Figure 1.17 C): When (AG + A) is less than 0. Here (counter intuitively), 
increasing the driving force leads to an increase in the activation energy and 
consequently a decrease in the observed rate of electron transfer. 
The above parameters deal solely with the thermodynamic factors which govern 
the rate of electron transfer. For a complete picture of electron transfer in proteins, the 
kinetic control must also be considered. Clearly both the distance between redox couples 
and the nature of the intervening medium will exert a degree of influence of the maximal 
rate constant for electron transfer. For efficient electron transfer, there must be a degree 
of overlap between the two electronic wavefunctions involved. This overlap has been 
shown to decrease exponentially as the distance between the two redox cofactors is 
increased and consequently, the electron-transfer rate is exponentially related to the 
distance between the two redox cofactors. Additionally, in biological systems where 
electron transfer can occur over relatively large distances, the nature of the intervening 
medium plays an important part in electron tunneling. Consequently the maximal electron 
transfer rate is proportional to: 
exp (13/2(d-d0)) 	(5) 
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Figure 1.17: Relative positions of the potential energy wells for A: normal electron 
transfer, B: activationless electron transfer and C: electron transfer in the Marcus 
inverted region. 
Where 	is the maximal turnover rate, d is the distance between the two species, d.,, is 
the Van-der-Waals contact distance and 13  is a coefficient describing the rate of decay of 
the coupling over a distance associated with a particular intervening medium. It has been 
shown that in a vacuum where 13 = 2.8 A- ' [ 108], electron transfer occurs over short 
distances only as at larger distances the orbital overlap is insufficient. In a fully 
covalently bridged redox system where electron transfer would be possible over large 
distances, the value of P is 0.9 A-'. 
The value of the 13 coefficient in protein systems has been a topic of some debate 
and there are essentially two schools of thought. The first describes a 13 value of 1.4 A- ' 
for all proteins with all electron transfers occurring 'through space' [108,110]. This 
places the intervening protein medium somewhere between a fully covalently bound 
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system and a vacuum. In this model the intervening medium can be considered as an 
'organic glass' and predicts that even a small difference in distance between redox 
cofactors could potentially lead to an order of magnitude difference in the rate of electron 
transfer. However, it is suggested that this model only provides a sufficient description of 
a system where the redox cofactors are arranged to maximize electron transfer rates such 
as the photosynthetic reaction centre in Rhodobacter sphaeroides [109]. In the 
photosynthetic reaction centre, the redox cofactors are placed close to each other and are 
primed for electron transfer. The distance between redox cofactors is critical for electron 
transfer. It has been shown that most biological systems place redox cofactors at less than 
14 A apart in order to optimise 'through' space electron transfer rates in order to support 
catalysis [1 10-111]. 
In some intra- and inter-protein electron transfer pathways, the intervening 
medium is better described as being heterogeneous. The alternative model proposed 
involves the through bond transition of electrons [110-112]. This alternative description 
allows the transfer of an electron between weakly coupled redox centers by a 
combination of tunneling processes through covalent bonds, H-bonds and even short hops 
through space. Each of these processes is assigned a 3 value and the net [3 is a 
combination of all these. Unfortunately however, this is frequently complicated by the 
presence of many potential 'through bond' electron transfer pathways. These defined 
electron pathways may have a regulatory function, ensuring that electron transfer occurs 
only between the intended redox cofactors. 
It is likely that the most appropriate model for describing electron transfer in 
biological systems would make use of both the through bond and through space 
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treatments where appropriate. For instance, in systems where cofactors are placed in 
close proximity, a through space model may be more applicable. In a system where the 
redox species are separated by a significant distance and are prevented from adopting a 
close configuration, a through bond approach may be more suitable. 
Regardless of which system is used, it can be seen that the major components 
which govern electron transfer are the driving force, the distance between cofactors and 
the reorganization energy. However other factors such as the nature of the intervening 
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2: MATERIALS AND METHODS 
2.1: Mutagenesis 
All P450 BM3 constructs were created by Dr. Caroline S. Miles, Institute of 
Cellular and Molecular Biology, University of Edinburgh. The P450 BM3 mutants 
(Table 2.1) characterised were generated by site-directed mutagenesis using the Kunkel 
Table 2.1: Oligonucleotide primers and Plasmid codes 




________ F I pBM20 







I HD _______ 
5'-CTGACCGTTTCCAGCCGGTTTAAACGC-3' 
(pCM8O 














I Im 5'-GACCACTTGTTGCTTCGTGTCCCGC-3' I pCM166 




F393H1T268A F 	I {pCMl72 
F HD 5'-GACCACTTGTITTCGTGTCCCGC-3' F I pCM164 




Q403A pCMl76 __ 
5'-GAGCGAACTGCQACCGATACAC-3' 
pCM168 




F393A1Q403A pCM 170 _____ 
{ 	 I 
5'-GAGCGAACTGCACCGATACAC-3' 
I pCM162 
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method [113]. The E. coli strain TG1 [supE, hsdA5, thi, A(lac-proAB), F'[traA36, 
proAB, lacII, 1acZAM15]] was used for the expression of both intact and heme domain 
constructs. Construction of the wild type and F393H, F393A, F393W and F393Y 
plasmids has been reported previously [44,76,114-115]. The WT plasmids pBM23 
(intact P450 BM3) and pBM20 (P450 BM3 heme domain) were used as templates for 
making the T268A,T268N, Q403A and Q403K single mutants. The P450 BM3 F393H 
plasmids pCM37 (intact) and pCM8 1 (heme domain) were used for construction of the 
F393H1T268A and F393H1T268N double mutants [47]. The P450 BM3 F393A plasmids 
pCM36 (intact) and pCM80 (heme domain) were used for construction of the 
F393A/Q403A and F393A1Q403K double mutants 
The Oligonucleotide primers used and the resulting expression plasmid codes are 
shown in table 2.1. Mismatches are underlined. The P450 BM3 coding sequences of all 
enzymes were sequenced on a Perkin-Elmer ABI Prism 377 DNA sequencer to verify 
that there were no secondary mutations. 
2.2 Expression and Isolation 
Small scale cultures were prepared for both the heme domain construct and holo 
enzyme. Single colonies were picked from LB-agar plates (25jigmF' carbenecillen) using 
a sterile wire loop and used to inoculate two sterelin tubes, each containing 
approximately 30 ml sterile LB fortified with 25 grnF' carbenecillen. The E. coli cells 
were grown for 10-14 hours overnight at 37.5 °C and 150 rpm in an orbital 
shaker/incubator. 
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Table 2.2: Growth Media and Agar 
Luna Bertani Broth (LB) For 1 litre: 10 g Bacto Tryptone 
5 gYeast Extract 
5 g NaCl 
Terrific Broth (TB) For 1 litre: 20 g Bacto Tryptone 
10 gYeast Extract 
5 gNaCl 
Prepared using MilliQ ultrapure water (of resistivity 18 Q cm') and autoclaved sterilized. 
LB Agar Plates 15 gU' agar dissolved in LB 
Autoclaved agar was allowed to cool to room 
temperature. 	Prior 	to 	setting, 	agar 	was 
augmented with 25 	gml" carbenecillin and 
poured into Petri dishes. 
Freezer stocks of the constructs for future inoculations were prepared by adding 
77 Itl DMSO to 1 ml of starter culture (7% DMSO by volume). DMSO stocks were 
stored at -80°C until required and kept on ice while in use. Subsequent small scale starter 
cultures were inoculated from DMSO stocks using a sterile pipette tip. The DMSO stocks 
were replaced every 6-8 months by preparing fresh LB agar plates from the old DMSO. 
In order to achieve this, a flame sterilised loop was dragged across the DMSO stock and 
used to streak out a fresh agar plate augmented with carbenecillen (25 jigml'). The plates 
were incubated overnight at 37 °C in order to promote the growth of bacterial colonies. 
Over-expression in the starter cultures was assessed in two separate ways. The 
cells from a small sample of the starter culture (1 ml) were isolated via centrifugation 
(2 minutes at 1400 rpm, Spectrafuge 16M) and the excess media was drained off. A deep 
red colour in the remaining pellet was indicative of successful P450 overexpression. For a 
more sensitive indication of expression, the pellet from -30 ml starter culture was 
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isolated via centrifugation (10 minutes at 2000 rpm, Falcon 6/300) and re-suspended in 
-40 ml purification buffer A (50 mM Tris, 1 mM EDTA, pH 7.5). The cells were lysed 
using a single 10 second burst of sonication at an amplitude of 15 microns (soniprep 
150). The cell debris was removed via centrifugation (10 minutes at 2000 rpm, Falcon 
6/300) and the lysate was analysed by SDS-page. The presence of intense bands at 
-'55 kDa and -118 kDa were indicative of the successful overexpression of the heme 
domain and intact constructs respectively. A more detailed discussion of SDS-page 
analysis is contained in section 2.5.1.2. 
Small aliquots (-lml) of the starter cultures were used to inoculate large scale 
growths of each of the constructs. Typically 24 x 400 ml LB (total volume 9600 ml) 
augmented with 25 zgml' carbenecillen in 1 litre baffled flasks were used. E. coli 
cultures were grown at 37.5 °C and 150 rpm in an orbital shaker/incubator until the 
optical density (O.D.) was in the region 0.5 - 0.8 (--6 hours). The temperature was then 
lowered to 30°C for a period of 18 - 20 hours. IPTG was not added for induction as SDS 
page analysis indicated that it had little effect on overexpression. Constructs with 
significantly lower levels of expression compared with wild-type were grown in a richer, 
buffered media (TB) in the same way as described above. In cases where expression was 
particularly poor, the growth period at 30 °C was extended to 40 hours. 
After the allotted time, the cell rich media were pooled and the cells were 
harvested by centrifugation at 15 000 rpm for 10 minutes (Sorvall RC-5B centrifuge with 
a SLA 3000 head at 4 °C). The resulting cell pellets were either lysed immediately or 
stored as a wet cell paste at -20 °C until required. Typically the wet cell pellets weights 
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from 9.6 litres of media were; from LB; heme domain 25 g, intact 50 g; from TB; heme 
domain 80 g, intact 130 g. 
2.3 Extraction and Purification 
2.3.1 Cell Extraction: 
The harvested cells were re-suspended in purification buffer A (50 mM Tris 1 
mM EDTA pH 7.5) allowing approximately 40 ml buffer for 25 g of wet cell pellet. 
Disruption of the E. co/i cells was achieved via short bursts of ultrasonication (lysis by 
cavitation) using a Sanyo soriiprep 150. To prevent the proteolysis of the heme domain 
construct, 1 ml PMSF (60 mgmF' in EtOH) was added to the cell mixture prior to 
sonication. For the intact enzyme, a protease inhibitor cocktail (COMPLETE TM, 1 tablet 
per 50 ml buffer) was also used in addition to the PMSF to prevent domain cleavage. 
Typically, 6 x 20 second bursts of sonication at 15 microns applied to a 40 ml cell 
suspension were required for efficient lysis. In order to ensure that the resulting lysate did 
Table 2.3: Purification Buffers 
Buffer A 1 mM EDTA 
50 mM Tris 
pH 7.5 
Buffer B 1 mM EDTA 
50 mM Ths 
10 mM NADP 
pH 7.5 
Buffer C 1mM EDTA 
50 	m Ins 
1 M KCI 
pH 7.5 
[Prepared using MiIIiQ ultrapure water (of resistivity 18 n cm') and pH adjusted using HCI 
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Figure 2.1: Purification protocols for P450 BM intact and heme domain construct 
not overheat, the beakers containing the cell suspension were kept packed in ice and a 1 
minute cooling period was allowed between each burst of sonication. Cell debris was 
removed via centrifugation at 20 000 rpm for 1 hour at 4 °C (Sorvall RC-B5 centrifuge 
with a SS34 head). The resulting supernatants containing the desired protein were pooled 
and kept on ice prior to purification. A deep red colouring in the supernatant was 
indicative of successful P450 over-expression. 
2.3.2 Column Chromatography: 
All protein purification steps were carried out in a cold-room at 4 °C using purification 
buffer A. 
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The purification profiles for the holo enzyme and heme domain construct are 
different due to the inability of the heme domain to bind NADPH analogues. An outline 
of the main purification steps is shown in figure 2.1. 
ADP Agarose Affinity Chromatography. The 2'5 ADP agarose gel is formed from 2,5 
Adenosine Diphosphate covalently linked to an Agarose matrix (Figure 2.2). The 2'5 
ADP is an analogue of the P450 BM3 cofactor NADPH and hence provides a basis for 
the highly selective binding necessary for affinity chromatography. The required amount 
of freeze dried ADP Agarose 
(- 
2.5 g) was suspended in 50 ml purification buffer A and 
packed under gravity to form a 1 cm diameter column to a height of approximately 10 
cm. The column was equilibrated with 5 - 10 column volumes of purification buffer A. 
Prior to protein loading, a further 2 column volumes of purification buffer augmented 
with protease inhibitor cocktail was passed down the column. The supernatant from the 
lysed cells containing the P450 was loaded onto the column, forming a tight red band at 
the top of the gel matrix indicative of strong binding. The column was washed with 
~a:,osy 
H 









Figure 2.2: Chromatography column Functional groups 	 I 
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a further 5 - 10 column volumes of purification buffer A with negligible migration of the 
bound protein. Elution was achieved with a 10 ml plug of buffer B containing 10 MM 
NADP+. The semi pure protein was collected as it was eluted from the column using a 
Pharmacia fraction collector (50 drops per fraction). The most highly coloured fractions 
were pooled and retained for further purification. 
Regeneration of the ADP agarose column was achieved by washing the column with 5 - 
10 column volumes of purification buffer A. 
Q-Sepharose Strong Anion Exchange Chromatography: A Q-sepharose column is 
comprised of a quaternary ammonium covalently linked to a sepharose gel matrix (Figure 
2.2). At the conditions used in purification, the immobilised ammonium in positively 
charged and hence can bind to negative regions of the protein. The column was prepared 
by pouring approximately 12-15 ml of an ethanol/gel suspension into a 1 cm diameter 
column to a height of-10 ml. After the column material had settled, any excess ethanol 
storage buffer was removed from the top of the column. Equilibration was achieved by 
extensive washing with purification buffer A to ensure no ethanol remained (> 20 colun -m 
volumes). Pooled protein fractions (either intact enzyme from the ADP agarose column 
or desalted heme domain after the DEAE column) were loaded onto the top of the 
column and washed with 5 -10 column volumes of buffer A. A diffuse red band in the 
upper section of the column was indicative of protein binding. Elution was achieved by 
running a linear salt gradient from 0 - 500 mM KC1 (Buffers A and Q. Typically, elution 
of the protein was achieved at —'200 mM KCI. The eluate was collected using a fraction 
collector (50 drops per fraction) and the most highly coloured fractions were pooled. 
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Column regeneration was achieved by washing with 2 column volumes buffer C 
to ensure all bound proteins had been eluted followed by 5 - 10 column volumes of 
purification buffer A. 
DEAE Sep hacel Weak Exchange Chromatography: A DEAE sephacel column is 
essentially the same as the Q-sepharose column. It is comprised of diethylaminoethyl 
groups attached via stable ether linkages to beaded cellulose (Figure 2.2). When 
equilibrated at pH 7.5, the immobilised amino group is positively charged and can 
interact with negatively charged portions of the protein. The nature of the beaded gel 
matrix makes this column material more conducive to purifying crude lysate compared 
with a Q-sepharose column. 
Preparation, running and maintenance are the same as for the Q-sepharose column 
with the exception of column size (diameter: 4 cm, height: 20 cm). 
G-25 Size Exclusion Chromatography: Gel filtration was used to remove the excess salt 
present after elution from either the Q-sepharose or DEAE sephacel columns. The gel 
contains pores of a strictly regulated size which allow small molecules to diffuse into the 
gel from the surrounding solution. The result is that large molecules pass through the 
column relatively quickly while the flow of the small molecules is significantly slowed. 
The required amount (-5 g) of freeze dried G-25 sephadex was suspended in 100 ml of 
buffer A and packed to form a 4 cm diameter column to a height of 20 cm. The resulting 
column was washed with 5-10 column volumes of buffer A prior to use. The pooled 
fraction from either the Q-sepharose or DEAE columns in a volume not greater than 8 ml 
were loaded onto the top of the column and washed though with more buffer A. The salt 
free red fractions were collected and pooled. 
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2.3.3 Dialysis: 
After completion of all chromatographic steps, any residual salt or NADP was 
removed by overnight dialysis (12 kDa exclusion limit) at 4 °C into 5 litres of purification 
buffer A (Table 2.3). 
2.4 Concentration and Storage 
Purified protein was concentrated via centrifugation using a FALCON 6-300 
centrifuge at 2000 rpm and Amicron Centriprep concentrators with a membrane size of 
30 kDa. This process was continued until protein concentration was in the region 200 AM 
- 1 mM. The purified protein was divided into 200 Al aliquots and flash frozen in liquid 
nitrogen. Protein samples were stored at -80 °C until required. 
2.5 Characterisation 
2.5.1 Purity Determination 
The final protein purity was determined by both analysis of UV/vis peak ratios 
and by SDS-PAGE (Sodium Dodecyl Sulfate-Poly Acrylamide Gel Electrophoresis). 
2.5.1.1 Peak Ratios: 
UV/vis spectra were recorded over the range 200 - 800 nm using a Shimacizu 
UV-2 101 PC spectrophotometer and quartz cuvette with a 1 cm path length. Typically 10 
A l of purified protein diluted in 990 jil buffer A was used. Ultimately, the purity was 
assessed by the ratio of the protein and Soret peaks (280 nm and 420 nm respectively) in 
the absorption spectra. The optimum ratio A280:A420 for pure protein was found to be 1:1 
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Figure 2.3: UV-vis spectra showing the Soret peak (420 nm) and protein peak 
(280 nm) for the intact and heme domain constructs of WT P450 BM3. 
for the holo enzyme and 1:2 for the heme domain (Figure 2.3) [116]. 
2.5.1.2 Gel Electrophoresis: 
All SDS-PAGE analysis was carried out using NuPAGE® Novex 4-12 % Bis-
Tris pre-cast polyacrylamide gels in combination with SeeBlue Plus 2® molecular weight 
markers. 
Gel electrophoresis was carried out on both the purified enzyme (to assess the 
purity and integrity of the enzyme) and on the lysed starter culture pellets (to check for 
overexpression). In each case the protocol was the same. The samples were prepared as 
described in table 2.4 and placed in boiling water for 5 minutes to denature the protein. 
The gel electrophoresis tank and pre-cast gel were washed with dH20 and assembled 
ensuring that the central partition containing the gel loading wells was water tight. 
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Table 2.4: SDS PAGE buffers and stains 
Sample Buffer 25 ji l NuPAGE® LDS 4x Sample preparation 
buffer pH 8.4 
25 jil diluted protein sample (>1 	M) or 
25 jA lysed cell pellet (0.03 gml') 
50ldH2O 
Running Buffer NuPAGE® MES SDS 20x Running buffer 
PH 7.0 
Coomassie Stain 50 ml dH20 
40 ml Methanol 
10 ml Acetic Acid 
1 ml Coomasie Brilliant Blue 
Destain 0 ml dH20 
 ml Methanol [40
0 ml Acetic Acid 
Prepared using MilliQ ultrapure water (of resistivity 18 C) cm'). 
Running buffer was added to both the central reservoir and tank. Special care was taken 
to ensure that the buffer in the central reservoir was covering the sample loading wells. A 
10 jil aliquot of each sample was loaded into a separate well, with at least one well 
containing SeeBlue Plus 20 molecular weight markers (10 tl). A voltage (150 V, 120 
mA and 60 W) was applied to the gel for approximately 1 hour. When the dye front 
reached the bottom of the gel, the applied voltage was removed and the gel was placed in 
coomassie stain (Table 2.4) for at least 1 hour. The coomassie stain will bind to any 
protein present and will give an indication of both the presence of the desired protein and 
the extent of any impurities. Excess stain was removed by soaking in destain (Table 2.4). 
Samples containing P450 BM3 intact enzyme or heme domain construct should produce 
bands at 118 kDa and 55 kDa respectively (Figure 2.4). 
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Figure 2.4: Coomassie stained SDS-PAGE analysis of WT P450 BM3. Lanes 1 and 3 
show the intact and heme domain proteins with molecular weights of 118 kDa and 55 
kDa respectively. Lane 3 shows SeeBlue Plus 29 molecular weight markers. 
2.5.2 Enzyme Concentration 
Enzyme concentrations were determined spectrophotometrically using the 
characteristic P450-CO bound complex in conjunction with the extinction coefficient E490 
450 = 92, 000 M'cm'. Calculating P450 concentrations from this species as opposed to 
the native oxidised species negates any errors which would result from the presence of 
P420, non cysteine-bound heme and partially reduced or mixed-spin protein. UV/vis 
spectra were recorded over the range 250 - 800 nm using a Shimadzu UV-210IPC 
spectrophotometer and quartz cuvette with a 1 cm path length. Protein samples (Typically 
10 jzl purified protein in 990 jil buffer A (Table 2.3)) were reduced using excess sodium 
dithionite (Na2S204) and bubbled with CO to form the stable ferrous-CO complex. It was 
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Figure 2.5: UV/vis spectra of oxidised (black), reduced (red) and reduced-CO bound 
(green) WT P450 BM3.The inset shows a close-up of the difference spectra [Fe(II)-
CO] - [Fe(II)]. 
noted during these experiments that the position of the Fe(II)-CO Soret peak was shifted 
in some of the mutant enzymes. The wavelengths used for calculating iAbs. values were 
altered accordingly to account for the movement in the Soret peak. Protein concentrations 
were calculated according to the Beer-Lambert Law (A = Ed) using the difference spectra 
[Fe(II)-CO] - [Fe(II)] and the extinction coefficient shown above. The relevant spectra 
are shown in Figure 2.5. 
2.5.3 Heme Content 
Clearly, the mutant constructs used in these experiments are all centred around the 
heme group at the active site of the enzyme. This creates sufficient concern as to the 
integrity of the heme itself. The failure to incorporate heme could result in altered 
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activities and as such, heme content must be assessed via the pyridine hemochrome 
assay. 
Table 2.5: Herne Content 
Buffer A 	 20 mM MOPS 
100 mM KCI 
pH 7.5 
Reagent A 	 0.2 ml % M NAOH 
2.5 ml pyridine 
2.3 ml H 20 
Prepared using MilliQ ultrapure water (of resistivity 18 0 cm') and p1-I adjusted using HCI 
Each enzyme sample (-5 iM) in assay buffer A (20 mM MOPS, 100 mM KC1 
pH 7.5) was diluted in equal volumes with the pyridine hemeochrome reagent A (Table 
2.5). The resulting solution was mixed thoroughly and reduced through the addition of 
minimum amounts of sodium dithionite (10 Itl 5 mg/mi Na2S204). A spectrum of the 
reduced pyridine structure was recorded and heme concentrations were calculated using 
A8556540 = 22, 100 M'cm 1 . Comparison of the P450 concentration calculated from the 
Fe(II)-CO species with the heme concentration calculated from the pyridine 
hemeochrome assay [117] gives an indication of heme incorporation. In all cases, 
concentrations derived for the pyridine hemeochrome assay and CO binding assay were 
in good correlation. 
2.6 Fatty-acid Binding 
Flavocytochrome P450 BM3 is a long-chain fatty-acid hydroxylase. The most 
commonly studied substrates for this enzyme are arachidonate and laurate (1.9). The 
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Table 2.6: Assay Buffers 
Buffer D 
Buffer E 
20 mM MOPS 
100 m KCI 
pH 7.5 
20 mM MOPS 
100 m KCI 
1 mM Sodium Laurate 
pH 7.5 
Prepared using MilliQ ultrapure water (of resistivity 18 n em") and pH adjusted using HCI 
addition of substrate causes the displacement of axially bound water from the heme 
resulting in a change in both geometry and spin state. These changes can be monitored 
spectrophotometrically as a shift in the absorption maxima from 420 nm to 390 nm 
(Figure 2.6). 
2.6.1 Measurement of Dissociation constants 
Arachidonate Binding Titrations: UV/vis spectra were recorded at room temperature over 
the range 250 - 800 rim using a shimadzu LTV-2101 PC spectrophotometer and quartz 
cuveue with a path length of 1 cm. Small aliquots of arachidonate (5 mM etanol stock) 
were added sequentially, using a Hamilton gas tight 10 Al syringe, to a 1 ml enzyme 
solution (typically 5-10 AM P450 in buffer D) up to a volume not exceeding 5 jzl ethanol 
(25 A M arachidonate). Spectra were recorded after each addition and difference spectra 
{Fe(III)} - Fe(III) ± sub} were generated. Dissociation constants (Kj) were calculated 
by plotting the maximal absorbance changes (AAAbs. 420 390) against substrate 
concentration and fitting to a rectangular hyperbola using Microcal Origin 7.0 software 
(Figure 2.6). 
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Figure 2.6: Fatty-acid binding titrations. Panel A shows the absolute spectra after 
each addition of substrate. The inset shows the difference spectra. Panel B shows an 
example of the plot of AAbs. 420.390 vs. substrate concentration. 
Laurate Binding Titrations: Due to the insoluble nature of sodium laurate, a different 
method was used for calculating the dissociation constants (K u). Two solutions were 
prepared, each containing identical concentrations of enzyme (5-10 AM) but with only 
one containing 1 mM laurate (buffer E). A I ml sample of the laurate free solution was 
placed in a quartz cuvette and the IJV/vis spectrum was recorded. Small aliquots (25 - 
100 tl) of the P450 solution were removed from the reaction mixture and replaced with 
corresponding aliquots from the 1 mM laurate solution. The resulting changes in the 
absorption spectra were recorded after each substrate addition. Dissociation constants 
were calculated from the absorbance changes as described above. 
1.0 
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2.6.2 Measurement of Relative Spin State Shifts 
Substrate induce spin state shift measurements were carried out at 15 °C in assay 
buffer D (20 mM MOPS, 100 mM KC1 pH 7.50) using a quartz cuveue with a path length 
of 1 cm. Maximum spin state shifts were generated through the addition of saturating 
concentrations of arachidonate (5 .i1 from a 30 mM ethanolic stock 120 ptM final 
concentration) to low spin oxidised enzyme. Spectra were recorded before and after the 
addition of substrate. Approximate spin state shifts were calculated by comparing the 
concentration normalised difference spectra {(oxidised + substrate) - (oxidised)} for each 
of the mutant enzymes with the difference spectrum for wild-type. Spin state shifts were 
expressed as the percentage spectral shift compared to wild type. This process makes the 
assumption that WT is 100% high spin. 
2.7 Steady-State Kinetics 
All steady-state kinetics experiments were carried out at 15 °C. Typically, enzyme 
concentrations were - 200 nM in lml assay buffer D. Turnover was initiated through 
addition of NADPH (10 t1 from a 16 mM stock - 160 p.M final concentration). Initial 
rates of NADPH consumption were assessed in the presence of varying concentrations of 
laurate ([laurate] = 0, 10, 30, 50, 100, 200, 500, 1000 p.M) by monitoring the fall in 
absorbance at 340 nm corresponding to NADPH oxidation (E340 = 6,210 M' cmj. 
Varying laurate concentrations were achieved by dilution of 1 mM laurate buffer E by 
assay buffer D. Steady-state kinetics samples were allowed to equilibrate in a water bath 
at 15 °C prior to use. Observed rates expressed as activities (mol NADPH oxidised per 
second per mol enzyme) were plotted against laurate concentrations. The rate constants 
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Figure 2.7: Steady State Kinetics Analysis. Panel A shows the decreasing absorbance 
at 340 nm associated with NADPH oxidation at different concentrations of laurate. 
Panel B shows a standard Michaelis-Menten plot of observed rates against 
concentration of substrate allowing the calculation of the rate constant (k cat) and 
Michaelis constant (K m) 
kcai and Michaelis constants Km were determined by fitting the data to the Michaelis-
Menten equation (Microcal Origin 7.0) (Figure 2.7). The observed rate constants at 
saturating concentrations of arachidonate (ksat) were determined in an analogous method 
to that described above. Initial rates of NADPH oxidation were measured in the presence 
of saturating concentrations of arachidonate (- 120 tM) and converted to activity units. 
2.8 Steady-State Kinetics Using Artificial Electron Acceptors 
Steady state kinetic analysis was performed on the intact enzyme for WT and the 
mutant enzymes F393A, Q403K, Q403A, F393A1Q403K and F393A1Q403A in order to 
asses the ability of the FAD and FMN components of the reductase to transfer electrons. 
All steady-state kinetics experiments were carried out at 15°C using a Shimadzu UV-
2101PC spectrophotometer and quartz cuvette with a path length of 1 cm. Typically, 
enzyme concentrations were - 200 nM in lml assay buffer D (20 mM MOPS, 100 mM 
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KC1 pH 7.5) in the absence of substrate to ensure minimal heme reduction. Turnover was 
initiated through addition of NADPH (10 p.1 of 16 p.M) and NADPH oxidation was 
monitored as above. Initial rates of NADPH oxidation were measured at varying 
concentrations of both ferricyanide (0.1, 0.2, 0.5, 1, 2, 4, 6, 8 and 10 mlvi) and 
cytochrome c (1, 2, 5, 10, 20, 30, 50, 70 and 100 MM). Steady-state kinetics samples were 
allowed to equilibrate in a water bath at 15 °C prior to use. Observed rates were plotted 
against concentration of artificial electron acceptor and fitted to the Michaelis-Meten 
equation in order to generate values of k eat and Km as described previously. 
2.9 Coupling Efficiencies 
2.9.1 Horse radish Peroxidase/o-Dianisidine Assay 
The degree of uncoupling to peroxide for each of the enzymes studied was 
determined by comparing [NADPH] consumed to [H 202] produced under normal assay 
conditions [118]. A catalytic amount of P450 (- 0.2 p.M) was added to a reaction mixture 
containing a saturating concentration of substrate and limiting concentration of NADPH 
(buffer D: 20 mlvi MOPS, 100 mM KC1 pH 7.4,[arachidonate] 120 p.M, [NADPH] = 50 
p.M). Absorption spectra were recorded immediately before addition of the enzyme to 
calculate the exact initial concentration of NADPH = 6210 M'cm) and several 
minutes after addition of the enzyme to ensure its complete oxidation. The resulting 
peroxide generated through the uncoupling pathway was then determined through the 
addition of horse radish peroxidase (10 p.! of 5 mgmF') and o-dianisidine (40 p.1 of 8 
mlvi). Horse radish peroxidase uses stoichiometric amounts of peroxide and o-dianisidine 
as cofactor and substrate respectively to generate a blue radical cation with an extinction 
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coefficient of E 440=1 1.6 mIvF 1 cm 1 . The concentration of o-dianisidine radical cation and 
hence concentration of peroxide were calculated using the Beer-Lambert law. The degree 
of uncoupling to peroxide was calculated from the ratio of [NADPH]:[H202]. Quoted 
values of percentage uncoupling to peroxide are the average of three separate 
experiments. 
2.9.2 Negative-Ion Electrospray Mass Spectrometry 
The coupling of NADPH to product was calculated for each mutant and wild type 
by analysing the relative amounts of unreacted substrate and hydroxylated product after a 
NADPH limited turnover assay using mass spectrometry. Turnover assays were carried 
out using catalytic amounts of enzyme, saturating concentrations of substrate and limiting 
concentrations NADPH (typically 0.05 p.M enzyme, 120 p.M AA, 70 p.M NADPH in 
buffer D 20 mM MOPS, 100 niM KC1 pH 7.50). Under these conditions, NADPH 
consumption can be ascribed solely to product formation or unproductive reduction of 
oxygen. After the reaction was complete, the sample was diluted 1:1 with 20 MM 
ammonium acetate. Mass spectrometry (Micromass Platform electrospray mass 
spectrometer) was used to assess the ratio of unreacted substrate (mlz 303) to 
hydroxylated product (mlz 319). Initial concentrations of NADPH were calculated from 
the absorbance spectrum using the extinction coefficient €340=6210 M 1 cm 1 . The degree 
of coupling was calculated from the expected ion count from 100% coupling of NADPH 
to product compared to the observed ion count for hydroxylated product. Quoted values 
of percentage coupling are the average of three separate experiments. 
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2.10 OTTLE Potentiometric Titrations 
All OTTLE (Optically Transparent Thin Layer Electrode) potentiometric 
titrations were carried out at 25 °C using a Cary UV/vis spectrophotometer and Autolab 
PGSTAT 10 potentiostat. In each case the Fe(II)/Fe(III) redox couple was investigated for 
Table 2.7: OTTLE Titration Buffers 
Buffer F 50 mM Tris 
500 mM KC1 
10% glycerol 
pH 7.5 
Buffer  50 	m Ins 
500 mM KC1 
pH 7.5 
Buffer  50 mM Tns 
500 mM KCI 
1mM Laurate 
pH 7.5 
Prepared using MilliQ ultrapure water (of resistivity 18 0 cm') and pH adjusted using HCI 
Table 2.8: OTTLE Titration Mediators 
Mediator Em (mV) vs SHE 
1,2-Napthoquinone + 135 
Pyocyanine + 80 
Phenazine Methosulfate + 30 
Phenazine Ethosulfate + 55 
2-Hydroxy-I,4-Napthoquinone - 145 
Flavin Mononucleotide - 200 
Benzyl Viologen -310 
Methyl Viologen -430 
Prepared using MilliQ ultrapure water (of resistivity 18 0 cm') and pH adjusted using HCI 
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the heme domain construct only. Holo P450 BM3 was not used in order to avoid the 
complex redox chemistry associated with the multiple redox states observed for the 
flavins. A list of buffers and mediators are shown in tables 2.7 and 2.8. 
For all enzymes studied, midpoint potentials (E m) were calculated in the absence 
and presence of saturating concentrations of arachidonate (120 MM). In addition, 
midpoint potentials for WT and F393W were calculated in the presence of saturating 
concentrations of laurate. Em values were also calculated in the presence of CO (+1-
arachidonate) for WT, F393H, T268A, T268N, F393H/T268A, F3931-I1T268N, F393A, 
F393W and F393Y. Although sample preparation varied between each of these 
experiments, the method for setting up and running the experiment and evaluating the 
data were the same in each case. 
2.10.1 Sample Preparation: 
All samples for OTTLE titration were prepared in a Belle Technology glove box 
under a nitrogen atmosphere, with 02 levels maintained at < 5 ppm. All buffers were 
degassed prior to use by bubbling with nitrogen gas for >1 hour. Enzyme samples were 
introduced to the box and allowed to degas under the nitrogen atmosphere for at least 1 
hour prior to use. 
Substrate Free: A sample of concentrated pure enzyme (> 300 M) was diluted to 100-
150 jtM in 0.5 ml OTTLE buffer F. In order to equilibrate the buffer and to remove any 
remaining oxygen, the protein was run down a pre-equilibrated (buffer F) G-25 size 
exclusion column generating approximately 1 ml of 50-75 1W enzyme. 
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Arachidonate Saturated: Sample preparation is essentially the same for the substrate free 
sample except that the G-25 column was pre-equilibrated with buffer F, augmented with 
120 jiM arachidonate. 
Laurate Saturated: Due to the insoluble nature of laurate, enzyme samples of the 
appropriate concentration necessary for the OTTLE experiment (1 ml of 50-75 jiM) were 
dialysed into 5 liters buffer H (saturated with 1 mM laurate) over a period of 24 hours (2 
ml slide-a-lyzer cassette, molecular cut-off 20 kDa). Laurate saturated enzyme samples 
were introduced to an anaerobic glove-box, placed in a 'cool-pack' and allowed to 
equilibrate overnight to ensure no oxygen was present. 
Potentiostat 
Reference 




hv 	 JV/vis detector 
Figure 2.8: OTTLE cell showing a diagrammatic representation of the potentiostat 
and electrodes. 
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Figure 2.9: Panel A shows the changes in spectra observed during reduction and - 
reoxidation of P450 BM3. Inset shows the difference spectra {oxidised}- {reduced}. 
Panel B shows a current vs. time plot for reduction and re-oxidation. Panel C shows a 
plot of proportion reduced vs. applied potential and the le- Nernst plot fit for this data. 
Panel D shows the Nernst equation. 
CO saturated (+1- substrate): Concentrated enzyme samples (>600 M) were run down 
a G-25 size exclusion column equilibrated with OTTLE buffer E to exchange buffers 
prior to being introduced to the anaerobic glove box. Enzyme samples were then allowed 
to equilibrate overnight to ensure no oxygen was present. OTTLE samples were prepared 
by diluting the neat enzyme in CO saturated buffer E in the presence and absence of 
arachidonate (120 j.M). CO saturate buffer E was generated by bubbling a sealed sterelin 
tube with CO for -5 minutes. 
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2.10.2 Mediators: 
Mediators (Table 2.8) were introduced into the anaerobic box as powdered 
samples and dissolved in degassed buffer F to a concentration of -2 mM. An appropriate 
selection of mediators spanning the estimated midpoint potential for each titration were 
chosen and added to a concentration of-2 pM. 
2.10.3 Potentiometry: 
A specially constructed cell comprised (Figure 2.8) of a modified quartz EPR cell 
with a path length of 0.3 mm, Pt/Rh (95/5) gauze working electrode (wire diameter 0.06 
mm, mesh size 1024 cm', Engelhardt, UK), platinum wire counter electrode and a 
Ag/AgCl reference electrode (model MF2052, Bioanalytical Systems, IN 47906, USA) 
was used. Enzyme samples were injected into the lower part of the cell using a Hamilton 
0.1 mm leur lock syringe. The remainder of the cell was filled with OTTLE buffer G. 
Special care was taken to ensure that the interface between the enzyme sample (10 % 
glycerol) and non glycerol buffer did not undergo any mixing. The lower part of the cell 
was placed into a carry 50 Probe spectrophotometer so that changes in the spectra could 
be observed. The potential was applied using a Autolab PGSTAT potentiostat via a Pt/Rh 
(95/5) (wire diameter 0.06 mm, mesh size 1024 cm 1 , Engelhardt, UK) gauze working 
electrode, platinum wire counter electrode and Ag/AgC1 reference electrode (model 
MF2052, Bioanalytical Systems, IN 47906, USA). An initial potential more positive than 
the approximate reduction potential was applied and lowered in 50 mV steps until 
reduction was achieved. The enzyme samples were allowed to equilibrate before the 
potential was moved on and spectra were recorded at each applied potential. Oxidation 
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was achieved by raising the potential in 50 mV steps, offset by 25 mV relative to the 
reductive trace. Difference spectra were calculated and the maximum absorbance changes 
associated with a change in the redox sate were plotted against applied potential (vs 
SHE). Em values were determined by fitting the data to the Nernst equation (Microcal 
Origin 7.0) (Figure 2.9). 
The Ag/AgC1 reference electrode was calibrated against indigotrisulfonic acid (Em 
= -99 mV vs SHE) and FMN (Em = -220 mV vs SHE). Applied potentials were corrected 
relative to the standard hydrogen electrode where {(potential AgIAgC1) + 205 mV} = 
{potential SHE}. 
2.11 Pre-Steady-State Kinetics 
Pre-steady-state kinetic measurements were all carried out at 15 °C using an 
Applied-Photophysics stopped-flow spectrophomoter (SX. 1 7MV) in conjunction with 
either a single wavelength or diode-array detector. The stopped flow apparatus was 
housed within an anaerobic glovebox (Belle Technology; [021 <5 ppm). Typically, the 
final concentration of enzyme used for all pre-steady state kinetic experiments was 5 
.tM and saturating concentrations of arachidonate were - 120 .tM. CO saturated buffers 
were generated by bubbling sealed containers with CO gas for 5 minutes. Aliquots of CO 
saturated buffer were removed via a rubber septum and syringe to ensure the [CO] 
remained relatively constant. 
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2.11.1 Heme Reduction Kinetics 
Rate constants for the first electron transfer from NADPH through the reductase 
domain to ferric heme in the presence and absence of substrate (arachidonate) were 
determined by monitoring the accumulation of the dead-end ferrous CO complex. The 
intact form of the enzyme in CO saturated assay buffer (20 mM MOPS, 100 mM KC1 pH 
7.50, [CO] 200 p.M) was mixed with a solution of NADPH (- 200 .tM) in CO saturated 
buffer using a stopped flow apparatus. The experiment was carried out in the presence 
and absence of saturating concentrations of arachidonate. The subsequent absorbance 
changes at 450 rim were monitored using a single wavelength detector. Due to differences 
in the Fe(II)-CO peak position for individual mutants, data were analysed at the following 
wavelengths; WT 449 nm, F393H 445 run, T268A 449 nm, T268N 450 nm, 
F393H1T268A 445 nm, F393H/T268N 447 nm, Q403A 449 run, Q403K 449 mn, 
F393A1Q403A 447 nm and F393A1Q403K 447 run. Generated traces were fitted to single 
or double exponentials using Microcal Origin 7.0 software. Substrate free experiments 
were monitored using both diode array and single wavelength detectors. However, 
electron transfer in the presence of substrate could only be monitored using the single 
wavelength detector as it would occur within the dead time of the diode array apparatus. 
The presence of multi phase data for the substrate free heme reduction was rationalised 
through the incomplete formation of the ferrous CO complex and through the presence of 
small quantities of substrate and/or substrate like contaminants. Absorbance changes for 
substrate saturate heme reduction were indicative of full conversion to Fe(II)- CO. 
Quoted rate constants are the average of three separate experiments. An example of the 
spectral changes seen on heme reduction is seen in figure 2.10. 
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Figure 2.10: Steady-state heme reduction kinetics: Panel A shows the change in 
absorbance over time associated with the I electron reduction of P450 heme by 
NADPH (black line) and the single exponential fit (red line). Panel B shows the 
initial and final spectra observed. The black line corresponds to the oxidised intact 
enzyme. The red line corresponds to the reduced CO-bound species. The large peak 
at 340 nm is a result of the presence of NADPH. Inset shows all measured 
intermediate spectra. 
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Figure 2.11: Steady-state oxy-ferrous decay kinetics: Panel A shows the change in 
absorbance over time associated with the decay of the P450 oxygen bound species 
(black line) and the single exponential fit (red line). Panel B shows the initial and final 
spectra observed. The black line corresponds to the iron-oxo species. The red line 
corresponds to the ferric species. Inset shows all measured intermediate spectra. 
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2.11.2 Autoxidation Kinetics 
Rate constants for the decay of the oxy-ferrous complex to the ferric from in the 
presence and absence of substrate (arachidonate) were evaluated using the diode array 
stopped flow apparatus. Pre-reduced heme domain (excess dithionite removed via gel 
filtration on a G-25 size exclusion column) was fired against oxygen saturated buffer D 
([021 200 .tM) using the stopped flow apparatus and the formation and subsequent 
decay of the oxy-ferrous species were monitored over the range 250-800 nm using a 
diode-array detector. Typically the formation of the oxy-ferrous species was so rapid that 
it was completed within the dead time of the stopped flow apparatus. Absorbance 
changes at 460 nm associated with oxy-ferrous decay were plotted against time and fitted 
to single exponentials using Origin 7 software. Quoted rate constants are the average of 
three separate experiments. An example of the typical spectral changes seen on oxy-
ferrous decay is seen in figure 2.11. 
2.11.3 Flavin Reduction Kinetics 
2.11.3.1 FAD and FMN Reduction 
Rate constants for the 2-electron reduction of FAD and the 1-electron reduction of 
FMN were measured for WT and the mutant enzymes Q403K and F393A1Q403K using 
the stopped flow apparatus. Oxidised P450 (30 pM) in CO saturated buffer D (20 mM 
MOPS, 100 mM KC1 pH 7.5, [CO] = 200 tiM) was fired against excess NADPH (-420 
pM) in CO saturated buffer D using the stopped flow apparatus. In the absence of 
substrate, the rate constants for first electron transfer (- 0.2 1)  are significantly slower 
then either rate constants for FAD or FMN reduction (— 10-600 s - 1 ) and as such should not 
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Figure 2.12: Steady-state flavin kinetics: Panel A shows the change in absorbance 
over time associated with the reduction of the FAD and FMN (black line) and the 
double exponential fit (red line). Panel B shows the spectra observed by the diode 
array. Inset shows the spectra of the flavins only with a baseline to the reduced heme. 
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be seen over the timescale of these experiments. The addition of CO to the reaction 
mixtures ensures that any heme reduction is easily identifiable through the formation of 
the characteristic Fe(II)-CO peak at 450 nm. Data were recorded with both diode array 
and single wavelength detectors. While diode array data integration times (0.0025 s) were 
not small enough to generate accurate rate constants, it proved useful in showing the full 
reduction of the flavins (bleaching of broad band 450-500 nm) and the formation of any 
reduce heme. Data from the single wavelength detector at 455 nm showing the biphasic 
reduction of the two flavins were fitted to double exponentials using Origin 7.0 software 
(Figure 2.12). Quoted rate constants are the average of three separate experiments. When 
the flavins are reduced their spectrum is bleached. This allows us to subtract the spectrum 
of the heme after flavin reduction from all other spectra in order to more accurately 
observe the changes associated with flavin reduction (Figure 2.12). 
2.11.3.2 The effect of Ionic Strength on Flavin Reduction 
In order to assess the effects of increasing ionic strength on flavin reduction, the 
above experiment was carried out over a range of salt concentrations. The salt 
concentrations used were 10, 20, 30 50, 70 and 100 mM MOPS @ pH 7.5. The 
experimental protocol was exactly the same as describe above. 
2.12 Pre Steady-State Multi-Mixing Kinetics 
All Pre-steady-state multi mixing kinetic measurements were all carried out at 
15°C in assay buffer D (20 mM MOPS, 100 mM KC1 pH 7.5) using an Applied-
Photophysics stopped-flow spectrophotometer (SX.17MV) in conjunction with either a 
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single wavelength or diode-array detector. The multi-mixing apparatus consists of two 
separate rams each controlling the injection of two syringes allowing the initial formation 
of a transient species and the subsequent reaction of this species with another reagent. A 
diagram showing the separate phases of this type of experiment is shown in figure 2.13. 
The syringes are marked A and B (initial reactants) and C and F (the third reactant C and 
flush solution F). Each ram is set to a total volume of 200 Al (100 Al from each syringe). 
The first ram fires reactants A and B together into an ageing loop (volume 200 Al). The 
lag time between the first and second rams can be altered (10 - 1000 ms) according to the 
time necessary to form the intermediate species. The second ram flushes the aged mixture 
from the ageing loop and subsequently mixes this species with the third reactant C. As 
the flush only displaces 100 Al of the aged species to react with 100 Al reactant C, the 
ratio of each reactant is 1:1:2 (A:B:C). After the second ram, the resulting spectral 
changes can be observed using either diode array or single wavelength detectors. 
2.12.1 P450 2nd  Electron Transfer 
Second electron transfer rates for addition of an electron to the oxy ferrous 
species were measured by stopped-flow multi-mixing experiments in both the presence 
and absence of saturating concentration of arachidonate (120 AM). The experiment was 
carried out on P450 BM3, WT, F393H, F393A, F393W, F393Y, T268A, T268N, 
F393H1T268A and F393H/T268A. Stoichiometric amounts of pre-reduced P450 heme 
domain in buffer D (pre-reduced with dithionite, excess removed via G25 gel filtration 
column) and oxygenated buffer (Typically 40 AM starting concentration, 10 AM final 
concentration) were fired against each other in order to generate the oxy-ferrous species 
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Figure 2.13: Protocol for firing a multi-mixing stopped flow experiment. Panel A 
shows the four syringes A, B, C and F full and ready to fire. Panel B shows the 
positions after the first drive mixing A and B into the ageing loop. Panel C shows 
the positions after the second drive with the flush F forcing the aged species (AB) to 
mix with C. The ratios of each reactant (A:B:C) after the final drive are 1:1:2. 
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Figure 2.14: Reaction profile of a 2 d  electron transfer multi-mixing experiment. 
The first drive mixes the Ferrous species (A) with oxygen (B) to form the oxy -
ferrous species in the ageing loop. The second drive mixes this iron oxo species 
with the artificial electron donor methyl viologen (C) to generate the iron peroxy 
species. 
as described in section 2.10.2. The reaction mixture was aged long enough to ensure full 
formation of the oxy-ferrous species, but short enough to ensure that no significant 
amount of decay to the ferric form had occurred (Typically 250 ms). The second ram 
delivered stoichiomethc amounts (20 jtM starting concentration, 10 jiM final 
concentration) of methyl viologen in order to reduce the oxy-ferrous complex. The 
resulting absorbance changes were recorded using both single wavelength and diode 
array detectors. Rates of oxy-ferrous reduction (and subsequent reactions) were 
monitored at 455 rim and fitted to a multiple phase kinetic equation using SPECFIT/32 
software. Rates of methyl viologen oxidation were monitored at 600 nm and fitted to 
single or double exponentials using Microcal Origin 7.0. 
The second-electron transfer experiment for WT, F393H and F393H!T268N P450 
BM3 were carried out at varying concentrations of methyl viologen to assess the effect on 
the observed rate constants of each of the observed phases. The concentrations used were 
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2, 5, 10, 15, 20 and 30 liM final concentration MV (IOM P450, 10M 02 final 
concentrations) 
2.12.1.1 Reactant Concentrations 
P450 heme domain concentrations were calculated as described previously. 
Methyl viologen concentrations were calculated using a carry 50 UV/vis 
spectrophotometer with a 1cm quartz cuvette contained within an anaerobic glove box. 
The appropriate concentration of methyl viologen was achieved by dilution of an 
electrochemically reduced stock solution (3 M). Absolute concentrations were calculated 
using the extinction coefficient e600= 13,000 M 1 cm 1 . 
Oxygen concentrations were determined using a carry 50 UV/vis 
spectrophotometer with a 1cm quartz cuvette contained within an anaerobic glove box. 
Assay buffer D (not degassed) was introduced into the box in sealed 2m1 cryo-vial 
containers. One buffer sample was used for each experiment to ensure 02 concentrations 
were uniform. A solution of methyl viologen (20 jIM) was prepared and the spectrum 
was recorded. 20 Al of the oxygenated solution was injected into the cuvette and the 
spectrum was recorded again. Oxygen concentrations were assessed from the difference 
of the two spectra at 600 nm (using 6600 = 13,000 M'cm') assuming that 4 methyl 
viologen molecules are required to provide the 4 electrons necessary to reduce oxygen 
to water. 
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Figure 215: Multi-mixing second-electron transfer: Panel A shows the changes in 
absorbance associated with transformations in the heme and 455 rim (black) and 
oxidation of methyl viologen at 600 rim. (green) along with their single exponential 
fits (red). Panel B shows the initial (0.02 s) and final (2s) spectra in black and red 
respectively. Inset shows all intermediate spectra. 
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2.12.1.2 Control Experiments 
Rates constants for the reduction of both oxygen and heme by methyl viologen 
were calculated by single mixing stopped-flow kinetics. For oxygen reduction, 
stoichiometric amounts of oxygen and methyl viologen in buffer D were fired against 
each other (typically 20 jzM of each). As oxygen itself has no visible spectrum, oxygen 
reduction was monitored as the oxidation of methyl viologen at 600 rim. Herne reduction 
by methyl viologen for WT and F393H hd enzymes was monitored by firing varying 
concentrations of viologen (5, 10, 20, 40 jIM) and heme against each other. Herne 
reduction was monitored as the decrease in absorbance at 455 run. Generated absorbance 
changes were plotted against time and fitted to single or double exponentials using 
Microcal Origin 7.0. 
Prior to every multi-mixing experiment, oxy-ferrous formation and decay were 
checked in the multi-mixing, multiple ram setup. These experiments were essentially the 
same as described for measuring the 2'' electron transfer except that the methyl viologen 
was replaced with assay buffer F and the ageing time was set to —20 ms. Under these 
conditions the formation and decay of the oxy-ferrous species was observed allowing 
more accurate calculation of the necessary ageing times for the second electron transfer 
experiments. An example of the spectral changes seen on oxy-ferrous reduction is seen in 
figure 2.15. 
2.12.1.3 FMN to Heme Electron Transfer 
In order to measure the rate constants for electron transfer from the 1-electron 
reduced FMN to heme in WT, Q403K and F393A1Q403K, multi-mixing pre steady state 
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kinetics were used. Initially, intact enzyme (20 1tM) in CO saturated assay buffer D, was 
fired against NADPH (100 jIM) in CO saturated assay buffer D. In the absence of 
substrate, reduction of the flavins is fast in comparison to reduction of the heme. Ageing 
times were calculated from the flavin reduction kinetic measurements described above to 
ensure complete FAD reduction and the formation of the FMN semiquinone. Under these 
conditions, the 1-electron reduction of FMN is fast whereas the 2-electron reduction is 
comparatively slow. The second ram introduced excess substrate (120 M) in CO 
saturated assay buffer D to the flavin reduced enzyme sample initiating electron transfer 
from FMN to heme. Herne reduction rates were monitored as an increase in the 
absorbance at 449 nm associated with the formation of the ferrous-CO complex. 
Generated kinetic traces were fitted to a single exponential using Microcal Origin 7.0. An 
example of the spectral changes seen on heme reduction are seen in figure 2.16. 
2.13 Crystallography (with Dr. Chris Mowat): 
Crystals of T268N, T268A and Q403 K cytocbromes P450 BM3 were obtained 
by the hanging drop vapour diffusion method at 4 °C in Limbo plates. Crystals were 
obtained with a well solution comprising 100 mM sodium PIPES, pH 6.0 - 7.5, 40 mM 
MgSO4, and 18 - 21 % PEG8000. Hanging drops of 4 p.L were prepared by adding 2 L 
of 40 mg/ml protein (in 50 mM TrisHCII 1 mM EDTA, pH 7.4) to 2 p.L of well solution. 
Plates of up to 1 x 0.3 x 0.3 mm were formed after approximately 1 week. Crystals were 
immersed in well solution containing 23 % glycerol as a cryoprotectant, prior to 
mounting in nylon loops and flash-cooling in liquid nitrogen. For the T268A, T268N and 
Q403K enzymes, data sets were collected to 1.9 A and 1.8 A and 1.9 A 
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Figure 2.16: FMN to heme electron transfer: Panel A shows the change in 
absorbance associated with heme reduction as measured by the formation of the 
Fe(II)-CO complex at —450 rim. (black line) and the single exponential fit to this 
data (red line). Panel B shows the spectral changes associated with heme reduction. 
The inset shows the same reaction performed in the absence of substrate 
highlighting the slow rate of electron transfer at this time scale. 
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resolution respectively. Data were collected at SRS Daresbury, at station 14.1 for the 
T268A enzyme (X = 0.9831 A), station 14.2 for T268N () = 1.488 A), station 9,6 for 
Q403K (X = 0.979 A). All data were collected using an ADSC Quantum-4 CCD detector. 
Crystals of all mutant enzymes were found to belong to space group P2 1 . Crystals of the 
T268A enzyme were found to have the following cell dimensions: a = 58.727 A, b = 
152.962 A, c = 61.732 A, and/9 = 94•37 O•  Those of the T268N enzyme had the following 
dimensions: a = 58.876 A, b = 153.241 A, c = 61.607 A, andfl = 94.48 0  Crystals of the 
Q403K mutant enzyme had cell dimensions of: a = 58.753 A, b = 152.792 A, c = 61.5.04 
A. Data processing was carried out using the HKL package [119]. The wild-type 
flavocytochrome P450 BM3 heme domain structure (PDB ID 2HDP) [18], stripped of 
water, was used as the initial model. Electron density fitting was carried out using the 
program TURBO-FRODO [120]. Structure refinement was carried out using Refmac 
[82]. The atomic coordinates for T268A and T268N have been deposited in the Protein 
Data Bank (1YQO:T268A; 1YQP:T268N). 
3. 
The Role of 
Threonine 268 
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3 The Role of Threonine 268 
3.1 Introduction 
There are many differences between individual P450s in terms of redox cofactors 
[50-53,121-122], substrates [26] and sequence [29]. However there are also a number of 
conserved features found throughout the P450 super-family, including the overall fold 
and tertiary structure [102]. In addition it is apparent from sequence alignments that there 
are several highly conserved residues [102] (Figure 3.1). Of these conserved residues, a 
threonine [123-124] (Threonine 268 in P450 BM3) located at the distal side of the heme 
has been associated with a variety of roles including oxygen activation [46,125], proton 
delivery [126-129], substrate recognition [130-131], electron transfer [132] and the 
Conserved Threonine 
240 	 230 	 260 	 270 	 260 	 290 	 300 
P450310 	 . 	flH 	- rT -, .j Ifl - 3. -
J.'JPev 
	H 
CYP51 F 1 	 3'FF. 	iT 	 HH 3 (5TH. WiT. 51 V H. L[L1H. 
P4502E4 	I V Y L RI KS 	33 HF H H LI ILl LS F 	I 	IT S 3FL II H V H Sr IQ IC S 
C3A4 L 	r 	s 	I ISHRH.LSDL ILl AQ 	IFS Y S 	1  
P450e..m 3.H6 VN.Z 	TH IANRM(SIT 	C. 	V' '4F SIFF F 	S 	r iN
Onor 	. . . . I 	KQ F ... L , JALc .kJ 	 F\ NVNKIAL A IJ 
conj.nau5O .dll.i..n.kdq. ....... sly. .1.livaG.sTtsi.f.l . .qkiq.s.d.v..d 
310 	 320 	 330 	 340 	 330 	 360 
P450310 	F, VT­ . .flKQVKKV, I 	'W1TH.R?.F3LfAKE I 	3]YFE 	I vL:pLH 	K'I 
CYP51 )L. 	H.NLR.IIFN_ NIL 	I 	H 	:1_MFVIAcL 	 RI.- H 	. .M .;ASPAI: 	ii ElI F 
P450234 	N2i IALDZHAK 5 1 j 	H Q 4LIRFGVFHI'/T 	TFRY 	P NT 	PVLSSA .1 H 
CYP3A4 . J FT DTVL H - T 	F .IAt'.RLE rC IN NF P WV IPSYAL 	 3 
P450ca 	 ............ ...(JP'A 	 J .Sl VASC.JSISYFH V - K 	 LFQML.III 	.FF H P45Oncr L_JK N_N 	S N 	N F 
cona.nsus,50 	p 	y. 	.qa y.d vvnr.].Rl.p ........... sdvs.gq. .i.kgd.v ....... rd.p. f. 
Heme Binding Region 
370 	 360 	 390 	 400 	 410 	 420 	 439 
P450BM3 	 VL F 	ENE ... 	I: . .H. HN 	1 - 	 CH 	•E .. 
CYPSS I 	 REU. INk 	I 	S K k 	i M. KIA svl s . EMI r SLY11U 
P450234 	3 	1 :H LDANG.AJNEC II K 	I 	ST 	Fl F 11311 	.s:Asp' P I 
CYP3A4 K I 	SKKNK.LN ICE-H 	1 	5 P IN 	S H 	LY, RI A  SHIV - 	.5 .FIC L1<
P450cm 	3 	r- . ........CSqVSI. . .II 	IL I 	ilL SR :ZT IKH!R TR:P 	51 	S K 
P4SOnor .. . . . . . . 	3- 	- RI. 	_j _' 	PJRV I T 
cona.naus50 ape. fdp.rf ........i tf p?g.G.h Cigq.fA. .01 lvi 	ilqnf.df. ...p. .qi.l. 
Figure 3.1: Section of sequence alignments for P450 BM3, P450 2134, P450cam, 
P450nor, cyp 51 and cyp 3A4 showing the conserved residues highlighted in red. The 
highly conserved active site threonine (268 in BM3 nomenclature) and heme binding 
regions are highlighted. 
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Figure 3.2: A section of the crystal structure of WT P450 BM3 (1 BU7) highlighting 
the positioning of Threonine 268 in relation to the I-helix and the heme. The distortion 
of the helix directly above the heme is ascribed as the oxygen binding pocket. 
positioning of the heme ligand water [78]. This residue forms part of the 1-helix which 
runs across the distal face of the heme [18,102,123] (Figure 3.2). Its location at the active 
site and role in forming a 'kink' in the 1-helix commonly referred to as the oxygen 
binding pocket has led to speculation that it may act as a hydrogen bond donor for the 
ferrous-dioxygen complex [46,125]. This interaction would in turn stabilise the oxy-
ferrous complex and help promote the addition of protons to form the catalytically 
important ferryl (Fe(IV)=O) species [71]. However, a recent study reporting the crystal 
structure of the dioxygen complex of P450cam has indicated that the threonine residue 
does not provide a hydrogen bond to the dioxygen complex. The authors 
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Figure 3.3: A schematic representation of two possible functions of the distal 
threonine in cytochrome P450s. Panel A shows the threonine hydroxyl hydrogen as 
an H-bond donor to the dioxygen bound species. Panel B shows the threonine 
hydroxyl oxygen as a hydrogen bond acceptor for the hydroperoxy species. 
suggested that the only role left for the threonine is that of a hydrogen bond acceptor 
from the hydroperoxy intermediate [16,72] (Figure 3.3). 
As the nature of oxygen activation and the precise mechanism of substrate 
hydroxylation are still a matter of some debate, a significant amount of research has been 
carried out to determine the exact role of this residue in a variety of P450 
enzymes [46,132-134]. Initial studies by Imai el al. showed that the hydroxyl group of 
threonine was essential for coupled enzymatic activity and that its removal resulted in a 
less stable oxy-ferrous complex [135]. They suggested that the threonine might play a 
role in both stabilising the oxy-ferrous complex via hydrogen bonding interactions and in 
the proton donation pathway (Figures 3.3 and 3.4). However, a subsequent study by 
Kimata et al. [136] demonstrated that the substitution of the threonine in P450cam with 
the unnatural amino acid methoxythreonine (removing the proton donating ability) 
resulted in a fully coupled enzyme. Hence the hydroxyl group of the threonine was not a 
pre-requisite for oxygen bond cleavage. Similar work has been reported on the most 
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Figure 3.4: Schematic representation of the two possible routes for the proton 
donating pathway in the cytochrome P450s. Panel A shows the final proton donor as 
an active site water, held in place by H-bonds from the conserved threonine and an 
asparagine. Panel B shows a similar scheme with the threonine as the proton donor. 
extensively characterised enzyme of this type, P450cam[125,127], a camphor 
hydroxylase from Pseudomonas putida. with the threonine —* alanine mutation resulting 
in a significantly smaller turnover rate constant and increased uncoupling. The crystal 
structure of the T252A mutant enzyme of P450cam shows how this substitution leads to 
structural changes in the active site and suggests that greater access for solvent water is 
the source of uncoupling [151] and not interference of the proton donating pathway. Thus 
another role for the threonine might be preventing active site access to solvent water 
molecules via the proton channel. 
The second most commonly studied enzyme of this type is P450 BM3 from 
Bacillus megaterium [35,123]. The substitution of Threonine 268 with an alanine 
(analogous to T252A in P450cam) results in a decrease in the rate constant for NADPH 
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oxidation and an increase in the conversion of electron equivalents into hydrogen 
peroxide instead of hydroxylated product [46,130]. However, while the threonine residue 
in P450cam is necessary for any NADPH consumption, the T268A mutant in P450 BM3 
exhibits a small, but significant amount of coupled activity [46,130]. From this 
observation it has been suggested that while the distal threonine might fulfil a similar role 
in all P450s, it may do so with a differing degree of importance. Reports by Peterson et 
al. [78,130] confirm the importance of Thr268 in maintaining coupled substrate 
hydroxylation in P450 BM3. However, they also propose that the threonine residue is 
required to bind fatty-acid substrates in the correct geometry required for efficient regio-
and stereo-specific hydroxylation. From a high-resolution crystal structure of N-
palmitoylglycine bound P450 BM3 [80], they propose an important role for Thr268 in the 
displacement of the heme ligand water. The crystal structure shows that there is 
movement of the I-helix on substrate binding and the authors suggested that this is 
essential for the displacement of the axially ligated water. In the oxidised form of the 
enzyme, A264 provides a hydrogen bonding interaction with this ligated water. When 
substrate binds, there are movements in the I-helix which reposition this alanine, creating 
a hydrogen bonding 'pocket' for the water with the hydroxyl group of Tbr268 [78] 
(Figure 3.5). This interaction is analogous to the T252/G248 amino acid pairing in 
P4SOcam. 
Thr243 of P450nor [126,138], a nitric oxide reductase from denitrifying fungi has 
been shown to play a critical role in the catalytic process. Substitutions of this residue 
lead to dramatically decreased activity, which may be related to electron transfer from 
NADH to the heme. It is thought that both electron delivery and the proton donation 
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Figure 3.5: The active site crystal structure of WT P450 BM3 in the absence (IBU7) 
and presence (I FAG) of N-Palrnioylglyceine highlighting the movement of the key 
residues A264 and T268. It is proposed that the movement of glutamine 264 on 
substrate binding helps to reposition the active site water away from the heme iron 
thus causing a change in spin state. 
occur at the distal site and that the hydrogen bonding network containing Thr243 may be 
related to either or both of these functions explaining poor turnover rates and uncoupling. 
It was also noted that mutation of Thr243 in P450nor resulted in a change in the high- to 
low-spin ratio in the ferric resting state suggesting that this residue might influence water 
coordination [126,138]. 
Several other P450 enzymes have been studied in order to elucidate the role of 
this threonine with varying results. Substitution of Thr302 in P450 2134 [139] shows that 
replacing this residue leads to a drastic decrease in the reaction rate over a broad substrate 
range. Conversely, substitution of Thr319 with an alanine in P450 1A2 [140-141] results 
in a 9-fold increase in Vm a x, clearly a result which contradicts work discussed earlier. 
From sequence alignments (Figure 3.6), it can be seen that there are several P450s 
which do not contain this highly conserved threonine residue. One such enzyme is 
P450 eryF in which the position is filled by an alanine [142-143]. It is believed, in this 
instance, that the role of the threonine side-chain hydroxyl is undertaken by a substrate 
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Figure 3.6: Section of sequence alignments for P450 BM3, P450 2B4, P450cam, 
P450nor, P450cm, P450 eryF, cyp 51 and cyp 3A4 showing the conserved residues 
highlighted in red. Note that the threonine in position 268 (BM3 numbering) is absent 
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Figure 3.7: Comparison of the substrate bound active sites of A:P450 BM3 with 
palmitoleate, B:P450cam with camphor, C:P450eryF with 6-deoxyerythronolide and 
D: P450 cin with cineole. 
EV 
Chapter 3: The Role of Threonine 268 
hydroxyl group which is positioned in the correct geometry (Figure 3.7). Substitution of 
this residue with a threonine results in an enzyme with the ability to oxidise substrates 
which do not possess a hydroxyl group in the equivalent position to 6-deoxyerythronlide 
(the physiological substrate for P450 eryF) [142]. This provides more evidence to suggest 
that the hydroxyl group has a specific function, and is necessary for efficient enzymatic 
turnover. P450cm, a 1 ,8-cineole monooxygenase from Citrobacter braakii, also does not 
posses a threonine at this position but instead contains an asparagine [22,52] (Figure 3.7). 
In this instance Asn242, analogous to Thr252 in P450cam, hydrogen bonds directly to the 
substrate, precluding it from playing some of the proposed roles for this residue. 
These previous studies indicate several possible roles for the active-site threonine, 
without conclusively identifying its function within the P450 super-family. It has been 
suggested that this residue may fulfil a different role or have varying importance within 
the P450 family depending on the nature of the substrate and flexibility of the substrate-
binding pocket. 
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3.2 Aims 
Earlier studies have shown that substituting the proximal residue Phe393 of P450 
BM3 with a histidine results in alterations to the electronic nature of the heme 
environment which in turn influence the heme reduction potential [44,45,76]. Substitution 
of Phe393 with a histidine led to a positive shift in the E m coupled to an increase in the 
rate of first-electron transfer and, importantly an increase in the stability of the oxy-
ferrous complex. 
In order to try and increase the stability of the oxy-ferrous complex even further 
we decided to combine the F393H mutation with additional substitutions at T268. Such a 
stabilised species would provide a platform for future work on the subsequent steps in the 
catalytic cycle. In addition, these substitutions were devised to probe both the hydrogen 
bonding and proton donating functions of this active site threonine in an attempt to 
further elucidate its function. The threonine residue was replaced with an alanine, 
removing the ability to hydrogen bond to and iron-oxygen complex and preventing it 
from taking part in the proton donating pathway. In addition, T268 was replaced with an 
asparagine, retaining the hydrogen bonding possibilities whilst obstructing the proton 
donating possibilities. A summary of the proposed mutations which will be discussed is 
shown in table 3.1. 
M. 
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TabIe3.1 Proposed Active Site Substitutions of P450 BM3 
H-Bonding at 1268 H Donation at T268 Possibility of Raised 
Enzyme 
position position Em 
WI -'I x 
F393H 
T268A x x x 
T268N 4 x X 
F393H1T268A x x 
F393H1T268N sj x 
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3.3 Results 
3.3.1 Expression and Purification: 
Wild-type P450 BM3 and the mutant enzymes F393H, T268A, T268N, 
F393H1T268A and F393H1T268N were successfully over-expressed and purified as both 
the holoenzyme and heme domain construct . Analysis of the spectral ratio of protein 
peak (300 nm) to Soret (410 nm) and the presence of a single band in SDS-page analysis 
(Figure 3.8) indicated that the purity was in excess of 95%. Each of the mutant enzymes 
exhibited an entirely low-spin oxidised spectrum with a Soret absorbance maxima at 418 
















Figure 3.8: SDS-Page analysis of P450 BM3 heme domain. Lanes I and 5 show 
molecular markers. Lane 2 shows the lysed cells. Lane 3 shows the enzyme after a 
weak anion exchange DEAE column. Lane 4 shows the enzyme after the final Q-
sepharose strong anion exchange column. The presence of a single band in lane 4 
indicates the high purity of the enzyme. 
all 
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nm and less intense a and P bands at 525-575 nm. Reduction of the mutant enzymes led 
to a shift in the Soret peak from 418 nm to 410 nm and the subsequent binding of CO 
generated the characteristic 450nm Fe(ll)-CO peak (Figure 3.9). Only a negligible 
amount of P420 (non cysteine bound heme) was found in the purified enzyme as defined 
by the presence of a band at 420 nm in the ferrous-CO IJV/vis spectra. 
3.3.2 Carbon Monoxide Bindin2: 
The ferrous form of wild type and each of the mutant enzymes was capable of 
generating the Fe(II)-CO bound species when treated with CO (Figure 3.9). The positions 
of the resulting Soret peaks varied across the series of mutants studied as shown in 
Table 3.2. 
Figure 3.9: Spectra of the ferric (black), dithionite reduced ferrous (red) and ferrous-
CO bound (green), species for WT P450 BM3. The large absorbance at < 400 rim is 
caused by the presence of dithionite. The small shoulder at 420 nm is attributed to 
non cysteine-ligated heme. The inset shows a close up of changes in the a and 3 
bands. 
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Figure 3.10: Diagram depicting the orbital mixing of CO bound ferrous heme. The 
cysteine thiolate ligand acts as an electron 'push', modulating the electronic nature of 
the heme. The heme, in turn, provides electron density to the Fe-CO bond. Clearly 
there is an overlap between the iron d-orbitals and the it-orbitals of the porphyrin 
ring. As the Soret band in the UV/vis is a result of it-it' transitions in the porphyrin 
ring, any changes in the electronic nature of the heme iron (e.g. by changing ligands) 
will influence the energy of the Soret. 
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The origin of the Soret band in the UV/vis spectrum of P450 BM3 are the 
porphyrin ic-t electronic transitions. From figure 3.10 we can seen that there is an 
overlap between the iron d-orbitals and porphyrin t-orbitals and that as a result, the 
electronic nature of the iron will influence the energy of the ir-it transitions 
Consequently, alterations in the electron donating or accepting nature of the porphyrin 
iron ligands can potentially influence the Soret peak by virtue of this orbital mixing 
(Figure 3.10). This is exemplified by the -40 nm shift in the Soret observed when water 
is replaced by CO as the 6 h-iron ligand. Changes in the position of the ferrous-CO Soret 
peak between BM3 active site mutants have been reported previously and are attributed 
to changes in the cysteine ligand [44-45]. The heme cysteine thiolate ligand provides an 
electron 'push' to the heme iron, allowing it to achieve the potentials it requires for the 
activation of molecular oxygen. The introduction of a histidine residue close to the 
cysteine draws electron density away from the Fe-S bond resulting in a less 
electronegative heme. This causes the degree of back-bonding from ferrous iron to the 
antibonding CO orbitals to decrease [44-45] influencing the irir  electron transitions 
(4nm blue shift). It is apparent that the substitution of Thr268 with an alanine in both the 
single mutant and in conjunction with F393H do not cause any distinct movement if the 
Fe(II)-CO Soret peak position. The substitution of Thr268 in the single and double 
mutants with an asparagine causes a small (1 nm) red shift in the spectrum. 
3.3.3 Steady-Sate Kinetics and Coupling Efficiencies: 
Steady-state turnover rate constants (kcat) with laurate and substrate-saturated 
turnover rate constants (ksat) with arachidonate are shown in table 3.3. These data show 
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Table 3.3: Steady-State Kinetics Parameters 
- Substrate 	 Laurate 	 Arachidonate 
Enzyme 
k0b (s') (sd) KM (p.NI) ' F (s') 
wild-type 0.2 ±0.1 84±2 1 	322±10 95±6 
F393H 0.3±0.1 
[ 	
36±2 190±7 31±1 
T268A 0.3±0.1 29±1 777±35 31±3 
T268N 0.3 ±0.1 29±3 
[ 	
318 ±21 28±2 
F393H1T268A 0.5±0.1 22±3 85±7 19±3 
F393H1T268N 3.4 ±0.3 10±1 13±4 7±1 
that the wild-type enzyme displays a significantly larger turnover rate constant compared 
to all the mutant enzymes. The kcag and ksag values are approximately equal and follow the 
same trend in turnover rate constants: WT>> F393H T268A T268N> F393H/T268A 
> F393H/T268N. Although the turnover rate constants are lowered by the mutations, it is 
worth noting that all the enzymes retain significantly high turnover rate constants in 
comparison to other P450s [44,129,142]. It is also apparent that the rate of substrate-free 
NADPH oxidation remains comparatively low and essentially constant for wild type and 
most of the mutant enzymes (0.2 - 0.5 s'). However, the F393H1T268N enzyme exhibits 
a substrate-free rate constant (3.4 1)  which is high, both in comparison to other 
substrate-free rate constants and its own substrate-saturated rate constant (8.7 s') 
The turnover rate constants are determined by following NADPH oxidation as 
discussed in the materials and methods section. It does not necessarily follow however, 
that consumption of electrons will lead to formation of product. As can be seen from the 
94 
Chapter 3: The Role of Threonine 268 
Table 3.4: Coupling Efficiencies 
Turnover Products (%) 
Enzyme 
H202 	 ROH 	 H202 + ROH 
wild-type 3 ± 2 90±2 93 ± 4 
F393H 6±2 75±4 81±6 
T268A 68±2 18±2 86±4 
T268N 51±3 F 	27±2 78±5 
F393H/T268A 72±4 6±1 78±5 
F393H/T268N 58±4 10±1 68±5 
catalytic cycle (Figure Lx); there are several uncoupling pathways to the non-functional 
production of superoxide (1 e => 02), peroxide (2 e > H202) and water (4 e > H 20). 
In order to assess the efficiency of an enzyme it is essential that the coupling of electron 
equivalents to hydroxylated product is measured. Table 3.4 shows the coupling 
efficiencies of wild type and all the mutant enzymes both in terms of their ability to 
produce hydroxylated substrate (mass spectrometry) and through their uncoupling to 
peroxide (o-dianisidine/HRP assay). It is evident that both the wild-type enzyme and 
F393H mutant retain a substantial degree of coupling to hydroxylated product (> 75%) 
whilst generating minimum amounts of hydrogen peroxide (3 and 6 % respectively). 
Mutant enzymes which incorporate substitutions at the distal threonine exhibit 
significantly smaller degrees of coupling to hydroxylated product (5 - 30 %). It is also 
clear from the o-dianisidine assay that the majority of uncoupling in these mutant 
enzymes (60-70 %) is to hydrogen peroxide. 
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3.3.4 Substrate Dissociation Constants and Spin-State Shift: 
The binding of substrate to P450 BM3 causes the displacement of the heme ligand 
water leading to a change in geometry and low- to high-spin state shift. The addition of 
saturating concentrations of arachidonate to wild type and the mutant enzymes 
highlighted significant differences in the degree of substrate induced spin-state shift. Both 
wild type and the proximal F393H mutant exhibit> 90 % spin-state conversion on the 
addition of saturating concentrations of substrate. Figure 3.11 and table 3.5 show that, in 
all cases, substitution of T268 to either alanine or asparagine results in a considerably 
lower proportion of high-spin protein at saturating concentrations of arachidonate. 
Mutant enzymes which incorporate the T268N substitution display almost negligible 
amounts of the high-spin complex. Dissociation constants for wild type and mutant 
enzymes using both arachidonate and laurate as substrates are shown in table 3.5. It is not 
possible to accurately determine substrate Kd values for F393H1T268N with arachidonate 
and laurate and T268N with laurate due to insufficient spectral shifts. Even so, it is 
Table 3.5 Binding constants and spin state shift 
- 	
Kd (pM) 
% Spin State Shift F Enzyme  
+ arachidonate 
__ 
Arachidonate 	 Laurate 
wild-type 100 3.6 ± 0.3 370 ± 8 
F393H 91±5 7.6±0.5 525±10 
T268A 68±5 6.9±0.5 413± 17 
T268N 13±2 4.0± 1.0 - 
F393H1T268A 33 ± 4 5.0 ± 0.6 285 ± 25 









































































300 	400 	500 	800 	100 	800 
A (nm)  
300 	400 	500 	600 	100 	800 
A(nrn) 
F393H1T268A 
300 	400 	500 	600 	700 	800 
A (nm) 
F393H/T268N 




















Figure 3.11: Observed spin-state shift at saturating concentrations of arachidonate 
(120 jiM) for WT, F393H, T268A, T268N, F393H1T268A and F393H1T268N. In 
each case the oxidised spectra are shown in black and the substrate-saturated spectra 
are in red. The ability of the enzyme to generate the high-spin complex at saturating 
concentrations of substrate is greatly diminished by the substitutions at the distal 
threonine site. 
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evident from these data that neither the substitutions of Thr268, Phe393 or combinations 
of the two result in any significant change in fatty-acid binding, however they do 
influence substrate recognition. 
3.3.5 OTTLE Potentiometric Titrations: 
Herne reduction potentials for substrate-saturated and substrate-free wild type and 
mutant enzymes are shown in Table 3.6. Figure 3.12 shows the data for WT in the 
presence and absence of substrate fitted to one-electron Nernst curves. Previous studies 
have suggested that the substrate induced potential shift in wild type (+ 127 mV) acts as a 
redox switch, facilitating electron transfer from the FMN redox partner [44-45,137]. It 
has been shown that mutations of phenylalanine 393 to a histidine, alanine, tyrosine and 
tryptophan do not significantly effect the magnitude of this shift (AE (sub) = +171 mV, 
161 mV, 123 mV and 120 mV) although they do influence the relative positions of the 
substrate-free and arachidonate-saturated midpoint potentials (E m-sub = 427, -332, -312, 
-418 and -480 mV for WT, F393H, F393A, F393Y and F393W) [44-45]. It is evident 
from table 3.6 and figure 3.13 that substitutions of the distal threonine influence the heme 
reduction-potential shift roughly in accordance with the degree of spin-state shift. 
Specifically, both mutant enzymes incorporating the T268A substitution display 
moderate shifts in both spin state (68 % and 33% for the single and double mutant 
respectively) and reduction potential (- +75 mV) on the addition of saturating 
concentrations of arachidonate. In contrast, both mutant enzymes incorporating the 
T268N substitution have almost negligible substrate induced spin-state shifts (<10 %) 
and small substrate-induced heme reduction-potential shifts (<10 mV). 
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Figure 3.12: Potentiometric data and 1-electron Nernst fits for WT P450 BM3 in the 
presence (red) and absence (black) of saturating concentrations of arachidonate. 
Open and closed circles represent the reductive and oxidative data respectively. In 
WT, the addition of substrate stimulates a positive shift in the potential of 127 mV. 
Table 3.6: Potentiometry 
Potentiometnc Parameters Potential Shifts 
Em (mV) Em (mV) 
Enzyme E m  (mV) zEm ( mV) AEm (mV) 
+Arachjdonate ± Laurate 
- substrate Arachidonate Laurate 
(120MM) (1 MM) 
WT -431±4 -304±4 -338± 12 +127±8 +93± 16 
F393H -332±6 -161±4 -247± 14 +171± 10 +85±20 
T268A -429 ± 9 -340 ± 6 - ±89 ± 15 - 
T268N -353±5 -358±8 - -5±13 - 
F3931-1/T268A -331 ±4 -255±6 - +76± 10 - 
F393H/T268N -280± 10 -269±9 - -4-11 ±19 - 
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Figure 3.13: Diagram depicting the relative positions of the substrate free (white) 
and substrate saturated (black) reduction potentials. Panel A shows a comparison of 
WT and the single mutants T268A and T268N. Panel B shows a comparison of 
F393H and the double mutants. 
Figure 3.13 shows a comparison of substrate-free and substrate-saturated heme reduction 
potentials to highlight the differences between the single (T268A and T268N) and double 
(F393H1T268A and F393H/T268N) mutations with wild type and F393H respectively. 
Previous mutations of Phe393 have been shown to cause alterations in the heme 
reduction potential for both the substrate-free and substrate-saturated forms and that these 
changes have important ramifications for the reactivity of the enzyme [44-45,76]. It is 
clear from the diagram that the single mutation T268A does not influence the substrate-
free reduction potential when compared to wild type. As was mentioned previously, the 
magnitude of substrate-induced potential shift for T268A is diminished. This effect was 
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maintained both in the comparison of T268A with wild type and F393H1T268A with 
F393H. The T268N single and double mutations do influence the substrate-free heme 
reduction potential, inducing a positive shift of 50-60 mV. However, substrate binding 
does not stimulate any significant increase in reduction potential. 
3.3.6 OTTLE Potentiometnc Titrations in the Presence of CO: 
One obvious point about the above data is that the OTTLE titrations are carried 
out in the absence of oxygen. Clearly if they were carried out in the presence of oxygen, 
not only would you observe turnover but also there would be problems associated with 
the electrochemistry of oxygen itself. However, the presence of oxygen is likely to 
influence the reduction potential of the P450 [144-145] not only through its function as a 
heme ligand but also by virtue of the structural changes it causes on binding. 
Table 3.7: Potentiometry with CO 





Em  (mV) 
+archidonate 
(120 p.M) + CO 
i\Em (mV) 
CO induced 
shift - sub 
AEm (mV) 
CO induced 




WT -270±4 -82±5 +161±4 +222±9 +188±9 
F393H -135±6 +30±4 +197±7 +191±11 +165±10 
T268A -262±7 -146±7 +167±9 +194±16 +116±14 
T268N 155±5 -123±8 +198±6 +235± 14 +32± 13 
F393H1T268A -136±8 -38±6 +195±8 +217±14 +98±14 
F393H1T268N -56±4 -42 ±7 T +224±5 +227± 11 +14± 11 
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Figure 3.14: Data and 1-electron Nernst fits for WT P450 BM3 in the presence of 
CO and in the presence (black) and absence (blue) of saturating concentrations of 
arachidonate. Open and closed circles represent the reductive and oxidative data 
respectively. In WT, the addition of CO stimulates a positive shift in the potential of 
200 mV. 
Consequently, the midpoint potentials were determined in the presence of CO as an 
oxygen mimic. As a diatomic molecule, we might expect the CO to stimulate similar 
changes both in P450 structure and consequently P450 reduction potential without having 
to worry about the problems associated with turnover. 
Heme reduction potentials in the substrate free and substrate saturated states in the 
presence of CO are shown in Table 3.6 and the data and 1-electron Nernst fit for wild 
type in the presence of CO with and without substrate is shown in figure 3.14. 
The major observation which can be made from these data is that the addition of 
CO causes a +200 mV shift in the potential both in the presence and absence of saturating 
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Figure 3.15: Reductive and oxidative traces for the OTTLE potentiometry of 
F393N/T268N heme domain. While the reductive trace fits to a 1-electron Nernst 
function. the oxidative trace does not. 
concentrations of substrate. The CO induced shift is independent of the substitutions at 
either the proximal or distal sides of the heme. 
One interesting feature observed in the potentiometry of F393H/T268N with CO 
in the presence and the absence of substrate was a form of hysteresis on the oxidative 
trace. Although data for the reduction of the enzyme fitted well to a 1 electron function, 
re-oxidation equilibration times were in excess of 5 hours per 50 mV shift, generating 
data which could not be fitted to any Nernst function (Figure 3.15). To ensure that the 
long equilibration times were not the result of poor mediation, the experiment was 
repeated several times with freshly prepared mediators. One possible explanation of this 
data is that there is a structural rearrangement on heme reduction leading to a kinetically 
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locked species. If this was the case then in order to re-oxidation the P450, the sample 
would have to overcome a kinetic barrier which could explain the long equilibration 
times. 
3.3.6 Heme Reduction Pre-Steady State Kinetics: 
The rate constants for the first flavin-to-heme electron transfer were measured 
through the formation of the 'dead end' Fe(II)-CO complex. In these stopped-flow 
experiments it is assumed that the rate of CO binding to ferrous iron is in excess of the 
rate of flavin to heme electron transfer. This assumption is supported by the fact that 
measured rate constants for CO binding were so large as to be at the limit of the stopped 
flow capabilities (>800 s'). The rate constants for the first electron transfer (kred) in the 
substrate-free and substrate-saturated states are shown in table 3.8 and kinetic traces are 
shown in figure 3.16. Absorbance changes for substrate-free heme reduction all fit to 
double exponential traces indicating a fast and slow phase for electron transfer. In each 
case the amplitude of the slow phase was 4-10 fold greater than the fast phase. The fast 
phase observed in the heme reduction traces in the absence of substrate does not appear 
to follow any obvious trend and in previous studies have been ascribed to the presence of 
small amounts of substrate or substrate like contaminants such as detergents [44-45]. The 
slow phase rate constants (kred) in the absence of substrate for wild type and all the 
mutant enzymes with the exception of F3931VT268N are small and constant ranging 
between 0.09 and 0.14 s* The kr?,J value for the F393H/T268N mutant in the absence of 
substrate is 10 fold greater than any other mutant. Absorbance changes for substrate 
saturated heme reduction all fit to single exponentials. The rate constants for this phase 
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Figure 3.16: Pre steady state heme reduction kinetics of wild-type P450 BM3 
(black) and the mutant enzymes F393H (green), T268A (red), T268N (blue), 
F393H/T268A (orange) and F393H/T268N (cyan). Panels A and C show the rate of 
formation of the ferrous - CO complex in the absence of substrate (A) and presence 
of saturating concentrations of arachidonate (C).Panels B and D illustrate the 
starting, oxidized spectra (black) and final, reduced - CO bound spectra (red) for the 
substrate free and substrate saturated heme reduction of wild type. Note the 
incomplete formation of the ferrous-CO complex in the absence of substrate. 
vary accordingly: F393H> F393H/T268A> WT> F393H/T268N > T268A > T268N. 
An important point to note is that the apparent rate constant for heme reduction in T268N 
is smaller than the overall turnover rate seen for this mutant enzyme. This observation 
has been repeatedly confirmed experimentally. Clearly the true heme reduction rate 
cannot be slower than the turnover rate. Although we have no definite explanation for 
this discrepancy, possibilities include differences between pre-steady-state and steady-
state methodologies and/or some gating mechanism due to the presence of the asparagine. 
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3.3.7 Auto-oxidation Pre-Steady State Kinetics: 
In general, the formation of the oxy-ferrous complex for wild-type P450 BM3 and the 
various mutant enzymes is too rapid to be monitored using stopped flow. As an indication 
of the stability of this complex, the rate constants for the decay of the oxy-ferrous species 
to the non-oxygen-bound ferric form were measured. Rate constants for the decay of the 
oxy-ferrous complex in the presence and absence of saturating concentration of substrate 
are shown in table 3.8 and kinetic traces are shown in Figure 3.17. The 
(nm) 	 A(nm) 
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Cr 
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Figure 3.17: Pre steady state oxy-ferrous decay for wild-type P450 BM3 (black) 
and the mutant enzymes F393H (green), T268A (red), T268N (blue), F393H/T268A 
(orange) and F393H/T268N (cyan). Panels A and B show spectra of the oxy ferrous 
complex (red) and oxidised decay product (black) for wild type in the presence and 
absence of arachidonate. Panel C shows the exponential decay of the oxy ferrous 
snecies at saturatinu concentrations of arachidonate. 
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experimental protocol requires the mixing of pre-reduced enzyme with oxygenated 
buffer. Since the iron is already in the one electron reduced ferrous form, it should be 
insensitive to kinetic barriers imposed by substrate and the oxy-ferrous decay rates should 
be the same regardless of whether substrate is present or not. The data show however that 
the F393H, F393H/T268A and F393H/T268N mutations display considerable differences 
in their substrate saturated and substrate-free rate constants. The reason for this is as yet 
unclear. The substrate saturated auto-oxidation rate constants (kautoox ) vary across the 
series of mutants accordingly T268N > T268A> WT> F393H1T268N > F393H/T268A 
> F323H. As reported previously, the F393H mutation stabilises the oxy-ferrous species. 
Here we see that mutations of T268 to both an alanine and an asparagine lead to a 
destabilisation of the oxy-ferrous species. The double mutations lead to a composite of 
both effects with stabilisation caused by the proximal F393H substitution dominating. 
Table 3.8: Pre-Steady-State Kinetic Parameters 
1-leme Reduction (k red )( s 1 ) Auto-oxidation(k au,)( s') 
Enzyme 
Substrate Free ± Arachidonate Substrate Free + Arachidonate 
wild-type 0.1 ±0.1 101± 4 0.09 ±0.02 0.059±0.008 
F393H 0.1 ±0.1 232± 15 0.018±0.002 0.0013±0.0002 
T268A 0.1 ±0.1 28±3 0.27±0.06 0.26±0.04 
T268N 0.1 ±0.1 5±2 0.46 ±0.09 0.37 ±0.04 
F393H/T268A 0.1 ± 0.1 116 ± 10 0.048 ± 0.006 0.0071 ± 0.0016 
F393H1T268N 1.7 ± 0.4 52 ± 5 0.053 ± 0.011 0.016 ± 0.002 
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3.3.8 Crystallography: 
The structures of the T268A and T268N mutant enzymes were refined to final R-
factors of 16.64 % (R-free = 20.63 %; 1.9 A resolution) and 17.44 % (R-free = 21.02 %; 
1.8 A resolution) respectively (Table 6). For each mutant enzyme the final model consists 
of two identical protein molecules (A and B) comprising residues Lys3-Leu188 and 
Asn2Ol-Leu455 and one heme. In addition the T268A enzyme model contains 986 water 
molecules and the T268N model contains 973 waters. For all molecules the electron 
density for the two N-terminal residues and for the loop region containing residues 
Gln189-Glu200 was not interpretable, so these have been omitted from the model. The 
RMSD fit of all backbone atoms for each of the mutant enzymes and the wild-type heme 
domain is 0.3 A, indicating no major differences between the structures. Due to the fact 
that there are two molecules in the asymmetric unit for each of these models, the RMSD 
values stated are the average over both molecules. The RMSD fit between both molecules 
(A and B) of each mutant enzyme model is found to be 0.2 A. Figures 3.18 (A) and (B) 
show the electron density surrounding the heme group, residue 268 and Thr438 for the 
T268A and T268N enzymes respectively. An overlay of the same region in the wild-type, 
T268A, and T268N enzymes is shown in figure 3.18 (C). From figure 3.18 it can be seen 
that in the case of the T268A mutant enzyme the only significant structural change is the 
replacement of Thr268 with alanine. As in the wild-type enzyme there is a water 
molecule (WAT216 in molecule A, WAT335 in molecule B) ligated to the heme iron. 
This water is hydrogen-bonded to the carbonyl 0 of Ala264 (2.7 A; all distances are the 
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average over molecules A and B) and to a second active site solvent molecule (WAT4I8 
in molecule A, WAT 199 in molecule B; 2.6 A). 
In the case of the T268N mutant enzyme, the sidechain of Asn268 is hydrogen-
bonded to the Fe-ligating water molecule (WAT348 in molecule A, WAT512 in molecule 
B; 3.1 A) and to the second active site water molecule (WAT534 in molecule A, WAT8 
in molecule B; 2.9 A). In addition, there is a hydrogen-bonding interaction between the 
Asn268 sidechain and the sidechain hydroxyl group of Thr438 (2.9 A). The sidechain of 
Thr438 is in a different orientation in the T268N enzyme compared to the T268A mutant 
and wild-type enzymes (figure 8(C)), leading to the formation of the hydrogen-bond with 
the Asn268 sidechain and preventing a steric clash between the Thr438 sidechain methyl 
group and Asn268. It should be noted that although Asn268 is shown with the sidechain 
amide NH2 group hydrogen-bonding to solvent molecules and the sidechain amide 0 
hydrogen-bonding to Thr438, the hydrogen bonding pattern is also compatible with a 
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Table 3.9 Crystallographic Parameters 
Parameter T268A 
resolution (A) 24.0 - 1.9 
total no. of reflections 756604 
no. of unique reflections 84625 




Rmerge in outer shell (%) 	 14.4 (1.97 - 1.90 A) 
Reryst 
(%)b 	 16.64 
Rfree 
(%)b 	 20.63 
rmsd from ideal values 
bond lengths (A) 
bond angles (deg) 
Ramachandran analysis 
most favoured (%) 
additionally allowed (%) 








34.8 (1.86- 1.80 A) 
17.44 
21.02 
measurement of reflection h, respectively. b 	= 	- FI ZhF.,  where F. and Fc are 
the observed and calculated structure factor amplitudes of reflection h, respectively. Rfree 
is the test reflection data set, 5 % selected randomly for cross validation during 
crystallographic refinement. 
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Figure 3.18: Stereoimages showing electron density of active site mutants T268A 
(Panel A) and T268N (Panel B). Panel C shown the overlay of WT (grey) with both 
T268A (cyan) and T268N (orange). 
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3.4 Discussion 
The cytochromes P450 are capable of catalysing some very difficult reactions 
such as the hydroxylation of unsaturated substrates [26,27,146-147]. In order to achieve 
this they must first activate molecular oxygen. Thus, the nature of the dioxygen, 
hydroperoxy and ferryl species are of critical importance. Studies on a highly conserved 
distal threonine in both cytochrome P450cam and P50 BM3 have linked this residue to 
the stabilisation of the ferrous dioxygen species [46,125] and implicated it in the proton 
donating pathway [126-129]. 
More recently, the crystal structure of the ferrous dioxygen complex has 
suggested a role not in proton donation or even dioxygen stabilisation but instead in the 
promotion of proton transfer through H-bonding interactions with the hydroperoxy 
species [72]. Substitutions of the Thr268 residue in P450 BM3 have also highlighted a 
potential role in substrate recognition [78,130]. Unnatural mutagenesis of the Thr252 
residue of P450cam has shown that the hydroxyl group in not necessary for catalytic 
turnover [136]. With such a range of studies on different P450 systems providing so many 
theories as to the role of this highly conserved residue, the mechanistic importance 
remains unclear. The present study is intended to further probe the role of Thr268 in P450 
BM3 and ascertain its importance as both a hydrogen-bonding and proton-donating 
residue. Further consideration was also given to the threonine's significance in substrate 
recognition and the subsequent ramifications on both catalytic turnover and coupling 
efficiency. 
There are many parallels which can be made between previous studies and the 
results which we report here. Mutation of the proximal side Phe393 residue to a histidine 
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results in enzymes with comparatively high rate constants for the first electron transfer 
and stabilised oxy-ferrous species both of which are directly linked to changes in the 
heme reduction potential [44-45,76]. The removal of the hydrogen bonding and proton 
donating possibilities of the threonine through its mutation to an alanine generates an 
enzyme with a significantly smaller turnover rate constant and considerably lower degree 
of productive coupling. Low turnover rates and poor coupling efficiencies are combined 
with lower rate constants for the first electron transfer and a less stable oxy-ferrous 
species in comparison to wild type. These data for turnover, coupling and electron 
transfer are in accordance with previous studies. The decrease in the stability of the oxy-
ferrous complex is also consistent with previous studies where the threonine had been 
substituted by both a valine and alanine and suggests an important role for T268 in 
producing an efficiently functioning enzyme [46,125]. 
On the other hand, mutation of the threonine to an asparagine, retaining the 
hydrogen bonding capability while removing the proton donating possibilities, also 
results in a highly uncoupled enzyme with comparatively small rate constants for 
catalytic turnover and first electron transfer, in addition to a destabilised oxy-ferrous 
species. The observed destabilisation of the oxy-ferrous species is not in accordance with 
the previous conservative mutation of P450cam by Imai et al. [129] in which the 
threonine was replaced with a serine with no significant changes in the stability of the 
oxy-ferrous species. 
Furthermore, there are contrasts with the work of Kimata et al. [136] which 
showed that removing the proton donating capability of the residue while retaining the 
hydrogen bonding properties did not disrupt the efficiency or function of the enzyme. 
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Figure 3.19: Representation of the a and ir bonding characteristics observed in the 
Fe(ll)-CO complex. Donation of electrons from the iron to the orbitals of the CO 
destabilises the Fe-CO bond leading to a red shift in the uv/vis Soret peak. The 
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Figure 3.20: Energy level diagram for the formation of CO. Note that any removal 
of electron density will be from a bonding orbital. 
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These data indicate that the change in the nature of the hydrogen bonding residue has a 
significant effect on the ability of the enzyme to function efficiently. 
It is apparent from the initial spectroscopic analysis of the ferrous CO-bound 
complex that substitutions on both the proximal and distal sides of the heme influence the 
position of the ferrous-CO Soret. The 5 nm blue shift observed in the F393H mutation 
has tentatively been ascribed to changes in the energies of the it and ir porphyrin 
molecular orbitals associated with the changing electronic nature of the heme (/Em = + 
99 mV cf. WT) [44]. Introduction of a histidine residue leads to a more electropositive 
iron and consequently to a decreases in the degree of backbonding to the ir CO-
antibonding orbitals. This in turn would lead to changes in the orbital mixing between the 
iron d-orbitals and the porphyrin Tr-orbitals leading to a shift in the position of the Soret 
peak. Similarly, it has been reported for the F393W mutant of P450 BM3 that a 1 nm red 
shift is observed in tandem with a —ye shift in the reduction potential (AE,,, = - 36 mV cf. 
WT) [76] where the opposite of the above argument would be true. 
The position of the threonine residue in the active site, on the opposite side from 
the cysteine thiolate would suggest that it is unlikely to have such a pronounced effect on 
the electronic nature of the heme. However, it is well documented that changes in the 
conformation of the vinyl and propionate groups of the heme are also capable of 
influencing the heme reduction potential [148]. The lack of any notable shift in Soret or 
heme reduction potential when the threonine is substituted with an alanine is entirely in 
keeping with this theory. However, the small red shift (consistent with a stronger CO 
bond) observed when the threomne is replaced with an asparagine, is incongruous with its 
positive shift in reduction potential compared with wild type (AE, = + 78 mV cf. WT). If 
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the changes in position of the ferrous-CO Soret are not proportional to changes in the 
electronic nature of the heme for T268N substitutions then it is likely that the differences 
are a result in structural changes in the distal heme region. 
By looking at the crystal structure of the T268N mutant, we see that the 
asparagine is oriented with the amine N112 group positioned towards the heme. In the 
oxidised crystal structure the N112  forms a hydrogen bond with the iron ligand water 
molecule. The orientation of the amine towards the iron and not the carbonyl of the 
asparagine is confirmed by the formation of a H-bond between the carbonyl and an amine 
hydrogen from the backbone carbonyl of A264. If the asparagine is capable of H-bonding 
to the water then it is also capable of interacting with CO. We see from the molecular 
orbital diagram (Figures 3.19 and 3.20) that the oxygen possesses a lone pair and that this 
lone pair is in a bonding orbital. If a hydrogen from the N11 2 formed a H-bond with the 
oxygen of CO in the Fe(II)-CO complex, then it would draw electron density away from 
the bonding orbital of the oxygen and this would in turn weaken the Fe-CO bond and 
influence the it- ic transitions. Although the shift in the Soret position for T268N is 
incongruous with previous observations linking Soret position to the heme potential, it 
does fit with the idea that a stronger Fe-CO bond leads to blue shift in the Soret while a 
weaker Fe-CO bond leads to a blue shift by virtue of orbital mixing with the delocalised 
porpohyrin it bonding system. 
P450 BM3 has one of the largest rate constants for turnover in the entire P450 
superfamily with rates of NADPH oxidation in the presence of arachidonate for wild type 
of >100 s_ I [44]. Steady-state analysis of NADPH oxidation for wild type and mutant 
constructs has shown that in all cases, single and double substitutions of both the T268 
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and F393 residues lead to smaller rate constants in comparison to wild type. It has been 
suggested that the catalytic cycle of P450 BM3 is finely balanced in order to maximise 
the rate of substrate hydroxylation [71,102]. It is reasonable to assume therefore, that any 
perturbations of the active site which may have an effect on any single step in the 
catalytic cycle are likely to influence the overall turnover rate constant. 
Despite the smaller rate constants, all substituted enzymes remain capable of 
consuming electrons at rates in excess of 10 s 1 . Although this does constitute a 10-fold 
decrease in the kcat in comparison to wild type, it must be remembered that this enzyme 
exhibits a remarkably high turnover rate for substrate hydroxylation. In comparison to 
other enzymes like P450cam and the P450 like NOS enzymes which exhibit turnover of 
only -30 s and -4 s respectively [149-150], the rate constants for NADPH 
consumption remain significant. 
However, the Michaelis-Menten kinetics as defined by the consumption of 
NADPH are clearly not the whole story. It does not naturally follow that the consumption 
of electrons will lead to the formation of hydroxylated product. While wild type and the 
F393H mutant retain a high degree of coupling to hydroxylated product (90 and 75% 
respectively), substitutions of the threonine residue lead to a highly uncoupled catalytic 
cycle (9-20 % coupled). 
This high degree of uncoupling has been reported for previous substitutions of 
this active site threonine and it is clear that this residue is important in maintaining an 
efficiently functioning enzyme [46]. This observation is logical if we consider the 
position of the substitutions we have made. The reductase domain is responsible for the 
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Figure 3.21: The oxygen-bound active site structure of P450cam wild type (1 AKD) 
and T252A mutant enzyme (2CP4). Clearly the substitution of the threonine residue 
does not lead to the removal of the active site water (shown in blue). 
substitutions which we have made are in the heme domain and as such are remote from 
the NADPH binding region. Consequently we might expect the substitutions to influence 
the ability of the enzyme to operate efficiently but not influence the ability to oxidise 
NADPH. The majority of NADPH consumption in the threonine substituted enzymes is 
attributed to the formation of hydrogen peroxide (Table 3.4), the uncoupling product 
from the ferric-hydroperoxo species (Fe(III)00H). As the subsequent step in the 
catalytic cycle requires the delivery of a proton (Figure 1.9), it is reasonable to assume 
that these substitutions may have interfered with the proton delivery pathway. Until 
recently it was assumed that substitutions on the distal side of the heme might alter the 
positions of the active-site waters and consequently interfere with the proton donating 
pathway. However, the recent crystal structure of the oxy-ferrrous T252A mutant of 
P450cam[72] has shown that this is not the case (Figure 3.21). 
There are several other possibilities which might account for the high degree 
of uncoupling. Substrate-induced potential shifts are directly linked via the Gibbs free 
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Figure 3.22: Comparison of the active site crystal structures of wild-type (1 BUZ), 
T268A (IYQP) and T268N (IYQO) highlighting the relative positions of the T438, 
A264 and T/A1N268 residues. The asparagine in T268N forms a hydrogen bond with 
both threonine 438 and alanine 264. 
energy relation (LIG = - flFE,,, and LXG = -RT1n(K)) to the substrate dissociation constants 
in the oxidised and reduced form. For wild-type P450 BM3, the positive shift in the 
reduction potential is associated with an increase in affinity for substrate on heme 
reduction. This increase in affinity may be necessary to achieve a high degree of 
coupling. The smaller substrate-induced potential shift observed in the threonine 
substituted enzymes will invariably lead to a less pronounced increase in affinity on 
reduction (from Gibbs free energy relation: WT Kd(red) = 16.5 nM, T268A Kd(red) = 0.4 
mM , T268N Kd(red) = 2.9 mM) which may have significant ramifications on the 
efficiency of the enzyme. 
In addition to this, it is clear from the crystal structure of the T268N mutant that it 
forms two H-bonding interactions with threonine438 and alanine264 (Figure 3.22). 
Crystal structures of both the substrate bound [80] and ferric-dioxygen species [72] have 
shown that individual steps of the catalytic cycle are accompanied by significant 
perturbations in protein structure, particularly the I-helix. Any extra hydrogen bonding 
119 
Chapter 3. The Role of Threonine 268 
interactions could easily prevent these movements with important ramifications on the 
catalytic cycle and the possibility of uncoupling. 
It has recently been suggested that the conserved threonine hydroxyl acts as a 
H-bond acceptor for the hydroperoxy species [72] as well as a H-bond donor for the 
ferrous dioxygen species. Removing the OH through its substitution with an alanine 
would clearly prevent it from fulfilling both these roles. Substitution of the threonine by 
an asparagine allows for the possibility of both accepting and donating a hydrogen bond 
via the carbonyl and NH 2 groups although not simultaneously as for the threonine 
hydroxyl group. However, the crystal structure shows that the NH 2 group is pointing into 
the active site. The orientation of the NH 2 group towards the iron as opposed to the 
carbonyl of the asparagine is confirmed by the presence of a H-bond between the 
carbonyl with the backbone of A264. While the NH 2 would be capable of donating a H-
bond to the ferrous dioxygen species it would not be able to accept one from the 
hydroperoxy ferric. This in turn may explain its high degree of uncoupling not by virtue 
of the disruption of the proton donating pathway but by destabilising the hydroperoxy 
species prior to the second proton transfer. 
The binding of substrate and more importantly, the substrates displacement of 
axially ligated water is a key step in the catalytic cycle [71]. In wild-type P450 BM3, this 
step initiates a positive shift in the reduction potential in conjunction with changes in 
geometry and spin state (low- to high-spin) which accelerates the rate of the first electron 
transfer by approximately 1000-fold [76]. Previous studies have shown that although 
changes in heme reduction potential are accompanied by changes in the rate of the first 
electron transfer, it is the kinetic control associated with the change in spin state which is 
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most influential [76]. This particular observation is reiterated by considering the data 
presented for WT and the F393H1T268N mutant enzyme. The reduction potentials of WT 
in the presence of saturating concentrations of substrate and the F393H/T268N mutant in 
the absence of substrate are fairly similar (E m = -280 and -304 mV for WT and 
F393H/T268N) while they exhibit significant differences in spin state. The WT enzyme 
is almost exclusively high spin while the F393H/T268N mutant is entirely low spin. If the 
thermodynamic driving force was the most important factor in determining the maximal 
rate constants for electron transfer then we would expect the rate constants (kred) to be the 
same. From the data we see that while WT can transfer electrons at -100 s 1 , the mutant 
enzyme has a kred on only 2 This would suggest that the difference in these rates is a 
result of the differences in spin state. If we compare enzymes with the same spin state but 
differing potentials, namely WT and F393H in the presence of substrate (E m = -304 and - 
161 mV respectively), we see that a relatively large positive shift in the driving force of 
153 mV only results in a 2 fold enhancement of the rate constant for first electron transfer 
(F393H k(red) = 230 s') . This shows that the change in spin state and geometry as a pre-
organisation step prior to electron transfer exerts more influence than the thermodynamic 
driving force. 
It is evident from these data that the present series of mutants displays differing 
degrees of substrate-induced spin-state shift. Clearly if the initiation of the catalytic cycle 
is intrinsically linked to substrate recognition then these changes can be expected to have 
serious ramifications on the subsequent steps of the catalytic cycle. Poulos et al. 
suggested that the drop in substrate-induced spin-state shift for the T252A mutant of 
P450cam was a result of the presence of an extra solvent water molecule at the active site 
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[151]. In contrast to this, Truan et. al. [130] showed that the T268A mutant of P450 BM3 
contained no extra water molecule at the active site despite observing the same drop in 
the spin-state shift. They proposed that the smaller size of the alanine residue, compared 
to threonine, leads to an active-site binding pocket which is notably larger than in the 
wild-type enzyme. This increase in size, they suggest, may allow both substrate and 
ligated water to co-exist in the active site. Both these arguments however cannot fully 
explain the observations we have made for both alanine and asparagine mutations. In 
accordance with Truan et al. crystal structures of the T268A and T268N mutant enzymes 
in 450 BM3 have revealed that there is no extra water molecule present at the active site. 
The increased size of the asparagine residue compared to the threonine makes it unlikely 
that the loss in ability to generate the high-spin complex is a result of substrate and water 
coexisting at the active site although it is possible that it may deny substrate access to the 
active site. 
Peterson et al. [78] suggested that structural movement of the I-helix on substrate 
binding was responsible for the displacement of water from the active site (Fig 3.22). 
They proposed that changes in this helix result in the formation of a hydrogen-bonding 
pocket between the backbone of A264 and the hydroxyl group of T268. The displaced 
water is held in this binding pocket and is in equilibrium between this position and the 
iron-bound state. This hypothesis is corroborated by a recent paper which indicates that 
altering the temperature of the substrate bound complex influences the spin state with low 
temperatures favouring the low-spin form [152]. 
Substitution of the threonine for an alanine would clearly weaken the hydrogen 
bonding interaction with displaced water and alter the equilibrium in favour of water 
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bound to the iron. Substitution of the threonine for an asparagine also influences the 
position of this equilibrium although in a slightly different way. The crystal structure of 
T268N shows that the NH2 group of the asparagine is positioned close to the ligand 
water, with the OH group hydrogen bonding to Threonine438. As with the alanine 
substitution, this will serve to remove the hydroxyl group from the high-spin water 
binding pocket. However, this does not entirely explain why T268N and F393H/T268N 
exhibit such a poor spin-state shift on substrate addition. The crystal structure of the 
T268N enzymes shows that there is a hydrogen bond formed between the N11 2 hydrogen 
and the iron ligated water. The addition of a H-bonding interaction would shift the 
equilibrium in favour of the low-spin form with water remaining bound to the iron 
(Figure 3.5). It is also possible that the addition of hydrogen-bonding interactions 
between N268 and both A264 and T438 will impede the shift of the I-helix on substrate 
binding. If the shift of this helix and movement of A264 is essential for the formation of 
the high-spin complex then this would clearly explain why the T268N substitutions lead 
to a reduced capacity for forming the high spin complex through the addition of substrate. 
If we look at the active site structure of P450cm [22] (Figure 3.23) which also possesses 
an asparagine residue in an analogous position to the N268 BM3 enzyme then we see that 
although the asparagine is in the same place, the residue directly above it (T264 in BM3) 
is a valine thus preventing the formation of a H-bond which might stabilise the I-helix. 
This is of course speculation in lieu of a substrate bound crystal structure for the T268N 
mutants. 
It is worth noting that when comparing the binding of the fatty acids arachidonate 
(C20) and laurate (C12), a significant difference in the degree of spin-state shift at 
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Figure 2.23: The active site crystal structure of WT P450 BM3 (I BU7), T268N 
BM3 (IYQP) and P450cm (1T2B) indicating the relative positions of key active site 
saturating substrate conditions is observed [44]. However, this is accompanied by 
considerable differences in the substrate dissociation constants. Across this series of 
mutants large differences in substrate-induced spin-state shift are observed, while 
essentially no differences are seen in the substrate dissociation constant values. This 
clearly shows that while the recognition of substrate is impaired by these threonine 
mutations, the binding of substrate is unaffected. This observation would appear to be 
logical as the substrate binding region is positioned at the mouth of the substrate binding 
channel some distance from the active site (Figure 3.24). Two residues (R47 and YSi) 














Figure 3.24: Diagram depicting the relative positions of the substrate binding 
residues Y51 and R47 in comparison to the heme in P450 BM3 (I FAG). 
acid substrate, holding it in position [14]. As the mutations in this study are not close to 
this region of the enzyme, we would not expect their substitution to greatly influence 
substrate affinity. 
The Phenylalanine393 residue heavily influences the electronic nature of the 
heme. Its substitution by a histidine results in a positive shift of about 100 mV in both the 
substrate-free and substrate-saturated heme reduction potentials [44-45]. This change in 
Em occurs as a result of interactions with the cysteine-thiolate ligand on the proximal side 
of the heme. Figure 3.13 shows a diagram depicting the positions of the substrate free and 
arachidonate saturated herne mid point potentials for wild type and the mutant enzymes 
F3931-I. 1-268A. T268N. F39311T268A and F393H/T268N. Substitution of the threonine 
by an alanine does not alter the substrate free E 1 values suggesting that the threonine 
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residue itself has no direct influence on the thermodynamic nature of the heme. 
Substitution of the threonine to an asparagine stimulates a positive shift in the substrate 
free Em of 60 mV. From the crystal structure, it can be seen that although the asparagine 
does not interact directly with the heme, it does form a H-bond with the heme ligand 
water. We might expect this hydrogen bonding interaction to draw electron density away 
from the water and weaken the Fe-0112 bond resulting in a small positive shift in the 
reduction potential. 
Interestingly, substitution of the T268 residue dramatically diminishes the degree 
of substrate-induced potential shift. These changes in the thermodynamic profile are 
roughly in correlation with the degree of spin-state shift. The T268A single and double 
mutations exhibit both a moderate degree of spin-state shift and substrate-induced 
potential shift. Both T268N substitutions display significantly smaller amounts of spin-
state shift and consequently smaller substrate-induced potential changes. The binding of 
substrate not only displaces the heme iron ligand but also causes structural 
rearrangements arround the heme, including relatively large movements of the I-helix. It 
would seem rational that if the characteristic substrate-induced potential-shift was linked 
to either of these factors, that inhibiting substrate recognition would result in smaller LE m 
values. 
We can see from the calculation of the heme reduction potentials in the presence 
of CO as a mimic for oxygen that the true midpoint potentials are more positive than 
those quoted in the absence of oxygen by approximately 200 mV in every case. As a 
result of the uniform increase in reduction potential, the same Em profile is observed 
across the series of mutations. In the presence of CO, substitutions of T268A do not 
126 
Chapter 3: The Role of Threonine 268 
	
100. 	 O 
80. 
/ 







0 20 40 60 80 ' 1;0 ' 120 ' 140 ' 0012 140 16V 180 200 
Substrate Induced Potential Shift 
Figure 3.25: Correlation between substrate induced potential shift in the presence of 
CO and the percentage spin-state shift fitted to a linear regression. 
influence the substrate free reduction potentials but do have an effect on the magnitude of 
the substrate induced potential shift. Similarly, T268N substitutions influence both the 
substrate free and substrate saturated values. Interestingly, in the presence of CO. the 
correlation between approximate spin-state shift and substrate-induced potential shift is 
no longer just a rough one. A plot of substrate-induced potential-shift in the presence of 
CO against percentage spin state shift can be fitted to a linear regression as seen in figure 
3.25. 
Substitution of phenvlalanine 393 to a histidine has been shown to 
dramatically increase the rate constant for the first-electron transfer in comparison to 
wild-type P450 BM3 [76]. Other mutations of this residue (F393A. F393W, and F393Y) 
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Figure 3.26: Correlation of kinetic parameters and heme reduction potential for 
wild-type P450 BM3 and the mutant enzymes F393H, T268A, T268N, 
F393H/T268A and F393H1T268N. The plot of the heme reduction rate constants 
(kred) vs heme reduction potential fitted to a linear regression. 
have also been shown to influence the first electron-transfer rate constants (k red) and these 
differences have been intrinsically linked to the substrate-bound heme reduction 
potentials. Changes in the heme reduction potential will ultimately lead to changes in the 
driving force for electron transfer (AG) between the FMN semiquinone and the heme 
(Fi(Iure 3.27). A positive shift in the heme reduction potential with respect to wild type 
viIl result in a larger positive IG and hence faster first electron transfer as seen for 
F393H. From this we would expect the rate constants for first electron transfer to vary 
across the series according to their heme reduction potential in accordance with non-
adiabatic electron transfer theory. This would predict a Gaussian distribution of electron 
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Figure 3.27: Relative positions of the FMN oxidisedlsemiquinone redox couple and 
the substrate saturated Em values in the presence of CO for WT and F393H. The 
diagram shows how the increase in potential leads to a larger driving force for 
electron transfer (AG). 
transfer rate constants on varying the heme reduction potential. Although what we see is 
a straight line correlation (Figure 3.26), this is likely to be the result of the limited 
potential range studied. 
It is evident, that the T268N substitutions do not fit this trend. F393H/T268N 
exhibits a rate constant for electron transfer which is incongruous with the value which 
would be predicted from its heme reduction potential. In addition, T268N has a rate 
constant for heme reduction which is two-fold less than its turnover rate, clearly 
impossible. Both these factors suggest that the measured kred values are an 
underestimation of the true rate constant. We suggest that, in this case, the experimentally 
derived values for heme reduction are artificially low due to a gating mechanism caused 
by the presence of the asparagine. It is possible that there is movement of the asparagine 
residue on reduction. This theory is corroborated by the potentiometric titration of the 
F393H/T268N mutant in the presence of CO which indicates that there may be some 
structural alteration on heme reduction. In the single turnover pre-steady-state experiment 
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Figure 3.28: Correlation of kinetic parameters and heme reduction potential for wild-
Lype P450 BM3 and the mutant enzymes F393H, T268A, T268N, F393H/T268A am 
F393H1T268N. The plot of the auto-oxidation rate constants (k autox) and hem 
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Figure 3.29: Diagram depicting the pathway of oxy-ferrous decay (k autox ). 
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(measurement of kred),  the rate of electron transfer may be limited by the movement of 
this asparagine residue. If this was the case then the observed rate constant for heme 
reduction would be artificially low in comparison to the other BM3 mutant constructs. In 
the steady-state experiment, the first turnover could result in the movement of the 
asparagine. The potentiometry of F393H/T268N mutant in the presence of CO suggests 
that the movement of this residue back to the 'oxidised' state is slow. We might therefore 
expect this residue to remain in the 'reduced' position in a turnover situation, essentially 
overcoming the kinetic barrier. This would explain why the rate constant for turnover is 
higher than the rate constant for heme reduction in the T268N mutant. 
Similarly, heme reduction potentials have been shown to influence the stability 
of the oxy-ferrous species. More negative Em values increase the ferric nature of the 
oxygen adduct and as decay to the ferric species can only occur via the oxy-ferric form, 
this increases the rate of decay of the oxy-ferrous species [76] Figure (3.29). Previous 
studies have shown the exponential dependence of the stability of the oxy-ferrous species 
on the heme reduction potential and all mutants examined in this study corroborate this 
relationship (Figure 3.28). If the hydrogen bonding nature of the threonine itself, and not 
just the potential of the heme, was responsible for modulating the stability of the oxygen-
bound complex, then its substitution by an alanine would be expected to generate a 
highly destabilised oxy-ferrous species. The fact that this does not seem to be the case 
suggests that oxy-ferrous stability has more to do with reduction potential than any 
hydrogen-bonding interactions with this distal threonine. It was hoped that substitution of 
the threonine residue with an asparagine might provide a stronger interaction with the 
ferrous-dioxygen complex. In fact there is evidence to suggest that the asparagine can 
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interact with both water and CO when they are iron ligands. The rate constants for the 
decay of the oxy-ferrous species show that there is a small destabilisation of the oxy-
ferrous complex which is directly linked to the heme reduction potential. This would 
suggest that threonine residue is less important for oxy-ferrous stability than previously 
thought. 
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3.5 Conclusions 
In conclusion we have shown that substitutions of the highly conserved distal 
threonine in P450 BM3 lead to: 
. Lower rates of NADPH oxidation. 
Significant increase in the uncoupled formation of hydrogen peroxide. 
. Lower degree of spin-state shift on substrate binding. 
. Smaller substrate-induced potential shift roughly in accordance with the 
degree of spin-state shift. 
. Modulated rate constants for the first electron transfer and oxy-ferrous 
decay in direct correlation with the heme reduction potential. 
These results show that the threonine residue is important in maintaining an efficiently 
functioning enzyme. It is clear that this residue most likely assists the delivery of protons 
which are necessary to form the ferryl species. It is evident however, that while it plays 
an important part, it is only one of a number of residues which are involved in this 
function. As the P450 mutant enzymes are still capable of generating some hydroxylated 
product, it is likely that the threonine does not act as a proton donor. Thus, removing the 
proton donating capabilities does not have as profound an effect as we might have 
expected. What is more important is the positioning and H-bonding interaction with the 
active site water. 
One of the aims of this set of mutations was to examine the importance of 
hydrogen bonding interactions between the active site threonine and dioxygen. However, 
we can see from the data presented above that the stability of the oxy-ferrous complex is 
more heavily influenced by the heme reduction potential than it is by the nature of the 
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threonine substitution. This would suggest that the H-bonding interaction is less 
important than was originally thought. One interesting suggestion is that the threonine is 
more important in stabilising the hydro-peroxy ferric species. If this was the case then the 
positioning of the asparagine NI1-1 2 would preclude it from fulfilling this role. What is 
clear is that mutation of this residue has a profound influence on the substrate induced 
spin state shift and in turn the potential and subsequent kinetic parameters. 
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4 P450 BM3 Second-Electron Transfer 
4.1 Introduction 
It is generally accepted that the insertion of an atom of oxygen into an organic 
substrate, follows a common catalytic cycle for all members of the cytocbrome P450 
super-family (Figure 1.9) regardless of substrate or function [15,71]. In the resting state 
of cytochrome P450, the heme iron is ferric low-spin and six-coordinate (Figure 1.6). The 
first step in the catalytic cycle requires the binding of substrate and the subsequent 
displacement of the axially ligated water forming a high-spin ferric species (STEP 1) 
(Figure 1.10). Substrate binding causes changes in both the thermodynamic and kinetic 
properties of the heme and acts as a switch, facilitating the first-electron transfer to form 
a ferrous-iron species (STEP 2). The subsequent binding of molecular oxygen generates 
the oxy-ferrous -* superoxy-ferric resonance hybrid (STEP 3). Transfer of a second 
electron leads to the formation of the ferric-peroxo intermediate (STEP 4), followed by 
two protonation steps to generate the ferric-hydroperoxo and ferryl species (STEP 5). The 
final steps have been characterised as the insertion of the ferryl oxygen into the C-H bond 
of an organic substrate (STEPS 6/7) often referred to as the rebound mechanism, 
followed by product dissociation (STEP 8). 
The first three steps detailing the formation of the oxy-ferrous complex and the 
fmal product-dissociation step have been extensively studied in many different P450 
enzymes [44,45,76.153-155]. However, the intermediate Steps (4-7) are not as well 
characterised due to the rapid protonation of the ferric-peroxo intermediate (STEP 4) and 
what is likely to be the even faster reaction of the iron-oxo complex. As a result of this, 
fifty years after the discovery of the first P450, the precise nature of the catalytically 
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functional species is still a topic of debate [68,88,156-160]. Current theories suggest that, 
although the high valent Fe(IV)=O species is capable of catalysing the majority of P450 
reactions, the peroxo and hydro-peroxo species catalyse some nucleophilic P450 
reactions such as the oxidative decarbonylation of aldehydes [90]. It has also been 
suggested by Newcomb et al. that the hydro-peroxo species acts as an electrophilic 
intermediate in olefin epoxidations. It has been proposed therefore that different P450 
enzymes may utilise different catalytic species depending on their function and the 
specific reactions associated with their substrates [68,88,156-160]. 
The final species which can be 'trapped' and observed by conventional UV/vis 
spectroscopy is the ferrous-oxygen complex. DFT analysis of the oxy-ferrous/superoxy-
ferric species has shown that the oxygen is in the singlet state with the empty Tr*(OO) 
orbital mixing with the occupied d yz iron orbital [161]. The second electron is transferred 
onto the iron bound oxygen generating a negatively charged iron-peroxo complex. Work 
by Harris et al. indicated that this electron predominantly populates the Tr*(OO)  orbital 
[162]. It has been reported for several P450 enzymes including P450cam that the second-
electron-transfer step is rate limiting [86,163-164]. The negatively charged (formally 2-) 
iron-peroxo complex formed in this apparently slow step is likely to be protonated 
quickly to generate the hydro-peroxo complex. The second protonation and the 
dissociation of water yield the iron-oxo species analogous to compound I in peroxidases 
where the iron has an oxidation state of +4 and the porhyyrin is a one-electron-deficient 
it-cation radical [65-166]. This high valent species is widely regarded as one of the most 
reactive in biology and as such, its reaction with substrate is likely to be rapid. It is 
widely accepted that in wild type P450 enzymes, the protonation steps and reaction of the 
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ferryl are faster than the second-electron transfer and as a result the Fe(III)-0, Fe(III)-
OOH and Fe(W)=O species are extremely short lived and consequently difficult to 
observe spectrophotometrically. 
Although it is not possible to observe the build-up of these species under turnover 
conditions using UV/vis spectroscopy, they have been detected by other methods. 
Davydov et al. used y-irradiation to provide the second electron to the oxy-ferrous 
species of P450cam at cryogenic temperatures [154,167]. Under these conditions the 
lifetimes of the intermediates were extended long enough to observe the iron-peroxo and 
iron-hydroperoxo species using ENDOR and EPR although there was no spectroscopic 
evidence of the build-up of the ferry! species. A number of groups have also succeeded in 
directly forming the P450 ferryl species via the addition of strong oxidising agents such 
as m-chloroperoxybenzoic acid and peroxyacetic acid. Egawa et al. [168] reported that 
the addition of m-chloroperoxybenzoic acid to P450cam led to the formation of a species 
which displayed a spectrum indistinguishable from that of the compound I from 
chloroperoxidase, with major absorption maxima at 367 nm and 694 nm. Schunemann et 
al. have also reported the presence of an ferryl species on the reaction of peroxyacetic 
acid with substrate saturated P450cam as characterised by EPR and Mossbaur 
spectroscopy [169-170]. 
Clearly, both protonation steps are dependant on the presence of a fast and 
efficient proton donating pathway. In P450cam this has been ascribed to the highly 
conserved T252 (analogous to T268 in P450 BM3) in conjunction with D251 and the 
protonated forms of Kl 78 and Rl 86 with the threonine ultimately providing the proton to 
the peroxy and hydro-peroxy species. Studies by Poulos et al. showed that removing one 
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of the residues (1325 1 in P450cam), which is essential for the proton transfer pathway 
leads to a lower turnover rate constant. In the D25 1A mutant, the rate-determining step is 
no longer the second-electron transfer but instead one of the protonation steps forming 
the hydroperoxy-ferric or ferryl species [171]. 
The transient nature of the reactive species not only makes their identification 
somewhat difficult, it also means that measuring the rate of the second-electron transfer is 
problematic. The experiment requires the in-situ generation of the oxy-ferrous complex 
and its immediate reaction with a reductant providing the second electron. There is no 
way to stop the reaction after the second-electron transfer and as a result, the kinetic 
traces are multi-phasic (representing steps 4-8 in the catalytic cycle) and are consequently 
difficult to accurately assign. There are several other problems with studying this reaction 
including the short lifetimes of the iron-oxygen complex and the multiple oxidation states 
observed for some of the physiological electron donors (e.g. CPR). 
Two recent studies by Zhang and Dawson [75,77] have attempted to quantify the 
second-electron transfer rate constants for P450 2B4 and P450cam respectively. Zhang et 
al. used a single-mixing stopped-flow setup to first generate the oxy-ferrous species and 
then deliver the second electron via a modified 5-deazaFAD reductase in a 1:1 ratio with 
the P450 [75]. The modified reductase was used in order to ensure that the FMN 
hydroquinone could deliver only one electron [172]. They report the formation of a 
relatively stable reduced oxy-ferrous species with multiple electron transfer rate constants 
of 8.4, 0.37 and 0.041 s. Although they identify the fast rate constant of 8.4 s 1 as the 
second-electron transfer they suggest that further investigation is required in order to 
identify each of the transitions observed. Global analysis of the diode-array spectra of 
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oxy-ferrous reduction failed to identify a spectrum corresponding to any of the 
intermediate compounds. 
Dawson et al. used a multi mixing stopped-flow setup for the turnover of the oxy-
ferrous species in P450cam using the pre-reduced physiological electron donor, 
putidaredoxin [77]. They report the presence of three distinct phases with rate constants 
of 140 s ' , 85 s' and <5 s 1 . They assign the first phase to the formation of a perturbed 
oxy-ferrous complex reflecting changes in H-bonding to the ubiquitous cysteine ligand. 
They also suggest that the second phase is attributable to the second-electron transfer rate 
constant. 
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4.2 Aims 
Until recently, the difficulties associated with measuring the second-electron-
transfer rate constant had meant that no data were available for this key step in the 
catalytic cycle. However, two new studies have detailed the kred2 values for P450 2B4 and 
P450cam using the physiological electron donors 5-deazaFAD reductase and 
putidaredoxin respectively [75,77]. 
In this study we have attempted to measure the second-electron transfer rate 
constant for cytochrome P450 BM3 by means of a multi-mixing pre-steady-state 
experiment using reduced methyl viologen (E m = -430 mV) as the electron donating 
species. Previous work has identified several key active site residues (F393 and T268) 
which influence both the heme reduction potential and (potentially) the proton donating 
pathway. It was hoped that monitoring the differences in the observed kinetic traces 
across a series of mutant enzymes would help the identification of the kred2 values. In 
addition, it was hoped that these experiments might providing additional insight into the 
function of these two active site residues. 
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4.3 Results 
4.3.1 Expression and Purification 
Wild type P450 BM3 and the mutant enzymes F393H, F393A, F393Y, F393W, 
T268A, T268N, F393H1T268A and F393H/T268N in the heme domain construct were 
over-expressed and purified to >95% purity as defined by the presence of a single band 
on an SDS-Page gel. Reduction of the enzymes with dithionite and the subsequent 
addition of CO, generated the characteristic ferrous-CO Soret band at -450 mm 
Successful purification yielded protein with an entirely low-spin spectrum in the oxidised 
state and minimal amounts of P420 (non cysteine ligated heme) in the UV/vis spectrum 
of the CO bound species. 
4.3.2 Control Experiments 
The use of methyl viologen as an external electron donor means that the electron 
transfer is not specific for the oxy-ferrous P450. The negative reduction potential of 
methyl viologen (430 mV) means that it is a powerful reducing species providing a 
strong thermodynamic driving force for electron transfer. As a result, if there is any 
excess oxygen or ferric heme it will be reduced and could complicate the kinetic traces 
associated with the reduction of the oxy-ferrous complex. Rate constants for oxygen and 
heme reduction by methyl viologen were measured using the stopped-flow apparatus in 
order to aid interpretation of the second-electron-transfer kinetic data. 
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Figure 4.1: Methyl viologen (MV) reduction of molecular oxygen. Panel A shows 
the spectra associated with MV oxidation. Note that the majority of the reduction has 
occurred between the first and second spectra (2.5 ms). Panel B shows the change in 
absorbance at 395 nm (black) and single exponential fit (black) with a rate constant 
of 1200 s'. This rate-constant is at the limit of what can be accurately measured 
using the stopped-flow apparatus. 
Figure 4.1 shows that at equimolar concentrations, methyl viologen reduces 
oxygen (4 electron reduction to water) extremely rapidly with a rate constant in excess of 
what can be accurately measured using the stopped-flow apparatus (>800  s'). The fast 
oxidation of methyl viologen leads to the bleaching of the UV/vis spectrum. The AAbs. is 
comparatively low for the concentrations of viologen and oxygen used as the majority of 
the reaction takes place within the dead time of the apparatus (—I ms). The reduction of 
oxygen to water requires four electrons and as methyl viologen provides only one 
electron per molecule, even a small amount of oxygen would result in the consumption of 
significant amounts of reduced viologen. Consequently, the concentration of oxygen must 
be kept to a minimum. The experimental protocol requires the mixing of stoichiometric 
amounts of 1 1450 and oxygen. As a result, there should be very little free oxygen present 
\ hen it is mixed v, jib methyl viologen. In addition, the wavelength chosen to monitor the 
second-electron transfer (455 nm) lies in a region of the spectrum which does not exhibit 
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Figure 4.2: Variation in heme reduction with increasing concentration of methyl 
viologen for WT ad F393H. Both sets of data are fitted to a linear regression yielding 
second order rate constants of 0.6 and 3.5 s 1 Ms 1 respectively. 
spectral changes associated with viologen oxidation. This means that the observed traces 
of oxy-ferrous reduction should not display any absorbance changes associated with the 
reduction of free oxygen. 
Figure 4.2 shows the reduction of ferric P450 heme with methyl viologen at 
varying concentrations of MV for WT and F393H. These two enzymes represent 
extremes of the reduction potential range studied in this series of enzymes (WT Em 
(+sub) = -304 mV, F393H Em (+sub) = -161 mV). As the electron-transfer rate-constants 
should vary in accordance with Em we would expect all the other enzymes to display rate-
constants between WT and F393H. The observed heme reduction rate-constants increase 
linearly with increasing viologen concentration giving second order rate constants of 0.6 
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Figure 4.3: Simulated oxy-ferrous decay for P450 BM3 F393W. The dotted arrows 
show that after 250 ms, > 95 % of the complex is still in the ferrous form. 
and 3.5 s'aM' for WT and F393H respectively. At equimolar concentrations of MV and 
heme (similar to those used in the multi-mixing experiments) the observed rate constants 
are 23 s_ I and 65 s 1 . Clearly, the reduction of any ferric heme present in the reaction 
mixture would lead to absorbance changes in a region of the IJV/vis spectrum used for 
monitoring the changes in the oxy-ferrous species and as such should he kept to a 
rnininun1. 
The experimental protocol requires the pre-reduction of the P450 heme with 
excess sodium dithionite and the subsequent removal of the reducing agent via gel 
filtration. In order to minimise the re-oxidation of the ferrous P450, all experiments were 
carried out under an anaerobic atmosphere ([0:] < S ppm) and reduced enzyme samples 
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were generated immediately prior to the experiment. On addition of oxygen (the first step 
in the multi mixing experiment) the oxy-ferrous/superoxy-ferric resonance hybrid is 
formed and slowly decays to ferric heme and superoxide. If the oxy-ferrous species was 
left to age for a long period prior to the addition of methyl viologen, then a significant 
amount of ferric enzyme will have built up. In order to minimise this, ageing times were 
limited to 250 ms. Under these conditions the fast formation (>600 s') of the oxy-ferrous 
species should be complete with a minimal build up of ferric P450. The most unstable 
oxy-ferrous complex in the series of enzymes studied is observed for the F393W mutant 
(kautox = 0.5 s'). Figure 4.3 shows a simulated exponential decay for the auto-oxidation of 
the F393W oxy-ferrous complex. After 250 ms, less than 5 % of the oxygen bound 
species has decayed to the ferric form and consequently its reduction would not 
contribute a significant amount of absorbance change to the observed kinetic traces. 
Theoretically, as all other enzymes in this study have a more stable oxy-ferrous species, 
they would contain less ferric-heme under the conditions used in the measurement of 
kred2. 
Prior to injecting the second electron, the multi-mixing-experiment was carried 
out with buffer instead of methyl viologen. Under these conditions, the decay of the oxy-
ferrous species was observed. The observed rate-constants for oxy-ferrous decay were 
compared to those previously measured under saturating concentrations of oxygen. The 
diode-array spectra were analysed to ensure that the reduction of heme and binding of 
oxygen were successful and that there were no large spectral contributions from residual 
ferric or ferrous heme. As equimolar concentrations of P450 and oxygen were used in 
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Table 4.1: kautox values in excess and stoichiometric amounts of oxygen 
kautox (5 1 ) 
Excess [021 	 Stoichometric [021 
Enzyme 	
+ sub 	 + sub 
-sub 	 -sub 
(120MAA) 	 F(120 AM AA) 
w'-r 0.091 ±0.020 0.059±0.008 f 0.11 ±0.01 0.10±0.01 
F393H 0.018±0.002 F-0013±0.0002 
[ 	
0.0021 ±0.0008 0.0036±0.0006 
F393A 0.0034 ± 0.0004 0.0061 ± 0.0012 
[ 	
0.0084 ± 0.0021 	j 0.010±0.002 
F393W 0.54±0.09 0.47±0.04 0.58±0.02 0.51 ±0.6 
F393Y 0.10±0.02 0.12±0.04 0.066±0.010 0.089±0.022 
T268A 0.27 ± 0.06 	j 0.26 ± 0.04 0.72 ± 0.14 0.31 ± 0.08 
T268N 0.46 ± 0.09 0.37 ± 0.4 
[ 	
0.38 ± 0.04 0.17 ± 0.02 
F393H1T268A 
- 
0.048±0.006 0.0071 ± 0.0016 j 0.015±0.04 0.0089±0.0021 
F393H1T268N P.053 ± 0.0 - I I 0.016±0.002 0.023±0.002 - 0.052±0.011 
this experiment, first-order kinetic traces were not generated. Under these conditions, the 
observed oxy-ferrous decay does not reach completion, exhibiting what appear to be 
multiphasic traces. However an approximate comparison of the two decay rates can be 
made as shown in Figure 4.4. 
Kinetic traces for kautoox at stoichiometric amounts of oxygen and P450 were fitted 
to a double exponential fitting function. The quoted rate constants are the faster of the 
two calculated values. In every case, the oxy-ferrous decay traces and rate constants were 
comparable to those generated under pseudo-first order kinetic conditions (Table 4.1). 
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Figure 4.4: Panel A shows a comparison of the kinetic traces for oxyferrous decay 
in the presence of excess and stoichiometric concentrations of oxygen. Panel B 
shows the typical spectral shifts observed on oxy-ferrous decay in the presence of 
substrate. 
4.3.3 Second-Electron Transfer 
4.3.3.1 Stoichiometric amounts of MV and Enzyme 
Initially, all experiments were carried out using stoichiometric amounts of methyl 
viologen and P450 in order to deliver the second electron to the oxy-ferrous species. 
Under these conditions, all the methyl viologen should be oxidized and all of the oxy-
ferrous complex should be reduced. Changes in the UV/vis spectra were monitored over a 
short time base using a diode-array detector. However, the minimum time base for the 
diode array detector is 2 seconds with an integration period of 2.5 ms. As this does not 
provide high enough resolution for an accurate interpretation of the kinetic traces, single- 
avelength absorbance traces were also recorded at 455 and 650 nm for P450 heme and 
MVrd respectively. Figure 4.5 shows the spectra of MV red and the WT P450 oxy-ferrous 
complex indicating the wavelengths used to observe the two species. Changes in the 
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Figure 4.5: UVIvis spectra of reduced methyl viologen (black line) and the oxy -
ferrous species of the wild-type oxy-ferrous species. The arrows indicated the 
wavelengths at which changes in heme and MV were observed. 
Figure 4.6: Absorbance changes at 455 nm observed on mixing oxy-ferrous P450 
with reduced methyl viologen. 
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isosbestic point, it is a wavelength at which there are minimal absorbance changes 
observed on oxidation of methyl viologen. Similarly, the oxidation of methyl viologen 
was monitored at 650 nm as there are minimal contributions from the heme at this 
wavelength. The kinetic traces observed at 455 nm, associated with changes in the P450 
heme, contained up to three phases. Figure 4.6 shows a composite of the kinetic traces 
observed for the wild type enzyme at 455 nm over multiple time bases as well as the 
diode array data recorded over 2s. All kinetic traces were fitted using the SPECFIT/32 
global analysis program using the model A—B--*C. Table 4.2 shows a summary of the 
phases and the rate constants associated with each of these. 
The fast phase (k 1 ) was consistent between repeated experiments and in all cases 
represented the largest change in absorbance. In every enzyme studied, the fast phase 
observed at the P450 was coupled to the oxidation of methyl viologen as shown for WT 
in figure 4.17. Rate constants for the fast phase varied between the enzymes studied 
accordingly: 
The values generated for k1 in the presence of substrate were essentially the same as those 
observed at saturating concentrations of arachidonate (120 IiM). 
The second phase (k2) was not observed in every enzyme studied and its 
amplitude was dependant on the relative amounts of viologen and P450 present in the 
sample. Lowering the concentration of viologen resulted in both a smaller amplitude and 
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Figure 4.7: Panel A shows the absorbance changes observed on the reaction of 
reduced methyl viologen and oxy-ferrous P450 BM3 WT. Panel B shows the 
absorbance changes at 455 and 650 tim used to monitor changes in the heme and 
viologen respectively. The data show that each of the three phases observed at the 
P450 are coupled to the oxidation of methyl viologen. 
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Figure 4.8: Stopped-flow kinetic traces showing the changes in the second phase (k2) 
on dilution of the methyl viologen stock solution. Concentrations of methyl viologen 
shown are prior to mixing. 
lower rate constant for this second phase (Figure 4.8). As a result, no definite value can 
be quoted for this intermediate rate constant. 
The third (slow) phase (k3) was observed at the P450 wavelength in almost all the 
enzymes studied and, in the presence of excess viologen, at the wavelengths associated 
with methyl viologen oxidation. The amplitude of the slow phase in comparison to the 
fast phase was variable and the rate constants were not dependant on the relative amounts 
methyl viologen or oxygen. Rate constants for k3 are shown in table 3, in some cases the 
amplitude of this phase was so small that reliable values could not be calculated. In all 
cases, the low rate constant for the third phase and its relatively small amplitude in 
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(120 1M Arachidonate) 
k, (s-') 





140±21 0.14±0.05 130± 13 0.16±0.05 
F393H 
[ 	
14±3 0.012±0.006 12±4 0.0045±0.0021 
F393A 
[ 	
7.4±2.1 0.0050±0.0025 8.6±3.4 - 
F393W F 500 ± 40 0.85 ± 0.39 F 	490 ± 65 0.11 ± 0.05 
F393Y 
[ 	
130±15 - 150±10 - 
T268A 
[ 	
14±2 0.16 ±0.08 24±3 0.15 ±0.04 
T268N 
[ 	





6.9± 2.5 - 
F393H/T268N 
[ 	
3.1 ±0.7 0.036±0.008 F 10±1 - 
comparison the first two phases meant that it did not significantly influence the fitting 
functions. 
Analysis of the changes in absorbance at 650 nm associated with the oxidation of 
methyl viologen also exhibited up to three phases. The phases corresponded exactly to 
the three phases observed during heme reduction. The first phase accounted for the 
majority of the total absorbance change and was consistent between experiments. The 
second and third phases were comparable to those observed for P450. However, these 
phases were dependant on the presence of excess methyl viologen. The suggestion from 
these results is that there are three definite transformations which are observed at 
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wavelengths used to study the heme, each of which can be linked to the consumption of 
reducing equivalents as indicated by the oxidation of MV red. 
4.3.3.2 Varyin2 amounts of MV and Enzyme 
It is clear that the one-electron reduction of ferric-P450 heme by methyl viologen 
is a second-order process and consequently, linearly dependant on the concentration of 
methyl viologen (Figure 4.2). It would reasonable to assume therefore that rate-constants 
for the second-electron transfer will also be dependant on the concentration of methyl 
viologen. Figure 4.9 shows the changes in k 1 for wild type, F393H and F393H/T268N 
mutants at varying concentrations of methyl viologen. The data show that both wild type 
and F393H have increasing rate-constants for k 1 at increasing concentrations of methyl 
viologen with second order rate-constants of 8.7 and 1.4 AM - 's -1 respectively. However, 
the k 1 rate-constants for the F393H/T268N mutant enzyme does not significantly increase 
with increasing methyl viologen concentration. The implication of this may be 
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Figure 4.9: Variation in k0b for the P450 BM3 second-electron-transfer step for wild 
type, F393H and F393H1T268N. Each of the data sets is fitted to a linear regression in 
order to determine the second order rare constants. 
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that some factor other than a simple electron transfer has become rate limiting for the 
T268 mutant enzymes. 
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4.4 Discussion 
The first three steps in P450 catalytic cycle, namely the binding of substrate, first-
electron transfer and the binding of molecular oxygen to ferrous iron, have been 
extensively characterised in a variety of P450 enzymes [44,45,76.153-155]. The fourth 
step, the second-electron transfer, leads to the formation of a transient peroxy-ferric 
species which rapidly picks up several protons to form the hydro-peroxy and ferryl 
complexes. These highly reactive complexes (the 'active' species in the catalytic cycle) 
react rapidly with substrate generating hydroxylated product and ferric, low-spin heme. 
The transient nature of the species in the catalytic cycle after the second electron transfer 
in addition to the relatively short life time of the oxy-ferrous complex has meant that it is 
particularly difficulty to measure a rate-constant for second electron transfer using 
conventional stopped-flow experiments. Several recent papers have described the second-
electron-transfer rate constants for P450 2B4 and P450cam by using single and multi-
mixing pre-steady-state kinetics experiments respectively [75,77]. In these experiments, 
the relatively short-lived oxy-ferrous complex is first generated then immediately reacted 
with a physiological electron donor in order to provide the second electron. 
Zang et al. report that when 5-deazaFAD P450 reductase is used to reduce the 
oxy-ferrous species of P450 2B4, three phases are observed for reductase oxidation and 
two phases are observed for changes in the P450 (FMNH2 - FMNH : 8.4, 0.37 and 
0.041 s, P450: 0.09 and 0.012 s'). Clearly there are differences between the two sets of 
rate constants. The authors suggest that the initial fast rate constant for flavin oxidation is 
representative of the second-electron transfer leading to the formation of a stable 
(Fe 3+00)2-or  (Fe3 OOH)' intermediate which is spectrally similar to the oxy-ferrous 
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complex. It is also reported that the first phase observed at the wavelength associated 
with changes in the P450 (0.09 s) is comparable to the rate of product formation under 
steady state conditions. They propose that this might correspond to the rate constant for 
the remaining steps in the catalytic cycle after the formation of the intermediate and that 
one of these steps (5-8) is rate limiting. The source of the other absorbance changes at the 
P450 and reductase however are not clarified and the authors themselves suggest that 
more work is required in order to identify them. 
Dawson et al. report a multi-mixing experiment whereby the oxy-ferrous complex 
is first formed and then reacted with reduced putidaredoxin in order to deliver the second 
electron. They report the presence of three phases associated with changes at the heme 
(140 s 1 , 85 s 1 and <5 s) although no data is given for Pdx oxidation. These three phases 
are characterised as an initial decrease in the absorbance at 418 rim for the fast phase, an 
increase in zAbs. for the intermediate phase and a further decrease for the slow phase. 
They assign the fist two phases to the re-organisation of the oxy-ferrous complex 
(possibly signifying a change in the H-bonding interactions with the heme ligating 
thiolate) and the second-electron transfer. They suggest that the trigger for the formation 
of the perturbed oxy-ferrous species is the binding of the putidaredoxin. 
In this series of experiments, the non-physiological electron donor methyl 
viologen has been used to supply the second electron required for the formation of the 
ferric-peroxy species in P450 BM3. A diagram depicting several possible reactions is 
shown in figure 4.10. Although this diagram indicates the most likely changes at the 
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reduction of oxygen and ferric iron. It can be seen that both of the pathways lead to the 
formation of ferric heme. Although the work of Zang and Dawson provides an interesting 
comparison to the work described here, the use of methyl viologen as opposed to a 
physiological electron donor, and the differences in the P450s themselves in terms of the 
rate constants for second-electron transfer, and the subsequent steps in the catalytic cycle, 
means that the results cannot be directly compared. 
As reported, each of the enzymes studied in this set of experiments exhibited up 
to three kinetic phases associated with changes at the heme and that these changes could 
be directly compared to the rate-constants for the oxidation of methyl viologen. The 
major challenge is assigning the origins of each of these phases. The magnitude and 
directions of the absorbance changes bear a striking resemblance to those reported by 
Dawson et al. [77]. However, the fast phase is directly linked to the oxidation of methyl 
viologen and therefore coupled to an electron transfer process. This would suggest 
therefore that the fast phase we observe in BM3 is not a rearrangement of the oxy-ferrous 
species as suggested for P450cam. Nor would we expect this to be the case as the 
proposed change in the oxy-ferrous species in P450cam is associated with the binding of 
the redox partner Pdx. In these experiments the physiological electron donor (fused P450 
BM3 reductase) is not present and therefore not available to perform this 'effector' role 
[173,174]. It is unlikely that the fast phase is the result of methyl viologen reducing 
oxygen as the rate-constants are not large enough (e.g. WT k1 = 140 s" , kO2red= >800 s 1 ). 
It is also unlikely to be the result of methyl viologen reducing ferric heme as the rate-
constants are too high in comparison to the control experiments (e.g. WT k1 = 140 
kredMV = 23 I)•  It is reasonable to assume therefore, that excluding all other possibilities, 
159 
Chapter 4: P450 BM3 Second Electron Transfer 
the fast phase can be attributed to the second-electron transfer to the oxy-ferrous complex 
hence k 1 = kred2. 
The assignment of the second phase can be elucidated by the comparison of 
kinetic traces for WT at different concentrations of methyl viologen (Figure 4.8). As the 
concentration of viologen is decreased, the rate constant for the second phase becomes 
smaller and the magnitude of the absorbance change also decreases. The implication of 
this is that the second phase corresponds to a reduction at the heme which is dependant 
on both the presence of excess methyl viologen and the concentration of methyl viologen. 
This explains why the second phase is only observed in some of the kinetic traces and is 
not consistent between experiments on the same enzyme. From figure 4.10 we can see 
that there are two possible routes after the addition of a second electron. The first is the 
dissociation of peroxide generating ferric heme. The second requires the addition of 
several protons and the formation of the ferry! species. If we assume that both the proton 
transfer steps and the subsequent reaction of the ferryl are significantly faster than the 
second-electron transfer step, then the product generated at the end of the fast second-
electron transfer phase will be ferric heme. In the presence of excess viologen, this ferric 
heme would be reduced and could explain the presence of the second phase. Comparison 
of k2 with the rate constant for heme reduction using stoichiometric amounts of heme for 
wild type shows that the two values are comparable (k2 = 26 5 1 , kredMV 23 s 1 ). 
The origin of the third phase is a little more difficult to explain. Interestingly, for 
all enzymes studied, the values for k3 corroborate roughly with the rate constants for oxy-
ferrous decay (kautox). If we look at the kinetic traces for T268A (Figure 4.11) we see 
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Figure 4.11: Kinetic traces at 455 nm (P450) and 650 nm (MV) observed on the 
reaction of T268A P450 oxy-ferrous with sub-stoichiometric amounts of reduced 
methyl viologen. Two phases are observed at the heme and only one phase is 
observed at the viologen. 
that in the presence of sub-stoichiometric amounts of methyl viologen, the slow phase is 
observed at the P450 only and is not coupled to methyl viologen oxidation. However, in 
the presence of excess viologen this slow phase is observed at both wavelengths (Figure 
4.7). One possibility which would explain this observation is that some unreduced oxy -
ferrous complex is decaying to ferric heme and oxygen. In the absence of reduced 
viologen this decay is only observed at the heme. In the presence of viologen. the oxygen 
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would be reduced as it as produced during the decay process and could explain why the 
third phase also appears to be linked to the oxidation of viologen. However, in the 
presence of excess viologen, we would expect that all of the oxy-ferrous complex will 
have been reduced and therefore the decay would not be seen. Another possibility is that 
the slow change in absorbance is the decay of the peroxy ferric species and it subsequent 
2-electron reduction to water. Whatever the case, this phase is extremely slow and 
generally contributes only a small percentage of the total absorbance change in 
comparison to the second-electron transfer and consequently does not influence the fitted 
data for the first two phases. 
Figure 4.12 shows a plot of the second-electron-transfer rate-constants (at 
equimolar amounts of P450 and viologen) against reduction potential. Previous work has 
indicated that there is a direct correlation between the rate constants for both the first-
electron transfer and oxy-ferrous decay with the heme reduction potential [76]. We can 
see that there is also a direct correlation between the rate constants for second-electron 
transfer and Em for the F393 mutant enzymes but that substitutions at the distal threonine 
lead to a small kred2 which are independent of the reduction potential. For the first-
electron transfer we observe that an increase in the reduction potential leads to an 
increase in the rate constant for heme reduction. 
This can be easily explained by considering the changes in the driving force (AG) 
for electron transfer. Increasing the Em, for example through the F393H mutation, will 
naturally provide a larger thermodynamic driving force for electron transfer and 
consequently lead to a larger rate constant. We might naturally expect the same 
observation for the second-electron transfer. A more positive reduction potential would 
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Figure 4.12: Correlation between reduction potential and the rate constant for 
second-electron transfer at stoichiometric amounts of P450 and viologen. P450 
enzymes incorporating substitutions at the F393 residue display an exponential 
dependence between kred2 and Em. P450 enzymes incorporating substitutions at 
T268 display kred2 values which are comparatively small and independent of 
lead to a larger AG and larger k,., 2 rate constants. However, we see that the inverse of this 
is true for the F393 mutant enzymes. There is an exponential dependence between the 
second-electron-transfer rate constants and the heme-reduction potential with more 
negative reduction potentials favoring larger kred2 values. The explanation of this 
observation ma he linked to the nature of the oxy-ferrous---*superoxy-ferdc resonance 
hybrid. I he superoxv-ferric species is kinetically predisposed to a second-electron 
transfer by virtue of the oxidation states of the iron and oxygen. Consequently, more 
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superoxy-ferric nature in the iron-oxygen complex will result in a faster second-electron 
transfer. Previous work has indicated that more negative reduction potentials increase the 
ferric nature of the oxygen adduct and therefore result in larger rate constants for the 
second-electron transfer [76]. This explains why a substitution such as F393H which 
stimulates a positive shift in the heme reduction potential leads to a smaller rate constant 
for kred2 while the opposite effect is seen for F393W which stimulates a negative shift in 
Em. 
It has been reported previously that substitutions of the proximal phenylalanine 
cause a change in the rate determining step in the catalytic cycle [44,45,76]. This 
observation is exemplified through the comparison of kred and kcat for wild type and the 
F393H substitution. For wild type the rate constants for first-electron transfer and the 
catalytic turnover are both approximately 100 s_ I indicating that the first-electron transfer 
is either rate limiting or at least equivalent to the RDS. For F393H, we see that the kred is 
increased to -250 I,  whereas the turnover rate constant is lowered to 30 s 1 . Clearly the 
first-electron transfer can no longer be rate limiting and so some other step in the 
catalytic cycle must have been impeded. The results reported here show that the increase 
in Em in F393H has a detrimental influence on the rate constant for the second-electron 
transfer suggesting that this may be the source of the decrease in kcag. There is essentially 
a 'see-saw' effect whereby, larger rate constants for kred result in smaller rate constants 
for kred2 and vice versa as seen in F393W and F393H. (F339W kred = 30 S, k &12 = 250 S 
, F393H kre,j = 205 S1 , kred2 = 14 s') 
The small rate-constants for kred2  reported for all of the T268 substitutions and 
their indifference to heme reduction potential may not actually be an accurate reflection 
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of the true rate constants for the second-electron transfer. Zang et al. [75] reported that 
the ferric-peroxo species has a spectrum which is largely the same as the oxy-ferrous 
species. It is possible therefore that the spectral changes we observe during the first phase 
are not directly associated with the Fe(III)-02  —).Fe(III)-0 2 2 transition, but instead 
represent the subsequent protonation and reaction steps as well. For both wild type and 
F393H, an increase in the concentration of viologen leads to a larger rate constant for the 
second-electron transfer generating second order rate constants of 8.7 and 1.3 zM 1 s 1 . 
However, the kred2 values for F3931-1/T268N do not increase with increasing MV 
concentration. This suggests that while in WT and F393H we are observing a transition 
which is entirely governed by the electron-transfer rate-constant, for F393H1T268N, k1 is 
limited by something other than electron transfer. The T268 residue in P450 BM3 is 
located at the active site, close to the oxygen binding pocket and has been implicated as 
an important residue in the proton donating pathway. It is reasonable to assume therefore, 
that its substitution to an asparagine and an alanine might have disrupted this pathway 
sufficiently so that proton donation has become rate limiting. It is possible therefore that 
the observed low rate constants for second-electron transfer are actually an artifact of the 
diminished rate constants for proton donation. This would explain the low turnover rate 
constants and high degree of uncoupling reported for the T268 mutant enzymes described 
in chapter 3. This is also in accordance with previous work which suggests that the 
mutation of D25 1, an important residue proton donating pathway of P450cam, causes the 
protonation step to become rate limiting [171]. 
Figure 4.13 shows a plot of the rate constants for first and second-electron transfer 
against heme reduction potential. Although the kred and kred2 are not directly comparable 
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Figure 4.13: Comparison of the rate constants for first and second-electron transfer 
for a variety of P450 BM3 mutant enzymes displaying a range of reduction 
potentials. 
due to the differing natures of the electron donating species they do provide an interesting 
contrast. Increasing the heme reduction potential favors a fast first-electron transfer but 
also results in a lower rate constant for the second-electron transfer. The opposite is also 
true for lowering the heme reduction potential. From the graph we can see that wild type 
falls almost at the intersection of the two lines indicating that it has adopted the optimal 
E 1 to maximize its first and second-electron-transfer rates. In may be that this finely 
tuned reduction potential is necessary to provide the high turnover rate constants 
obser\ed in 1`4() BM3. In addition, figure 4.14 shows the overlay of the electron transfer 
data with the overall turnover rate constants (kcat). In each case the turnover rate constants 
correlate well with the lower of the two electron transfer rate constants indicating that at 
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Figure 4.14: Comparison of the rate constants for first and second-electron transfer 
for a variety of P450 BM3 mutant enzymes displaying a range of reduction potentials 
and the correlation of these with the overall turnover rate constants (k cat). 
least for BM3, the rate determining steps across this series of mutants are the two 
electron-transfer processes. 
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4.5 Conclusion 
In conclusion, we have monitored the absorbance changes which occur when oxy-
ferrous P450 BM3 is reacted with reduced methyl viologen. The three phases which are 
seen have bee ascribed to the reduction of the oxy-ferrous species, reduction of ferric 
P450 and potentially the decay of an oxygen bound P450 species. The kred2 values varied 
exponentially across a series of mutant enzymes with a potential range of 200 mV. We 
suggest that the dependence on the heme reduction potential is a result of the nature of 
the oxy-ferrous/superoxy-ferrric resonance hybrid which is influenced by Em. 
Substitutions of T268 led to observed kred2 values which were low and did not fit the 
observed trend with Em. It is likely that in this case, the quoted values are artificially low 
due to the inhibition of the proton donating pathway. 
Finally, comparison of the rate constants for both the first and second-electron 
transfer against heme reduction potential indicates that wild type has adopted a reduction 






Chapter 5: Inhibiting Inter-Flavin Electron Transfer 
5 Inhibiting Inter-Flavin Electron Transfer 
5.1 Introduction: 
One of the major differences between the cytochromes P450, is the nature of the 
supporting redox cofactors [18,34-35,47-49]. In general, bacterial systems such as 
P450cam use separate FAD and 2Fe2S ferrodoxins [34] while microsomal systems such 
as P450 2E1 utilise a fused FAD/FMN reductase [9]. However, there are numerous 
variations to this such as P450cm [22,52] which has individual FAD, FMN and heme 
sub-units or P450 Rh!' [50,51] which has FMIN, 2Fe2S and heme domains fused into a 
single polypeptide. Although these vary, they all perform the same role; to sequentially 
transport electrons from NAD(P)H to the catalytic heme group. Despite the wealth of 
experimental evidence available for the P450 superfamily, including extensive modelling 
studies, the specifics of donor-acceptor recognition and the exact reaction profile for 
electron transfer are not entirely resolved [175]. 
In flavocytochrome P450 BM3 the redox cofactors closely resemble, in structure 
arrangement and sequence, the FADIFMN containing microsomal NADPH-cytochrome 
P450 reductase (CPR) [176]. However, in P450 BM3 the reductase domain is fused to the 
heme domain via a polypeptide linker leading to a single component system. The 
similarity to the mammalian system coupled with the simple, single component 
arrangement are two of the main reasons that P450 BM3 has been used as a model system 
for P450 study for so long. Although this arrangement of cofactors was initially unique in 
P450 biochemistry, several BM3 structural homologues such as P450 102A2 from 
Bacillus subtilis have now been discovered [177]. The cytochrome P450 reductase (CPR) 
is one of only a few enzymes which binds both FAD and FMN in a single protein fold. 
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Figure 5.1: Sequence alignment of microsomal P450 reductase and the reductase 
domain from P450 BM3. Conserved residues are highlighted in red. 
Other notable examples of this are nitric-oxide synthase [178], heme oxygenase [179] 
and squalene monooxygenase [180]. Although the structure of BM3 reductase is not 
available, we can make certain comparisons with the mammalian CPR due to the high 
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Figure 5.2: Crystal structure of microsomal P450 reductase (1AMO). Panel A shows 
the individual domains: connecting domain (green), FAD-binding domain (red) 
FMN-binding domain (yellow) and an NADPH-binding domain (blue). Panel B 
shows a close-un of the FAD-FMN interface. 
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connecting domain, FAD and FMN binding domains and an NADPH binding domain 
(Figure 5.2). The modular structure of CPR suggests that it may have evolved from 
smaller units such as flavodoxins and ferredoxin NADP reductases [181-183]. The loop 
between the FIvIIN domain and the connecting domain is disordered in the crystal 
structure and forms a 'hinge' between the two domains. It has been proposed that this 
flexible connecting domain is responsible for orienting the two redox cofactors in the 
correct geometry for efficient electron transfer and therefore, for modulating electron 
transfer between the flavins. It is evident from figure 5.2 B that the two flavins are 
positioned end on with the closest distance between them being about 3.5 A [176]. 
Essentially, the two isoalloxazine rings form an almost continuous chain indicating that 
the electron transfer between the two is direct as opposed to through intermediate amino 
acids. Redox active proteins frequently position their cofactors in close proximity to 
facilitate rapid and precise electron transfer pathways without the need for coupling via 
extensive sigma-bonded chains. This observation is consistent with kinetic measurements 
in CPR which show that electron transfer between FAD and FMN is fast [184]. 
In P450 BM3, the FAD cycles between three oxidation states: the oxidised; 1-
electron reduced semiquinone; and 2-electron reduced hydroquinone. The FMN, on the 
other exists in only two redox states: the oxidised; or 1-electron reduced species 
(Figure 5.3) [185-187]. During the catalytic cycle the FAD accepts two electrons from 
NADPH in the form of a hydride. These electrons are then transferred sequentially to the 
heme via the FMN cofactor. The species which is responsible for donating an electron to 
the heme has been identified as the red, anionic, FMN semiquinone while the frilly 
173 















H3CCH3 	 113CCH 3 
0 e- 0 0 
N 	N—R 	 HN 	N—R 
ON 	 0-- 0 '/,N 
Ft Q 
Oxidised 	 Semiquinone 
H 3CCH3 




Figure 5.3: Panel A shows the electron transfer reaction cycle for cytochrome P450 
BM3 reductase. Panel B shows the redox changes in the flavins isoalloxasine ring. 
The FAD cycles between oxidised, semiquinone and hydroquinone states. The FMN 
cycles between oxidised and semiquinone states only. 
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Table 5.1: F1%'LN reduction potentials for P450 BM3 and nNOS  
Table 1: FMN reduction potentials 
	
11 Flavin Species 	 BM3 	 CPR 	j 	nNOS 
Semiqwnone 	j i0mTr=110mvL-4rnv 
HydrOqUInOIIe 	 -160 mV 	 -270 mV 	 -274 mV 
reduced hydroquinone is never formed [185]. This is in direct contrast to other enzymes 
which use FAD/FMIN reductases, such as NOS [188] and the mammalian P450 reductase 
[189], where the FMN hydroquinone species acts as the electron donor. This disparity is a 
result of differences in the reduction potentials of the FMN oxidised/semiquinone and 
semiquinone/hydroquinone couples (Table 1). In BM3 the more electronegative 
semiquinone provides a larger driving force for electron transfer and hence is favoured as 
the electron donating species [190]. The positions of these potentials are reversed in NOS 
and mammalian CPR so that the hydroquinone form provides the largest thermodynamic 
driving force for electron transfer [188-189]. In addition, the di-reduced FIvIN 
hydroquinone has been reported to be catalytically inactive in BM3 and is unable to 
transfer electrons to the heme domain [191]. Its formation would result in a dead-end 
complex and prevent turnover. Studies have shown that the formation of the FMN 
hydroquinone in P450 BM3 is kinetically disfavoured [185,187] and hence the electron 
transfer is slow. The reversal of the potentials and the preference of the semiquinone as 
the electron-donating species prevent the formation of the hydroquinone and the 
inactivation of the enzyme. The explanation as to why P450 BM3 employs a different 
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electron donating species is unclear although it could be used as a regulatory mechanism 
to halt catalysis after the depletion of oxygen or substrate. Alternatively it may be that the 
FMN semiquinone is a more efficient electron donating cofactor, allowing for the high 
turnover rate constants seen in BM3. 
The interaction between P450 and CPR is comprised of both electrostatic and 
hydrophobic interactions although it is generally accepted that the electrostatic 
contribution is the most important for docking and binding [175,192]. It is believed that 
the hydrophobic interactions are more likely to aid electron transfer via their it-stacking 
interactions. A great deal of research has been carried out on a number of P450s in order 
to try and ascertain the relative orientations of the heme and reductase on binding. This 
research has focused on identifying specific surface residues important for docking in 
both P450 heme and cytochrome P450 reductase. The substitution of these residues 
allows their importance in terms of electron transfer and binding to be ascertained. 
There is clear evidence that CPR interacts with its physiological partners; P450 
and cytochrome b5, in different conformations [175,192]. However, it is assumed that as 
all P450s have a similar tertiary structure [36], that their interaction with their reductases 
will also be comparable. As a result of this supposition, data amassed from all P450 
mutagenesis probing the reductase-heme interaction has been mapped onto the heme 
domain of P450 BM3 as seen in Figure 5.4 [175]. Panels A and B show the two sides of 
P450 BM3 as defined by the 'face on' positioning of the heme group. Panel A 
corresponds to the proximal side of the heme while B is the distal side. It is clear that the 
majority of the residues on the heme domain which are important for reductase binding 
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A 	 - 
Figure 5.4: Space-filled crystal structure of cytochrome P450 BM3 (IBU7). Surface 
residues implicated in CPR binding and shown in red. Panel A corresponds to the 





Figure 5.5: Space-filled crystal structure of microsomal cytochrome P450 reductase 
(IAMO). Surface residues implicated in P450 heme binding and shown in green. 
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are centred on the proximal heme region. This suggests that the electron donating FMIN 
semiquinone would be positioned close to the distal heme face prior to electron transfer. 
Similarly, two clusters of amino acids in the FMN domain of CPR have been 
highlighted as regions of interaction with cytochromes P450 (Figure 5.5) [193]. These 
two regions of aspartic acid and glutamic acid residues have been shown to play an 
important part in the interaction of CPR with cytochrome P450. These binding regions 
are positioned directly above the FMN cofactor. 
It would appear that there are specific electrostatic interactions between the FMIN 
domain of the reductase and P450 heme that position the FMN in close proximity to the 




Figure 5.6: Space filled crystal structure of cytochrome P450 BM3-FMIN complex 
(1 BVY). Panel A corresponds shows the interaction of FMN (green) and P450 heme 
(red). Panel B shows the distance between heme and FMN (-18A) and the location 
of surface resides in both the heme (red) and FMN (green) implicated in complex 
formation 
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holo P450 BM3 is not available, the crystal structure of the FMN-heme fragment has 
been solved (Figure 5.6) [194]. It is important to note that in the crystal structure, the 
heme-FMN linker has been proteolysed. This casts some doubt on how well this structure 
might compare to the physiological orientation of heme and FMN. However, this fused 
structure does pose some interesting questions as to the mechanism of interaction 
between P450 and its associated reductase. The interaction between heme and ThIN 
clearly involves the central region of amino acids directly below the proximal heme face 
as shown in figures 5.4 and 5.6. However, the binding residues identified on the FMN 
domain do not appear to play a part in domain binding in the Heme-FMN structure 
(Figure 5.6). In addition there are several regions of amino acids on the heme domain 
which have been identified as P450/reductase interaction sites which do not appear to be 
involved in the heme-FMN interaction. This could suggest that there are additional 
interactions between FAD and heme or that FI%4N can bind to heme in more than one 
conformation. From analysis of the contact regions between the heme and FMN domains 
in P450 BM3, there are two direct hydrogen bonds, one salt bridge and several water-
mediated contacts holding the two domains together. This represents a relatively weak 
interaction over the -1000 A2 interface area suggesting that the link between heme and 
FIMN domains is not strong. 
From panel B in figure 5.6, we can see that the FMN cofactor binds end on to the 
heme, with the dimethylbenzene ring perpendicular to the plane of the porphyrin ring at 
a distance of 18 A. However, in the structure of microsomal CPR, the dimethylbenzene 
ring is orientated towards the FAD (Figure 5.2B) which would preclude it from being 
bound to both the heme and FAD domains simultaneously. The combination of these 
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Figure 5. 7. Diagram depicting the movement of the FMN required for the interaction 
of the FMN with FAD (A) and heme (B). It is proposed that the movement facilitates 
the electron transfer from FAD to heme. 
two structural observations suggests that there is considerable movement of the FMIN 
between accepting an electron from FAD and delivering it to the heme (Figure 5.7) 
[102]. Presumably, motion of the hinge region would allow the FMN domain to move 
between heme and FAD domain during catalysis. Such movements of the flavins relative 
to each other have also been suggested for rat CPR [176]. 
The heme-FMN crystal structure places the heme-FM1N cofactor separation at 18 
A which is too large a distance for adequate physiological electron transfer [194]. 
Calculations show that this separation could yield an electron transfer of 12 s, clearly 
not sufficient for supporting a catalytic turnover of 100 s' [102]. Initially it was claimed 
that electron transfer could occur via the heme-linking peptide chain positioned close to 
the FMIN, although this 50 a-bond pathway was later shown to be unfeasible. Clearly, 
the FMN must be repositioned closer to the herne in order to allow efficient electron 
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transfer. It has been reported that there are significant conformational changes in the 
heme structure both on substrate and oxygen binding [21,72]. It is entirely possible that 
one of these structural movements allows the P450 heme and FMIN to approach close 
enough to achieve sufficient rates for electron transfer. 
Domain movement as a method of facilitating electron transfer is not 
unprecedented in biochemistry although proven examples are rare due to the large 
amount of experimental data required for unequivocally proof. One enzyme in which this 
type of domain motion has been conclusively shown is cytochrome bc1 [195-196]. 
Cytochrome bc 1  and its analogues are found in mitochondria, photosynthetic bacteria and 
other prokaryotes and are key components in both respiratory and photosynthetic 
transport chains. Their role is to transfer electrons and protons across the membrane in 
order to create the electrochemical proton gradient necessary for ATP synthesis. The 
enzyme is comprised of a number of subunits (-.11) of which only three contain redox 
active species; a cytochrome b subunit containing two b-type hemes, a cytochrome c 
subunit with a c-type heme and a Rieske Fe-S subunit with a [2Fe2S] cluster. The 
catalytic cycle is divided into two separate single turnover steps. In the first step, one 
electron (derived from hydroquinone oxidation) is transferred to the 2Fe2S site via the 
high potential b-type heme of the cytochrome b subunit. Another electron is transferred to 
the low potential heme of the cytochrome b subunit and then onto a quinone molecule in 
order to generate the semiquinone. The second turnover event repeats the electron 
transfer to the low potential heme thus producing the hydroquinone. The overall effect of 
this is to transport 2 H per electron to one side of the membrane while moving one 
electron across the membrane. Transfer of the electron along the high potential path onto 
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Figure 5.8: Crystal structure of redox active domains in cytochrome bcl in the 
absence (1BE3) and presence (2A06) of the inhibitor stimatellin. Panels A and B 
show the movement in the Fe-S Rieske domains attributed to controlling the 
bifurcation of the electron transfer process. 
the FeS cluster is thermodynamically favourable, consequently, during the second 
turnover; there must be some mechanism by which this pathway is disfavoured. From the 
crystal structure of the bovine bci complex it can be seen that the addition of the inhibitor 
stigmatellin stimulates significant conformational changes in the positioning of the 
Rieske subunit (Figure 5.8) [195-197]. The implication of this is that there is a major 
rearrangement of the domains within the enzyme. Kinetic evidence has shown that this 
movement of domains results in the inability to transfer electrons to the FeS cluster and 
hence suggests that domain movement is necessary to control the bifurcation of electron 
transport [195-197]. From the crystal structures of the relevant domains it can be seen 
that in one conformation (Figure 5.8A) the iron sulfur is positioned close to the high 
potential heme in the cytochrome b subunit. The second conformation, induced by the 
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binding of stimatellin, shows significant movement (57 0 rotation, 10 A translation) of the 
FeS cluster away from the heme (Figure 5.8B) [198-200]. It is believed that this domain 
movement acts as an intra-complex electron shuttle. 
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5.2 Aims 
Although difficult to prove, the movement of groups within a protein would 
provide an interesting mechanism to impart kinetic control on some catalytic reaction 
steps such as electron transfer. Movements of this kind have been reported for 
cytochrome bc i  [195-200], cytochrome b2 [201] and potentially CPR [102]. The 
mechanism by which these movements take place is likely to involve numerous protein-
protein interactions. Crystallographic data for P450 BM3 has indicated that there may be 
domain movement involved in the FMIN to heme electron transfer process [176,194]. As 
such the interface between the FMIN and heme sub-domains in P450 BM3 and the nature 
of the intermediate groups between FMN and heme are likely to be important factors. 
Figure 5.9: Crystal structure of fused P450 BM3 and FMN domains (IBVY). The 
location of the heme and FMN are shown in addition to the F393 and Q403 residues. 
WE 





A: F  
F393A 
Q403 Q403 
Figure 5.10: Active site crystal structure of wild type (IBU7) and F393A mutant 
(1 POV) P450 BM3 highlighting the different position of the Q403 residue. Removal 
of the benzene ring allows the glutamine residue to 'flip' into the active site and form 
a H-bond with C400. 
Two proximal residues in P450 BM3 (F393 and Q403) are positioned directly 
between heme and FMN as seen in Figure 5.9 [44-45]. Substitutions of the highly 
conserved proximal phenylalanine have succeeded in modulating the heme reduction 
potential across a 200 mV [44-45,76]. However, attempts at introducing positive and 
negatively charged residues near the heme by substitution of the phenylalanine to an 
arginine and glutamic acid residue respectively have been unsuccessful. Substitution of 
F393 for an alanine results in a positive shift in the reduction potential of 115 mV 
[44,45]. This is similar to the positive shift in the reduction potential observed when the 
phenylalanine is substituted for a histidine, clearly an unusual result considering the 
differing nature of these two residues. The crystal structure of the F393A heme domain 
(Figure 5 10) shows that the removal of the phenylalanine sidechain from the proximal 
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side of the heme creates enough space for a glutamine residue (Q403) to 'flip' into the 
active site, forming an intramolecular hydrogen bond with the cysteine thiolate. 
By removing both the phenylalanine and the glutamine residues though their 
substitution with an alanine (F393A/Q403A), it was hoped that the influence of the 
phenylalanine residue could be elucidated. In addition, it was hoped that by combining 
the F393A substitution with the substitution of Q403 by a lysine (F393A/Q403K) that a 
positive residue could be introduced into the active site. As both the F393 and Q403 
residues lie close to or on the proximal surface of the P450, special consideration was 
given to the possible effects these substitutions might have on electron transfer and heme-
FMN interaction. 
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5.3 Results 
5.3.1 Expression and Purification 
Wild-type P450 BM3 and the mutant enzymes F393A, Q403K, Q403A and 
F393A/Q403A were successfully over-expressed and purified. Analysis of the spectral 
ratio of protein peak (300 rim) to Soret (410 nm) and the presence of a single band in 
SDS-page analysis indicated that the purity was in excess of 95%. Each of the mutant 
enzymes exhibited an entirely low-spin oxidised spectrum with a Soret absorbance 
maxima at 410 nm and less intense a and 0 bands at 525-575 nm. Reduction of the 
mutant enzymes led to a shift in the Soret peak from 418 nm to 410 nm and the 
subsequent binding of CO generated the characteristic 450nm Fe(II)-CO Soret. Only a 
negligible amount of P420 (non cysteine bound heme) was observed in the UV/Vis 
spectra of the purified enzymes. The F393A/Q403K mutant enzyme was successfully 
over-expressed and purified, albeit in exceptionally low yields, in the intact form. 
However, the heme domain construct failed to yield significant amounts of P450. A high 
concentration of non cysteine ligated P420 heme protein was detected throughout the 
purification stages of this particular construct. 
5.3.2 Carbon Monoxide Binding: 
On treatment with carbon monoxide, the reduced P450 species was capable of 
forming the Fe(ll)-CO species. The positions of the ferrous-CO Soret peaks are listed in 
table 5.2. The stated value for the F393A/Q403K Fe(ll)-CO Soret was calculated using 
the intact enzyme as opposed to the heme domain construct. As a control experiment, the 
CO complexes of the heme domain construct and intact enzyme of WT BM3 were 
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generated. The ferrous-CO Soret peak positions were identical in each case. Previous 
studies have suggested that some active site substitutions influence the electronic nature 
of the heme and consequently influence the orbital mixing between the heme iron and 
porphyrin ring (chapter 3) [44,45]. As a result, these changes have an effect on the 
position of the ferrous-CO Soret peak. The data below show that neither of the single 
glutamine substitutions (Q403A or Q403K) have any measurable influence on the 
position of the CO bound Soret. However, both the double substitutions cause a Soret 
shift to higher wavelengths (+3nm) relative to F393A although the peak is still at a lower 
wavelength (-2nm) in comparison to WT. 
Table 5.2: Fe(II)-CO peak positions  





----------- 	 I r- 	F393A/Q403A 	 - 	 - 447 
F393A/Q403K 	 - 	 447 
5.3.3 Substrate Dissociation Constants: 
Substrate dissociation constants (Kj) using the long chain fatty acids laurate (C16) 
and arachidonate (C20) for wild type and the mutant enzymes are shown in Table 5.3. It 
is evident that none of these substitutions has an influence on the fatty-acid binding 
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properties of the enzyme. In addition, there are no major changes in the magnitude of the 
maximal substrate-induced spin-state shift for any of the enzymes studied. Data for 
F393A/Q403K could not be generated due to poor protein expression. 
Table 5.3 Binding constants (Ki) 
Ka(pM) 
Enzyme  
Arachidonate 	 Laurate 
wi1d1YPe_J1 	 3.6 ± 0.3 	
370 ± 8 
F393A 1 2.6±0.4 230±11 
Q403A 
[ 	
5.0±0.7 310± 18 
Q403K 	
- 
[-__3.2 ±0.3 190±8 
F393AJQ403A 	 2.8 ± 0.3 	 430 ± 22 
F393A/Q403K - - 
5.3.4 Steady-Sate Kinetics and Coupling Efficiencies: 
Data for the kinetics of fatty acid oxidation in the wild type and mutant enzymes 
are shown in table 5.4. Rate constants (kcat) and Michaelis constants (Km) for the turnover 
kinetics in the presence of lautate (as defined by the Michaelisl-Menten equation) are 
show in addition to rate constants at saturating concentrations of arachidonate (ksat). For 
all the enzymes tested, turnover in the absence of substrate was low and constant and 
maximal rate constants for arachidonate and laurate were in good correlation. As reported 
previously, substitution of F393 by an alanine causes a decrease in the rate constant for 
NADPH oxidation although a significant amount of catalytic activity was still observed 
[44,45]. The smaller turnover rate constants are the result of the perturbation of one or 
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Table 5.4: Steady-State Kinetics Parameters 
Substrate 	 Laurate 	 Arachidonate 
Enzyme 
k01,,(s) 	 KM(PIM) 
wild-type o .2±0.1j84±2 - 320± 10 95±6 
F393A 	0.2±0.1 	 18±1 	 220±18 	 45±6 
Q403A 	0.1 ±0.1 	 92±4 	 89± 16 	 109±9 
Q403K 	0.2 ± 0.1 	 4.8 ±7[930 ± 230 	 8.6 ± 1.5 
F393A1Q403A 0.3 ±0.1 31±2 	1 420±52 39±5 
Li[ 0.3±03 35±1 510±30' 43±4 
more steps in the catalytic cycle. As shown in chapter 4, the step which is most likely to 
have been affected is the second electron transfer step which forms the ferric-peroxy 
species and ultimately the ferryl complex. The substitution of Q403 for an alamne 
appears to have little effect on the overall turnover rate constant either in the single 
substitution compared to wild type or in the double substitution compared with F393A. 
The single substitution of Q403 for a lysine causes an approximately 17-fold decrease in 
the turnover rate constant. Interestingly, the combination of this substitution with the 
F393A mutation leads to a recovery of the rate constant by some 7-fold. It is evident 
therefore that the Q403K mutation is having an effect on some step in the catalytic cycle 
which is subsequently relieved by the F393A substitution. 
Measurements of the coupling efficiencies (Table 5.5) show that substitution of 
the glutamine reside for an alanine has no effect on the ability of the enzyme to produce 
hydroxylated product from stoichiometric amounts of reducing equivalents. Substitution 
of this residue for a lysine causes a small decrease in the ability of the enzyme to generate 
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hydroxylated product coupled to a small increase in the production of 11202. In all cases, 
the majority of NADPH consumption is coupled to the production of hydroxylated 
product. 
Table 5.5: Coupling Efficiencies 
Turnover Products (%) 
Enzyme 
ROH 	 11202+ROII - 
wild-type 	 3 ± 2 	 1 	90 ± 2 	 93 ± 4.0 
F393A 	
{ 	
8±4 	- 	76±7 	 84 ±11 	
-J 
Q403A1 3±1 1 	83±5 	 86±6 
Q403K 	 13±3 	1 	68±6 	 81±9 
	
iF393AJQ403A 	 4 ±1 	 89 ± 1 	 92 ± 2 
F393A/Q403K 	 16±3 	 66±8 	 82± 11 
5.3.5 OTTLE Potentiometric Titrations: 
Previous studies have shown that changing the nature of the residues around the 
heme-ligating cysteine thiolate has a profound effect on the heme reduction potential 
[44-45,76]. Therefore, the most telling result in assessing a change in the electronic 
nature of the heme is the measurement of the heme reduction potential. The substrate-free 
and substrate-saturated (arachidonate) heme reduction potentials for WT and the mutant 
enzymes F393A, Q403A, Q403K and F393A/Q403A are shown in Table 5.6. No data 
was obtained for F393A/Q403K due to its poor expression in the heme domain construct. 
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Table 5.6: Potentiometric Parameters 
Enzyme FE.  (mV) Substrate Arachidonate(l2OpiM) Arachidonate 
wild-type 431±4 -304 ±4 I 	+127± 8 





Q403A -442±9 -307±7 +135±9 
Q403K -426±8 -315± 14 +111± 11 
F393A/Q403A 	-386± 12 	 -271±7 	 +115±8 
F393A/Q403K 1 
The data show that the F393A substitution results in a positive shift in the reduction 
potentials with and without substrate (Figure 5.11). As mentioned previously, this has 
been ascribed to the movement of a glutamine residue, providing a hydrogen bonding 
interaction to the cysteine thiolate sulfur. This would result in electron density being 
drawn away from the iron and hence a more electropositive heme. We can see that the 
single substitutions of the glutamine residue have no significant influence of the 
reduction potential of the heme (Figure 5.11). This result was largely expected as when 
the phenylalanine is present; the glutamine itself does not interact with the thiolate. As a 
result we would not expect the glutamine substituents to interact with the thiolate. 
Consequently we would not expect its removal or replacement with a lysine to have an 
effect on the reduction potential. Although a full set of data is not available, it is evident 
that the double deletion mutants are different from the single. The F393A1Q403A mutant 
enzyme exhibits a negative shift in Em of 61 mV with respect to the single F393A mutant 
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Figure 5.11: Diagram depicting the relative positions of the substrate free and 
arachidonate saturated heme domains for WT and the mutant enzyme Q403A, 
Q4031C, F393A and F393A/Q403A. Panel A shows a comparison of the single 
Q403A and Q403K mutations to wild type. Panel B shows a comparison of the 
double F393A/0403A mutation to F393A. No data was available for F393A/0403K. 
wild type. 
The addition of 4-cyanopyridine to heme domain or holo P450 BM3 results in the 
formation of a charge transfer band at approximately 650 nm (Figure 5.12). The position, 
and hence energy, of this band has been directly linked to the heme reduction potential 
according to the equation EMLCT = (3.53 x E..) + 17,005 cm' [81]. The addition of this 
ligand to reduced P450 therefore provides an approximate estimate of the heme reduction 
potential. The Em values derived from the positions of the 4CNPy MLCT for the mutant 
enzymes Q403A, Q403K and F393A/Q403A are consistent with experimentally derived 
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Figure 5.12: Panel A shows the spectra of the P450 BM3 Q403K mutant in the 
oxidised, reduced and 4-CNPy bound forms. The presence of a band at 650 nm is 
ascribed as a MLCT. Panel B shows the correlation between EMLCT and Em. 
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(OTTLE) values. From the wavelength of the MILCT, the predicted Em for 
F393A1Q403K will be similar to the F393A1Q403A mutant enzyme at around 350 mV in 
the absence of substrate (Table 5.7). 
Table 5.7: MLCT energies and predicted Em values 
Enzyme A.MLCT (nm) Energy MLCT (cm-') 
 (mV) + Predicted &E 11. 
Arachidonate 
Q403A 647.0 15446 -442 
Q403K 646.5 15468 435 
F393A1Q403A 635.0 15748 -356 
F393A1Q403K 634.5 15760 -352 
5.3.6 Pre-Steady-State Kinetics: 
5.3.6.1 Heme Reduction: 
Rate constants for the first electron transfer (NADPH—*FAD--.FMN--heme) 
were measured via the formation of the 'dead end' ferrous-CO complex. Rates of CO 
binding were in excess of the limits of the stopped flow apparatus (> 800 s') and as such 
were faster than electron transfer and not rate limiting. The rate constants for first 
electron transfer (k red) in the absence and presence of substrate (arachidonate) are shown 
in table 5.8. As described in chapter 3, all substrate-free absorbance changes fit to a 
double exponential, with the slower phase providing the majority of the amplitude. Faster 
phases were attributed to the presence of small quantities of substrate or substrate like 
contaminants. The quoted rate constants for in the absence of substrate are all taken 
from the slower phase. As can be seen from table 5.8, rate constants for electron transfer 
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Figure 5.13: Pre-steady -state heme reduction kinetics of wild type P450 BM3 and 
the mutant enzymes F393A, Q403A, Q404K, F393A1Q403A and F393A1Q403K. 
Kinetic traces show the formation of the ferrous-CO complex using NADPH as the 
source of electrons. 
in the absence of substrate are small and constant throughout the series of mutant enzyme 
studied. First electron-transfer rate constants in the presence of substrate all fitted to 
single exponentials and varied accordingly across the series F393A F393A1Q403A > 
WT - F393A1Q403K> Q403A > Q403K (Figure 5.13). 
The F393A substitution results in a 2.4 fold increase in the rate constant for 
first-electron transfer in comparison to wild type. This has been directly ascribed to a 
positive shift in the reduction potential (-100 mV) which provides a larger driving force 
(AG) for electron transfer [76]. The Q403A substitution results in a small decrease in kred 
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compared to WT. This observation is mimicked in the double F393A/Q403A substitution 
compared with the F393A mutant. The Q403K substitution results in a 10-fold decrease 
in k1 in comparison to wild type. The double substitution leads to a recovery of this rate 
with F393A/Q403K exhibiting a kred only 3-fold lower than F393A. Essentially this result 
mirrors what we observe in the turnover experiments. The single substitution Q403K, 
leads to a decrease in the rate constant (kj) which is partially relieved through the 
double substitution. 
It has been shown previously that there is a direct link between the heme 
reduction potential and the rate-constant for the first-electron transfer [76]. As the Q403  
and Q403K single mutants exhibit essentially the same Em in the presence of substrate we 
would expect them to have the same kred. As this is clearly not the case we must consider 
that some factor other than heme reduction potential is controlling the rate constant for 
electron transfer to the heme in the Q403K enzyme. 
5.3.6.2 Autoxidation: 
As the formation of the oxy-ferrous complex for wild-type P450 BM3 and the 
various mutations is too rapid to be monitored using stopped flow, the rate of decay of 
the oxy-ferrous species provides a convenient handle on the effects these mutations have 
on the stability of the oxy-ferrous species. Rate constants for the decay of the oxy-ferrous 
complex in the presence and absence of saturating concentrations of substrate are shown 
in table 5.8. The experimental protocol requires the mixing of pre-reduced enzyme with 
oxygenated buffer. Since the iron is already in the one electron reduced ferrous form, it 
should be insensitive to the kinetic barriers imposed by substrate and as such the two sets 
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Figure 5.13: Pre-steady -state oxy-ferrous decay kinetics of wild type P450 BM3 and 
the mutant enzymes F393A, Q403A, Q404K and F393A1Q403A. Kinetic traces show 
the decay of the oxy-ferrous to the ferric form of the enzyme. 
of data (+1- substrate) should correlate well. No data is shown for the F393A1Q403K 
mutant due to lack of enzyme. The substrate saturated autoxidation rate constants (kaux) 
vary across the series of mutants accordingly Q403A Q403K WT > F393A > 
F393A1Q403A (Figure 5.14). As was reported previously, the stabilisation of the oxy-
ferrous species correlates closely with the heme reduction potential. Here we see that the 
single substitutions of Q403 by both a lysine and alanine which have no real influence on 
the heme reduction potential exhibit similar values of kauto-ox to wild type. Changes in the 
reduction potential of the F393A/Q403A mutant in comparison to F393A are followed by 
changes in the rate constant for oxy-ferrous decay. 
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Table 5.8: Pre-Steady-State Kinetic Parameters 
Ileme Reduction (k)( s') Autoxidation(k,J( s 1) 
Enzyme 
Substrate Free Arachidonate 
+ Substrate Free + Arachidonate 
wild-type 0.1 ± 0.1 100 ± 4 0.089 ± 0.015 0.059 ± 0.008 
F393A 0.4 ± 0.1 240 ± 6 F0.0064 ± 0.0002 0.0030 ± 0.0003 
Q403A - 0.1±0.1 59±2  - 0.11±0.010.14±0.01 
Q403K 0.1 ±0.1 9.0 ±0.7 0.11 ± 0.03 0.10±0.01 
F393A1Q403A 0.1 ±0.1 220 ±9 
[ 	
0.018±0.003 	1 0.019±0.004 
[F393A/Q403K 0.7 ± 0.4 83 ± 
5 
5.3.7 Steady-Sate Kinetics Using Artificial Electron Acceptors: 
Steady-state kinetics using the artificial electron acceptors cytochrome c and 
ferricyanide were carried out in order to probe electron transfer within the flavin domain 
of intact P450 BM3. Only the wild type and mutants Q403K and F393A/Q403K were 
studied. All experiments were carried out in the absence of substrate so that the electron 
transfer was observed through the flavins only. Under these conditions rate constants for 
Table 5.9: Steady-State Kinetics Parameters With Artificial Electron Acceptors 
Cytochrome c 	 Fericyanide 
Enzyme 
I __k(s1) 	KM(LM) 	 k., (s-1) 	
KM 
(MM) 
____ - -- L 
- 
wild-type [7130 ±3 17 ± 1 250 ± 6 0.8±0.1 
Q403K 11 ± 1 r 	7.9 ± 0.7 250 ± 14 5.8 ± 0.7 
F393AJQ403K F 93±3 5.8±0.8 280±6 1.7±0.2 
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Figure 5.15: Steady-state-kinetics data and fits to the Michael is-Menten equation 
using cytochrome c (Panel A) and ferricyanide (Panel B) as external electron 
accentors for WT 0403K and F393A/0403K 
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electron transfer to the heme are low and as such should not interfere with electron 
transfer from the flavins. Since cytochrome c is reduced by the FMN only, while 
ferricyanide can accept electrons from either of the two flavins, these results provide a 
good indication of changing inter-flavin electron-transfer rates over the series of enzymes 
studied. Maximum turnover rate constants (k) and Michaelis constants (KM) are shown 
in table 5.9. The experimentally derived data and fits to the Michaelis-Menten equation 
are shown in figure 5. 15.The data show that, when cytochrome c is the electron acceptor, 
the Q403K substitution leads to a smaller rate constant in comparison to wild type. The 
double substitution leads to the recovery of the rate constant to a level comparable to wild 
type. When ferricyanide is the electron acceptor, neither of the mutations influences the 
maximal rate of ferricyaide reduction with respect to wild type. However, there is a 
distinct increase in the Michaelis constant (KM) for the Q403K mutant. Again, this 
phenomenon is reversed in the double mutant. The implications of this are that the 
Q403K substitution suppresses the ability of the FMN to transfer electrons. However, the 
combination of the Q403K substitution with F393A reverses the inhibition observed in 
the single mutation. 
5.3.8 Pre-Steady-Sate Kinetics of Flavin and Heme Reduction: 
The results above indicate that some process within the first electron transfer 
chain (NADPH—FAD--*FMN--->heme) has been altered in a manner which is 
independent of herne reduction potential. The first electron transfer pathway (Figure 5.3) 
consists of the 2-electron reduction of the FAD, 1 -electron reduction of the FMIN and 
I-electron reduction of the heme In order to try and ascertain the source of the unusual 
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turnover and kied results observed for the lysine substitutions, pre-steady -state kinetics 
were used to assess the rate constants for these individual steps. The rates of flavin and 
heme reduction were measured separately in an attempt to avoid complicated kinetic 
traces. 
5.3.8.1 Flavin Reduction: 
In order to ensure that observed absorbance changes were a result of flavin 
reduction only, experiments were carried out in the absence of substrate. Under these 
conditions, electron transfer to heme is slow (0. 1 s') and should not interfere with the 
observed traces associated with flavin reduction over the timescale used in these 
experiments (Figure 5.16). The experiments were repeated at varying salt concentrations 
1.2- 
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Figure 5.16: Changing spectra associated with the reduction of FAD and FMN in 
Q403K P450 BM3. Inset shows the same spectra baseline against the oxidised 
heme spectrum showing just the spectra of the flavins. 
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Figure 5.17: Debye-Huckel plots of In k0b vs [ionic strength] 
112  for flavin reduction 
in WT, Q403K and F393A1Q403K. The plots show that only FMN reduction is 
influence by increasing ionic strength. Kinetic traces for flavin reduction at 
increasing salt concentration for Q403K are also shown. 
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Table 5.10: Rate constants for Flavin Reduction by NADPH at Varying Ionic Strength 
FAD reduction 	 FMN reduction 
Ionic 	 (s) 	 (s') 
Strength I 
WT 	Q403K 	[93A/Q403K 	WT 	IQ403K 	F393A/Q403K 
0.1 	220±22 	200±31 	230± 11 	49±7 	8.5± 1.2 	33±3 
0.2 	240±14 	240± 18 	250±23 	57±6 	1 13±2 	31±3 
03 	[260±12 	210±17190±17 	60±10 	21±3j 	38±3 
0.5 	270±27 	F240± 17 	270±28 	68±9 	25±4 	43±5 
0.7 	F220 	32 	200 	19 	300 JL L_27 	
5±j 
1.0 190±25200±20_'I ]L±!JL_J_i 
to assess the effects of increasing ionic strength on these rates (Figure 5.17). Table 5.10 
shows that the rate constants for FAD reduction are high and consistent across the 
enzymes studied. Increasing the ionic strength has no influence on the observed rate 
constants for FAD reduction. The rate constants for FMN reduction are relatively high for 
WT and the F393A/Q403K mutant and constant at increasing ionic strengths. The FMN 
reduction rate constants for the Q403K substitution are comparatively small at low ionic 
strengths and increases as the salt concentration is increased. According to the Debye-
Huckel equation, ln(k0bs) was plotted against [ionic strength]hh'2  and fitted to a straight line 
function (Figure 5.17). 
An important point to note is that although the rate constants for FMN reduction 
in wild type and the F393A/Q403K enzymes are relatively high, the value obtained for 
WT is less than what is observed for the total heme reduction. Clearly this cannot be a 
true reflection of the FMN reduction rate. One possible explanation for this could 
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originate from the experimental protocol of these experiments which require the absence 
of substrate. This problem will be discussed later in the text. 
5.3.8.2 Heme Reduction: 
Multi mixing stopped flow techniques were used to assess the rate constant for 
heme reduction by reduced FMIN semiquinone. Flavin reduction experiments for each of 
the enzyme studied were used to assess the optimal ageing time for FMIN reduction. It is 
reported that the semiquinone is kinetically locked, preventing the fast formation of the 
hydroquinone species. In the presence of excess amounts of reductant, FMN reduction 
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Figure 5.18: Changing spectra associated with the reduction of heme by FMIN in 
WT P450 BM3. Inset shows the change in absorbance at 450 nm associated with 
heme reduction. 
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experiment (30-250 ms) there is not enough time for an appreciable amount of the 
catalytically inactive hydroquinone to form. Data for wild type, Q403K and 
F393A1Q403K are shown in table 5.11 and the heme reduction trace for wild-type is 
shown in figure 5.18. Rate constants for heme reduction are high and constant for WT 
and F393A1Q403K. The Q403K substitution displays considerably lower rates for 
electron transfer between FMIN and heme. Rate constants for the first electron transfer 
process (kred) match the rate constants for heme reduction by FMIN in the single and 
double substitutions of Q403 and in wild type suggesting that this is the rate determining 
step. Neither the observed rate constants for heme reduction by FMIN or first electron 
transfer rate constants are influenced by increasing the ionic strength (Figure 5.19). 
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Figure 5.19: Debye-Huckel plots of In kth vs [ionic strength] 
112  for heme reduction 
in WT, Q403K and F393A1Q403K. Panel A shows data for heme reduction by FMIN. 
Panel B shows data for the entire first electron transfer process. 
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Table 5.11: Heme Reduction by FMIN and Heme Reduction Through Flavins at 
Varying Ionic Strengths  
	
Heme Reduction by FAIN 	 Heme Reduction Through Flavins 
Ionic  
Strength 
- 	 WT 	Q403K i F393A/Q4O3Kl 	WT 	Q4O3K F393A/Q403K 
O.lI13o±22j _9.2±1.3f93±9l110±18 _9.0±1.187±6 
7 
0.3 	- 	- 	
- 	 - 	
12±2 	 - 
_ 
05 	110 :13 11 92±61 
L±LHL_____L±i 
1.0 	130± 17 r6±0.9 	93±11 	130 ± 11 IF4.3 ±0.6 	81±11 
5.3.8.3FlavinReductioninthePresenceof Substrate: 
Pre-steady-state stopped-flow experiments were carried out in order to assess the 
effects of substrate (arachidonate) on the rate constants for both FAD and PvIN 
reduction. Unfortunately, the ferrous-CO bound Soret peak formed on heme reduction 
partially masks the spectral changes associated with flavin reduction. In addition, the 
absorbance of the heme Soret (6450 -100, 000 cm'M') is more intense than the flavins 
(6450 —10, 000 cm 1M 1) which leads to difficulties in assigning the correct absorbance 
changes. Consequently the heme reduction isosbestic point at 480 nm was chosen in 
order to monitor the reduction of the FAD and FMN. At this wavelength, the LAbs. 
values are small and as a result large concentrations of enzyme were necessary. Heme 
reduction was followed at 450 nm. Although this is not a flavin reduction isosbestic 
point, the absorbance changes for flavin reduction at this wavelength are very small in 
comparison to those observed for heme reduction, contributing less than 5% of the total 
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Figure 5.20: Changing spectra associated with the reduction of heme and flavins by 
NADPH in the presence of substrate for WT P450 BM3. Kinetic traces show changing 
absorbances associated with flavin reduction (480 nm) and heme reduction (450 nm). 
absorbance change. As a result absorbance changes at this wavelength can be fitted to a 
single exponential corresponding to heme reduction only. Figure 5.20 shows the 
absorbance changes over a 2 second timescale and the associated absorbance changes 
ascribed to the FAD, FMN (480 nm) and heme (450 nm) reduction rate constants. The 
data shows that the addition of substrate accelerates both the hydride transfer and FMIN 
reduction rates in the wild type enzyme. 
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5.19Crvsta11oraphv: 
The structure of the Q403K mutant enzymes was refined to a final R-factor of 
18.19 % (R-free = 23.25 %; 1.9 A resolution) (Table 5.12). The final model consists of 
two identical protein molecules (A and B) comprising residues Lys3-Leu188 and 
Asn20 1 -Leu455 and one heme. In addition the model contains 800 water molecules. For 
both protein molecules the electron density for the two N-terminal residues and for the 
loop region containing residues G1n189-Glu200 was uninterpretable, so these have been 
	
_4 	.\ 
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Figure 5.21: Stereoimage showing electron density of active site mutant Q403  and 
overlay of WY (grey) with Q403K (green). 
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Table 5.12: Crystallo 
resohition(A) 
[total no. of reflections 
24.0-1.9 
 443413 	_ 
[no. of unique reflections 	 I 8 2___ 
!I completeness (1/o) 97.4 	 - 
16.8  
67 	 - 
in outer shell (1.97 - 1.90 A)(%) 
R(0/"w )b 
34.3 
 18.19  
R 	(%)b 	 _____ __________ 23.25  
rmsd from ideal values  
bond lengths (A)  0.024  
bond angles   1.912 
chandran analysis 
Imostfavoured(%) 91.5 
additionally allowed (%) 8.5 	- 
a Rmerge = 1h1iV(h) - I1(h)J1 hEaJI(h), where 11(h) and 1(h) are the ith and mean 
measurement of reflection h, respectively. b  = hlFo - FI/ EhF., where F. and F are 
the observed and calculated structure factor amplitudes of reflection h, respectively. Rfree 
is the test reflection data set, 5 % selected randomly for cross validation during 
crystallographic refinement. 
omitted from the model. The RMSD fit of all backbone atoms for the mutant enzyme and 
the wild-type heme domain is 0.3 A, indicating no major differences between the 
structures. Due to the fact that there are two molecules in the asymmetric unit for each of 
these models, the RMSD values stated are the average over both molecules. The RMSD 
fit between both molecules (A and B) of the mutant enzyme model is found to be -P0.2 A. 
Figure 5.21A shows the electron density surrounding the heme group, residues Phe393, 
Cys400, and Lys403. An overlay of the same region in the wild-type and Q403K 
enzymes is shown in Figure 5.21B. From figure 5.21B it can be seen that in the Q403K 
mutant enzyme the only significant structural change is the replacement of Gln403 with 
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lysine. This introduced lysine residue is oriented towards the surface of the protein and is 
found to be H-bonded to two surface water molecules. Crystallographic parameters are 
shown in table 5.12. 
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5.4 Discussion: 
Modulation of an active-site phenylalanine adjacent to the ubiquitous P450 
cysteine heme ligand has been shown to exert thermodynamic control over the reduction 
potential of the Fe(H)/Fe(Hl) redox couple [44-45,76]. It has been proposed that the 
strong electron donating nature of the thiolate ligand provides an electron 'push' towards 
the heme, regulating the heme reduction potential in order to facilitate stabilisation of 
high iron oxidation states [40-43]. Consequently, alterations in the electronic nature 
around the cysteine ligand will have a secondary effect on the heme. Multiple 
substitutions of this phenylalanine have resulted in generating catalytically functional 
enzymes displaying reduction potentials which vary across a 200 mV range. The 
variation of Em in these mutant enzymes has a knock-on effect on the rate constants for 
the first electron transfer and the stability of the oxy-ferrous complexes as discussed in 
previous chapters. However, previous attempts to introduce a positive charge close to the 
cysteine have proved unsuccessful. In this study, we have attempted to achieve this 
outcome by using multiple substitutions of the phenylalanine and an active site 
glutamine. 
The crystal structure of the F393A mutant enzyme shows that a glutamine residue 
'swings' into the space which was previously occupied by the phenylalanine and forms 
an intramolecular hydrogen bond with the cysteine thiolate (Figure 5.10) [44-45]. It was 
hoped that, by combining the F393A mutation with the Q403A substitution, we would 
remove any contribution to the electronic nature of the heme by an adjacent residue. This 
would allow us to assess the contribution of the phenylalanine residue to the cysteine 
thiolate and subsequently the heme. Similarly, combination of F393A with the Q403K 
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substitution could allow the introduction of a positive charge close to C400. The 
introduction of a positive charge would provide a significant electrostatic interaction 
between the charged residue and the cysteine leading to an increase in its lewis acidity. 
This in turn would draw density away from the iron, destabilising the Fe-S bond resulting 
in a positive shift in the reduction potential. 
5.4.1 Modulating the electronic nature of P450 BM3; 
The results from overexpression trials of the various mutant constructs 
immediately indicated that there was a problem in purifying the F393A/Q403K enzyme. 
Previous attempts at introducing a positive charge to the active site had also failed to 
yield any functional enzyme. Although this result is unfortunate it was not entirely 
unexpected. The introduction of a positive charge would draw density away from the 
iron, destabilising the Fe-S bond. It is possible that, as the cysteine ligand provides the 
only link between the protein backbone and the porphyrin, this destabilisation would lead 
to the dissociation of the heme. Although this is speculative, it is consistent with the 
presence of large amounts of P420, generally attributed to non cysteine ligated heme, 
during the purification process for the F393A/Q403K heme domain construct. It is 
unusual however that the same mutant was successfully purified, albeit at low yield, in 
the intact form. Whether this is the result of some stabilizing effect of the reductase 
domain, artifice of the different purification protocols or some entire unrelated effect is 
unclear. 
As would be expected from the remote nature of the substrate binding region 
(Figure 3.25) [14], substrate dissociation constants (Kd) were unchanged across the series 
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of enzymes studied. In addition, the magnitude of spin-state shift at saturating 
concentrations of substrate was high and consistent. 
Previous substitutions of the phenylalanine for an alanine, histidine, tryptophan 
and tyrosine have highlighted two parameters which give the best indication of the 
electronic changes at the heme conferred through the cysteine heme ligand. These are the 
position of the ferrous-CO Soret peak in the UV/vis spectrum and the heme reduction 
potential. Substitution of F393 for an alanine causes a 5 Mn shift to lower wavelengths in 
the Fe-CO Soret peak due to changes in the ir transition in the porphyrin as a result of 
the intramolecular H-bond from Q403 [44,45]. These changes are concomitant with a 
positive shift in the reduction potential of —100 mV. The single substitutions Q403  and 
Q403K do not alter the position of the ferrous-CO Soret or the reduction potentials with 
or without substrate in comparison to wild type. This result is entirely logical as neither 
the glutamine residue itself or either of the substituted residues should be in close 
proximity to the thiolate while the phenylalanine is still present. 
The double mutants F393A/Q403A and F393A/Q403K both display a +3nm shift 
to higher wavelengths in the Soret peak in comparison to F393A (-2nm shift in 
comparison to wild type). In addition, comparison of the potentials derived from the 4-
CNPy assay [81] and through OTILE titrations of the F393A1Q403A mutant shows that 
both double substitutions exhibit similar reduction potentials which are —50 mV more 
positive compared to F393A and -50 mV more negative compared to wild type. If we 
had succeeded in both removing any interaction with the thiolate ligand from an 
adjoining residue (F393/Q403A) and introducing a positive charge to the thiolate 
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(F393A/Q403K) then we would not expect them to display the same shift in their Soret or 
heme reduction potential. 
If the source of the 100 mV positive shift in Em observed for the F393A 
substitution is the result of a H-bond then we would expect that the introduction of a 
positive charge so close to the heme would lead to an even larger positive shift in Em and 
a lower wavelength Soret. Clearly this is not the case and as a result some doubt is cast 
on the success of this mutation in introducing a positive charge close to C400. If the 
phenylalanine donates some electron density to C400, strengthening the electron 'push' 
exerted by the cysteine then its removal would be expected to lead to a net loss in 
electron density at the heme. This would manifest itself as a positive shift in the reduction 
potential and a shift in the ferrous-CO Soret to lower wavelengths in comparison to wild 
type. This effect is unlikely to be as strong as we would see from the presence of a 
hydrogen bond. Consequently we would expect the removal of the interactions between 
F393 and Q403 with C400 to result in a reduction potential and ferrous-CO Soret 
between that of wild type and the F393A mutant. Figure 5.11 shows that this is precisely 
the case, with both the substrate-free and arachidonate-saturated heme reduction 
potentials lying between those of wild type and F393A. 
The experiments discussed above demonstrate that both double substitutions have 
had an influence on the electronic nature of the heme in comparison to F393A while both 
single substitutions do not. Although the heme reduction potentials observed are 
consistent with the removal of the phenylalanine interaction and inconsistent with the 
introduction of a positive charge, the nature of these changes is difficult to rationalise 
without crystallographic data It is entirely possible that the changes in Em are the result 
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of a number of other factors such as the increase in solvent exposure of the heme or even 
the presence of another residue at the active site. 
5.4.1: Modulating Inter-Flavin Electron Transfer: 
The most interesting feature of this series of mutations surrounds the single and 
double Q403K substitutions. Steady-state kinetics shows that the Q403K mutation causes 
a substantial decrease in the turnover rate constant which is in turn relieved by the double 
mutation (F393A/Q403K). This suggests that some step in the catalytic cycle is perturbed 
by the presence of the single lysine substitution only. This observation is mirrored in the 
heme reduction kinetic data but not in the oxy-ferrous decay which implies that the step 
which is impeded occurs during the electron transfer pathway from NADPH to heme. 
Differences in the heme reduction kinetics have previously been ascribed to changes in 
the thermodynamic driving force (AG) for electron transfer. It has been reported that over 
the Em range -150 to -350 mV, the correlation between reduction potential and heme 
reduction rate constant fits to a linear regression [76]. Figure 5.22 shows that the Q403K 
substitution does not fit to this trend. In addition, analysis of the mutant enzymes Q403A 
and Q403K show that they display similar reduction potentials but appreciably different 
heme reduction rate constants (Q403A: Em = -442 mV, kred = 58.5 s', Q403K: Em = -426 
mV, '(red = 9.0 s 1 ). The implication of this is that the disruption of the '(red and 
subsequently the turnover rate constant k at is a kinetic rather than thermodynamic effect. 
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Figure 5.22: Correlation between heme reduction rate constant and midpoint 
potential with associated linear regression. It is evident that k 1 for Q403K does not 
fit this trend. 
The artificial electron acceptors ferricyanide and cytochrome c were used to probe 
the electron transfer rates from FAD and FMN. The data shows that the rate constant for 
cytochrome c reduction (which can accept electrons from the FMIN only) is substantially 
lowered in the Q403K mutant while F393A/Q403K and wild type are directly 
comparable. The rate constants for ferricyanide reduction (which can accept electrons 
from both FAD and FMN) are the same for all the enzymes however the Michaelis 
constant is significantly increased in the Q403K mutant. The suggestion from this is that 
in the Q403K enzyme, the rate at which FMIN can donate electrons is impeded while for 
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Figure 5.23: Crystal structure of Q403K mutant of P450 BM3. Panel A shows the 
protrusion of the lysine residue into the middle of a patch of residues implicated in 
FMN binding (red). Panel B shown the lysine residue protruding from the surface of 
the heme. 
electron transfer from the FMN has been impeded by the Q403K substitution. Once again 
this effect is reversed when the Q403K substitution is combined with F393 A. 
It would appear remarkable that a substitution at the heme domain is capable of 
influencing the electron transfer rates either to or from a flavin cofactor contained within 
a separate domain. However, if we consider the crystal structure of Q403K, we can see 
how this might be the case. Figure 5.23 shows that K403 protrudes from the surface of 
the heme on the proximal side of the porphyrin, directly into the middle of a region of 
residues highlighted as important for heme-reductase interaction. It is possible that the 
addition of a positive charge to this binding region might provide an extra electrostatic 
bonding interaction between heme and FMN. As the interaction between heme and FMN 
is not considered to be a strong one, the addition of an extra electrostatic interaction 
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would constitute a significant stabilisation of the heme-FMN complex. As discussed in 
the introduction, the crystal structures of CPR and the FMN fused heme domain of P450 
BM3 suggest that the FMN cannot be bound to the heme and FAD at the same time. The 
implication of this is that the FAD, FMN and heme do not form a single complex primed 
for catalysis. Instead the FMN exists either in an 'open' or 'closed' confirmation for 
electron transfer to the heme and from the FAD respectively. If the addition of a positive 
residue to the surface of the heme domain resulted in a strengthening of the binding 
interaction between FIvIN and heme then it would disfavour the formation of the FAD-
FIv1N complex. In theory this would result in lower electron transfer rate constants from 
FAD to FMN. 
Pre-steady-state kinetics of flavin reduction show that the rate constants for FAD 
reduction (hydride transfer) in WT, Q403K and F393A/Q403K are in the region 200 -250 
S-1  and are constant both across the series of enzymes studied and across a range of ionic 
strengths. This would seem logical as the substitutions are at the heme domain and the 
hydride transfer occurs between NADPH and FAD which we would expect to be remote 
from the heme-CPR interface. 
From Table 5.10 we see that the FMN reduction rate constants for wild type and 
the F393A/Q403K mutant remain relatively high and constant across a range of ionic 
strengths. However, the rate constants for FMN reduction in the Q403K mutant increase 
linearly with increasing ionic strength (Figure 5.17). These data are consistent with the 
suggestion that there is an increased heme-FMN electrostatic binding interaction which 
disfavours the association of FAD and FMN. Increasing the ionic strength would mask 
the electrostatic interaction and remove the preference for the heme-FMN complex. 
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Although this explains why there is a change in the flavin reduction rate constant for 
Q403K, it does not explain why this observation is not seen in the double F393A1Q403K 
mutation. It has been reported that the substitution of F393 for an alanine causes the 
Q403 residue to 'flip' into the active site removing the carbonyl and NH2 moietys from 
the surface of the heme (Figure 5.24) [44,45]. It is entirely possible therefore that the 
K403 residue would also 'flip' into the active site removing the positive NH3 group from 
the heme-FMN interface. Although the thermodynamic data discussed previously 
suggests that the lysine does not interact with the cysteine, this does not preclude it from 
adopting some other conformation within the active site. With the lysine no longer 
protruding into the FMN-heme binding region, it would not be able to interfere with 
FMN binding and we would expect the rate constants for flavin reduction to revert to the 
levels observed for wild type. 
Looking at the rate constants for heme reduction by the FMN semiquinone 
species, it is evident that the wild type and F393A/Q403K species display comparable 
rate constants which are unaffected by ionic strength. The Q403K mutant enzyme has a 
rate constant for heme reduction which is some 10-fold less than the other two enzymes 
and again this is not affected by increasing ionic strength. This shows that the Q403K 
substitution not only interferes with the interfiavin electron transfer but also impedes the 
F1N-heme electron transfer. As this rate is not influence by increasing ionic strength we 
can surmise that the lower rate constant is not the result of the electrostatic interaction 
causing the FMN to bind in a conformation which is unfavourable for electron transfer. 
We must assume instead that the presence of the lysine directly behind the heme is 
specifically disrupting the electron transfer pathway from FMN to heme. Although the 
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Figure 5.24: Crystal structure of WT (IBU7) and F393A (IPOV) P450 BM3. The 
Q403 residue is highlighted in green in each case. Panel A shows the wild type 
enzyme with the NI-I 2 and carbonyl residues on the surface of the heme domain. Panel 
B shows the F393A enzymes with the NH 2 and carbonyl residues on the inside of the 
exact mechanism by which this occurs is not clear, one possibility is that the increase in 
size of the lysine in comparison to the glutamine simply prevents the FMN from 
approaching the heme close enough for maximal rates of electron transfer. As there is a 
marked dependence of the electron transfer rate on the distance between redox cofactors, 
it is possible that a small change in the distance might cause a significant change in the 
rate constant. 
The rate constants for heme reduction by FMN and rate constants for the entire 
first electron transfer process (heme reduction through flavins), are directly comparable 
suggesting that this is the rate limiting step in the first electron transfer process. This 
explains why that while FMIN reduction rates increase with increasing ionic strength, the 
heme reduction rates (k r j) remain low for F393A/Q403K. 
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There is one problem associated with the measurement of the individual electron 
transfer rate constants involved in the heme reduction pathway; namely the rate constants 
for FMN reduction are too low to support subsequent steps in the catalytic cycle. This 
observation is particularly poignant for wild type as the maximum rate constant for FMN 
reduction (one electron process) is only 60 s_ i , whereas the turnover rate constant (two 
electron process) is 100 s_ i . Clearly, the quoted rate constant for FMN reduction is not 
sufficient for catalysis. The answer to this problem is in the manner in which the 
experiments were carried out. The flavin reduction experiments were carried out in the 
absence of substrate so that the observed traces were not masked by the reduction of the 
heme. The quoted heme reduction and turnover rate constants are in the presence of 
saturating concentrations of substrate as in the absence of substrate, heme reduction is 
kinetically and thermodynamically unfavourable. The data show that the flavin reduction 
rate constants are substantially increased through the addition of substrate. While a FIvIN 
reduction rate of 60 s in the absence of substrate is not capable of sustaining a heme 
reduction electron transfer rate constant of - 100 s_ i , the substrate saturated FMN 
reduction rate constant of 140 s -1 is. 
This result has some startling ramifications. It has often been mentioned in the 
literature that the binding of substrate in P450 BM3 causes some large structural 
movements in the heme domain [21,80]. There are several different outcomes of this 
movement. Firstly it closes off the substrate binding channel ready for catalysis (Figure 
1.6). Secondly, the binding of substrate also regulates the enzyme by making it 
thermodynamically and kinetically unfavourable to transfer electrons in the absence of 
substrate [44-45]. This prevents the wasteful cycling of electrons and consumption of 
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Figure 5.25: Crystal structure of NOS reductase (ITILL) and calcium bound 
calmodulin (1MW). The NADPH, FAD and FMIN cofactors are shown in blue, 
yellow and green respectively. The binding of calmodulin to part of the NOS 
polypeptide causes an increase in the rate constants for electron transfer from the 
NADPH in the absence of substrate. We see here that the binding of substrate also acts to 
regulate electron transfer rates in both FAD and FMN, an astonishing result given the 
distances between FAD and heme. Although it is difficult to predict the mechanism by 
which the rate constants are enhanced, it is likely to be the result of some structural 
movement in the FAD-FMN-heme complex. In terms of the FMN-heme electron transfer 
rate, the fused structure shows the flavin positioned to be 12 A from the heme [194], 
exhibiting a theoretical electron transfer rate of 12 s_ i [102]. It is possible that the 
structural movements of the heme associated with substrate binding could allow the FMIN 
to reposition itself closer to the heme prior to electron transfer and hence increase the rate 
constant for FMIN to heme electron transfer. 
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This kind of behaviour, where the binding of a cofactor causes dynamic changes 
in species which are remote from the binding site, has been reported previously for NOS 
[202]. It has been shown that neuronal nitric-oxide synthesis is activated by the calcium 
dependent binding of calmodulin to a portion of the polypeptide linking the reductase and 
heme domains as seen in figure 5.25. The binding of calmodulin increases the rate at 
which electrons are transferred to heme but also the rate at which FMN can transfer 
electrons to an external electron acceptor (cytochrome c). This is clearly an example of 
how the binding of a cofactor in one part of a protein can stimulated increased rates for 
electron transfer between cofactor a significant distance away. 
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5.5 Conclusions 
In conclusion, our attempt to remove the interaction of the phenylalanine and 
glutamine residues with the cysteine ligand and our attempts at introducing a positively 
charged residue at the same site were not entirely successful. Although there is some 
evidence to suggest that the former has succeeded and the latter has not, without the 
crystal structures of the F393A1Q403A and F393A1Q403K enzymes, it is impossible to 
conclusively prove that this is the case. 
However, what is more interesting is that the single heme domain mutation of 
glutamine 403 for a lysine alters the electron transfer rates from FAD to FMN. It is 
proposed that these observations are the result of an increase in the strength of FMN -
heme interaction. The mechanism by which this occurs appears to be electrostatic in 
nature as it is disrupted by high ionic strength. In addition, the Q403K substitution leads 
to a decrease in the electron transfer rate from FMN to heme suggesting that this 
mutation is also impeding the electron transfer route to the heme. 
Finally, some initial measurements of the rates of FAD and FMN reduction in the 
presence and absence of substrate have suggested that both hydride transfer and FAD to 
FMN electron transfer are increased on substrate binding. The implication of this is that 
substrate binding regulates the enzyme not just by altering the thermodynamic and kinetic 
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DERIVATION OF EQUATIONS 
1. The Michaelis-Menten Equation 
The Michaelis-Menten equation applies to a generalised scheme for an 
enzyme [E] catalysed reaction whereby a substrate [S] is converted to product [P]. It 
this model, substrate binding is rapid and reversible and the rate determining step is 
the formation of product, hence: 
Equation Al. 
k1 	 k2 
E + 	S 	 ES 	>E 	+ 	P k  
As the overall rate of the reaction (v) is limited by the step ES —* E + P, this will 
depend on two factors - the rate of that step (i.e. k 2) and the concentration of the 
enzyme-substrate complex, i.e. [ES]. This can be written as: 
Equation AZ 
v = k2 [ES] 
There are several assumptions made in this scheme. Firstly that there is a vast excess 
of substrate, so that [S]>>[E]. Secondly, it is assumed that the system is in steady-
state, such that the concentration of the enzyme-substrate  [ES] is constant. Thus for a 
steady state model we can write: 
245 
Equation A3. 
k1 [EJ[S] = k 1 [ES] + k2 [ES] 
By pooling all the rate constants (k 1, k 1 and k2) into a new constant (KM) and 




The total concentration of enzyme [ET] is equal to the total amounts of substrate-
bound [ES] and substrate-free [E] enzyme. Hence: 
Equation A5. 
[Er] = [ES] ± [E] 
And 
[E] = [ET J —[ES] 
Substitution into equation A4. gives: 
Equation A6 
[ES] = ([E]- [ES])[S] 
KM  
This simplifies to: 
246  
Equation A 7. 
[ES]= [ET][S] 
[S] + KM 




[S] + [KM] 
The maximum rate, which we can call kt, would be achieved when all of the enzyme 
molecules are substrate bound. Under steady state conditions where the substrate 
concentration vastly exceeds the concentration of enzyme it is reasonable to assume 
that all [E] will be in the form [ES]. Therefore [ET] = [ES]. By substituting keat and 
[ES] into equation Al we get: 
Equation A9. 
k =k2[E] 





2. The Debye-Huckel Equation 
The activity of an ion in solution can be determined by means of the 
concentration and the activity coefficient, y.  The activity of some species A, ActA, is 
equal to the concentration of [A] times the activity coefficient of A, y,  for a given 
solution. 
Equation All. 
ActA= [A] * 7 
The Debye-Huckel Equation enables the determination of the activity coefficient, ', 
of an ion in an aqueous solution of known ionic strength according to the equation: 
Equation Al2. 
logy = -Az 2 'IJ 
where y  is the activity coefficient, A is a temperature and solvent dependant conastan, 
zj is the integer charge of the ion and I is the ionic strength of the aqueous solution. 
By combining equation Al2 with the Bronsted relation we generate the Debye-
Bronsted equation: 
Equation A13. 
log k 2  =log k.  +2Az,zji 
24S 
Where k2 is the second order rate constant and ko is the second order rate constant at 
1=0. A plot of logk2 vs. /1 generates a straight line allowing the calculation of the 
charges involved in thereaction between two species. 
249 
APPENDIX II 
P450 BM3 PEPTIDE SEQUENCE 
The heme domain is comprised of residues 1472, the reductase domain is comprised 
of residues 473-1048. 
1 	 11 	 21 	 31 	 41 	 51 
I I I I 
1 TIKEMPQPKT FGELJLPIL NTDKPVQALM KIADELGEIF KFEAPGRVTR YLSSQRLIKE 	60 
61 ACDESP.FDKN LSQLKFVRD FAGDGLFTSW THEKNWKKAH NILLPSFSQQ AMKGYH?1MV 120 
121 DIAVQLVQXW ERINADEHIE VPEEMTRLTL DTIGLCGFNY RFNSFYRDQP HPFITSMVRA 180 
181 LDEAMNKLQR ANPDDPAYDE NKRQFQEDIK \ft4NDLVDKII ADRKASGEQS DDLLTHMING 240 
241 KDPETGEPLD DENIRYQIIT FLIAGHETTS GLLSFALYFL VKNPHVLQKA AEEAARVLVD 300 
301 PVPSYKQVKQ LKYVWLNE ALRLWPTAPA FSLYAKEDTV LGGEYPLEKG DELMVLI PQL 360 
361 HRDKTIWGDD VEEFRPERFE NPSAI PQHAF KPFGGQRAC IGQQFALHF.A TLVLG14LKH 420 
421 FDFEDHTNYE LDIKETLTLK PEGFVVKPKS KKIPLGGIPS PSTEQSAKKV RKKAENAHNT 480 
481 PLLVLYGSNM GTAEGTARDL ADIP1SKGFA PQVATLDSHA GJLPREGAVL IVTASYNGHP 540 
541 PDNAKQFVDW LDQASADEVK GVRYSVFGCG DKNWATTYQK VPAFIDETLA AKGAENIPDR 600 
601 GEADASDDFE GTYEEVREHM WSDWAYFNL DIENSEDNKS TLSLQFVDSA AL1'1PL1KMHG 660 
661 AFSTNVVASK ELQQPGSARS TRHLEIELPK EASYQEGDHL GVIPRNYEGI VRVTARFGL 720 
721 DASQQIRLEA EEEKLAHLPL AKTVSVEELL QYVELQDPVT RTQLRNW\K TVCPPHKVEL 780 
781 EALLEKQAYK EQVLAKRMM LELLEKYPAC EMKFSEFIAL LPSIRPRYYS ISSSPRVDEK 840 
841 QASITVSWS GEPWSGYGEY KGIASNYLAE LQEGDTITCF ISTPQSEVII PKDPETPLIM 900 
901 VGPGTGVAPF RGFVQARKQL KEQGQSLGEA HLYFGCRSPH EDYLYQEELE NAQSEGIITL 960 
961 HTAFSRMPNQ PKTYVQHVME QDGKKLIELL DQGAHFYICG DGSQMAPAVE ATLMKSYADV 1020 
1021 HQVSEADARL WLQQLEEKGR YAKDVWAG 
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Abstract: In flavocytochrome P450 BM3, there is a conserved phenylalanine residue at position 393 
(Phe393), dose to Cys400, the thiolate ligand to the heme. Substitution of Phe393 by Ala, His, Tyr, and 
Trp has allowed us to modulate the reduction potential of the heme, while retaining the structural integrity 
of the enzyme's active site. Substrate binding triggers electron transfer in P450 BM3 by inducing a shift 
from a low- to high-spin ferric heme and a 140 mV increase in the heme reduction potential. Kinetic analysis 
of the mutants indicated that the spin-state shift alone accelerates the rate of heme reduction (the rate 
determining step for overall catalysis) by 200-fold and that the concomitant shift in reduction potential is 
only responsible for a modest 2-fold rate enhancement. The second step in the P450 catalytic cyde involves 
binding of dioxygen to the ferrous heme. The stabilities of the oxy-ferrous complexes in the mutant enzymes 
were also analyzed using stopped-flow kinetics. These were found to be surprisingly stable, decaying to 
superoxide and ferric heme at rates of 0.01-0.5 The stability of the oxy-ferrous complexes was greater 
for mutants with higher reduction potentials, which had lower catalytic turnover rates but faster heme 
reduction rates. The catalytic rate-determining step of these enzymes can no longer be the initial heme 
reduction event but is likely to be either reduction of the stabilized oxy-ferrous complex, i.e., the second 
flavin to heme electron transfer or a subsequent protonation event. Modulating the reduction potential of 
P450 BM3 appears to tune the two steps in opposite directions; the potential of the wild-type enzyme 
appears to be optimized to maximize the overall rate of turnover. The dependence of the visible absorption 
spectrum of the oxy-ferrous complex on the heme reduction potential is also discussed. 
Introduction 
Cytochromes P450 (P450s) are b-heme-containing monooxy-
genases implicated in numerous biosynthetic and metabolic 
processes) They are able to catalyze oxygen atom insertion (eq 
1) into a wide variety of substrates. 
RH+O2 +2e - ROH+H2O 	(1) 
This is made possible by the ability of P450s to seductively 
activate molecular oxygen at the heme center. The heme-iron 
is axially ligated by a cysteine thiolate ligand this distinguishes 
P450s from other oxygen activating enzymes such as the globins 
and peroxidases, which utilize histidine. The electronic influence 
of the axial ligand on the heme-iron in P450s is the key to their 
unique catalytic abilities.25 The importance of cysteine as the 
School of Chemistry. 
The Institute of Cell and Molecular Biology. 
(I) Ortiz de Montellano, P. R., Ed. Cyiodirome P450: Sn-uc,ure, Mechanism 
and Biochemislry, 2nd ed.; Plenum Press: New York. 1995. 
(2) Dawson, J. H.; Holm, R. H.; Trundell, J. 11; Barth, G.; Limier, R. E.; 
Bimnenberg, E.; Djemssi, C.; Tang, S. C. J. Am. Chem. Soc. 1976, 98, 
3707-3709. 
axial heme ligand can be inferred from its absolute conservation 
in every member of the P450 family and has been demonstrated 
to be essential for monooxygenase activity in studies of model 
complexes and mutant P450s.69 The cysteine is believed to 
provide an electronic "push" to the heme-iron, which increases 
the electron density at the iron to promote the heterolytic 
cleavage of heme-bound dioxygen)° IL 
Although the mechanism of oxygen activation by cyto-
chromes P450 has been extensively studied, 12-15  the factors 
Poulos, T. 1.; Finzel, B. C.; Gunsalus, L C.; Wagner, G. C.; Kraut, J. J. 
Biol. C/tern 1985, 260, 16122-16130. 
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Tani, F.; Matsu-wu, M.; Nakayama, S.; Nartua, Y. CoonS Cheer Rev. 2002, 
226, 219-226. 
Auclair, K.; Moenne-Loccoz, P.; Ortiz tie Montellano, P. R. J. Am. Chem. 
Soc. 2001, 123, 4877-4885. 
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553. 
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controlling activation itself are less well understood. Dioxygen 
binds to ferrous heme-iron but has negligible affinity for the 
ferric form. Heme reduction occurs only after substrate binding, 
which induces a change in the iron coordination geometry from 
octahedral to square-based pyramidal, an event which is 
accompanied by a change from a low- to high-spin state at the 
ferric iron.' 6,11 These steps initiate the P450 catalytic cycle, and 
their rigorously sequential nature helps to prevent unproductive 
cycling. 18 In a productive cycle, the oxy-ferrous complex (once 
formed) is reduced by a second electron from the reductase. 
On protonation, this complex decomposes to the reactive oxy-
ferryl (Fe"=O) moiety responsible for oxygen atom insertion. 
Although this sequence of steps is common to all P450s, the 
rate at which the steps occur is highly variable as demonstrated 
by the variability in the catalytic turnover rates of the many 
P450 isoforms studied.' These are influenced by additional 
factors such as interprotein recognition, electron transfer, 
substrate recognition, and product release. Molecular oxygen 
activation must be carefully controlled in each case to ensure 
efficient substrate oxygenation without uncoupling, i.e., unpro-
ductive dissociation of reduced oxygen species from the heme 
prior to reaction with substrate. 18 P450s must therefore balance 
their ability to reduce molecular oxygen against their ability to 
stabilize reactive-oxygen intermediates. Other oxygen-binding 
hemoproteins have very different properties; oxidases promote 
the release of reduced oxygen species, while the globins 
reversibly bind dioxygen.' 92' The question of how this balance 
is achieved is of fundamental importance. 
While the sequence identity of P450s is quite low (typically 
15-25%), particular regions do exhibit a high degree of identity. 
The heme binding loop runs from the home ligand (Cys), 
through a glycine residue to a phenylalanine residue (Phe393 
in P450 BM3), all of which are highly conserved .22  This 
structural motif is fundamentally important to P450s since the 
Fe—Cys bond is the only formal bonding interaction between 
the home and the protein. Substituting the cysteine ligand results 
in one of two outcomes, (i) catalytic deactivation or (ii) failure 
to incorporate heme, 8 '9 both of which demonstrate the necessity 
for a cysteine ligand but neither of which explains why. 
P450 BM3 is a single component fatty acid monooxygenase 
from Bacillus megalerium.45 It is composed of a P450-home-
containing oxygenase domain, which is connected via a short 
protein linker to a diflavin reductase domain. The reductase 
domain is related to mammalian microsonial P450 reductase 
and binds 1 equiv each of FMN and FAD. The reductase domain 
functions as an NADPH dehydrogenase, supplying electron 
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equivalents directly to the home. The unusual structure of P450 
BM3 makes it an ideal model of a mammalian P450 system 
contained within a single component. It is particularly useful 
for studying how electron transfer is coupled to oxygen 
activation in the P450s. Our earlier studies showed how 
substitution of phenylalanine 393 of P450 BM3 influences the 
home reduction potential and the stability of the oxy-ferrous 
complex.1"24 Here, we extend this work to examine how the 
thermodynamic properties of the heme influence the key steps 
in the P450 catalytic cycle: electron transfer, and oxygen 
activation. 
Experimental Procedures 
Escherichia coil Strains and Plasmids. The preparation of plasmids 
for the overexpression of full-length and hone domain constructs of 
WT P450 BM3 (pBM23 and pBM20), F3939A (pCM36 and pCM80), 
F393H (pCM37 and pCM81), and the F393Y (pCMI09 and pCM125) 
mutant enzymes has been reported previously.' The F393W mutant 
was constructed by oligonucleotide-directed mutagenesis of the wild-
type plasmids pJM23 and pJM20, respectively, using the Kunkel 
methcxi1' The oligonucleotide punier used in the mutagenesis procedure 
is shown below (mismatches are indicated by the italicized bases) 
5'CTGACCGTFTCCCCACGGTTFAAACG 3'. The resulting full-
length and hone domain constructs were named pCM1 11 and pCM1 10, 
respectively. Both plasmids were sequenced on a Perkin-Elmer ABI 
Prism 377 DNA sequencer to ensure no secondary mutations had 
occurred. The E. coli strain TG1 [supE, hsdtt5, thi, E(lac-proAB), F' 
[tra36, proAB, laclq,  IacZAM 15)] was used for all cloning work 
and for overexpression of the full-length and hone domain proteins. 
Enzyme Preparations. All enzymes were isolated and purified as 
described previously.23 All pure proteins were concentrated to >500 
1tM by ultrafiltration and were flash frozen in liquid nitrogen prior to 
storage at —80 °C. Enzymes were used within 1 month of isolation. 
Specfrophotometric Analysis of Fatty Acid and Carbon Mon-
oxide Binding to P450s. IN/visible absorption spectra were recorded 
over the 300-800 not range using a Shimadzu 2101 spectrophotometer 
and quartz cuvettes of 1 cm path length. Typically, the concentration 
of P450 13M3 used was 1-5 pM in 1 mL of assay buffer (100 mM 
MOPS pH 7.0) at 30 °C. Substrate dissociation constants were 
determined for arachidonate and laurate according to established 
procedures. 23 
Steady-State Kinetics. All steady-state kinetic measurements were 
performed at 15°C in air saturated assay buffer using 1 cm path length 
quartz cuvettes. Initial rates of NADPH oxidation were measured, as 
described previously, 1' by monitoring the decrease in absorbance of 
NADPH (c340 = 6.21 mM cm) with time, under substrate-free or 
substrate-saturating ([arachidonate] = 100 pM) conditions. Enzyme 
concentrations used were typically 2-10 pM for substrate-free assays 
and 10-100 nM for arachidonate-saturated assays. The quoted rate 
constants (Icon) are the average of three separate experiments. 
Pre-Steady-State Kinetics. All pre-steady-state measurements were 
performed at 15 °C using an Applied Photophysics stopped-flow 
spectrophotometer (SX. 17MV) contained within an anaerobic glovebox 
(Belle Technology; [02] < 5 ppm) using either single-wavelength or 
diode-array detectors. 
A. Herne Reduction. Rate constants for the first flavin-to-heme 
electron-transfer step (k,) were determined by monitoring the formation 
of the ferrous-CO (Fetm—CO) adduct of the full-length flavocytochromes 
with time. One syringe contained NADPH (100 aM), and the second 
Ost, T. W. B.; Miles, C. S.; Munro, A. W.; Murdoch, J.; Reid, G. A.; 
Chapman, S. K. Biochemislry 2001, 40. 13421-13429. 
Ost, T. W. B.; Munro, A. W.; Mowat, C. G.; Taylor, P. IL; Pesseguiero, 
A.; Fulco, A. J.; Cho, A. IC; Cheesman, M. IL; Walkinshaw, M. D.; 
Chapman, S. K. Biochemiriry 2001, 40, 13430-13438. 
Kunkel, W. H. Proc. Nail. Acad. Sd. U.S.A. 1985, 82, 488-492. 
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-289 ± 5 
67 ± 7 
99 ± 10 
140 ± 10 
-427 ± 4 
0.09 ± 0.01 
-360 ± 5 
41±4 
29 ± 3 
540 ± 50 
-480±5 
0.08 ± 0.01 
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Table 1. Thermodynamic and Kinetic Parameters Determined for Wild-Type and the F393 Series of Mutant Enzymes of Flavocytochrome 
P450 BM3 
mzyme 




-151±4 -176±4 	 -295±6 
18±2 21±2 66±7 
240±24 205±21 	 94±10 
10±1 3±1 110±10 
Substrate-free (SF)" 
-312±4 -332±6 	 -418±6 
0.27 ± 0.03 028 ± 0.03 0.12 ± 0.01 
03 ± 0.1 (71%) 	0.2 ± 01 (48%) 	0.2 ± 0.1 (18%) 	0.14 ± 0.05 (28%) 	0.3 ± 0.1 (11%) 
3.1(24%) 	 1.3(14%) 	 0.9(60/o) 	 2.6(8%) 	 11(15%) 
10±1 5±1 90±9 110±20 440±50 
reduction potential (mV ,' 
turnover (k, s - I) 
heme reduction (k,, s 
autoxidation(k,,,,,, x 103 s)' 
reduction potential (mV)c4 
turnover (k, s- ly  
heme reduction 
slow phase (k,, s - 1)1,r 
fast phase (k,j, s - 1)1-r 
autoxidation (k,jsa,)( iO S - 1), 
Determined in the presence of saturating concentrations (100 ,uM) arachidonate. "Determined in the absence of substrate. I Values for wild-type, F393A, 
F393H, and F393Y reported in ref 23. d  Experiments conducted at 25 "C in 100 mM KPi pH 7.0 except for F393W where the buffer was 100 mM Tris/500 
mM KCI, pH 70. "Experiments conducted at 15 °C in 100 mM MOPS pH 7.0. IHeme reduction slow phase (k,) and fast phase (k,), with percentage 
of total heine reduction in each phase. SExperimental conditions are described in the Experimental Procedures section. 
syringe contained full-length wild-type or mutant P450 BM3 (1-5 pM). 
Both syringes contained anaerobic assay buffer previously saturated 
with CO by bubbling for 5 mm ([CO] = '-200pM). In the case of the 
substrate-saturated experiments, full conversion (>95%) to the Fen-
CO complex was observed; the data were monophasic and were 
evaluated by fitting the absorbance change to a single-exponential 
function (2 = 450 nm (WT, F393Y, F393W), 445 am (F393H), and 
444 nra (F393A)). In the absence of substrate, incomplete conversion 
to the Fe°-CO complex was observed; the data were biphasic and 
were evaluated by fitting the absorbance change to a double exponential 
function. The slow phase constituted the greatest proportion of the 
amplitude. Analyses were performed using Microcal Origin 7 software. 
Values quoted are from the averages of four separate measurements. 
Rate constants determined for the fast phase were less predictable; 
examples are shown in Table 1. 
B. Autoxidation. Rate constants (k) for the decay of the oxy-
ferrous complexes of the wild-type and mutant P450 BM3 heme 
domains were determined by monitoring the rates of autoxidation to 
ferric P450 with time. The heme domain proteins (--10 pM) were 
prereduced by addition of 40 pM sodium dithionite. Excess dithionite 
was removed prior to experimentation by elution of the reduced P450s 
through a pre-equilibrated 10 mL 025 gel-filtration column. Reduction 
was confirmed by UV/visible spectrometry on a Varian Cary 50 Bio 
spectrophotometer, also contained within the glovebox. Formation of 
the oxy-ferrous complex was achieved by mixing the reduced P450 
(syringe A) with air-saturated assay buffer ([021  200 pM (syringe 
B)). Formation of the oxy-ferrous species was too lhst to measure (>600 
s- 1), yet in each case, the decay occurred over a period of seconds and 
could be conveniently measured. Autoxidation of ferrous P450 (FO'  
- 02 - Fe + 02) was followed using a PDA detector across the 
range 300-700 nm. The variation in A470 with time was monophasic 
for both the substrate-free and substrate-saturated experiments and was 
evaluated by fitting the data to a single exponential (Microcal Origin 
7). This wavelength gave the most consistent results over all the 
different conditions. For substrate-free enzyme some high to low spin 
conversion can be seen in the Soret region over long time scales. Over 
short time scales, some oxyferrous formation can also be observed. 
Optically Transparent Thin Layer Electrochemical (OTLE) 
Potentiometry. Spectroelectrochemical analysis of the F393W mutant 
home domain was conducted in an OITLE cell constructed from a 
modified quartz EPR cell with a 0.3 mm path length, containing a Pt/ 
Rh (95/5) gauze working electrode (wire diameter 0.06 mm, mesh size 
1024 cm', Engelhardt, UK), a platinum wire counter electrode and a 
Ag/AgCI reference electrode (model MF2052, Bioanalytical Systems, 
IN 47906, USA). Enzyme samples (0.5 mL x 100-200 pM) were 
eluted through a 025 column pre-equilibrated with 0.1 M Tris pH 7.5, 
15012 J. AM. CHEM. SOC. • VOL. 125, NO. 49,2003 
0.5 M KCI in an anaerobic glovebox. The following mediators were 
then added. 2-hydroxy-1,4-naphthoquinone (20 pM), FMN (5 pM), 
benzyl viologen (10 pM) and methyl viologen (10 sM). Spectro-
electrochemical titrations were performed at 25±2°C using an Autolab 
PGSTAT10 potentiostat and a Cary 50 UV/vis spectrophotometer. The 
potential of the working electrode was decreased in 30 mV steps until 
the enzyme was fully reduced and increased stepwise until reoxidation 
was complete. After each step, the current and UV/vis absorption 
spectrum were monitored until no further change occurred. This 
equilibration process typically lasted 15 mm. Absorbance changes were 
plotted against the potential of the working electrode and analyzed using 
the Nernst equation. The Ag/AgCI reference electrode employed in the 
OTTLE cell was calibrated against indigotrisulfonic acid (E,,, = -99 
mV vs SHE) and FMN (Em = -220 mV vs SHE) in the same buffer 
conditions. All electrode potentials were corrected accordingly by +182 
± 2 mV relative to the standard hydrogen electrode. 
Crystallization and Refinement. Crystallizations of F393A, -W, 
and -Y heme domains were carried out by hanging drop vapor diffusion 
at 4 "C in Linbro plates. Crystals were obtained with a well solution 
comprising 100 m sodium PIPES, pH 6.5-7.5,40 mM MgSO4, and 
18-21% PEG 8000. Hanging drops of 4 uL were prepared by adding 
2 pL of 40 mg/mL protein (in 50 m TrisHCl/1 mM EDTA, pH 7.4) 
to 2 uL of well solution. Plates of up to 1 x 0.3 x 0.3 min' were 
formed after about 1 week. Crystals were immersed in well solution 
containing 22% glycerol as a cryoprotectant, prior to mounting in nylon 
loops and flash-cooling in liquid nitrogen. For the F393A mutant heme 
domain, a data set was collected to a 2.05 A resolution on beamline 
xli (2 = 0.8482 A) at DESY Hamburg, for the F393W heme domain, 
a data set was collected to a 2.0 A resolution on beamline BM14 (2 = 
1.0332 A) at ESRF Grenoble, and for the F393Y heme domain, a data 
set was collected to a 2.0 A resolution on beamline x 13 (2 = 0.802 
A) at DESY Hamburg. All data were collected using a Mar CCD 
detector. Crystals of all three mutant forms belong to space group P21. 
Crystals of the F393A home domain were found to have the following 
cell dimensions: a = 58.694 A, b = 152.911 A, c = 61.197 A, and fl 
= 94.640°. Those of the F393W hem e domain had the following 
dimensions: a = 58.911 A, b = 153.538 A, c = 61.430 A, and fl = 
94.424°. Those of the F393Y heme domain had the following 
dimensions: a = 59.608 A, b = 152.983 A, c = 61.774 A, and fi = 
94.539°. Data processing was carried out using the HKL package _21 
The wild-type flavocytochrome P450 BM3 home domain structure 
(2HPD),11 stripped of water, was used as the initial model. Electron 
Otwinowski, Z.; Minor, W. Methods Enzy,nol. 1997, 276, 307-326 
Ravichandran. K. G.; Boddupalli, S. S.; Hasemann, C. A.; Peterson, J. A.; 
Deisenhofer, J. Science 1993, 261, 731-736. 
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density fitting was carried out using the program TURBO-FRODO 
(in Silicon Graphics Geometry Partners Directory 86, Silicon Graphics, 
Mountain View, CA). Structure refinement was carried out using 
Refinac. 2929 The atomic coordinates have been deposited in the Protein 
Data Bank (1POV:F393A 1POW:F393W; 1PDX:F393Y). 
Results 
Characterization of the F393W Mutant. The ferrous 
F393W mutant (in both full-length and heme domain) formed 
a typical P450 complex with CO, with a Soret absorption 
maximum at 449 rim. Titration of the mutant enzyme with 
substrate (either arachidonate or laurate) induced a shift in the 
absorption spectrum consistent with the low- to high-spin 
transition of ferric heme iron. The substrate dissociation 
constants were determined to be 578 ± 35 ,UM for laurate and 
2.0 ± 0.4 jtM for arachidonate, both of which are similar to 
values determined for the wild-type enzyme. The most obvious 
change caused by the mutation is a large decrease in the heme 
reduction potential in the presence and absence of substrate. 
These values are -480 ± 5 mV and -360 ± 5 mV for the 
substrate-free and substrate-saturated F393W heme domain, 
respectively (Table 1), compared to values of -427 mV and 
-289 mV for the wild-type enzyme, respectively. These 
potentials are substantially more negative than the midpoint 
potential of NADPH (-320 my) and probably also of the FMN 
cofactor of P450 BM3, 48 making electron transfer to the heme 
in the F393W mutant enzyme thermodynamically unfavorable 
even in the presence of substrate. In the wild-type enzyme, home 
reduction in the presence of NADPH is favored only after 
substrate binding. This effect, together with the spin-state 
change, acts as an electron-transfer control mechanism. The 
other mutants included in this study have been characterized 
previously: 4 the F393A and F393H mutants both have higher 
reduction potentials than the wild-type enzyme and blue-shifted 
Soret absorption bands for their ferrous heme-CO complexes. 
The F393Y mutant, on the other hand, is similar to the wild-
type enzyme in these respects. All the mutants have similar 
substrate binding affinities and associated spin-state shifts. This 
is the first indication that some key properties of the enzyme 
active site are unaffected by the mutation despite the large shifts 
either way in home reduction potential. 
Steady-State Kinetics. The krat values for wild-type P450 
BM3 and the F393A, -H, -Y, and -W mutants are shown in 
Table 1. The background rate constant for NADPH oxidation 
in the absence of substrate is small (k < 0.3 s) for all the 
mutants, and in all cases, the k, increases by 2 orders of 
magnitude (18-67 s) in the presence of substrate. This is 
consistent with the established idea that substrate binding gates 
electron transfer to the heme, such that reducing equivalents 
are only consumed when substrate is present. The F393W 
mutant was found to couple NADPH consumption to substrate 
monooxygenation with greater than 90 % efficiency. The other 
mutants and the wild-type enzyme couple similarly well 23 (i.e. 
> 80%) except for the F393A mutant, which is slightly less 
efficient (56% coupling). The substrate saturated k, t varies 
across the series of enzymes studied (WT F393Y > F393W 
>> F393H F393A) by approximately 3-fold, but there is no 
Roussel, A.; Cainbillasi, C. Silicon Graphics Geometry Partners Dictionary 
86; Silicon Graphics: Mountain View, CA. 
Muishudov, G. N.; Vagni, A. A.; Dodson, E. J. Ada Cryszallogr. 1997, 
D53. 240-255. 
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Figure 1. Heme reduction of flavocytochrome P450 BM3. Panels A and 
B show the time courses for formation of the P450 complex from the 
substrate-saturated (A) and substrate-free (B) forms of the wild-type (MIT) 
and mutant enzymes. Each trace is labeled with the one letter code 
corresponding to the particular F393X substitution and is shown fitted to a 
single (panel A) or double (panel B) exponential function. The abscissa in 
panel B has been resealed to show the proportion of ferrous CO complex 
formed during the second (slow) exponential phase (k,). For wavelengths, 
see Experimental Procedures. Panel C shows the absorption spectra of 
substrate-free ferric (solid line), substrate-bound ferric (broken line), and 
the ferrous-CO complex (dotted line) of the wild-type enzyme. 
linear correlation with reduction potential. The wild-type enzyme 
has the largest A 5 (67 s'), and this is similar to the F393Y 
mutant (which has a similar reduction potential). The F393W 
mutant turns over at half this rate and has a more negative 
reduction potential. The F393H and F393A mutants on the other 
hand are slower still but have more positive reduction potentials. 
This complex trend suggests that the reduction potential of the 
wild-type enzyme is optimized to give the fastest overall 
catalytic rates. 
Heme Reduction In a series of stopped-flow experiments, 
rate constants were determined for the formation of ferrous CO 
complex on reaction of the holoenzymes with NADPH (Figure 
1). These data (Table 1) approximate to the rate of first electron 
transfer to the home. The ferrous form generated by electron 
transfer to the home, is trapped by CO binding. 49 Binding of 
CO by reduced enzyme is rapid, occurring at rates in excess of 
1000 s I in CO-saturated buffer in the wild-type and mutant 
enzymes. The overall process has many individual steps, most 
of which occur quickly, nevertheless, slight lag phases can be 
observed in some of the traces in Figure 1. A contributing factor 
may be reduction of the flavins, which is also a multiphasic 
process observed at 450 nm as a decrease in absorbance. 49 In 
the absence of substrate the home reduction traces are biphasic, 
with a small fast phase being followed by a larger slow phase. 
The fast phase showed no obvious trend and varies erratically 
(examples only are presented in Table 1). Larger fast phases 
are obtained with enzyme containing a larger proportion of high-
spin home this has been found to result from contamination with 
detergents during preparation, which bind irreversibly to the 
enzyme. The slow phase was consistent for all the mutants, with 
very little change across the series. However, its amplitude 
appears to increase with reduction potential. It appears that the 
electron-transfer process is an equilibrium, the position of which 
depends on the reduction potential of the CO-bound home and 
Arr 
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Scheme I 
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Em  (Fe) Substrate bound heme reduction potential; 
Em  (0) One electron reduction potential of thoxygen; 
= Equilibrium constant for oxygen binding; 
= Equilibrium constant for superoxide binding; 
= Rate constant for oxygen dlssodatfon; 
Rate constant for superoxide dissociation; 
e = electron. 
that of the FMN. The rate constants observed are then the sum 
of the forward and reverse rate constants. With this taken into 
account, in the absence of substrate, heme reduction appears to 
be slow enough to limit steady-state turnover for all the enzymes 
studied (k,,& < 0.4 s). For the F393W mutant, the rate 
constant (slow phase) determined for heme reduction is 5-fold 
faster than k, but only 11% heme reduction occurs in the slow 
phase, suggesting that the reverse process is favored by the 
extremely negative heme reduction potential. 
In the presence of substrate, the rate constants for heme 
reduction increase by 2 orders of magnitude (krod is 29 s_I or 
more) for all the enzymes studied. However, there is now a 
clear correlation with the heme reduction potential. At more 
negative reduction potentials (i.e., for the F393W and F393Y 
mutants and the wild-type enzyme) the rate of heme reduction 
slows and is similar to the rate of catalytic turnover, indicating 
that FMN to heme electron transfer is rate determining. At more 
positive reduction potentials, the rate of heme reduction is 
faster: kd for the F393A mutant in the presence of substrate 
is 10-fold greater than for the F393W mutant. However, the 
rate of catalytic turnover is slower, such that km d is now 10-
fold greater than knst. This indicates that a change in the rate- 
determining step has occurred for the F393A and F393H 
mutants. 
Oxy-Ferrous Decay. In the P450 catalytic cycle, heme 
reduction is followed by the binding of dioxygen, to form an 
oxy-ferrous/superoxy-ferric complex (Scheme 1). This is the 
starting point for the multistep oxygen activation process. Using 
rapid-scanning UV/vis stopped-flow spectrophotometty we were 
able to obtain spectra of the oxy-ferrous complexes of all the 
mutants and the wild-type enzyme and monitor their rates of 
decay to ferric heme, probably via the dissociation of superoxide. 
Figures 2-4 show the spectra of the wild-type enzyme and the 
F393A and F393W mutants in the presence and absence of 
substrate, and their respective time-courses for decay. The Soret 
peak positions were at 423 and 425 nm for the substrate-free 
and substrate-bound oxy-ferrous complexes respectively, regard-
less of mutation, but differences were observed in the long-
wavelength region. These are shown in Figure 5, panel C. The 
similarities of the Sorel bands of the mutant enzymes spectra 
indicate that they are all of oxy-ferrous complexes. The 
differences observed in the a-fl region are not, therefore, due 
to contamination by oxidation products, but indicate that the 
heme electronic structure is perturbed by the mutations. 
Although decay of the oxy-ferrous complex is a nonproduc-
tive process so far as catalytic turnover is concerned, its rate is 
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Figure 2. Formation and decay of the oxy-ferrous species of the P450 
BM3 F393A-heme domain at 15 °C under substrate-free (panel A) and 
substrate-saturating conditions (panel B). In both cases, the oxy-ferrous 
species is shown by the broken line, the solid lines correspond to ferric 
low-spin (panel A) and high-spin P450 (panel B). Panel C shows the 
exponential decay (k) of substrate-free (upper trace) and substrate-
saturated (lower trace) oxy-ferrous complexes, monitored at 470 mo. Both 
are shown fitted to single-exponential decay functions. 
indicative of complex stability. The oxy-ferrous complexes of 
all the F393X enzymes decayed to the ferric high-spin form in 
the presence of substrate and primarily to low-spin ferric home 
in the absence of substrate, as expected. However, in the latter 
reaction, a proportion of the enzyme remained high-spin 
(<20%), possibly due to oxidative damage of the active site. 
Rate constants for the autoxidation of the ferrous P450s in the 
absence (k,) and presence of substrate (k sB ) are shown 
in Table 1. Two major observations can be made. First, the 
autoxidation rate is essentially independent of the presence of 
substrate. This indicates that substrate has little effect on the 
stability of the oxy-ferrous complex in this P450 and is unlikely 
to be involved directly in catalytic oxygen activation. The slight 
increase in stability may be a reflection of the increased 
hydrophobicity of the active site when substrate is bound. 
Second, the oxy-ferrous decay rate constants correlate with 
the home reduction potentials. The F393H oxy-ferrous complex 
was the most long-lived (k5su = 3.0 x 10-3  s- 1), with a 
40-fold slower autoxidation rate than the oxy-ferrous complex 
of the wild-type enzyme (k.0 = 0.14 s- 1 ). The F393W oxy-
ferrous complex, on the other hand, decayed 4 times faster 
(sn = 0.54 s- 1 ) than that of the wild-type enzyme. The 
oxy-ferrous complex is therefore destabilized in mutants with 
lower reduction potentials and vice versa. The formation of 
superoxide on decay of the oxy-ferrous complex is likely to 
contribute to uncoupled turnover of the enzymes. The viability 
of this can be ascertained by comparing the rate constants for 
oxy-ferrous decay to the steady-state turnover rates. In the 
presence of substrate, catalytic turnover is 2 orders of magnitude 
faster than autoxidation for all the mutants, indicating that 
uncoupling via this route is not viable. Coupling percentages 




300 	400 	500 	600 	700 
	
300 	400 	500 	600 	700 





0.5 	 B 
0.4 
< 0.2 
	 < 0.3 	/ 





1- 0 . 04 
10 15 20 25 
Time (s) 
Figure 3. Formation and decay of the oxy-ferrous species of the wild-
type P450 BM3 heme domain at 15 °C under substrate-free (panel A) and 
substrate-saturating conditions (panel B). In both cases, the oxy-ferrous 
species is shown by the broken line, the solid lines correspond to ferric 
low-spin (panel A) and high-spin P450 (panel B). Panel C shows the 
exponential decay (k,,) of substrate-free (upper trace) and substrate-
saturated (lower trace) oxy-ferrous complexes, monitored at 470 am. Both 
are shown fitted to single-exponential decay functions. 
were found to be greater than 90% for all mutants except the 
F393A mutant (56%), which must uncouple after the second 
electron transfer event. In the absence of substrate, the rate of 
background turnover appears to be limited by the rate of heme 
reduction, however, subsequent electron transfer events are 
likely to be faster than autoxidation avoiding the generation of 
superoxide. For the F393A and F393H mutants substrate-free 
turnover is > 30-fold faster than autoxidation, indicating that 
this is the case. 
Crystal Structures. Data sets to a resolution of 2.0 A (2.05 
A for F393A) were used to refine the structures of the F393A, 
F393W, and F393Y heme domains to final R-factors of 16.87% 
(R = 23.73%), 15.93% (R,,, = 22.13 0/6), and 17.17% (Rfr 
= 23.70%) respectively (Table 2). For the F393A-heme domain, 
the final model consists of two protein molecules (molecule A 
comprising residues Lys3-Leu188 and Asn2Ol-Leu455; mol-
ecule B comprising Lys3-Leu188 and Tyr198-Leu455) each 
containing 1 heme and a total of 1408 water molecules. For 
the F393W-heme domain and F393Y-heme domain, each of 
the final models consists of two protein molecules (molecule 
A comprising residues Lys3-Leul88 and Asn201-Leu455; 
molecule B comprising Lys3-Argl9O and Pro196.-Leu455) each 
containing 1 heme and a total of 1420 and 1238 water molecules, 
respectively. For all molecules, the electron density for the first 
two N-terminal residues and all (or most of) the loop region 
containing residues Gin 189-Glu200 was uninterpretable, so these 
have been omitted from the model. The RMSD fit of all 
backbone atoms for each of the F393X-heme domain structures 
and the wild-type heme domain is 0.3 A indicating no major 
differences between the four structures. Due to the presence of 










Figure 4. Formation and decay of the oxy-ferrous species of the P450 
BM3 F393W-herne domain at 15 °C under substrate-free (panel A) and 
substrate-saturating conditions (panel B). In both cases, the oxy-ferrous 
species is shown by the broken line, the solid lines correspond to ferric 
low-spin (panel A) and high-spin P450 (panel B). Panel C shows the 
exponential decay (k) of substrate-free (upper trace) and substrate-
saturated (lower trace) oxy-ferrous complexes, monitored at 470 rim. Both 
are shown fitted to single-exponential decay functions. 
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Figure 5. Comparison of the visible absorption spectra of P450 BM3 with 
oxyhemoglobin. Panel A shows the characteristic visible absorption spectra 
of the ferric high-spin (Fern  (HS)), ferric low-spin (Fern  (LS)) and 
caibonmonoxy-ferrous (Fe°-CO (LS)) forms of the wild-type P450 BM3 
heme domain. Panel B shows the visible absorption spectrum of oxy-
hemoglobin (F&'-02). Panel C shows the visible absorption spectra of the 
oxy-ferrous complexes (Fe"-02) of F393A, wild-type, and F393W P450 
BM3 home domains. 
the RMSD values stated are the average over both molecules. 
In addition, the RMSD fit between both molecules (A and B) 
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Table 2 Data Collection and Refinement Statistics 
F393A F393W F393Y 
resolution (A) 20.0--2.05 20.0-2.0 17.0-2.0 
total no. of reflections 361447 498626 837703 
no. of unique reflections 66956 72 855 67 437 
completeness (%) 98.7 99.6 91.0 
(1)4u(I)] 8.6 13.2 10.0 
R,,' (%) 8.6 6.5 8.5 
R., 	in outer shell (%) 24.5 20.9 18.3 
(2.12-2.05 A) (2.12-2.0 A) (2.07-2.0 A) 
16.87 15.93 17.17 
23.73 22.13 23.70 
RMSD from ideal values: 
bond lengths (A) 0.013 0.012 0.013 
bond angles (deg) 2.8 2.4 2.6 
ramachandran analysis: 
most favored (%) 90.9 90.7 91.4 
additionally allowed (%) 8.6 8.8 8.1 
- I,(h)I/LJ,<h), where 11(h) and 1(h) are the jib 
and mean measurement of reflection h. respectively. JFO - F01/ 
Yh F0, where F. and F0 are the observed and calculated structure factor 
amplitudes of reflection h, respectively. Rr, is the test reflection data set, 
5°4 selected randomly for cross validation during crystallographic refine-
ment. 
is "'0.2 A for each of the mutant enzyme structures. Electron 
density for the heme binding region of each of the F393X-heme 
domain structures is shown in Figure 6. Apart from the expected 
structural difference associated with the change in the side chain 
caused by the substitution of phenylalanine 393, the heme 
binding region of all of these mutant forms remains relatively 
unperturbed by the particular substitution. The exception to this 
is the F393A mutant where a conformational change in the 
orientation of a nearby surface glutamine residue (G1n403) 
occurs. Comparison of the WT and the other mutant structures 
shows that the amide side chain of G1n403 points away from 
the heme, out toward the protein:solvent interface. However, 
in the case of the F393A-heme domain mutant structure, this 
glutamine has flipped 45° toward the heme, with the amide 
head occupying the void left by the substitution of the bulky 
phenyl side chain of F393 by alanine (Figure 7a). The amide 
group of Gln403 is the same distance (3.6 A) from the heme 
ligand as the histidine side chain is in the F393H mutant (3.7 
A). Both may form hydrogen-bonding interactions with Cys400. 
This would explain why the redox properties of the two mutant 
enzymes are so similar; they are the result of a common 
interaction. A hydrogen bond to the axially ligating cysteine 
would be expected to reduce its potency as a strong a and x 
donor, leading to the increase in heme reduction potential 
observed. The imidazole group of the F393H mutant may also 
mediate the reduction potential by electrostatically interacting 
-r 
' 	.i'•' 	ii; 
Trp393 
G1n403 
Figure 6. Stereoviews of the heme-binding region of P450 13M3 F393A (A). F393Y (B). and F393W (C). Electron density is shown in cyan. while the 
herne and peptide are shown in atom-type colors (red = 0; blue = N; yellow = S; orange = Fe). In each case, the substituted residue (X393) and the 
important glutarnine 403 (Gln403) are labeled The electron density map was calculated using Fourier coefficients (2F,, - F,,). where F. and F. are the 
observed and calculated structure factors, respectively. The contour level is 1.0o, where or is the RMS electron density. This diagram was generated using 
BOBSCRIPTst and RASTER 3D47. 
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Figure 7. Overlaid stereoviews of the hone-binding region of P450 BM3 heme domain. Panel A shows the overlay of the F393A (atom type colors) and 
F393H (magenta) structures. Panel B shows the overlay of wild-type (atom type colors) with the F393Y (red) and the F393W (green) mutant structures. This 
diagram was generated using BOBSCRIPT46 and RASTER 3D. 
with the heme, 23 whereas the F393A mutant is unable to do 
this. The F393W-heme domain mutant structure (Figure 7b) 
shows that the indole nitrogen of Trp393 is not in the correct 
orientation to hydrogen-bond with Cys400, but the increased 
size of the residue side chain results in a closer interaction 
between it and the heme macrocycle. The F393W mutant has a 
more negative reduction potential than the wild-type enzyme. 
This is probably due to changes in the dielectric environment 
of the heme and its axial ligand, which appear to be heavily 
shielded from the aqueous solvent in this mutant enzyme. 
Discussion 
Substitutions of Phe393 of P450 BM3 have been shown to 
modulate the reduction potential of the heme over a 200 mV 
range, while retaining the structural integrity of the enzyme's 
active site. The fact that the active site of the enzyme is 
structurally unaffected by the mutations enables a quantitative 
examination of the effect of modulating heme reduction potential 
on individual steps in the P450 catalytic cycle. Consequently, 
we are able to probe the kinetics and thermodynamics of heme 
reduction and oxygen activation in a structurally consistent 
environment. The electronic properties of the flavins in the 
reductase domain of the enzyme have been shown to be 
unperturbed, both kinetically and thermodynamically, by the 
presence of the heme domain."' It is unlikely, therefore, that 
the mutations would have a significant influence on these 
cofactors. 
P450 BM3 is a supremely efficient monooxygenase system, 
able to hydroxylate unactivated alkyl chains at rates of > 100 
s (at 25 °C) with >95% coupling between substrates. 23.30 
Coupling is aided by a mechanism, common in P450s, in which 
substrate binding induces a simultaneous spin-state shift (from 
(30) Narhi, L. 0.; Fulco. A. J. J. Biol. Chem. 196. 261, 7160-7169. 
low to high-spin Fern)  and a reduction potential increase to favor 
heme reduction. Consequently, the wild-type enzyme's turnover 
rate is 500-fold higher with substrate than without. The substrate-
free F393A and -H mutants have similar reduction potentials 
to the substrate-bound wild-type enzyme; therefore, by compar -
ing the heme reduction rates of the wild-type enzyme and the 
F393A or -H mutants (Table 1) and assuming that the mutations 
only affect the electronic properties of the heme, we are able to 
calculate the individual contributions of the spin-state shift and 
the reduction potential shift to the overall acceleration effect. 
These factors have been the subject of intense scrutiny, ' 6'31 but 
to date, the importance of the relative contribution of each effect 
remains experimentally unverified. Despite its similar reduction 
potential, the substrate-free F393A mutant has a 200-fold slower 
turnover rate than the substrate-bound wild-type enzyme. 
Conversely, the substrate-bound F393W mutant, which has a 
70 mV lower reduction potential, is only 50% slower. It is clear, 
therefore, that the spin-state shift is the dominant activation 
mechanism and is 100-fold more important than the reduction 
potential shift. The rate constants for heme reduction add further 
insight; these are low for all the substrate-free enzymes, which 
have low-spin heme and increase by at least 70-fold on substrate 
binding. For the substrate-bound enzymes, the rate constants 
for heme reduction increase linearly with reduction potential 
(Figure 8) but only by a factor of 8 over 200 mV. Clearly this 
is not enough to cause a 500-fold increase in k 1 on substrate 
binding. The results are consistent with nonadiabatic electron 
transfer theory, 32  which predicts a Gaussian dependence of 
electron-transfer rate on driving force (AG). The linear relation-
ship obtained is almost certainly an artifact of the limited 
reduction potential range studied; the plot would be expected 
(3 1) Honeychurch, M. J.; Hill, A. 0.; Wong, L.-L. FEBS Len. 1999.451,351-
353. 
(32) Marcus. R A.; Sutin. N. Biochem. Biophys. Ada 1955. 811, 265-322. 
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Figure 8. Dependence of kinetic parameters on reduction potential. Panel 
A shows the plot of kc., versus reduction potential (•); panel B shows the 
plot of k,,j (left axis, C), fitted to a straight line) and km, (right axis, 0, 
fitted to an exponential decay) versus reduction potential. The arrow denotes 
the position of wild-type P450 BM3. 
to adopt Gaussian characteristics out with this range. Certainly, 
it is difficult to believe that k t would drop to zero at —375 mV 
as suggested by the ordinate intercept. Nevertheless, the clear 
trend observed with reduction potential does suggest that the 
electron-transfer rate is not being heavily perturbed by structural 
changes at the heme—flavin interface, which would be likely 
to introduce random scatter. The mutated residue does lie within 
the proposed area of interdomain contact 5° and may be involved 
in a pathway for electron transfer, but the structural changes 
induced by the mutations appear to have little effect on the rate 
of electron transfer, i.e., there is only an 8-fold variation across 
the series, which correlates with the shifts in the home reduction 
potential. 
Electron transfer in the substrate free enzyme is complicated 
by the fact that the home is low-spin, six-coordinate ferric prior 
to reduction but becomes high-spin ferrous afterwards. The 
driving force for electron transfer in this case depends on the 
reduction potential of the heme in a fixed low-spin six-
coordinate environment, which is likely to be very negative. 
Electron transfer may also be initiated by spontaneous spin-
state equilibration. In this case, the proportion of home in the 
high-spin state (populated thermally) detemiines the rate of 
electron transfer. Both mechanisms appear to be extremely 
inefficient for all the enzymes studied, until a large-scale spin-
state shift is induced by substrate binding. 
Various steps in the P450 catalytic cycle have been postulated 
to be rate determining. These include the following: transfer 
of the first electron to the heme (this is certainly the step 
activated by substrate binding); transfer of the second electron; 
oxygen activation (possibly involving protonation of a peroxo-
ferric species); and product release. 1-4 It is also likely that the 
rate-determining step will vary between different P450 enzymes, 
given the variety of redox partners and substrates utilized by 
these systems. Nevertheless, all P450s share the same mecha-
nism of oxygen activation. All the intermediate heme-oxy 
complexes on the catalytic pathway are unstable, making their 
characterization difficult. Great progress has recently been made 
in this area by Sligar, Petsko, and co-workers, 14  who have used 
time-dependent X-ray crystallography to obtain structures and 
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spectra of the oxy-ferrous and oxyferryl complexes of P450cam 
under cryogenic conditions. 
Generation of the oxy-fermus P450 complex 33 is the initial 
oxygen activation step, but this species is not directly involved 
in substrate hydroxylation. 34  In the absence of additional 
reducing equivalents, it decays spontaneously to ferric P450 and 
superoxide (autoxidation). While this is an unproductive reaction 
so far as catalysis is concerned, the rate of autoxidation is a 
quantitative measure of the stability of the oxy-ferrous species. 
As shown in Figure 8, the rate of decay increases exponentially 
as the reduction potential of the home decreases for the mutants 
studied, which suggests a direct relationship between the heme 
reduction potential and the activation energy for dissociation 
of superoxide. This is clearly reasonable for a simple bond 
scission event. Scheme 1 illustrates the relationship between 
the home reduction potential and the rate of autoxidation. The 
reduction potential of the dioxygen/superoxide couple is constant 
at approximately —160 mV; therefore, changes in the reduction 
potential of the herne will be manifested solely in changes to 
the equilibrium dissociation constants for dioxygen (K) and 
superoxide (K,) from oxy-ferrous heme. The rate constants 
for association are second order and diffusion controlled and 
are therefore unlikely to show much dependence on reduction 
potential. The dissociation rate constant for dioxygen (k_ 05), 
on the other hand, is likely to be affected by changes in the 
Fell—dioxygen bond energy 
The oxy-ferrous complex is shown in Scheme 1 along with 
its alternative resonance form, the superoxy-ferric complex; 
however, the true nature of the complex lies somewhere between 
these two extremes. The oxy-ferrous/superoxy-ferric content of 
this complex is determined by the relative positions of the Fe 
3d-orbital energy levels and the oxygen orbital after bonding. 
This will also determine the strength of bonding and, therefore, 
the rate of autoxidation. A simplified MO diagram is shown in 
Figure 9•19  According to this model, the oxy-fermus/superoxy-
femc character of the complex is determined by the energy gap 
(A) between the iron d, 5 (d, d,) and the 	molecular orbitals. 
If A is large, the low-spin complex with oxy-ferrous character 
will be favored. Decreasing A results in the population of the 
jro, orbital and superoxy-ferric character. In our series of 
mutants, A will be dependent on the energy of the Fe 
orbitals prior to oxygen binding, which will determine both their 
position relative to the 	orbital and the magnitude of their 
bonding interaction with it. The energy of the Fe 	orbitals 
relates directly to the reduction potential of the heme and is 
likely to be dependent on the sr-donor strength of the thiolate 
axial ligand. Additional H-bonding interactions (i.e., in the 
F393A and F393H mutants) are likely to weaken the rr-donor 
ability of the thiolate and increase the reduction potential of 
the home. Electrostatic interactions between the imidizoliuni ion 
that may have been formed in the F393H mutant and the home 
would also lower the energy of the Fe 3d-orbitals and increase 
the reduction potential of the home. The sr-bonding interaction 
between the d and Jr*o, orbitals will shift electron density from 
the iron to the oxygen and will cause the two orbitals to move 
further apart in energy. However, if the .7r-bonding interaction 
is weak, then an increase in the energy of the d orbitals caused 
Peterson, J. A.; Ishimuca, Y.; Griffen, B. W. Arch. Biochem Biophys. 1972, 
149, 197-208. 
Lipscomb, J. D.; Sligar, S. 0.; Naintvedl, M. J.; Gunsalus, I. C. J. Biol. 
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Figure 9. Qualitative molecular orbital diagram for P450 oxy-ferrous complexes (adapted from ref 19). This scheme illustrates how possible changes in the 
2r-donor character of the axial ligand could cause changes in A. The two situations shown are where A > pairing energy (Fe n-02) and where A <pairing 
energy (Fe —O,1. 
by a mutation (e.g., F393W) will take the nonbonding d,a  orbital 
closer in energy to the orbital giving the electrons a greater 
tendency to unpair. 
Some insight into the nature of the oxy-ferrous complex can 
be gained from the long-wavelength visible spectra shown in 
Figure 5. Panel A shows the spectra of high-spin ferric, low-
spin ferric, and carbonmonoxy-ferrous forms of wild-type P450 
BM3. Compared with these are the spectra of oxyhemoglobin 
(panel B) and the oxy-ferrous complexes of the F393A, WT, 
and F393W mutants of P450 BM3 (panel Q. The bond 
vibrational energy of bound dioxygen in oxyhemoglobin 
determined using FTIR spectroscopy (vo—O = 1107 cm) 
indicates that the oxy-ferrous form of oxyhemoglobin has much 
of its electron density delocalized across the dioxygen bond. 15-16 
Panel C compares the spectra of the oxy-fenous complexes of 
the P450 BM3 enzymes. The spectrum of the F393A mutant 
closely resembles the carbonmonoxy-ferrous form of the 
enzyme, with fused a and fi bands. That of the F393W mutant 
resembles the ferric low-spin spectrum and that of oxyhemo-
globin, whereas the spectrum of the wild-type oxy-ferrous 
complex is intermediate. This trend is likely to be caused by 
changes in the energies of the Fe 3d orbitals in the oxy-ferrous 
complex and may reflect a shift in the balance of oxy-ferrous/ 
superoxy-ferric character or a shift of electron density toward 
the oxygen, as a result of changes in the sr-bonding properties 
of the heme axial ligand. It is impossible to determine the 
electronic configuration of the complex from the visible 
absorption spectra alone. However, the changes observed do 
Mosnenteau, M.; Reed, C. A. Chem. Rev. 1994, 94,659-698. 
Wittenberg, J. B.; Wittenberg, B. A.; Peisach, J.; Blumberg, W. E. Pc. 
Nail. Aced. Sd. U.S.A. 1970, 67. 1846-1853. 
show that the oxyferrous complexes of the mutants are different 
and have altered electronic properties. 
In our series of mutants the active-site structure is retained, 
making it unlikely that interactions between bound dioxygen 
and active site residues could have been altered. Other oxygen-
binding hemoproteins utilize active-site residues to stabilize 
bound dioxygen. Both the globins and peroxidases form 
stabilized oxy-ferrous heme complexes in which histidine 
residues (and also an Arg for pemxidase) interact with the bound 
dioxygen.17" The active sites of P450s are often hydrophobic, 
with proton delivery occurring via an active-site Thr residue 
(Thr268 in P450 BM3) working in tandem with an Asp. 39 This 
environment is likely to disfavor occupation of the oxygen r 
orbitals, either through a spin-state change or via bonding 
interactions. The overall result is an activated P450 oxy-ferrous 
complex in which its stability with respect to superoxide 
dissociation (which is decreased by a lower heme reduction 
potential) is balanced against its rate of reduction. Measuring 
the rate of electron transfer to the oxyferrous complex directly 
is beyond the scope of this study, but either this step or a 
protonation event leading to oxygen activation is a likely rate-
determining step for the F393A and -H mutants. There is a 
complex relationship between k., and the heme reduction 
potential in the P450 BM3 mutants gable 1). At low potentials, 
electron transfer to the home is clearly rate determining, whereas, 
at high potentials, a subsequent catalytic step becomes important 
(Figure 8). The increased stability of the oxyfermus complexes 
observed is an indication that the second electron transfer event 
Phillips, S. E.; Schoenborn, B. P. Nature 1951, 292, 81-82. 
Miller, M. A.; Shaw, A.; Kraut, J. Na,. Siruc!. Rio!. 1994, 1, 524-531. 
Yeom. H,; Sugar, S. G.; Li, H.; Poulos, T. L.; Fulco, A. J. Biochemistry 
1995, 34, 14733-14740. 
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may have been slowed. There are two mechanisms by which a 
second electron can be accepted by the heme system: (1) An 
electron can be transferred directly into the dioxygen ,r*  orbital. 
This orbital is, however, further from the electron donor (FMN) 
and is high in energy. (2) If the dioxygen 2r*  orbital is already 
populated to some extent, the electron can transfer into the Fe 
d, orbital, which will now be half-filled. This would be more 
favorable. Thus, the electronic nature of the oxyferrous complex 
holds the key to the subsequent steps of catalysis and warrants 
further investigation. 
Recent studies on P450cam 39 '1 and nitric oxide synthase4 ' 
(NOS) have shown that removal of hydrogen bonds to the 
thiolate heme ligand decreases the reduction potential of the 
iron. Introducing such hydrogen bonds clearly has the opposite 
effect, as demonstrated in this study 23 and that of Ueyama et 
al.42 It is likely that the presence/absence of a hydrogen bond 
affects the iron reduction potential by modulating the ir- and 
a-donor characteristics of the thiolate ligand. It is also interesting 
to compare the oxy-ferrous complexes of P450cam and P450 
BM3. The visible spectrum of the former has fused a and 
bands, and the complex is relatively stable = 0.001 s). 
These properties are remarkably like those of the F393A and 
F393H mutants of P450 BM3 and may indicate that their 3d 
orbitals are of similar energy. It is also worth noting that the 
camphor-bound reduction potential of P450cam is also similar 
to those of the mutants (-175 mV). In P450cam, electron 
transfer is rate limiting, primarily due to the requirement for 
formation of the productive P450/putidaredoxin complex. 43"' 
Yoshioka, S.; Takahashi, S.; Ishiniori, K.; Monshisna, 1. J. inorg. Biochern. 
2000, 81, 141-151. 
Adak, S.; Crooks, C.; Wang, Q.; Crane, B. R.; Tamer, J. A.; Getzoff, E. 
0.; Stoehr, D. J. J. BioL Chem. 1999, 274, 26907-26911. 
Ueyaina, N.; Nishikawa, N.; Yamada, Y.; Okarnurn, T.; Oka, S.; Sakurai, 
H.; Nakamura, A. lnorg. Chern. 1998, 37, 2415-2421. 
Hui Bon Hoa, G.; Begard, E.; Debye, P.; Gunsalus, 1. C. Biochemistry 
1978, 17, 2835-2839. 
Hintz, M. J.; Mock, D. M.; Peterson, L. L.; Tuttle, K.; Peterson, J. A. J. 
Biol. Chem. 1982, 257, 14324-14332. 
For P450cam, a stable oxy-ferrous complex may be required 
to compensate for any delay in the delivery of the second 
electron from putidaredoxin. For P450 BM3, the integral 
reductase domain ensures the rapid delivery of two successive 
electron equivalents49 and the stability of the oxy-ferrous 
complex is poised to maximize the rates of both. 
In summary, we have shown that decreases in the heme 
reduction potential lead to home reduction being rate limiting, 
whereas increases in the heme reduction potential lead to 
increases in the stability of the oxy-ferrous complex. The latter 
may result in the second FMN to home electron transfer being 
rate limiting. The 3d orbital energies of the home-iron in wild-
type P450 BM3 are optimized such that both the first electron 
transfer and the subsequent oxygen activation steps occur at 
similar rates, maximizing the overall rate of catalytic turnover. 
We have also shown that the first electron transfer is gated 
almost entirely by the substrate-induced spin-state shift and that 
the contribution of the simultaneous reduction potential shift is 
negligible by comparison. 
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The nitrogenous u-acceptor ligand 4-cyanopyridine 
(4CNPy) exhibits reversible ligation to ferrous heme in 
the flavocytochrome P450 BM3 (Kd = 1.8 bias for wild type 
P450 BMW via its pyridine ring nitrogen. The reduced 
P450-4CNPy adduct displays unusual spectral properties 
that provide a useful spectroscopic handle to probe par-
ticular aspects of this P450. 4CNPy is competitively dis-
placed upon substrate binding, allowing a convenient 
route to the determination of substrate dissociation con-
stants for ferrous P450 highlighting an increase in P450 
substrate affinity on henie reduction. For wild type P450 
BM3, Kd(red)(laurate) = 82.4 gesa (cf. Kd(ox) = 364 i). In 
addition,, an unusual spectral feature in the red region of 
the absorption spectrum of the reduced P450-4CNPy ad-
duct is observed that can be assigned as a metal-to-ligand 
charge transfer (MLCT). It was discovered that the energy 
of this MLCT varies linearly with respect to the P450 
heme reduction potential. By studying the energy of this 
MLCT for a series of BM3 active site mutants with differ-
ing reduction potential (Eec) the relationship E. = 
(3.53 x E,,.) + 17,005 cm was derived. The use of this 
ligand thus provides a quick and accurate method for 
predicting the heme reduction potentials of a series of 
P450 BM3 mutations using visible spectroscopy, without 
the requirement for redox potentiometry. 
Cytochromes P450 are monooxygenases found within every 
domain of life from Archaea to mammals. They catalyze the 
activation and insertion of an atom of oxygen (derived from 
molecular oxygen) into a wide array of organic substrates (1, 2) 
from small molecules such as nitric oxide (P450nor) to larger 
molecules such as cholesterol (P450scc). They are often essen-
tial for many important metabolic, catabolic, and biosynthetic 
processes in vivo (3), and as a result have been the subject of a 
great deal of research. 
The name P450 derives from the characteristic Soret absorp-
tion spectrum of the ferrous-CO adduct that occurs at 450 am 
(4, 5), hence "Pigment-450." Since this initial observation, UV-
visible spectroscopy has become the primary and most inten-
sively exploited spectroscopic technique for the study of such 
hemoproteins. Spectral shifts associated with changes in redox 
state (6, 7) and the binding of substrates and other exogenous 
ligands (8-10) can provide an enormous wealth of mechanistic 
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Centre. The costs of publication of this article were defrayed in part by 
the payment of page charges. This article must therefore be hereby 
marked "advertisement" in accordance with 18 U.S.C. Section 1734 
solely to indicate this fact. 
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4760; Fax: 44-131-650-6453; E-mail: s.k.chapman0ed.ac.uk .  
data, which provides a useful basis for further study using 
other specialized and complementary techniques such as EPR, 
resonance Raman, and magnetic circular dichroism. 
Studies have suggested that the affinity of a P450 enzyme for 
substrate is dramatically increased on reduction (11, 12). Ac-
cording to the Gibbs free energy relation, the shift in reduction 
potential upon substrate binding (Em ) is related to the sub-
strate dissociation constants (Kd) of the two redox states of the 
enzyme, i.e. —RTln(Kd(ox)/Kd(red)) = — nFi.E,,,. This implies 
that the positive shift in the heme reduction potential often 
associated with substrate binding is directly linked, through 
concomitant changes in the Gibbs free energy, with tighter 
substrate binding to the ferrous forms of these enzymes. A 
simple schematic showing the relative changes in the free 
energies (AG) on substrate binding and reduction is shown in 
Fig. 1. 
Such an increase in affinity may be important for the reac-
tion in terms of efficient coupling by positioning the substrate 
in preparation for subsequent steps of the catalytic cycle (11, 
12). However, substrate dissociation constants are difficult to 
quantify for the ferrous form of cytochromes P450. The method 
by which dissociation constants are determined for the ferric 
state relies on the spectral shifts associated with the low spin 
(419 nm) to high spin (390 run) conversion of the heme iron 
induced upon addition of substrate. Binding of substrate to 
P450s displaces a weakly ligated water ligand that occupies the 
sixth coordination site of the heme iron, hence the iron geom-
etry changes from octahedral (low spin, S = 112) to square-
based pyramidal (high spin, S = 5/2) (8, 11). Unfortunately, 
determination of the substrate dissociation constant for the 
reduced form, Kd(red), cannot be measured in an analogous 
fashion to the oxidized form, as the substrate-free and sub-
strate-bound ferrous complexes are both high spin and hence 
exhibit indistinguishable absorption spectra (A m,, = 410 nm) 
(13, 15). There are several techniques available that allow us to 
calculate ferrous P450 dissociation constants such as isother-
mal titration calorimetry and potentiometry (using —RTIn(K-
d(ox)/Kd(red)) = —n.Fi.Em ). However, these techniques offer 
their own problems, and neither is as straight forward as a 
simple substrate titration. 
Catalytic regulation of cytochromes P450 is critical in order 
to prevent the uncoupled oxidation of NADPH. One way in 
which this regulation is achieved is through substrate binding, 
an event that controls electron transfer by a combination of 
kinetic and thermodynamic processes associated with the heme 
iron. In P450 BM3, the binding of substrate kinetically controls 
electron transfer by decreasing the reorganization energy of 
reduction, while simultaneously shifting the midpoint poten-
tial of the heme to more positive, thus exerting thermodynamic 
control (14). Knowledge of P450 heme reduction potentials is 
- 
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FIG. 1. A schematic showing the dissection of the total Gibbs' 
free energy for substrate binding and reduction of a P450 into 
its components. The energy levels denoted by solid lines are as fol-
lows: E, oxidized P450; E,,,, reduced P450; S. substrate; 1EO,S1, oxi-
dized P450-substrate complex IE,,,S1, reduced P450-substrate com-
plex. The difference between the energy levels, denoted by arrows, 
corresponds to the free energies for reduction of the substrate-free 
(AG,(SF)) and substrate-bound (G,(SB)) P450, as well as the free 
energies of substrate binding to oxidized (AG, Ub(ox)) and reduced 
(tG.jred)) P450, respectively. G,(SF) and AG,(SB) correspond to 
the heme reduction potentials in the absence and presence of substrate 
via the equation AG = –nFE,,,. AG.b(ox) and G..h(red) are directly 
related to the ferric substrate dissociation constant via the equation 
AG = –RTInK. Values of G,.,(SF), iG(SB), and iG Ub(OX) are 
directly obtainable from the corresponding lCd or E. values. AG,(red) 
are only obtainable from the other free energy values assuming fl.FEm  = 
RTInK. 
central to understanding the P450 mechanism and yet is ex- 
perimentally complicated to determine for several reasons. The 
inherent reactivity of P450 heme with molecular oxygen means 
that potentiometry has to be performed in strictly anaerobic 
conditions, often requiring the use of sophisticated cells or 
glove boxes (6, 7, 23). The technique also requires soluble 
protein of high concentration and the use of mediators to 
achieve efficient electrical communication with the electrode, 
also equilibration periods are often long and solutions require 
continual stirring. All these factors lead to difficulties in easily 
calculating heme reduction potentials. A simple spectroscopic 
method for approximately estimating the midpoint potential 
for a series of hemoproteins, such as the P450 BM3 wild type 
and mutant enzymes reported in this paper, would be of con- 
siderable interest. 
This paper reports the development of two assays, involving 
the use of a heme ligand, 4-cyanopyridine, which provides a 
route to the quick and easy determination of substrate disso-
ciation constants for reduced P450 BM3, and presents a means 
of estimating herne reduction potentials across a series of 
closely related BM3 mutants without the requirement for 
redox potentiometry. 
EXPERIMENTAL PROCEDURES 
Protein Preparation—Heme domain proteins of P450 BM3 (wild type, 
F393H, F393W, F393A, and F393Y) were overexpressed and purified 
from Escherichia coIl strain TG1 as described previously (9, 14). All 
P450 BM3 enzymes were extracted and purified according to the estab-
lished protocol (16). Purified samples were flash-frozen in liquid nitro-
gen prior to storage at –80 'C and were used within 6 months of 
manufacture. 
Purification of 4-Cyanopyridine--Crude 4-cyanopyridine (4CNPy)' 
was purchased from Sigma (– 80% purity) and was purified by vacuum 
sublimation onto a cold finger. Purified 4CNPy was stored in a dessi-
cater at room temperature and used within 1 month of sublimation. The 
use of crude 4CNPy must be avoided because it contains a significant 
amount of free cyanide, which ligates tightly and preferentially to P450 
'The abbreviations used are: 4CNPy, 4-cyanopyridine; MLCT, metal-
to-ligand charge transfer absorption OTTLE, optically transparent 
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FIG. 2. Absorption spectra showing the ligation of 4-cyanopy-
ridine to wild type P450 BM3. Only subtle differences in the spec-
trum of the ferric-4CNPy adduct (dotted line) with respect to the abso-
lute ferric spectrum (heavy solid line) are observed, whereas the 
spectrum of the ferrous-4CNPy adduct (light solid line) is significantly 
different to that of the ferrous P450 (dot-dashed line). Inset is a X4 
magnification of the z/$ region. 
TABLE I 
4-Cyanopyridine binding constants to wild type and 
point mutations of cytochrome P450 BM3 
Dissociation constants for 4CNPy with the ferric (Fe") and ferrous 
(Fe") P450s were determined (25 'C in 20 mm MOPS, 100 mat KCI, pH 
7.4) as outlined under 'Experimental Procedures." 
K,(4CNPy) 
Fe" 	 Fe" 
PM 
P450 BM3 WT 	 1130 ± 45 	1.80 ± 0.7 
P450 BM3 F393H 1257 ± 100 2.15 ± 0.5 
P450 BM3 F393W 	 1460 ± 200 	3.80 ± 0.8 
in both oxidation states. Vacuum sublimation generates sufficiently 
pure 4CNPy (spectrum of ferrous P450-4CNPy has no trace of ferrous 
P450-CN) for the purpose of these experiments. The aqueous 4CNPy 
stocks were prepared by using assay buffer (20 mm MOPS, 100 mm KC1, 
pH 7.4). Fresh stocks (I4CNPyI = 180 mm) were used for each 
experiment. 
Ligand Binding Titrations—The dissociation constants for 4CNPy 
with wild-type P450 BM3 and the mutant enzymes F393H and F393W 
were determined by titrating small aliquots of aqueous 4CNPy (180 mm 
stock) into samples of either oxidized or reduced protein (-5 ) (25 'C 
in 20 mm MOPS, 100 mm KCI, pH 7.4). The resultant visible absorption 
spectra were recorded after each addition. Difference spectra were 
generated by subtraction of the absolute oxidized (or reduced) protein 
spectrum from each 4CNPy-bound spectrum. Dissociation constants 
were calculated by plotting the maximum absorbance change in the 
difference spectra versus [4CNPyJ and evaluated by fitting the data to 
a rectangular hyperbola (Microcal Origin). Titrations involving oxi-
dized enzymes were performed on a Shimadzu 1601 spectrophotom-
eter on the bench. All 4CNPy titrations of reduced P450s were per-
formed in an anaerobic environment (Belle Technology Glove box) 
with the oxygen concentration maintained at <5 ppm, using a Varian 
Cary 50 UV-visible spectrophotometer. Enzyme samples were re-
duced in the anaerobic box by the addition of a few grains of solid 
sodium dithionite immediately prior to the titration. Excess dithion-iwas removed by elution through a pro-equilibrated G-25 gel fil-
tration column. 
Fatty Acid Binding Titration—Dissociation constants for fatty acid 
(laurate and arachidonate) binding to ferric wild-type P450 8M3 and 
the mutant enzymes F393H and F393W have been determined and 
reported in previous publications (9, 14) (25 'C in 20 mm MOPS, 100 mat 
KC1, pH 7.4). However, to ensure that K(red) and S.E,,, values deter-
mined via the 4CNPY and OTTLE methods were directly comparable, 
the dissociation constants for laurate with P450 BM3 in high salt 
(YVFLE potentiometry buffer (100 mm Tris, 500 mm KCI, pH 7.50) were 
calculated. Substrate dissociation constants were determined essen-
. 11y as described for 4CNPy. Small aliquots (25-100 p.!) of the P450 
BM3 enzyme solution were removed from the reaction mixture (-6 p.M 
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Position and energy of the ferrous P450-4CNPy MLCT 
The position of the MLCT was determined ± 1 nm and was converted into cm -1  to give the energy of the charge transfer absorption. E. 
values 
denote the substrate-free heme reduction potentials of the P450s studied and are taken from previous work as referenced. E,,, + laurate denotes 
the laurate-saturated heme reduction potentials as determined by O'l'T'LE potentiometric titration (25 °C in 100 mm Tris, 500 mm KCI, pH 7.5). 
Parameter 
EMU 	 E,,, (mV vs. SHE) 	 E. (mV vs. SHE) + laurate 
	
nm 	 cm' 
P450 BM3 WT 	 647 15,456 	 -427 ± 4° 	
-338 ± 10 
P450 BM3 F393H 632 	 15,823 -332 ± 6° 
-248 ± 12 
P450 BM3 F393W 	 652 15,337 	 -480 ± 76 
	 -389 ± 8 
P450 BM3 F393Y 644 	 15,528 -420 ± 6° 
P450 BM3 F393A 	 628 15,924 	 -312 ± 41 
° Values are from Ref. 9. 
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enzyme in OPTLEIassay buffer) and replaced with corresponding ali-
quots from an identical solution containing 1 mm laurate. The resulting 
changes in the absorption spectra associated with the substrate-in-
duced spin state shift were recorded after each addition using a Shi-
madzu 1601 spectrophotometer. Dissociation constants were calculated 
by plotting the maximum absorbance changes in the difference spectra 
against substrate concentration and fitting to a rectangular hyperbola 
(Microcal Origin). 
Competitive Ligand Binding Studies—To evaluate the dissociation 
constant for ferric BM3 with substrate, 4CNPy titrations were carried 
out in the presence of varying concentrations of laurate (25°C in 20 mm 
MOPS, 100 mm KCI, pH 7.4; wt Kd(ox) = 364 jLM; [lauratel used was 
-20, 40, 60, 80, 120, and 160 rs). The apparent dissociation constants 
(R) were evaluated and plotted against the corresponding laurate 
concentrations. The inhibitor constant (Ka(red)) was evaluated as the 
intercept/gradient. Titration of 4CNPy into substrate-bound, ferrous 
P450 competitively displaces the substrate as it ligates the heme. The 
substrate laurate was chosen for these studies as its Kd value for the 
oxidized protein (-400 j.M) was found to be sufficient to be displaced 
by a modest concentration of 4CNPy. Substrates that exhibited sig-
nificantly lower K,, values for the oxidized enzyme (arachidonate, 
K,,(ox) = 3.6 jxm (9)) bound too tightly in comparison to 4CNPy and did 
not display double-reciprocal plots indicative of competitive 
inhibition. 
O?'I°LE Potentiomeiry—According to the equations, AG = -n.FE and 
AG = -RTInK, a correlation exists between the change in binding 
constant on reduction and the change in potential on substrate bind-
ing (-nFtE = -R71n(K,(ox)/K,,(red)). If the dissociation constant of 
the oxidized form of the enzyme and the substrate-induced potential 
shift are both known, then this relationship allows the evaluation of 
the dissociation constant for the reduced form. Consequently, the 
evaluation of the substrate-induced potential shift provides us with a 
useful tool to measure the suitability of the 4CNPy technique in  
calculating K,,(red) values. Herne reduction potentials for wild type 
BM3 and the mutant enzymes F393H and F393W in the absence of 
substrate have been determined and reported previously (9, 14). To 
provide a comparison to the 4CWPy competitive binding experiments, 
OTFLE potentiometry was used to resolve the heme reduction poten-
tials of the laurate-saturated (-1 mm) form of the enzymes. A spe-
cially constructed cell comprised of a modified quartz EPR cell with a 
path length of 0.3 mm, Pt/Rh (95/5) gauze working electrode (wire 
diameter 0.06 mm, mesh size 1024 cm 1 , Engelhardt, UK), platinum 
wire counter electrode, and a Ag/AgCl reference electrode (model 
MF2052, Bioanalytical Systems, IN 47906) was used. Enzyme sam-
ples (1 ml -100 M) were dialyzed into 100 mm Tris, 500 mm KCI, pH 
7.50, saturated with laurate (1 mm), and allowed to equilibrate in an 
anaerobic glove box overnight. The following range of mediators was 
added to ensure efficient reduction and reoxidation: 2-hydroxy-1,4-
naphthaquinone, FMN, benzyl viologen, and methyl viologen. OVFLE 
potentiometric titrations were carried out according to a protocol 
reported previously (14). Maximum absorbance changes associated 
with a change in the redox state were plotted against applied poten-
tial (versus standard hydrogen electrode), and E,,, values were deter-
mined by fitting the data to the Nernst equation (Microcal Origin). All 
potentials were corrected relative to standard hydrogen electrode by 
+ 195 mV to account for the Ag/AgCI electrode. 
Energy ofMLCT—The energies of the metal to ligand charge transfer 
band were determined for wild type P450 BM3 and the mutant enzymes 
F393H, F393W, F393Y, and F393A. Enzyme samples were pre-reduced 
with sodium dithionite prior to the addition of saturating concentra-
tions of 4CNPy. Absorption spectra were recorded before and after 
addition of the [igand. The appearance of a peak at 630-650 tim in the 
4CNPy-saturated spectra was ascribed as a MLCT band. The energy of 
the MLC'F was calculated from the wavelength of the resulting peak 
using the equation EmLcT = 1/A. 
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FIG. 4. The linear variation of R(4CNPy) with increasing 
substrate concentrations for wild type P450 BM3 with laurate 
(A) (A), F393H P450 BM3 with laurate (0) (B), and F393W P450 
BM3 with laurate (•) (C). 
RESULTS 
4-Cyanopyridine—Visible spectra of the P450,,,4CNPy com-
plexes are essentially the same as their respective ligand-free, 
ferric forms (Fig. 2). Conversely, the reduced complex exhibits 
a significant change in the Soret absorption from 419 nm 
(P4504CNPy) —* 440 am (P450-4CNPy). Similar shifts 
were observed for P450 BM3 to those observed for pyridine 
binding to P450cam (21), indicating the same binding mode for 
4CNPy via the pyridine nitrogen. Two noteworthy observations 
obtained from the ligand titrations, not seen when pyridine was 
used as the ligand, are as follows: first, the formation of a new 
absorption band (Fig. 2) assigned as the metal-to-ligand charge 
transfer (MLCT) Fe(U) —* a'4CNPy (4CNPy is a good ir-acid 
with low lying 1ri  anti-bonding orbitals (17, 24) in the red 
region of the spectrum (A = 620-670 nm)); and second, an 
increase in the affinity of 4CNPy for ferrous P450 (Table I) in 
comparison to the ferric form. The affinity of 4CNPy for re-
duced heme is -2-3 orders of magnitude greater than for 
oxidized heme, and this has implications for the competitive 
binding studies which will be discussed in detail later. 
Laurate Binding—The dissociation constants calculated for 
laurate with P450 BM3 in high salt O'ITLE buffer were found 
to be in good correlation with the dissociation constants ob-
tained in the standard assay buffer used for 4CNPy competitive 
binding studies. The dissociation constants quoted in Table II 
correspond to the values determined in high salt (100 mMTris, 
500 mMKC1, pH 7.5) buffer. As the Kd(ox)  values do not signif-
icantly change in the presence of higher concentrations of salt, 
a direct comparison can be made between the dissociation 
constants and substrate-induced potential shift calculated 
through the 4CNPy assay and the 071'LE technique (i.e. a 
comparison of K,(red) and estimated iE,,, (4CNPy assay) with 
the calculated E,,, and estimated Ka(red) (OTrLE)). 
.500 	-400 	-300 	-200 	-100 
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FiG. 5. OTI'LE potentiometry for laurate-saturated cyto-
chrome P450 BM3 wild type, F393H, and P393W. A shows the fully 
oxidized and fully reduced spectra of wild type P450 BM3. Note the mix 
spin nature of the oxidized, substrate-bound species exhibiting a peak 
at 420 nm (low spin) and shoulder at 390 nm (high spin). Also note the 
relatively large change in absorbance around 450-460 nm. B shows the 
normalized £4 at 455 nm values plotted against the applied potential 
and the 1 electron Nernst function fit used to evaluate the mid-point 
reduction potential for each of the enzymes studied (wild type (•), 
F393H (A), and F393W (U)). 
Competitive Binding between 4CNPy and Laurate—The fer-
rous form of P450 BM3 and its active site mutants displayed 
competitive ligation between 4CNPy and laurate, allowing the 
Kd  value for laurate with the ferrous form of the enzyme 
(Kd(red)) to be measured. In all cases, the apparent dissociation 
constant for 4CNPy (Kr) increased with increasing substrate 
concentration. In this respect, substrate can be considered as 
acting as an inhibitor of 4CNPy ligation (in this context, sub- - 
strate will be referred to as the "competitor" of 4CNPy binding). 
K 1''was evaluated by plotting the maximum absorbance 
change induced upon 4CNPy ligation to the ferrous heme ver-
sus [4CNPyJ at each inhibitor concentration. The double-recip-
rocal plots (1iAA.,,, versus 1J[4CNPyI at each [competitor]) for 
P450 BM3 (laurate) are shown in Fig. 3. The convergence of the 
double-reciprocal plots on they axis confirms the nature of the 
inhibition to be competitive. By plotting Ky" versus substrate 
concentration, a linear relationship was observed (Fig. 4), from 
which the Kd  value for laurate with reduced P450 (Ka(red)) was 
determined from the slope and intercept of the plot for each of 
the enzymes studied. For wild type P450 BM3, Kd(red) (lau-
rate) = 82.4 p.s; F393H, Kd(red) (laurate) = 58.1 jig; and 
F393W, Kd(red) (laurate) = 105 ILM. These values of Kd(red)  are 
significantly lower than the dissociation constants for these 
substrates with oxidized enzyme (Ka(ox)) as determined. For 
wild type P450 BM3, Kd(ox)  (laurate) = 364Am; F393H, Kd(ox) 
(laurate) = 578 jLrs; and F393W, Kd(ox) (laurate) = 525 ILM, 
data not shown. 
48880 	 4-cyanopyridine and Cytochrom-e P450 BM3 
0I7LE Potentiometric Titrations—To verify the applicabil-
ity of the 4CNPy technique in calculating Kd(red) and hence 
m' 0711E potentiometry was used to determine the S.E,,, for 
BM3 thus providing another route to the evaluation of Kd(red). 
Since AE_ is the difference in the substrate-free and substrate-
bound heme reduction potentials, this necessitated the calcu-
lation of the laurate-saturated mid-point potential. Fig. 5A 
shows the spectral shifts observed during the potentiometric 
titration of wild type BM3 containing saturating concentra-
tions of laurate. For wild type BM3 and the mutant enzymes 
F393H and F393W, saturating concentrations of laurate lead to 
a mixed spin enzyme (-35% high spin), a factor that can be 
seen clearly in the oxidized spectra. Fig. 5B shows the absorb-
ance changes at 455 nm plotted against the measured potential 
(versus standard hydrogen electrode) in conjunction with the 
one-electron Nernst function fit for each of the enzymes stud-
ied. The calculated laurate-saturated Em  values (Table II) in 
conjunction with the previously determined substrate-free val-
ues generated AE_ values of +89, +84, and +91 mV for wild 
type, F393H, and F393W, respectively. It is clear that whereas 
wild type and the point mutations, F393H and F393W, have 
significantly different substrate-free reduction potentials (Ta-
ble H), the magnitude of the substrate-induced potential shift 
remains constant. The importance of these figures as a com-
parison to the 4CNPy assay will be discussed in detail later. 
Prediction of P450 Hems Reduction Potentials—The position 
of the new MLCT absorption generated upon ligation of 4CNPy 
to ferrous heme was observed to vary with the proteins studied 
(Fig. 6A). The wavelength of this absorption band for the P450s 
studied is shown in Table II alongside their respective reduc-
tion potentials. A linear relationship is observed between the 
energy of the absorption band and the heme reduction potential 
(E cr = (3.53 )< Em) + 17,005 cm', Fig. 4B), indicating that 
the origin of the absorption is sensitive to the redox nature of 
the heme iron in keeping with the band assignment to MLCT. 
DISCUSSION 
The two features of 4-cyanopyridine that make it an ideal 
ligand for the type of studies outlined in this paper are as 
follows: first, its selective and tight reversible binding to fer-
rous heme (with little affinity for ferric heme), and second, the 
unusual spectral properties of the 4CNPy-ferrous heme adduct. 
The methodology outlined for the determination of substrate 
dissociation constants for reduced P450 exploits these observa-
tions. The specificity of 4CNPy for reduced P450 allows the 
evaluation of substrate dissociation constants for purely the 
reduced enzyme and eliminates interference from binding of 
4CNPy/substrate to ferric heme. 
An increase in substrate binding affinity upon heme reduc-
tion is inferred by the potential difference between the reduc-
tion potentials of the substrate-free and substrate-bound forms 
of cytochromes P450 (11). Introduction of substrate into the 
active site increases the heme reduction potential, typically by 
-100-150 mV depending on the nature of the substrate, thus 
thermodynamically controlling electron transfer from the re-
ductase (6) (G = -nFE). Consideration of the Gibbs free 
energy relation (AG = -R71nK) suggests that this increase in 
reduction potential must be because of a decrease in the mag-
nitude of the equilibrium constant, K in this case; K can be 
considered as the ratio of the substrate dissociation constants 
(Kd(ox)/Kd(red)). Theoretically, lCd should decrease upon pro-
tein reduction. It is widely accepted that there is considerable 
peptide motion upon substrate binding to P450 BM3, associ-
ated with dehydration of the active site (18, 19). A similar 
conformational contraction may be expected upon reduction, to 
bring the substrate closer to the heme to facilitate oxygenation. 
This is substantiated by NMR relaxation experiments, which 
(nm) 
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FIG. 6. A shows a magnification of the a1J3 region of the ferrous-
4CNPy adducts of 5 ILm wild type P450cam, wild type P450 8M3, and a 
selection of P450 BM3 F393X mutants (spectra: i, P450 13M3 F393A ii, 
P450 BM3 F393H; iii, P450 BM3 F393Y; iv, P450 BM3 WT; and v, P450 
BM3 F393W). Each spectrum has been shifted along the ordinate axis 
for clarity; hence the units are arbitrary. The dotted line indicates the 
change in the position of the characteristic MLCT absorption band. B 
shows the linear variation in the energy of the MLCT with substrate-
free P450 reduction potential. 
show a dramatic 6-A movement of the substrate toward the 
heme upon reduction (12). In addition, a recent study by Mor-
ishima and co-workers. (29) shows that complexation of 
P450cam with its electron transfer partner, putidaredoxin, 
causes significant conformational changes in the active site. 
These types of active site contractions probably serve a variety 
of purposes as follows: to ensure dehydration of the active site, 
improve coupling (3, 25), and also to stabilize the Michaelis 
complex. Analysis of the palmitoylate-bound crystal structure 
of P450 BM3 supports this (20), because in the oxidized form, 
the terminus of the substrate is too far from the heme (-8 A) to 
allow oxygenation, thus invoking an argument to support some 
movement of the substrate prior to hydroxylation. 
The magnitude of the substrate binding constants for the 
ferrous P450s (Kd(red)) calculated by both the 4CNPy tech-
nique and through O'ITLE measurements are considerably 
lower than those determined for the ferric enzymes as pre-
dicted. These measurements help quantify the degree to which 
substrate is bound tighter to the active site in the catalytically 
relevant, ferrous form of the enzymes. Substrate binding con-
stants can be used to determine the Gibbs free energy (AG) of 
substrate binding to ferric and ferrous P450 by using the equa-
tion AG = -RTlnK d. The difference between these calculated 
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TABLE m 
Ferrous and ferric substrate binding constants and substrate-induced heme reduction potential shifts for cytochromes P450 BM3 and the 
mutant enzymes F393H and F393W using the substrate laurate 
Kd(ox) is the ferric substrate dissociation constant as determined by fatty acid titration (26 C in 100 mm Tris, 500 
mm KCl, pH 7.5). 
K(redX4CNPy) is the ferrous substrate dissociation constant determined by using the 4CNPy method (25 IC in 20 mm MOPS, 100 mm KCI, pH 
7.5), and n.E,, (4CNPy) is the substrate-induced potential shift calculated from Ka(ox) and K(redX4CNPy) by using the equations 
AG = -n.FAE and 
AG = -RIInK,,. IE,(OVFLE) is the substrate-induced potential shift as determined by O'VFLE potentiometric titrations (25 °C in 100 
mM tris, 
500 mm KCI, pH 7.5), and Kd(redXOTTLE) is the ferrous dissociation constant calculated from E,,,(O'ITLE) by using the above equations. 
Kd(ox) 	
Ka(red) 	 AE.
4CNPy 	 OVFLE 	 4CNPy 	 OTPLE 
PM 	 PM 	 mV 
P450 BM3 + laurate 	 364 ± 8 82.4 ± 3 	 11.3 ± 1.5° 	 38 ± 6" 	 89 ± 14 
F393H BM3 + laurate 525 ± 23 	 58.1 ± 5 19.8 ± 2.71 56 ± 
gb 84 ± 18 
F393W BM3 + laurate 	 578 ± 15 105 ± 10 	 16.6 ± 2.11 	 44 ± 8" 	 91 ± 15 
° Values were calculated from E,,,(OTTLE). 
b  Values were calculated from K(red)(4CNPy) 
values gives an indication of the relative stabilities of the ferric 
substrate-bound P450 compared with the ferrous substrate-
bound P450. Clearly, the AG value for the ferrous complex will 
be greater than that for the ferric complex indicating a more 
stable (lower in energy) reduced species. In addition, we can 
hypothesize that as the Kd(Ox) for wild type BM3 with arachi-
donate is lower than that observed for laurate, it will likely 
have a similarly smaller K,(red). Therefore, it follows that 
AG(red) values observed using the substrate arachidonate 
(>90% substrate-induced potential shift) would be of a greater 
magnitude than for laurate (-35% substrate-induced potential 
shift). This suggests that more stable ferrous complexes are 
formed with more appropriate substrates. 
As mentioned previously, by using the equation -RTIn(Kd(ox)/ 
Kd(red)) = -nFtl.E,,, and assuming that we know the value of 
Kd(ox), we can calculate the value of iS.E,afrom Kd(red) and vice 
versa. This allows the calculation of two numbers for each 
parameter (Kd(red) and iE,,,) derived by using both the 4CNPy 
assay and the OTTLE potentiometric technique. The compari-
son of these values (LEm(071'LE) compared with iIE(4CNPy) 
and Kd(red)(OTI'LE) compared with Kd(redX4CNPY)) provides 
a convenient method for assessing the suitability of the 4CNPy 
technique in estimating Kd(red) and  £iEm . 
Table III shows the comparison of these calculated values for 
wild type P450 BM3 and the mutant enzymes F393H and 
F393W. It can be seen that the values are of a similar magni-
tude although they do not correlate exactly. The use of the 
4CNPy assay correctly predicts an increase in substrate affin-
ity on heme reduction and subsequently an increase in the 
heme reduction potential, which highlights the applicability of 
the 4CNPy competitive titration in predicting Ka(red). It is 
obvious, however, that the two sets of data do not match exactly 
and that there is a discrepancy between the two techniques. 
This can be illustrated in the case of wild type P450 BM3 with 
laurate (i.E(4CNPy) = +38 mV, 1Em(071'LE) = +89 mV, 
K(redX4CNPy) = 82.4 pat, and Kd(redXOTTLE) = 11.3 pat). 
The difference in the predicted and measured values is likely to 
be a consequence of the nature of the competition between 
ligand and substrate. In P450 BM3, substrate binding occurs at 
the mouth of the active site where two residues, Tyr-51 and 
Arg-47 (30) form a H-bond and salt bridge with the substrate 
carboxylate head. The consequence of this is that the binding of 
substrate is not directly influenced by the binding of 4CNPy to 
the iron, although there is competition between the substrate 
tail and 4CNPy. As a result, it is unlikely that laurate and 
4CNPy display pure competition, a factor that may lead to the 
overestimation of the K(redX4CNPy). 
It has also been demonstrated that 4-cyanopyridine can be 
exploited to predict the substrate-free P450 heme reduction 
potentials. This feature makes 4-cyanopyridine a fundamen-
tally important mechanistic probe. The energy of the MLCT  
absorption upon formation of the 4CNPy-ferrous adduct varies 
linearly with heme reduction potential. Similar observations 
have been noted in studying the correlation of absorption band 
energy of simple inorganic complexes with reduction potential 
(26-28). However, the previous correlations have been re-
ported for MLCT energies and metal-based redox potentials of 
the same compounds. In this study the linear relationship 
exists between the MLCT (Fe(ll) -+ 4CNPy) band maximum 
and the Fe(llhIII)-based couple of the substrate-free heme. The 
experimental observation of a linear relationship between the 
MLCT band position of the 4CNPy-bound heme and the reduc-
tion potential of the free heme indicates that the interaction 
between the iron center and the lowest energy 7r5 orbital of 
4CNPy must be similar in all cases. Thus, observation of the 
MLCT transition of 4CNPy-bound P450s provides a convenient 
route by which heme reduction potentials can be accurately 
estimated for a series of active site mutants of a single P450. 
The data presented here act as a calibration chart, against 
which reduction potentials of subsequent P450 BM3 point mu-
tations can be estimated. The relationship shown in Fig. 6B 
(EML = (3.53 X Em ) + 17,005 cm) allows the evaluation of 
a P450 heme reduction potential, simply by knowing the energy 
of the MLCT absorption of the P450 5-4CNPy adduct. 
CONCLUSION 
The ligand 4-cyanopyridine exhibits a strong preference for 
ferrous heme and produces a P450,,.-4CNPy adduct with very 
unusual spectral properties. These observations have led us to 
develop an extremely convenient method for the determination 
of Kd values for substrate binding to reduced P450s. In addi-
tion, an analysis of the correlation between P450 reduction 
potentials and the energy of the MLCT bands seen for P450-
4CNPy adducts opens up a novel method for the prediction of 
reduction potentials for P450 BM3 and even perhaps for heme-
thiolate proteins in general (e.g. chloroperoxidase and nitric-
oxide synthase). 
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Abstract 
In flavocytochrome P450 BM3 there are several active site residues that are highly conserved throughout the P450 superfamily. Of 
these, a phenylalanine (Phe393) has been shown to modulate heme reduction potential through interactions with the implicitly conserved 
heme.ligand cysteine. In addition, a distal threonine (Thr268) has been implicated in a variety of roles including proton donation, oxygen 
activation and substrate recognition. Substrate binding in P450 BM3 causes a shift in the spin state from low- to high-spin. This change 
in spin-state is accompanied by a positive shift in the reduction potential (AE. [WT + arachidonate (120 MM)] = +138 my). Substitution 
of Tbr268 by an alanine or asparagine residue causes a significant decrease in the ability of the enzyme to generate the high-spin complex 
via substrate binding and consequently leads to a decrease in the substrate-induced potential shift (AE. [T268A + arachidonate 
(120 1iM)] = +73 mV, i.Em [T268N + arachidonate (120 pM)] = +9 mV). Rate constants for the first electron transfer and for oxy-fer-
rous decay were measured by pre-steady-state stopped-flow kinetics and found to be almost entirely dependant on the heme reduction 
potential. More positive reduction potentials lead to enhanced rate constants for heme reduction and more stable oxy-ferrous species. In 
addition, substitutions of the threonine lead to an increase in the production of hydrogen peroxide in preference to hydroxylated product. 
These results suggest an important role for this active site threomne in substrate recognition and in maintaining an efficiently functioning 
enzyme. However, the dependence of the rate constants for oxy-ferrous decay on reduction potential raises some questions as to the 
importance of Thr268 in iron-oxo stabilisation. 
© 2005 Elsevier Inc. All rights reserved. 
Keywords: Cytochrome P450; Oxygen activation; Electron transfer; Oxyferrous species; Iron-oxo stabilization 
1 Introduction 
The cytochromes P450 [1] are a large and extensively 
studied family of heme containing redox enzymes [2-4]. 
They are responsible for a variety of biologically important 
reactions on a huge range of substrates in almost every 
organism from bacteria to humans [5-7], primarily catalys-
ing the insertion of an atom of oxygen into a CH bond [8]. 
There are currently around 4500 named P450 sequences 
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identified on the cytochrome P450 homepage [91 a number 
which is steadily increasing  as more genomic sequences 
become available. 
There are many differences between individual P450s in 
terms of redox cofactors [10-141 substrates [5] and 
sequence [9], however there are several conserved features 
found throughout the P450 superfamily. The overall fold 
and tertiary structure are consistent [15] and it is apparent 
from sequence alignments that there are several highly con-
served and hence possibly catalytically important residues 
[16]. of these conserved residues, a threonine [17,18] 
located at the distal side of the heme has been associated 
with a variety of roles including oxygen activation 
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[19,201 proton delivery [21-241 substrate recognition 
[25,261 electron transfer [27] and the positioning of the 
heme-ligand water [28]. This residue forms part of the I-
helix which runs across the distal face of the heme 
[16,17,291 Its location at the active site and role in forming 
the oxygen binding pocket has led to speculation that it can 
hydrogen bond to the ferrous-dioxygen complex [19,20], 
stabilising it and aiding the formation of the catalytically 
important oxy ferryl or ferric hydroperoxy species [30]. 
However, a recent study detailing the crystal structure of 
the dioxygen complex of P450cam has indicated that the 
threonine residue does not form a hydrogen bond with 
the dioxygen complex but instead suggests it may be a 
hydrogen bond acceptor from the hydroperoxy intermedi-
ate [31]. As the nature of oxygen activation and the precise 
mechanism of substrate hydroxylation are still a matter of 
some debate, a significant amount of research has been car-
ried out to determine the exact role of this residue in a vari-
ety of P450 enzymes [19,27,32,33]. 
Initial studies by Imai et al. showed that the hydroxyl 
group of threonine was essential for coupled enzymatic 
activity and that its removal resulted in a less stable 
oxy-ferrous complex [34]. They suggested that the threo-
nine might play a role in both stabilising the iron oxo 
complex and in the proton donation pathway. However, 
a subsequent study by Kimata et al. [35] demonstrated 
that the substitution of the threonine in P450cam with 
the unnatural amino acid methoxythreonine (removing 
proton donating ability) resulted in a fully coupled 
enzyme. Hence the hydroxyl group of the threonine was 
not a pre-requisite for oxygen bond cleavage. Concomi-
nantly, similar work was being carried out on the exten-
sively characterised enzyme of this type, P450cam 
[20,221 a camphor hydroxylase from Pseudomonas putida. 
The crystal structure of the P450cam active site mutant 
Thr252A1a shows how this substitution leads to structural 
changes in the active site and suggests that greater access 
for solvent water is the source of uncoupling [36]. Hence 
another role for the threonine is suggested in preventing 
active site access to solvent water molecules through the 
proton channel. 
The second most commonly studied enzyme of this type 
is P450 BM3 from Bacillus megateriwn, a convenient model 
for studying P450s due to its combination of redox cofac-
tors [10,371 The substitution of Threonine 268 with an ala-
nine (analogous to Thr252Ala in P450cam) results in a 
decrease in the rate constant for NADPH (-nicotinamide 
adenine dinucleotide phosphate) consumption and an 
increase in the conversion of electron equivalents into 
hydrogen peroxide instead of hydroxylated product 
[19,25]. However, while in P450cam, the threonine residue 
is necessary for any NADPH consumption, the Thr268Ala 
mutant in P450 BM3 exhibits a small, but significant 
amount of coupled activity [19,251 It is suggested that this 
may indicate that while the distal threonine may fulifi a 
similar role in all P450s, it may do so with a differing degree 
of importance. Several papers by Peterson et al [25,28]  
confirm the importance of Thr268 in maintaining coupled 
substrate hydroxylation. 
There are numerous other examples of similar substitu-
tions cited in the literature [21,38-41] highlighting this res-
idues importance in electron delivery, proton transfer and 
the high/low-spin character of the ferric resting state. In 
P450 1A2 it is even reported that the T3 19A substitution 
leads to a 9-fold increase in V., clearly a result which 
contradicts those discussed earlier. 
These previous studies indicate several possible roles for 
the active-site threonine, without conclusively identifying 
its function within the P450 super-family. It has been sug-
gested that this residue may fulfil a different role or have 
varying importance within the P450 family depending on 
the nature of the substrate and flexibility of the substrate-
binding pocket. 
Our earlier studies have shown that substituting the 
proximal residue Phe393 of P450 BM3 to a histidine results 
in alterations in the electronic nature of the heme environ-
ment which in turn influence the heme reduction potential 
[42-441 Substitution of Phe393 with a histidine led to a 
positive shift in the Em  which was concomitant with an 
increase in the rate of first-electron transfer and impor-
tantly, an increase in the stability of the oxy-ferrous 
complex. 
In order to attempt to increase the stability of the oxy-
ferrous complex even further we decided to combine the 
F393H mutation with additional substitutions at Thr268. 
Such a stabilised species would provide a platform for 
future work on subsequent steps in the catalytic cycle. In 
addition it was hoped that these substitutions would help 
to further elucidate the function of the Thr268 residue 
and assess its importance in hydrogen bonding, proton 
donation and substrate recognition in P450 BM3. 
2. Materials and methods 
2.1. Mutagenesis 
The P450 BM3 mutants characterised here were gener-
ated by site-directed mutagenesis using the Kunkel method 
as described previously [42,53]. The wild type (WT) plas-
mids pBM23 (holo P450 BM3) and pBM20 (P450 BM3 
heme domain) were used as templates for making the 
T268A and T268N single mutants. The P450 BM3 
F393H plasmids pCM37 (holo protein) and pCM8 1 (heme 
domain) were used for construction of the F393H/T268A 
and F393H/T268N double mutants [42]. 
Oligonucleotides used were T268A: 5' GACCACTTG-
TFGCTTCGTGTCCCGC and T268N: 5' GACCACTT-
GTGI1IICGTGTCCCGC. Mismatches are underlined. 
The resulting expression plasmids were pCM 174 and 
pCM166 (T268A holo protein and heme domain, respec-
tively), pCM175 and pCM167 (T268N holo protein and 
heme domain), pCM172 and pCM164 (F393H/T268A 
holo protein and heme domain) and pCM 173 and 
pCM 165 (F393H1T268N holo protein and heme domain). 
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The P450 BM3 coding sequences of all were sequenced to 
verify that there were no secondary mutations. Mutants 
were overexpressed in Escherichia coli strain TG 1 as before 
[42]. 
2.2. Growth and purification 
Wild type and mutant enzymes (F393H, T268A, T268N, 
F393H/T269A and F393H1T268N) were expressed, iso-
lated and purified in accordance with previously estab-
lished protocol [42,451 Pure proteins (as determined by 
SDS-PAGE) were concentrated via centrifugation to 
>300 IiM, flash frozen in liquid nitrogen and stored at 
-80 °C. Enzyme stocks were used within 1 month of isola-
tion. During the purification of both the heme domain and 
holo protein enzymes, great care was taken to ensure that 
no detergents were allowed in contact with the P450. Some 
detergents were found to induce changes in spin state indic-
ative of substrate binding. Any P450 exhibiting a signifi-
cant peak at 390 nm or 650 nm was considered to be 
contaminated and discarded. 
2.3. Spectrophotometric analysis of CO binding, enzyme 
concentration and substrate dissociation constants 
Absorption spectra were recorded over the range 300-
800 urn using a Shimadzu 2101PC spectrophotometer in 
conjunction with a quartz cuvette of path length of 1 cm. A 
standard assay buffer of 20 mM Mops (3-(morpholino)-pro-
panesulfonic acid), 100 mM KC1 at pH 7.40 was used for all 
enzyme dilutions. The characteristic P450 Fe(II)-CO spectra 
were generated through the reduction of the enzymes with 
sodium dithionite prior to bubbling with CO. Absorption 
spectra were recorded before and after treatment with CO. 
P450 concentrations were calculated from the difference 
spectra {(reduced CO bound) - (reduced)} using the 
extinction coefficient &450 490 =92,000 M cm '.Substrate 
dissociation constants (Kd) for fatty acid binding to ferric 
P450 using both laurate and arachidonate were determined 
for T268A, T268N, F393H/T268A and F393H/T268N. 
Fatty acid titrations were carried out in accordance with a 
previously described experimental procedure [42]. Dissocia-
tion constants were calculated by plotting the observed 
changes in absorption spectra (i.A 41 2 390)  against substrate 
concentration and fitting to a rectangular hyperbola 
(Microcal Origin). Kd values for wild type P450 BM3 and 
F393H mutant have been reported in a previous publication 
[42]. 
2.4. Steady-state kinetics 
All steady-state kinetics experiments were carried out at 
15 °C. Typically, enzyme concentrations were 200 nM in 
I ml assay buffer (20 mM Mops, 100 mM KC1, pH 7.40), 
turnover was initiated through addition of NADPH 
(10 jil of 16 jiM). Initial rates of NADPH consumption 
were assessed in the presence of varying concentrations of  
laurate ([laurate] = 10-1000 jiM) by monitoring the fall in 
absorbance at 340 nm corresponding to NADPH oxidation 
(eo = 6210 M cm-1) as described previously [42,461 
Observed rates expressed as activities (mol NADPH oxi-
dised per second per mol enzyme) were plotted against lau-
rate concentrations. The turnover rate constants and 
Michaelis constants Km  were determined by fitting the data 
to the Michaelis-Mentin equation (Microcal Origin). The 
observed rate constants at saturating concentrations of 
arachidonate (k.) were determined in an analogous 
method to that described above. Initial rates of NADPH 
oxidation were measured in the presence of arachidonate 
(i-.. 120 jiM) and converted to activity units. The quoted lau-
tate rate constants (k), Michaelis constants (Km) and ara-
chidonate saturated observed rate (k,) are the average of 
three separate experiments. 
2.5. Coupling efficiencies 
2.5.1. Horseradish peroxidaselo-dianisidine assay 
The degree of uncoupling to peroxide was determined 
by comparing [NADPH] consumed to [H202] produced. 
A catalytic amount of P450 (0.2 jiM) was added to a 
reaction mixture containing a saturating concentration of 
substrate and limiting concentration of NADPH (20 mM 
Mops, 100 m KC1, pH 7.4, [arachidonate] 120 jiM, 
[NADPH] = 50 jiM). Absorption spectra were recorded 
immediately before addition of the enzyme to calculate 
the exact initial concentration of NADPH (s o = 
6210 M' cm) and several minutes after addition of the 
enzyme to ensure its complete oxidation. The resulting per-
oxide generated through the uncoupling pathway was then 
determined through the addition of horseradish peroxidase 
(10 j.tl of 5 mg ml- ) and o-diamsidine (40 jil of 8mM). 
Horseradish peroxidase uses stoichiometric amounts of 
peroxide and o-dianisidine as cofactor and substrate, 
respectively, to generate a blue radical cation with an 
extinction coefficient P440 = 11.6 mM cm . The concen-
tration of o-dianisidine radical cation and hence concentra-
tion of peroxide were calculated. The degree of uncoupling 
to peroxide was calculated from the ratio of [NADPH]:[o-
dianisidine radical cation]. Quoted values of percentage 
uncoupling to peroxide are the average of three separate 
experiments. 
2.6. Negative-ion electrospray mass spectrometry 
The coupling of NADPH to product was calculated for 
each mutant and wild type by analysing the relative 
amounts of unreacted substrate and hydroxylated product 
after a NADPH limited turnover assay using mass spec-
trometry. Turnover assays were carried out using catalytic 
amounts of enzyme, saturating concentrations of substrate 
and limiting concentrations NADPH (typically 0.05 jiM 
enzyme, 120 jiM AA, 70 jiM NADPH in 20 mM Mops, 
100 mM KC1, pH 7.40). Under these conditions, NADPH 
consumption can be ascribed solely to product formation 
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or unproductive reduction of oxygen. Mass spectrometry 
(Micromass Platform electrospray mass spectrometer) was 
used to assess the ratio of unreacted substrate (m/z 303) 
to hydroxylated product (m/z 319). Initial concentrations 
of NADPH were calculated form the absorbance spectrum 
using the extinction coefficient F34o = 6210 M' cm. The 
degree of coupling was calculated from the expected ion 
count from 100% coupling of NADPH to product com-
pared to the observed ion count for hydroxylated product. 
Quoted values of percentage coupling are the average of 
three separate experiments. 
2.7. Substrate-induced spin-state shift 
All spectral substrate induce spin state shift measure-
ments were carried out at 15 °C in assay buffer (20 mM 
Mops, 100 reM KC1, pH 7.40) using a quartz cuvette with 
a path length of 1 cm. Maximum spin state shifts were gen-
erated through the addition of saturating concentrations of 
arachidonate (- 120 sM) from a 30 mM ethanolic stock to 
low spin oxidised enzyme. Spectra were recorded before 
and alter the addition of substrate. Approximate spin state 
shifts were calculated by comparing the concentration nor-
malised difference spectra {(oxidised + substrate) - (oxi-
dised)} for each of the mutant enzymes with the 
difference spectrum for wild type [47]. Spin state shifts were 
expressed as the percentage spectral shift compared to wild 
type. This process makes the assumption that arachidonate 
saturated WT is 100 11/o high spin. However, saturating con-
centrations of substrate do not necessarily mean full spin 
state conversion [421 Despite this, it is believed that this 
internal comparison will prove useful in assessing the abil-
ity of the substrate to generate the high-spin complex. 
2.8. Optically transparent thin layer electrode (OTTLE) 
potentiometry 
Spectroelectrochemical analysis of the heme domain 
reduction potentials was carried out at 25 °C in a modified 
quartz EPR OTTLE cell with a path length 0.3 mm both in 
the presence and absence of saturating concentrations of 
arachidonate. The experiments were carried out in accor-
dance with a previously established protocol [42,44]. The 
potential was applied using a Autolab PGSTAT potentio-
stat via a Pt/Rh (95/5) (wire diameter 0.06 mm, mesh size 
1024 cm, Engelhardt, UK) gauze working electrode, 
platinum wire counter electrode and AgIAgCl reference 
electrode (model MF2052, Bioanalytical Systems, IN 
47906, USA). Potential induced reduction and re-oxidation 
were monitored using a Cary 50 UV/vis spectrophotome-
ter. A range of mediators covering the estimated midpoint 
potential range (2-hydroxy- 1 ,4-napthaquinone, FMN, ben-
zyl viologen and methyl viologen) were added to ensure 
efficient reduction and reoxidation. The Ag/AgCl reference 
electrode was calibrated against indigotrisulfonic acid 
(Em = -99 mV vs standard hydrogen electrode (SHE)) 
and FMN (Em = -220 mV vs SHE). Applied potentials  
were corrected relative to the standard hydrogen electrode 
where ((potential Ag/AgCl) + 205 mY) = (potential 
SHE). Applied potentials vs SHE were plotted against 
the absorbance changes (AA 390  420 nm) and the heme reduc-
tion midpoint potentials (Em) were determined by fitting 
the data to the Nernst equation using Origin software. 
2.9. Pre-steady-state kinetics 
All pre-steady-state kinetic measurements were carried 
out at 15 °C using an Applied-Photophysics stopped-flow 
spectrophotometer (SX. 17MV) in conjunction with either 
a single-wavelength or diode-array detector. The stopped-
flow apparatus was housed within an anerobic glovebox 
(Belle Technology; [02] <5 ppm). Typically, the final con-
centration of enzyme used for all pre-steady-state kinetic 
experiments was '5 jiM and saturating concentrations of 
arachidonate were -.120 jiM. 
2.9.1. Herne reduction kinetics 
Rate constants for the first electron transfer from 
NADPH through the reductase domain to ferric heme in 
the presence and absence of substrate (arachidonate) were 
determined by monitoring the accumulation of the dead-
end ferrous-CO complex as reported previously [42]. The 
holo form of the enzyme in CO-saturated buffer (20 mM 
Mops, 100 mM KC1, pH 7.40, [CO] 200 jiM) was mixed 
with a solution of NADPH (200 jiM) in CO-saturated 
buffer using the stopped-flow apparatus. The subsequent 
absorbance changes at 450 nm were monitored using a sin-
gle wavelength detector. Due to differences in the Fe(ll)-
CO peak position for individual mutants, data were ana-
lysed at the following wavelengths; WT 449 urn, F393H 
445 rim, T268A 449 nm, T268N 450 nm, F393H/T268A 
445 urn, F393H1T268N 447 mn. Kinetic traces were fitted 
to single or double exponentials using Origin 7 software. 
Substrate-free experiments were monitored using both 
diode-array and single-wavelength detectors. However, 
due to the large rate constants for electron transfer in the 
presence of substrate, only the single-wavelength detector 
could be used to evaluate rate constants, since the diode-
array apparatus was not sensitive enough to accurately 
measure the electron transfer. The presence of multi phase 
data for the substrate-free heme reduction was rationalised 
through the incomplete formation of the ferrous-CO com-
plex (Fig. 5) and through the presence of small quantities 
of substrate and/or substrate like contaminants. Absor-
bance changes for substrate-saturated heme reduction were 
indicative of full conversion to Fe(II)-CO. Quoted rate 
constants are the average of three separate experiments. 
2.9.2. Autoxidation kinetics 
Rate constants for the decay of the oxy-ferrous complex 
to the ferric form, in the presence (120 p.M arachidonate) 
and absence of substrate, were evaluated according to a 
previously reported method [42]. Pre-reduced heme domain 
(excess dithiomte removed via gel filtration) was mixed 
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with oxygen-saturated buffer ([021 200 ILM) using the 
stopped-flow apparatus and the formation, and subsequent 
decay, of the oxy-ferrous species was monitored over the 
range 250-800 tim using a diode-array detector. Typically, 
the formation of the oxy-ferrous species was so rapid that it 
was completed within the dead time of the stopped-flow 
apparatus. Several mutant enzymes displayed absorbance 
changes attributed to the formation of the oxy-ferrous spe-
cies. Typically, these absorbance changes represented only 
a small proportion of complex formation and as such were 
not analysed. Absorbance changes at 460 nrn associated 
with oxy-ferrous decay were plotted against time and fitted 
to single exponentials using Origin 7 software. Quoted rate 
constants are the average of three separate experiments. 
2.10. Crystallography 
Crystals of T268N and T268A cytochromes P450 BM3 
were obtained by the hanging drop vapour diffusion method 
at 4 °C in Lmbro plates (Table 6). Crystals were obtained 
with a well solution comprising 100 mM sodium Pipes 
(piperazine-N,N'-bis[2-ethanesulfonic cis]), pH 6.0-7.5, 
40 m MgSO4, and 18-21% PEG8000. Hanging drops of 
4 ILL were prepared by adding 2 p1 of 40 mg/ml protein 
(in 50 m Tris—HC1 (tris(hydroxyl)aminomethane)/l mM 
EDTA (ethylenediaminetetraacetic acid), pH 7.4) to 2 1iL 
of well solution. Plates of up to 1 x 0.3 x 0.3 mm were 
formed after approximately 1 week. Crystals were 
immersed in well solution containing 23% glycerol as a 
cryoprotectant, prior to mounting in nylon loops and 
flash-cooling in liquid nitrogen. For the T268A and 
T268N enzymes data sets were collected to 1.9 and 1.8 A 
resolution, respectively. Data were collected at SRS Dares-
bury, at station 14.1 for the T268A enzyme (A = 0.9831 A) 
and at station 14.2 for T268N (A = 1.488 A). All data were 
collected using an ADSC Quantum-4 CCD detector. Crys-
tals of both mutant enzymes were found to belong to space 
group P2 1 . Crystals of the T268A enzyme were found to 
have the following cell dimensions: a = 58.727 A, 
b = 152.962 A, c = 61.732 A, and jJ = 94.37. Those of the 
T268N enzyme had the following dimensions: 
a=58.876A, b=153.241A, c=61.607A, and /1= 
94.48°. Data processing was carried out using the HKL 
package [48]. The wild-type flavocytochrome P450 BM3 
heme domain structure (PDB ID 2HDP) [29], stripped of 
water, was used as the initial model. Electron density fitting 
was carried out using the program TURBO-FRODO [49]. 
Structure refinement was carried out using Refmac [50]. 
The atomic coordinates have been deposited in eth Protein 
Data Bank (1YQO:T268A; 1YQP:T268N). 
3. Results 
3.1. Expression wid purfi cation 
Wild type P450 BM3 and the mutant enzymes T268A, 
T268N, F393HJT268A and F393H1T268N were success- 
fully overexpressed and purified. Analysis of the spectral 
ratio of protein peak (300 nm) to Soret (410 nm) and the 
presence of a single band in SDS—PAGE analysis indicated 
that the purity was in excess of 95%. Each of the mutant 
enzymes exhibited an entirely low-spin oxidised spectrum 
with a Soret absorbance maxima at 410 nm and less intense 
cx and 13  bands at 525-575 nm. Reduction of the mutant 
enzymes led to a shift in the Soret peak from 410 to 390 
tim and the subsequent binding of CO generated the char-
acteristic 450 tim Fe(ll)—CO peak. Only a negligible 
amount of P420, non-cysteine-bound heme was found in 
the purified enzyme. 
3.2. Carbon monoxide binding 
The ferrous form of wild type and each of the mutant 
enzymes was capable of generating the Fe(ll)—CO-bound 
species when treated with CO. The positions of the result-
ing Soret peaks varied across the series of mutants studied 
(Table 1) as shown in Fig. 1. Changes in the position of 
the ferrous CO peak are attributed to changes in the 
CO bond energy [421 Previous studies have suggested that 
the mutation of Phe393 to a histidine decreases the elec-
tron density at the heme and as a result of this; the degree 
of back-bonding from ferrous iron to the CO antibonding 
orbitals is decreased [42]. This strengthening of the CO 
bond would result in a blue shift in the Fe(ll)—CO 
absorption. it is apparent that the substitution of 
Thr268 with an alanine in both the single mutant and 
in conjunction with F393H does not cause any observable 
-WT 
F393H 
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X (nm) 
Fig. 1. UV-vis spectra highlighting changes in the position of the 
characteristic ferrous-CO bound Soret absorption maxima between wild-
type P450 BM3 and the mutant enzymes F393H, T268N and F393H1 
T268N. The starting absorbance values have been offset in order to aid 
interpretation. A vertical dotted line corresponding to the wavelength of 
the wild-type ferrous-CO absorption maxima was also added to aid 
interpretation. The F393H mutant exhibits a blue shift with respect to wild 
type (5 rim). The T268N mutant exhibits a red shift with respect to wild 
type (p.4 rim). 
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spectral changes. The substitution of Thr268 with an 
asparagine causes only a small (1 nm) red shift in the 
spectrum. 
3.3. Steady-sate kinetics and coupling efficiencies 
Steady-state turnover rate constants (krat) with laurate 
and substrate-saturated turnover rate constants (k 55) With 
arachidonate are shown in Table 2. These data show that 
the wild-type enzyme displays a significantly larger turnover 
rate constant compared to all the mutant enzymes. The 
and ksat values are approximately equal and both follow the 
trend in turnover rate constants of WT >> F393H 
T268A T268N> F393H/T268A> F393H/T268N. 
Although the turnover rate constants are diminished by the 
mutations, it is worth noting that all the holoenzymes retain 
significantly high turnover rate constants in comparison to 
other P450s [241 It is also apparent that the rate of sub-
strate-free NADPH oxidation remains comparatively low 
and essentially constant for wild type and most of the 
mutant enzymes (0.2-0.5 s'). However, the F393H/ 
T268N double mutant exhibits a substrate-free rate con-
stant (3.4 s- 1 ) which is high both in comparison to other 
substrate-free rate constants and its own substrate-satu- 
Table 1 
Binding constants and Fe(I1)-CO peak: indicates the positions of the 
ferrous P450-CO Soret peaks (tFe(i1)CO) 
Enzyme £Fe(ll)CO (nm) K. (LM) 
Arachidonate Laurate 
Wild-type 449 3.6±0.3 370±8 
F393H 445 7.6 ± 0.5 525 ± 10 
T268A 449 6.9±0.5 413±17 
T268N 450 4.0 ± 1.0 - 
F393H/T268A 445 5.0 ± 0.6 285 ± 25 
F393H1r268N 447 - - 
In addition, fatty acid dissociation constants for oxidized (Fe') P450 
using the substrates laurate and arachidonate are shown (25 °C in 20 mM 
Mops, 100mM KCI, pH 7.4). 
Table 2 
Steady-state kinetic parameters: steady-state kinetic parameters for 
NADPH oxidation of wild type and mutant enzymes of P450 BM3 
(15°C in 20 m Mops, 100 m KCI, pH 7.5) 
Enzyme Steady-state kinetic parameters 
Substrate Laurate Arachidonate 
k 	(s) k, (s) KM (IiM) k 1 (s') 
Wild-type 0.2 ± 0.1 84.1 ± 2.0 322 ± 10 94.7 ± 6.2 
F393H 0.3 ± 0.1 36.4 ± 1.6 190 ± 7 31.0± 1.1 
T268A 0.3±0.1 29.1±1.0 777±35 31.1±1.3 
T268N 0.3 ± 0.1 28.9 ± 1.7 318 ± 21 28.2 ± 1.5 
F393H/T268A 0.5±0.1 22.0±0.9 85±7 18.6±2.4 
F393H/r268N 3.4 ± 0.3 9.8 ± 1.1 13 ± 4 7.2 ± 0.7 
- substrate' is the observed rate constant in the absence of substrate. 
'k,,, + arachidonate' is the observed rate constant at saturating concen-
trations of arachidonate (120 pM). The catalytic rate constant (km,) and 
Michaelis constant (KM) with laurate are also shown.  
rated rate constant (8.7 s - 1 ). The significance of these values 
will be discussed later in the text. 
Table 5 shows the coupling efficiencies of wild type and 
all the mutant enzymes both in terms of their ability to pro-
duce hydroxylated substrate (mass spec) and through their 
uncoupling to peroxide (o-dianisidine/HRP assay). It is evi-
dent that both the wild-type enzyme and F393H mutant 
retain a substantial degree of coupling to hydroxylated 
product (>80%) whilst generating minimum amounts of 
hydrogen peroxide (2.5% and 6.2%, respectively) due to 
uncoupling of the catalytic cycle. Mutant enzymes which 
incorporate substitutions at the distal threonine exhibit sig-
nificantly smaller degrees of coupling to product (5-30%). 
It is also clear from the o-dianisidine assay that the major-
ity of uncoupling in these mutant enzymes (60-70%) is to 
hydrogen peroxide. 
3.4. Substrate dissociation constants and spin-state shift 
The addition of saturating concentrations of arachido-
nate to wild type and the mutants enzymes highlighted sig-
nificant differences in the degree of substrate-induced spin-
state shift. Both wild type and the proximal F393H mutant 
exhibit >90% spin-state conversion on the addition of sat-
urating concentrations of substrate. Fig. 2 and Table 3 
show that, in all cases, substitution of T268 to either ala-
nine or threonine results in a considerably lower propor-
tion of high-spin protein at similar concentrations of 
arachidonate. Mutant enzymes which incorporate the 
T268N substitution display almost negligible amounts of 
the high-spin complex. Dissociation constants for wild type 
and mutant enzymes using both arachidonate and laurate 
as substrates are shown in Table 1. It is not possible to 
accurately determine substrate Kd values for F393H/ 
T268N with arachidonate and laurate and T268N with lau-
rate due to insufficient spectral shifts. Even so, it is evident 
from these data that neither the substitutions of Thr268, 
Phe393 nor combinations of the two result in any signifi-
cant change in fatty-acid binding properties. 
3.5. OTTLE potentiometric titrations 
The heme reduction potentials for substrate-saturated 
and substrate-free wild type and mutant enzymes are 
shown in Table 3. Figs. 3a and b show the fits to one-elec-
tron Nernst curves for T268A, T268N, F393H/T268A and 
F393H/T268N in conjunction with simulated curves for 
wild type and F393H. Previous studies have highlighted 
the importance of the substrate-induced potential shift in 
wild type (+ 138 mV) as a red ox switch, facilitating electron 
transfer from the FMN redox partner [42,43,51]. It has 
been shown that mutations of phenylalaaine 393 to a histi-
dine, alanine, tyrosine and tryptophan do not significantly 
effect the magnitude of this shift (+156, 161, 123 and 120, 
respectively) although they do influence the relative posi-
tions of the substrate-free and arachidonate-saturated mid-
point potentials [421 However, it is shown (Table 3 and 
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Fig. 2. Absorption spectra and difference spectra highlighting substrate-
induced spectral shifts for wild-type P450 BM3 and the mutant enzymes 
T268A and F393H/T268N. (A) Substrate-induced spectral shifts at 
saturating concentrations of arachidonic acid (120 pM) in comparison 
to oxidised substrate-free wild-type heme domain. Oxidised wild type in 
the absence of substrate is shown as a solid line. Substrate saturated wild 
type, T268A and F393H/T268N are shown as dotted (•), dashed  (—) 
and dot/dash (----) lines, respectively. (B) Difference spectra 
[(P4500  + arachidonate) - (P4500,,)] highlighting the difference in low to 
high spin state shift at saturating concentrations of enzyme observed for 
enzymes incorporating Thr268 substitutions. 
Figs. 3a and b) that substitutions of the distal threonine do 
influence the heme reduction-potential shift roughly in 
accordance with the degree of spin-state shift. Specifically, 
both mutant enzymes incorporating the T268A substitu-
tion display moderate shifts in both spin state (68% and 
33% for the single and double mutant, respectively) and 
reduction potential ('..d-75 my) on the addition of saturat-
ing concentrations of arachidonate. Whereas, both mutant 
enzymes incorporating the T268N substitution have almost 
negligible substrate-induced spin-state shifts (<10%) and 
substrate-induced heme reduction-potential shifts 
(<10 mV). 
Fig. 4 shows a comparison of substrate-free and sub-
strate-saturated heme reduction potentials to highlight 
the differences between the single (T268A and T268N) 
and double (F393H/T268A and F393H/T268N) muta-
tions with wild type and F393H, respectively. Previous 
mutations of Phe393 have been shown to cause altera-
tions in the heme reduction potential for both the sub-
strate-free and substrate-saturated forms and that these 
shifts have important ramifications for the thermody-
namic properties of the enzymes. it is clear from the dia-
gram that the single mutation T268A does not influence 
the substrate-free reduction potential when compared to 
wild type. As was mentioned previously, the magnitude 
of substrate-induced potential shift for T268A is dimin-
ished. This feature was maintained both in the compari-
son of T268A with wild type and F393H/T268A with 
F393H. The T268N single and double mutations do influ-
ence the substrate-free heme reduction potential, inducing 
a positive shift of 50-60 mV. However, substrate binding 
does not induce any significant increase in reduction 
potential. 
3.6. Heme reduction pre-steady-state kinetics 
The rate constants for the first flavin-to-heme electron 
transfer were measured through the formation of the 'dead 
end' Fe(ll)–CO complex. In these stopped-flow experi-
ments it is assumed that the rate of CO binding to ferrous 
iron is in excess of the rate of flavin to heme electron trans-
fer. This assumption is supported by the fact that measured 
rate constants for CO binding were so large as to be at the 








Potentiometry and spin state shifts: arachidonate-induced spin-state shift (with respect to wild type) and thermodynamic properties of P450 BM3 for the 
point mutants F393H, 1268A, T268N, F393H/T268A and F393H/T268N 
Enzyme % Spin state shift + arachidonate OTFLE potentiometry (mV) 
Em  (mV vs SHE) 	Em (mV vs SHE) + arachidonate AE0, (mV vs SHE) 
Wild-type 100 -427 + 4 	 -289 ± 5 138 ± 9 
F393H 91±5 -332±6 -176 ± 4a 156±10 
T268A 68±5 -428±6 	 -355±4 73±10 
T268N 13±2 -367±11 -358±10 9±21 
F393H/r268A 33+4 -330±9 	 -255±9 75±18 
F39311J7268N 4+1 -282±7 -2706 12±13 
Em  denotes the substrate-free heme reduction potentials of the P450s studied and 'Em + arachidonate' denotes the arachidonate saturated heme reduction 
potentials as determined by OTFLE (25 °C in 100 m Tris, 500 m KCl, pH7.5). Some values are taken from previous work as referenced. AEm is the 
arachidonate induced potential swing. 
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Fig. 3. O1TLE potentiometric data and simulated 1 electron Nernst functions for wild-type P450 BM3 heme domain and the heme domain constructs 
F393H, T268A, T268N, F393H/T268A and F393H/Y268N. Substrate free and substrate saturated Nernst curves are shown as dotted ( -•) and solid (—) 
lines, respectively. (a) depicts the simulated Nernst curves for wild-type P450 BM3 and the experimentally derived data and fitted 1 electron nernst curves 








Enzyme 	 Enzyme 
Fig. 4. Diagram depicting substrate free and arachidonate saturated 
(120 pM) heme reduction potentials of wild-type P450 BM3 and the 
mutant enzymes F39311, T268A, T268N, F393H/T268A and F393H/ 
T268N. Substrate-free potentials are represented as an oped box while 
substrate saturated potentials are represented as as a filled box. The 
vertical gap between the two corresponds to the substrate-induced 
potential shift. (A) highlights the effect of single T268 substitution with 
respect to wild type. (B) highlights the effect of double T268 substitutions 
with respect to F393H. 
constants for the first electron transfer (k d) in the sub-
strate-free and substrate-saturated states are shown in 
Table 4. Absorbance changes for substrate-free heme 
reduction all fit to double exponential traces indicating a 
fast and slow phase for electron transfer. In each case the 
amplitude of the slow phase was 2-4-fold greater than 
the fast phase. The slow phase rate constants (k) in the 
absence of substrate for wild type and all the mutant 
enzymes with the exception of F393H/T268N are small 
and constant ranging between 0.09 and 0.14 s- 1 (Fig. 5). 
As observed in the substrate-free steady-state kinetics, the 
krcd value for the F393H/T268N mutant in the absence 
of substrate is 10 fold greater than any other mutant. 
The fast phase observed in the heme reduction traces do 
not appear to follow any obvious trend and in previous 
studies have been ascribed to the presence of small 
amounts of substrate or substrate like contaminants such 
as detergents. The rate constants for this series of muta-
tions vary accordingly F393H> F393H/T268A > WT> 
F393H/T268N > T268A> T268N as shown in Fig. 5. An 
important point to note is that the apparent rate constant 
for heme reduction in T268N is smaller than the overall 
turnover rate constant seen for this mutant enzyme. This 
observation has been repeatedly confirmed experimentally. 
Clearly the true heme reduction rate cannot be slower than 
the turnover rate. Although we have no definite explana-
tion for this discrepancy, possibilities include differences 
between pre-steady-state and steady-state methodologies 
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Table 4 
Pre-steady-state kinetic parameters: pre-steady-state kinetics of heme reduction (k d) and oxy-ferrous decay (k 0 ,1) for wild type and mutant constructs of 
P450BM3 
Enzyme Pre-steady-state kinetics 
Heme reduction (k r j) (s) Autoxidation 	(s - 1) 
Substrate free +Arachidonate Substrate free ±Arachidonate 
Wild-type 0.1 :E 0.1 101.3 + 4.1 0.089 ± 0.015 0.059 10.008 
F393H 0.1 +0.1 231.5+ 14.4 0.018+0.002 0.0013 ±0.0002 
T268A 0.1 + 0.1 27.6+2.7 0.27 ± 0.06 0.26 + 0.04 
T268N 0.1 +0.1 14.7±2.4 0.46+0.09 0.37+0.04 
F393H/T268A 0.1 +0.1 115.7±9.4 0.048±0.006 0.0071 ±0.0016 
F393H/T268N 1.7 +0.4 51.7±5.0 0.053 ±0.011 0.016+0.002 
Rates were determined in the presence (120 jiM I and absence of arachidonate (15 C in 20 m Mops, 100 m KCl, pH 7.5) 
3.7. Autoxidation pre-steady-state kinetics 
In general, the formation of the oxy-ferrous complex for 
wild-type P450 BM3 and the various mutations is too rapid 
to be monitored using stopped flow. As an indication of the 
stability of this complex, the rate constants for the decay of 
the oxy-ferrous species to the non-oxygen-bound ferric 
form were measured. Rate constants for the decay of the 
oxy-ferrous complex in the presence and absence of satu-
rating concentration of substrate are shown in Table 4. 
The experimental protocol requires the mixing of pre-
reduced enzyme with oxygenated buffer. Since the iron is 
already in the one electron reduced ferrous form, it should 
Time (s I 
15  
be insensitive to kinetic barriers imposed by substrate. The 
data show however that the F393H, F393H/T268A and 
F393H/T268N mutations display as much as a 10-fold dif-
ference in their substrate saturated and substrate-free rate 
constants. The substrate saturated autoxidation rate con-
stants (k autox ) vary across the series of mutants accordingly 
T268N > T268A > WT> F393H/T268N > F393H/T268A 
> F323H (Fig. 6). As was reported previously, the F393H 
mutation stabilises the oxy-ferrous species. Here we see 
that mutations of T268 to both an alanine and an aspara-
gine lead to a destabilisation of the oxy-ferrous species. The 
double mutations lead to a composite of both effects with 
the proximal F393H substitution dominating. 
X (nm) 
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0.0 	 . 	o_'os 	 0.10 	400 	ii. 	ISO 	70 
Time (1) 	 ). (nm) 
Fig. 5. Pre-steady-state heme-reduction kinetics of wild-type P450 BM3 and the mutant enzymes F393H, T268A, T268N, F393H/T268A and F393H/ 
T268N. (A) and (C) show the rate of formation of the ferrous-CO complex in the absence of substrate (A) and presence of saturating concentrations of 
arachidonate (C). In the absence of substrate, all enzymes exhibit the same rate constant with the exception of F393H/T268N (cyan). In (C) the substrate 
saturated rate constants vary across the series with F393H (green)> F193H1T268A (orange)> WT (black)> F393H1T268N (cyan) > T268A 
(red)> T268N (blue). (B) and (D) illustrate the starting. oxidised spectra (black) and final, reduced CO bound spectra (red) for the substrate free and 
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Fig. 6. Pre-steady-state oxy-ferrous decay of wild-type P450 BM  and the 
mutant enzymes F393H, T268A, T268N. F3931-I/T268A and F393H/ 
T268N. (A) and (B) show spectra of the oxy ferrous complex (red) and 
oxidised decay product (black) for wild type in the presence and absence of 
arachidonate (A and B. respectively). (C) shows the exponential decay of 
the oxy ferrous species at saturating concentrations of arachidonate. Rate 
constants for autoxidation vary across the series with T268N 
(blue)> T268A (red)> wt (black)> F393H1T268N (cyan)> F3931-lJ 
T268A (orange)> F393H (green). 
3.8. Crystallography 
The structures of the T268A and T268N mutant 
enzymes were refined to final R-factors of 16.64% (R-
free = 20.63%; 1.9A resolution) and 17.44% (R-
free = 21.02%; 1.8A resolution), respectively (Table 6). 
For each mutant enzyme the final model consists of two 
identical protein molecules (A and B) comprising residues 
Lys3-Leul88 and Asn2OI-Leu455 and one heme. In addi-
tion the T268A enzyme model contains 986 water mole-
cules and the T268N model contains 973 waters. For all 
molecules the electron density for the two N-terminal resi-
dues and for the loop region containing residues Gln 189-
G1u200 was uninterpretable, so these have been omitted 
from the model. The root mean square deviation (RMSD) 
fit of all backbone atoms for each of the mutant enzymes 
and the wild-type heme domain is 0.3,k, indicating no 
major differences between the structures. Due to the fact 
that there are two molecules in the asymmetric unit for 
each of these models, the RMSD values stated are the aver-
age over both molecules. The RMSD fit between both mol-
ecules (A and B) of each mutant enzyme model is found to 
be —'0.2 A. Figs. 8a and b show the electron density sur-
rounding the heme group, residue 268 and Thr438 for the 
T268A and T268N enzymes respectively. An overlay of 
the same region in the wild-type, T268A, and T268N 
enzymes is shown in Fig. 8c. From Fig. 8 it can be seen that 
in the case of the T268A mutant enzyme the only signifi-
cant structural change is the replacement of Thr268 with  
alanine. As in the wild-type enzyme there is a water mole-
cule (WAT216 in molecule A. WAT335 in molecule B) 
ligated to the heme iron. This water is hydrogen-bonded 
to the carbonyl 0 of A1a264 (2.7 A: all distances are the 
average over molecules A and B) and to a second active site 
solvent molecule (WAT4I8 in molecule A. WAT 199 in 
molecule B; 2.6 A). 
In the case of the T268N mutant enzyme, the side-
chain of Asn268 is hydrogen-bonded to the Fe-ligating 
water molecule (WAT348 in molecule A. WAT5I2 in 
molecule B; 3.1 A) and to the second active site water 
molecule (WAT534 in molecule A, WAT8 in molecule 
B; 2.9 A). In addition, there is a hydrogen-bonding inter-
action between the Asn268 sidechain and the sidechain 
hydroxyl group of Thr438 (2.9 A). The sidechain of 
Thr438 is in a different orientation in the T268N enzyme 
compared to the T268A mutant and wild-type enzymes 
(Fig. 8c), leading to the formation of the hydrogen-bond 
with the Asn268 sidechain and preventing a steric clash 
between the Thr438 sidechain methyl group and 
Asn268. It should be noted that although Asn268 is 
shown with the sidechain amide NH 2 group hydrogen-
bonding to solvent molecules and the sidechain amide 
0 hydrogen-bonding to Thr438, the hydrogen bonding 
pattern is also compatible with a 180° rotation of the 
sidechain amide group. 
4. Discussion 
The cytochromes P450 are capable of catalysing some 
very difficult reactions such as the hydroxylation of unsat-
urated substrates [5-8]. In order to achieve this they must 
first activate molecular oxygen. Thus, the nature of the 
dioxygen, hydroperoxy and ferryl (OFe( IV)) species are 
of critical importance. Studies on a highly conserved distal 
threonine in both cytochrome P450cam and P50 BM3 have 
linked this residue to the stabilisation of the ferrous dioxy-
gen species [19,20] and implicated it in the proton donation 
pathway [21-24]. More recently, the crystal structure of the 
ferrous dioxygen complex has suggested a role not in pro-
ton donation or even dioxygen stabilisation but instead in 
the promotion of proton transfer through H-bonding inter-
actions with the hydroperoxy species [31]. Substitutions of 
the Thr268 residue in P450 BM3 have also highlighted a 
potential role in substrate recognition [25,28]. Unnatural 
mutagenesis of the Thr252 residue of P450cam has shown 
that the hydroxyl group is not necessary for catalytic turn-
over [35]. With such a range of studies on different P450 
systems providing so many theories as to the role of this 
highly conserved residue, the mechanistic importance 
remains unclear. The present study is intended to further 
probe the role of Thr268 in P450 BM3 and ascertain its 
importance as both a hydrogen-bonding and proton-
donating residue. Further consideration was also given to 
the significance of this threonine in substrate recognition 
and the subsequent ramifications on both catalytic turn-
over and coupling efficiency. 
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Fig. 7. Correlation of kinetic parameters and heme reduction potential for wild-type P450 BM3 and the mutant enzymes F393H, T268A, T268N, F393H/ 
T268A and F393H/r268N. (A) shows a plot of the he.me reduction rate constants (k,) vs heme reduction potential fitted to a linear regression. (B) shows 
a plot of the auto-oxidation rate constants (kauox) vs heme reduction potential fitted to an exponential decay. 
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Fig. 8. Stereoiinages showing electron density of active site mutants 
T268A (A) and T268N (B). (C) shows the overlay of WT (grey) with both 
T268A (cyan) and T268N (orange). 
The removal of the hydrogen bonding and proton 
donating possibilities of the threomne through its mutation 
to an alanine generates an enzyme with a significantly smal-
ler turnover rate constant and considerably lower degree of 
productive coupling. These low turnover rates and poor 
coupling efficiencies are combined with lower rate 
constants for the first electron transfer and a less stable  
oxy-ferrous species in comparison to wild type. These 
results are comparable with previous studies in which the 
threonine was substituted with alanine and valine [19,20]. 
Mutation of the threonine to an asparagine, retaining the 
hydrogen bonding capability while removing the proton 
donating possibilities, also results in a highly uncoupled 
enzyme. In addition, comparatively small rate constants 
for catalytic turnover and first electron transfer and a 
destabilised oxy-ferrous species are observed. This provides 
a contrast to the work of Kimata et al. [25] which showed 
that removing the proton donating capability of the residue 
while retaining the hydrogen bonding properties did not 
disrupt the efficiency or function of the enzyme. These data 
indicate that the change in the nature of the hydrogen 
bonding residue has a significant effect on the ability of 
the enzyme to function efficiently. 
It is apparent from the initial spectroscopic analysis of 
the ferrous CO-bound complex that substitutions on both 
the proximal and distal sides of the heme influence the posi-
tion of the ferrous-CO Sorel (Fig. I). The 5 nm blue shift 
observed in the F393H mutation has tentatively been 
ascribed to changes in the electronic nature of the heme 
(AE, = +99 mV cf. WT) [42]. Similarly, it has been 
reported for the F393W mutant of P450 BM3 that a 
I nm red shift is observed in tandem with a negative shift 
in the reduction potential (AE,,, = —36 mV cf. WT) [44]. 
The position of the threonine residue in the active site, 
on the opposite side from the cysteine thiolate would sug-
gest that it is unlikely to have such a pronounced effect 
on the electronic nature of the heme. However, it is docu-
mented that changes in the conformation of the vinyl and 
propionate groups are also capable of influencing the heme 
reduction potential [53]. The lack of any notable shift in 
either ferrous-CO Sorel peak or heme reduction potential 
when the threonine is substituted with an alanine is entirely 
in keeping with this theory. However, the small red shift 
when the threonine is replaced with an asparagine is incon-
gruous with its positive shift in reduction potential com-
pared with wild type (iEm = +78 mV cf. WT). If the 
changes in position of the ferrous-CO peak are not related 
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to changes in the electronic nature of the heme then it is 
likely that the differences result from the changing nature 
of the CO binding region on the distal side of the heme. 
P450 BM3 has one of the largest rate constants for turn-
over in P450 enzymes, with rates of NADPH oxidation in 
the presence of saturating concentrations of arachidonate 
of >10O S -1  [42]. Steady-state analysis of NADPH has 
shown that in all cases, single and double substitutions of 
both the T268 and F393 residues lead to smaller rate con-
stants in comparison to wild type. It has been suggested 
that the catalytic cycle of P450 BM3 is finely balanced in 
order to maximise the rate of substrate hydroxylation. It 
is reasonable to assume therefore, that any perturbations 
of the active site which may have an effect on any single 
step in the catalytic cycle are likely to influence the overall 
turnover rate constant. 
Despite the smaller rate constants, all substituted 
enzymes remain capable of consuming electrons at rates 
in excess of 10 s'. However, while wild type and the 
F393H mutant retain a high degree of coupling to hydrox-
ylated product (90% and 75%, respectively), substitutions 
of the threonine residue lead to a highly uncoupled cata-
lytic cycle (9-20%). This high degree of uncoupling has 
been reported for previous substitution of this active site 
threonine and it is clear that this residue is important in 
maintaining an efficiently functioning enzyme [19]. The 
majority of NADPH consumption in the threonine substi-
tuted enzymes is attributed to the formation of hydrogen 
peroxide (Table 5), the uncoupling product from the fer-
ric-hydroperoxo species. As the subsequent step in the cat-
alytic cycle requires the delivery of two protons, it is 
reasonable to assume that these substitutions may have 
interfered with the proton delivery pathway. 
Until recently it was assumed that substitutions on the 
distal side of the heme might alter the positions of the active 
site waters and consequently interfere with the proton 
donating pathway. However, the recent crystal structure 
of the oxy-ferrous T252A mutant of P450 cam [3 11 has indi-
cated that this is not the case. There are several other possi-
bilities which might account for the high degree of 
uncoupling. Substrate-induced potential shifts are directly 
linked via the Gibbs-free energy relation (G = - flFE.. 
and AG = -RTln(K) to the substrate dissociation con-
stants in the oxidised and reduced form. For wild type 
P450 BM3, the positive shift in the reduction potential is 
associated with an increase in affinity for substrate on heme 
reduction. This increase in affinity may be necessary to 
achieve a high degree of coupling. The smaller substrate-
induced potential shift observed in the threonine substituted 
enzymes will invariably lead to a less pronounced increase 
in affinity on reduction (from Gibbs-free energy relation: 
WT K.red = 16.5 nM, T268A K,jred = 0.4 mM, T268N 
Kdred = 2.9 mM) which may have significant ramifications 
on the efficiency of the enzyme. 
In addition to this, it is clear from the crystal structure 
of the T268N mutant that it forms a H-bond with threo-
nine438 (Fig. 9). Crystal structures of both the substrate 
Table 5 
Turnover products: percentage coupling to hydroxylated product (ROH) 
and percentage uncoupling to hydrogen peroxide (11202) as determined by 
the mass spectrometry and o-dianisidine assays 
Enzyme Turnover products (%) 
H 202 ROH H202+ROH 
Wild-type 2.5 ± 1.6 90.4 + 2.4 92.9 ± 4.0 
F393H 6.2±2.3 75.4+4.2 81.6±6.5 
T268A 68.3 + 2.6 17.9 + 1.7 86.2 ± 4.3 
T268N 51.3 ± 3.1 27.0 ± 2.0 78.3 + 5.1 
F3931{/T268A 72.1 +4.3 5.7 +0.7 77.1 ± 5.0 




Resolution (A) 24.0-1.9 24.0-1.8 
Total no. of reflections 	756,604 679,954 
No. of unique reflections 84,625 99,832 
Completeness (%) 99.4 99.4 
11141)) 33.4 10.1 
4.3 9.1 
in outer shell (%) 	14.4 (1.97-1.90A) 34.8 (1.86-1.80A) 
(%)" 16.64 17.44 
R1,, (%)b 20.63 21.02 
rm.vd from ideal values 
Bond lengths (A) 	 0.019 	 0.019 
Bond angles (deg) 1.7 1.7 
.Ramachandran analv,sis 
Most favoured (%) 	 92.2 	 91.5 
Additionally allowed (%) 	7.8 8.5 
' Rng = > 5>41(h) - 1Ah)I1h>JiJ,(h), where lAh)  and 1(h) are the ith 
and mean measurement of reflection h, respectively. 
= 	- F0J/,,F0 . where F. and F. are the observed and 
calculated structure factor amplitudes of reflection h, respectively. Rtr, is 
the test reflection data set, 5 9/o selected randomly for cross validation 
during crystallographic refinement. 
bound [55] and ferric-dioxygen species [31] have shown that 
individual steps of the catalytic cycle are accompanied by 
significant perturbations in the protein structure, particu-
larly the 1-helix. Any extra hydrogen bonding interactions 
could easily impede these movements with important ram-
ifications on the catalytic cycle. It has recently been sug-
gested that the conserved threonine hydroxyl acts as a H 
bond acceptor for the hydroperoxy species [311 stabilising 
it and acting to promote the addition of the second proton. 
Removing the OH through its substitution with an alanine 
would clearly prevent it from fulfilling this role. Substitu-
tion of the threonine for an asparagine allows for the pos-
sibility of both accepting and donating a hydrogen bond. 
However, the crystal structure shows that the NH 2 group 
is pointing into the active site. The differentiation between 
the NH, and carbonyl groups of the threonine residue is 
confirmed by the presence of a H-bond donation to the 
backbone carbonyl of alanine264. While the NH 2 would 
be capable of donation of a hydrogen-bond to the ferrous 
dioxygen species it would not be able to accept a hydrogen 
bond from the hydroperoxy ferric species. This in turn may 
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Fig. 9. Active site crystal structures of substrate free and palmitoleate bound WT P450 BM3 indicating the movement of A1a264 and iron bound water on 
palmitoleate binding. In this case, Thr268 and A1a264 provide a hydrogen binding pocket for the substrate displaced water. 
The binding of substrate and more importantly, the 
substrates displacement of axially ligated water is a key 
step in the catalytic cycle [301 In wild-type P450 BM3, 
this step initiates a positive shift in the reduction potential 
in conjunction with changes in geometry and spin state 
(low- to high-spin) which accelerates the rate of the first 
electron transfer by approximately 500-fold [441 Previous 
studies have shown that although changes in heme reduc-
tion potential are accompanied by changes in the rate of 
the first electron transfer, it is the kinetic control associ-
ated with the change in spin state which is most influential 
[44]. It is evident from the data that the present series of 
mutants displays differing degrees of substrate-induced 
spin-state shift (Fig. 2). Clearly if the initiation of the cat-
alytic cycle is intrinsically linked to substrate recognition 
then these changes can be expected to have serious rami-
fications on the subsequent steps of the catalytic cycle. 
Poulos et al. suggested that the drop in substrate-induced 
spin-state shift for the T252A mutant of P450cam was a 
result of the presence of an extra solvent water molecule 
at the active site [36]. In contrast to this, Truan et al. 
[25] showed that the T268A mutant of P450 BM3 con-
tained no extra water molecule at the active site. They 
proposed that the smaller size of the alanine residue, com-
pared to threomne, leads to an active-site binding pocket 
which is notably larger than in the wild-type enzyme. This 
increase in size, they suggest, may allow both substrate 
and ligated water to co-exist in the active site. Both these 
arguments however cannot fully explain the observations  
we have made for both alanine and asparagine mutations. 
In accordance with Truan et al. crystal structures of the 
T268A and T268N mutant enzymes have revealed that 
there is no extra water molecule present at the active site. 
The increased size of the asparagine residue compared to 
the threonine makes it unlikely that the loss in ability to 
generate the high-spin complex is a result of substrate 
and water coexisting at the active site although it is pos-
sible that it may deny substrate access to the active site. 
Peterson et al. [28] suggested that structural movement 
of the I-helix on substrate binding [54] was responsible 
for the displacement of water from the active site 
(Fig. 9). They suggest that, changes in this helix result 
in the formation of a hydrogen bonding pocket between 
the backbone of A264 and the hydroxyl group of T268. 
The displaced water is held in this binding pocket and 
is, in fact, in equilibrium between this position and the 
iron bound state. The substitution of the threonine for 
an alanine would clearly weaken the hydrogen bonding 
interaction with displaced water and alter the equilibrium 
in favour of water bound to the iron (Fig. 10). Substitu-
tion of the threonine for an asparagine also influences 
the position of this equilibrium although in a slightly dif-
ferent way. The crystal structure of T268N shows that the 
NH2 group of the asparagine is forming a hydrogen bond 
with the ligand water, with the carbonyl group hydrogen 
bonding to Threonine438. As with the alamne substitu-
tion, this will serve to remove the hydroxyl group from 
the water binding pocket (Fig. 10) while simultaneously 
Fig. 10. Comparison of the active site cry stal structures for WT, T268A and T268N P450 BM3. 
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stabilising the iron-bound water through the addition of 
an H-bond, making displacement more difficult. It is also 
possible that the addition of a hydrogen bonding interac-
tion between N268 and T438 prevents the full shift of the 
I-helix on substrate binding. This is of course speculation 
in lieu of a substrate bound crystal structure. 
It is worth noting that when comparing the binding of 
the fatty acids arachidonate (C20) and laurate (C12), a 
notable difference in the degree of spin-state shift at satu-
rating substrate conditions is observed [42]. However, this 
is accompanied by significant differences in the substrate 
dissociation constants [42]. While large differences in sub-
strate-induced spin-state shift are observed across this ser-
ies of mutants, essentially no differences are observed in the 
substrate dissociation constant values. This clearly shows 
that while the recognition of substrate is impaired by these 
threonine mutations, the binding of substrate is unaffected. 
This observation would appear to be logical as the sub-
strate binding region is positioned at the mouth of the sub-
strate binding channel some distance from the active site. 
Two residues (R47 and Y51) form a salt bridge and hydro-
gen bond, respectively, to the carboxylate head of the fatty 
acid substrate, holding it in position [52]. As the mutations 
in this study are not close to this region of the enzyme, we 
would not expect their substitution to greatly influence sub-
strate affinity. 
The Phenylalanine393 residue heavily influences the 
electronic nature of the heme. Its substitution by histidine 
results in a positive shift of about 100 mV in both the sub-
strate free and substrate saturated heme reduction poten-
tials [42,431 These changes in Em  occur as a result of 
interactions with the cysteine thiolate ligand on the proxi-
mal side of the heme. Fig. 4 shows a diagram depicting 
the positions of the substrate free and arachidonate satu-
rated heme mid point potentials for wild type and the 
mutant enzymes F393H, T268A, T268N. F393H/T268A 
and F393H/T268N. Substitution of the threonine for an 
alanine does not alter the substrate-free Em  values suggest-
ing that the threonine residue itself has no direct influence 
on the thermodynamic nature of the heme. Substitution of 
the threonine to an asparagine stimulates a positive shift in 
the substrate-free Em  of 60 mV. From the crystal structure, 
it can be seen that although the asparagine does not inter-
act directly with the heme, it does from a hydrogen bond 
with the heme ligand water. Although the presence of this 
H-bond may be the cause of this shift in potential although 
changes in the active site structure influencing the nature of 
the vinyl and propionate groups cannot be ruled out. 
Interestingly, substitution of the T268 residue dramati-
cally diminishes the degree of substrate-induced potential 
shift. These changes in the thermodynamic profile are 
roughly in correlation with the degree of spin-state shift. 
The T268A single and double mutations exhibit both a 
moderate degree of spin-state shift and substrate-induced 
potential shift. Both T268N substitutions display signifi-
cantly smaller amounts of spin-state shift and consequently 
smaller substrate-induced potential changes. 
Mutation of the phenylananine 393 to a histidine has 
been shown to dramatically increase the rate constant 
for the first electron transfer in comparison to wild-type 
P450 BM3 [44]. Other mutations of this residue (F393A, 
F393W, and F393Y) have also been shown to influence 
the first electron-transfer rate constants (k md) and these 
differences have been intrinsically linked to the sub-
strate-bound heme reduction potentials as reported previ-
ously (Fig. 7). Changes in the heme reduction potential 
will ultimately lead to changes in the driving force for 
electron transfer (AG) between the FMN semiquinone 
and the heme. A positive shift in the heme reduction 
potential with respect to wild type will result in a larger 
positive gap in AG and hence faster first electron transfer 
as seen for F393H. From this we would expect the rate 
constants for first electron transfer to vary across the ser-
ies according to there heme reduction potential (Fig. 7). 
The T268N substitutions clearly do not fit this trend. 
F393H/T268N exhibits a rate constant for electron trans-
fer which is incongruous with the value which would be 
predicted from its heme reduction potential. In fact 
T268N appears to have a rate constant for heme reduc-
tion which is 2-fold less than its turnover rate, clearly 
impossible. Both these factors suggest that the measured 
krcd values are an underestimation of the true rate con-
stant. We suggest that, in this case, the experimentally 
derived values for heme reduction are artificially low 
due to a gating mechanism caused by the presence of 
the asparagine in both single and double mutations. How-
ever, we cannot rule out experimental differences in pre-
steady-state and steady-state methodologies. 
Similarly, heme reduction potentials have been shown to 
influence the stability of the oxy-ferrous species. More 
positive Em  values increase the ferric nature of the oxygen 
adduct and hence favour the decay of the oxy-ferrous/ 
superoxy-ferric species to the ferric form [44]. Previous 
studies have shown the exponential dependence of the sta-
bility of the oxy-ferrous species on the heme reduction 
potential and all mutants examined in this study corrobo-
rate this relationship [44] (Fig. 7). If the hydrogen bonding 
nature of the threonine itself, and not just the potential of 
the heme, was responsible for modulating the stability of 
the oxygen bound complex, then its mutation to an alanine 
would be expected to generate a highly destabilised oxy-fer-
rous species. The fact that this does not seem to be the case 
suggests that oxy-ferrous stability is more heavily influ-
enced by reduction potential than any hydrogen bonding 
interactions with this distal threonine. It was hoped that 
substitution of the threonine residue with an asparagine 
might provide a stronger interaction with the ferrous diox-
ygen complex. The rate constants for the decay of the oxy-
ferrous species show that this is not the case. If the threo-
nine residue is less important for oxy-ferrous stability than 
previously thought then this would explain the instability 
of this complex. 
In conclusion we have shown that substitutions of the 
highly conserved distal threonine in P450 BM3 lead to: 
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• Lower rates of NADPH oxidation. 
• Significant increase in the uncoupled formation of 
hydrogen peroxide. 
• Lower degree of spin-state shift on substrate binding. 
• Smaller substrate-induced potential shift roughly in 
accordance with the degree of spin-state shift. 
• Modulated rate constants for the first electron transfer 
and oxy-ferrous decay in direct correlation with the 
heme reduction potential. 
5. Abbreviations 
P450 BM3 	cytochrome P450 monooxygenase from 
B. megateriurn 
P450 cam cytochrome P450 monooxygenase from 
P. putida 
WT wild type 
Em  midpoint potential 
k rcrj rate constant for first electron transfer 
k autox rate constant for oxy-ferrous decay 
turnover rate constant 
Km  Michaelis constant 
k., at turnover rate constant at saturating 
concentrations of arachidonate 
Kd dissociation constant 
UV/vis UV/visible 
OTTLE optically transparen thin layer electrode 
SDS-PAGE sodium dodecylsulphate-polyacrylamide 
gel electrophoresis 
Mops 3-(morpholino)-propanesulfonic acid 
Tris tris(hydroxyl)aminomethane 
NADPH -nicotinamide adenine dinucleotide 
phosphate 
EDTA ethylenediaminetetraacetic acid 
FMN fiavin mononucleotide 
SHE standard hydrogen electrode 
EPR electron paramagnetic resonance 
PIPES piperazine-N,N'-bis[2-ethanesulfonic cis] 
PDB protein data bank 
RMSD root mean square deviation 
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